[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fVAyTCGFnpU0uPpHBJYsrQr_cV8BfkYkE1cYK2GIui4I":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":37,"phaseBuckets":87,"rows":94},"Tanta University",[4],877,false,223,102,87098,189,433,[14,17,20,23,26,29,31,34],{"name":15,"count":16},"Dexmedetomidine",33,{"name":18,"count":19},"Analgesia",22,{"name":21,"count":22},"Erector Spinae Plane Block",19,{"name":24,"count":25},"Postoperative Analgesia",18,{"name":27,"count":28},"Sepsis",16,{"name":30,"count":28},"Ultrasound",{"name":32,"count":33},"Postoperative Pain",15,{"name":35,"count":36},"Pain",13,[38,43,48,53,58,63,68,73,77,82],{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05624138","The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy","2024-04-04","Ketotifen Oral",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT05897034","Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men","2024-06-20","Doxycyclin",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT06507410","Additive Effects of Clonidine Used in Propofol Sedation in Colonoscopy","2024-09-01","Propofol",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT06641206","Intra-Articular Dexmedetomidine: A Treatment for Chronic Knee Pain","2025-01","Triamcinolone Acetonide",{"nctId":59,"briefTitle":60,"date":61,"intervention":62},"NCT06601036","Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients","2025-02-01","Sevoflurane",{"nctId":64,"briefTitle":65,"date":66,"intervention":67},"NCT06927726","Assessment of Anesthetic Efficacy and Hemodynamic Stability of Two LA Drugs for Hypertensive Patients","2025-02-10","4% Articaine HCL With 1:100,000 Epinephrine",{"nctId":69,"briefTitle":70,"date":71,"intervention":72},"NCT06641128","The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate","2025-03-10","MTX SC or IM",{"nctId":74,"briefTitle":75,"date":71,"intervention":76},"NCT06724952","Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate","MTX S.C or IM and Silymarin 140 mg tab",{"nctId":78,"briefTitle":79,"date":80,"intervention":81},"NCT06759298","The Effects of Methylphenidate on Symptomatology in Individuals With Borderline Personality Disorder","2025-03-25","methylphenidate",{"nctId":83,"briefTitle":84,"date":85,"intervention":86},"NCT06067698","Alpha Lipoic Acid in Ulcerative Colitis","2025-04-01","\"Mesalamine\" and \"alpha-lipoic acid\"",[88,89,90,91,92,93],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[95,512,546,570,596,623,641,665,683,704,731,749,780,798,816,834,859,887,907,925,1137,1225,1281,1323,1428,1479,1554,1589,1689,1767,1807,1842,1871,1902,1928,1976,2021,2062,2103,2136,2161,2196,2229,2251,2278,2303,2321,2347,2365,2383,2401,2419,2437,2455,2473,2496,2514,2532,2558,2576,2594,2616,2634,2652,2678,2701,2725,2743,2765,2791,2809,2834,2852,2870,2896,2914,2932,2950,2968,2986,3008,3081,3131,3169,3219,3254,3295,3325,3350,3375,3413,3445,3478,3505,3527,3548,3571,3589,3607,3625,3643,3661,3679,3702,3720,3738,3761,3779,3797,3823,3841,3859,3877,3899,3917,3943,3961,3979,4006,4026,4044,4068,4154,4216,4264,4327,4370,4421,4443,4478,4524,4557,4593,4631,4666,4700,4726,4748,4766,4790,4815,4833,4851,4874,4892,4910,4928,4952,4970,4988,5013,5031,5049,5077,5095,5121,5139,5157,5175,5201,5219,5237,5255,5273,5299,5317,5342,5364,5382,5400,5426,5453,5471,5489,5508,5526,5544,5562,5586,5610,5631,5657,5675,5693,5715,5741,5759,5784,5802,5826,5874,5900,5936,5971,5999,6026,6055,6092,6116,6134,6160,6178,6202,6220,6238,6256,6282,6300,6325,6343,6361,6383,6409,6436,6454,6472,6497,6515,6540,6565,6583,6601,6619,6644,6666,6684,6707,6733,6751,6769,6793,6811,6829,6853,6877,6895,6918,6941,6965,6983,7001,7019,7037,7055,7081,7099,7117,7135,7160,7185,7203,7226,7244,7271,7295,7313,7331,7364,7399,7424,7446,7475,7503,7521,7543,7561,7579,7600,7618,7636,7660,7678,7703,7721,7739,7760,7782,7800,7822,7840,7858,7876,7900,7921,7944,7962,7983,8007,8033,8051,8069,8087,8105,8131,8149,8167,8190,8208,8231,8255,8280,8298,8319,8344,8371,8389,8417,8449,8471,8494,8512,8537,8555,8573,8591,8615,8639,8657,8675,8693,8719,8737,8755,8781,8799,8823,8847,8865,8883,8901,8924,8947,8965,8989,9014,9032,9050,9072,9095,9120,9138,9164,9182,9206,9224,9246,9270,9288,9306,9329,9355,9373,9398,9422,9440,9465,9492,9515,9537,9561,9587,9680,9732,9773,9806,9832,9861,9892,9925,9951,9985,10019,10055,10086,10112,10142,10164,10201,10227,10245,10268,10292,10310,10334,10352,10377,10395,10420,10447,10465,10483,10501,10519,10543,10561,10586,10613,10631,10649,10673,10694,10712,10737,10755,10773,10797,10823,10841,10863,10887,10905,10923,10941,10959,10977,10995,11022,11040,11058,11076,11100,11118,11136,11154,11172,11190,11208,11231,11255,11280,11304,11322,11346,11376,11394,11419,11437,11460,11485,11508,11526,11554,11572,11590,11614,11632,11657,11675,11701,11719,11737,11755,11773,11791,11816,11834,11852,11877,11895,11917,11935,11953,11976,12004,12022,12040,12066,12084,12102,12120,12145,12163,12181,12199,12217,12235,12260,12278,12302,12326,12344,12362,12380,12398,12425,12443,12461,12484,12511,12529,12547,12571,12589,12607,12629,12647,12671,12695,12719,12743,12761,12786,12809,12833,12851,12869,12887,12910,12928,12946,12970,12988,13014,13039,13057,13083,13101,13119,13143,13168,13186,13211,13234,13252,13270,13297,13315,13333,13351,13376,13394,13418,13436,13454,13477,13495,13518,13546,13564,13582],{"intervention":15,"totalTrials":96,"cells":97},34,{"EARLY_PHASE1":98,"PHASE1":101,"PHASE2":132,"PHASE3":148,"PHASE4":189,"NA":248},{"trials":99,"activeCount":100},[],0,{"trials":102,"activeCount":100},[103,120],{"nctId":104,"briefTitle":105,"status":106,"phases":107,"primaryCompletion":108,"completion":109,"start":110,"enrollment":111,"conditions":112,"interventions":116},"NCT05124067","Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children","COMPLETED",[89],"2022-01-30","2022-03-12","2021-10-27",4,[113,114,115],"Postoperative Nausea and Vomiting","Post Operative Pain","Emergence Delirium",[117,118,15,119],"Dexamethasone","Ondansetron","normal Saline",{"nctId":121,"briefTitle":122,"status":123,"phases":124,"primaryCompletion":125,"completion":126,"start":127,"enrollment":128,"conditions":129,"interventions":131},"NCT05487742","Neuroprotective Effect of Dexomitomidine","UNKNOWN",[89],"2022-12","2023-01","2022-06-04",80,[130],"Dexmedetomidine Neuroprotective Effect in Traumatic Brain Injury",[15],{"trials":133,"activeCount":100},[134],{"nctId":135,"briefTitle":136,"status":106,"phases":137,"primaryCompletion":138,"completion":139,"start":140,"enrollment":141,"conditions":142,"interventions":144},"NCT07510217","ERAS Approach for Post-Craniotomy Headache and Psychological Recovery",[90],"2025-12-25","2026-02-20","2024-08-10",139,[143],"Post-Craniotomy Headache",[145,146,147],"Scalp block with 0.5% plain Marcaine","dexmedetomidine","Intraoperative Analgesia",{"trials":149,"activeCount":188,"soonestReadout":155},[150,164,178],{"nctId":151,"briefTitle":152,"status":153,"phases":154,"primaryCompletion":155,"completion":155,"start":156,"enrollment":157,"conditions":158,"interventions":162},"NCT06935292","Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients","NOT_YET_RECRUITING",[90,91],"2026-04","2025-04",70,[159,160,161],"Tracheal Intubation Morbidity","Laryngoscopy","Hemodynamic Response",[15,163],"Melatonin",{"nctId":165,"briefTitle":166,"status":153,"phases":167,"primaryCompletion":168,"completion":169,"start":170,"enrollment":171,"conditions":172,"interventions":175},"NCT06848595","Mg Sulfate Versus Dexmedetomidine on Cerebral Oxygen Saturation",[91],"2027-01-20","2027-01-31","2025-02-23",90,[173,174],"Cerebral Desaturation Events","Spine Surgeries",[176,15,177],"Magnesium sulfate","Normal Saline",{"nctId":179,"briefTitle":180,"status":123,"phases":181,"primaryCompletion":182,"completion":182,"start":183,"enrollment":184,"conditions":185,"interventions":187},"NCT03466632","Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Colonosopy",[91],"2020-04-01","2016-04-01",100,[186],"Colonic Diseases",[52,15],2,{"trials":190,"activeCount":247,"soonestReadout":229},[191,202,213,224,234],{"nctId":192,"briefTitle":193,"status":106,"phases":194,"primaryCompletion":195,"completion":195,"start":196,"enrollment":197,"conditions":198,"interventions":200},"NCT05719506","A Comparative Evaluation of Nebulized Dexmedetomidine and Nebulized Ketamine as a Premedication in Pediatric Surgeries",[92],"2021-12-21","2021-07-21",60,[199],"Anesthesia Refusal",[15,201],"Ketamine",{"nctId":203,"briefTitle":204,"status":106,"phases":205,"primaryCompletion":206,"completion":206,"start":207,"enrollment":197,"conditions":208,"interventions":212},"NCT04652661","Intranasal Dexmedetomidine Versus Intranasal Midazolam for MRI In Pediatrics",[92],"2022-01-01","2020-12-10",[15,209,210,211],"Midazolam","MRI","Pediatrics",[15,209],{"nctId":214,"briefTitle":215,"status":106,"phases":216,"primaryCompletion":217,"completion":218,"start":219,"enrollment":197,"conditions":220,"interventions":223},"NCT05640479","Pregabalin Versus Dexmedetomidine for Delirium Prevention After Cardiac Surgery",[92],"2024-12-03","2025-01-02","2022-12-15",[221,15,222],"Pregabalin","Delirium",[221,15],{"nctId":225,"briefTitle":226,"status":227,"phases":228,"primaryCompletion":229,"completion":229,"start":219,"enrollment":157,"conditions":230,"interventions":233},"NCT05640453","Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting","RECRUITING",[92],"2026-05-15",[221,231,232,15],"Delirium Treatment","Coronary Artery Bypass Grafting",[221,15],{"nctId":235,"briefTitle":236,"status":106,"phases":237,"primaryCompletion":238,"completion":238,"start":239,"enrollment":171,"conditions":240,"interventions":245},"NCT04397406","Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor",[92],"2021-10-31","2020-07-01",[241,242,15,243,244],"Epidural Analgesia","Painless Labor","Fentanyl","Levobupivacaine",[246,15,243],"levobupivacaine",1,{"trials":249,"activeCount":511,"soonestReadout":56},[250,260,269,282,294,306,314,328,341,350,364,375,385,396,412,422,432,446,457,468,478,490,501],{"nctId":251,"briefTitle":252,"status":123,"phases":253,"primaryCompletion":254,"completion":254,"start":255,"enrollment":171,"conditions":256,"interventions":257},"NCT06076668","Dexmedetomidine Infusion Versus Oral Melatonin for Prevention of Intensive Care Delirium",[93],"2024-10-20","2023-10-16",[15,163,222],[15,258,259],"Melatonin 3 MG","Saline",{"nctId":261,"briefTitle":262,"status":106,"phases":263,"primaryCompletion":264,"completion":71,"start":265,"enrollment":157,"conditions":266,"interventions":268},"NCT06567587","Dexmedtomodine Effect on Agitated Psychotic Patients Suffer COPD",[],"2024-11-10","2024-06-10",[267],"Response of Agitated Patients to Dexmedetomidine",[15],{"nctId":270,"briefTitle":271,"status":106,"phases":272,"primaryCompletion":61,"completion":61,"start":273,"enrollment":274,"conditions":275,"interventions":280},"NCT06879288","Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia After Elective Laparoscopic Cholecystectomy",[93],"2023-07-01",75,[15,276,277,278,24,279],"Magnesium Sulfate","Adjuvants","Intraperitoneal Bupivacaine","Elective Laparoscopic Cholecystectomy",[281,15,176],"Bupivacaine",{"nctId":283,"briefTitle":284,"status":106,"phases":285,"primaryCompletion":286,"completion":287,"start":288,"enrollment":289,"conditions":290,"interventions":292},"NCT02122510","Transverse Abdominal Block for Analgesia in Casarean Section",[93],"2014-05","2014-06","2013-03",120,[291],"Analgesia Disorder",[293,15],"Bupivacine group",{"nctId":295,"briefTitle":296,"status":123,"phases":297,"primaryCompletion":298,"completion":299,"start":300,"enrollment":157,"conditions":301,"interventions":304},"NCT05703048","The Effect of Esmolol Versus Dexmedetomidine on Postoperative Pain Control in Endoscopic Sinus Surgery: A Randomized Trial",[93],"2024-05-30","2024-06-30","2022-12-30",[302,303],"Patient's Satisfaction","Depth of Anesthesia",[305,15],"Esmolol Esterase",{"nctId":54,"briefTitle":55,"status":227,"phases":307,"primaryCompletion":56,"completion":308,"start":309,"enrollment":157,"conditions":310,"interventions":312},[93],"2025-03","2024-09-17",[311],"Chronic Knee Pain",[57,313,15],"Bupivacaine Hydrochloride",{"nctId":315,"briefTitle":316,"status":106,"phases":317,"primaryCompletion":318,"completion":318,"start":319,"enrollment":171,"conditions":320,"interventions":327},"NCT07054138","Efficacy of Nebulized Dexmedetomidine on Blunting Hemodynamic Changes During Intubation and Pneumoperitoneum in Morbid Obese Patients During Laparoscopic Bariatric Surgery",[93],"2025-11-30","2025-07-10",[321,15,322,323,324,325,326],"Nebulization","Hemodynamic Changes","Intubation","Pneumoperitoneum","Morbid Obesity","Laparoscopic Bariatric Surgery",[15,177],{"nctId":329,"briefTitle":330,"status":123,"phases":331,"primaryCompletion":332,"completion":332,"start":333,"enrollment":197,"conditions":334,"interventions":339},"NCT06125665","Aminophylline on Perioperative Lung Mechanics in COPD Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery",[93],"2024-04-01","2023-11-11",[335,336,337,326,15,338],"Aminophylline","Chronic Obstructive Pulmonary Disease","Obese","Lung Mechanics",[340,15],"Aminophylline-Dexmedetomidine",{"nctId":342,"briefTitle":343,"status":123,"phases":344,"primaryCompletion":345,"completion":345,"start":346,"enrollment":171,"conditions":347,"interventions":349},"NCT06014359","Preoperative Nebulized Dexmedetomidine on Hemodynamic Changes in Laparoscopic Bariatric Surgery.",[93],"2024-02-01","2023-08-27",[15,348,326],"Hemodynamics",[259,15],{"nctId":351,"briefTitle":352,"status":227,"phases":353,"primaryCompletion":354,"completion":354,"start":355,"enrollment":184,"conditions":356,"interventions":363},"NCT07108764","Intraoperative Infusion of Either Lidocaine or Dexmedetomidine on Regional Cerebral Oxygen Saturation and Postoperative Delirium in Elderly Patients Undergoing Abdominal Surgeries",[93],"2027-04-01","2025-04-17",[357,358,15,359,360,361,362],"Intraoperative Infusion","Lidocaine","Cerebral Oxygen Saturation","Postoperative Delirium","Elderly Patients","Abdominal Surgeries",[358,15],{"nctId":365,"briefTitle":366,"status":106,"phases":367,"primaryCompletion":368,"completion":368,"start":369,"enrollment":370,"conditions":371,"interventions":374},"NCT06331182","Dexmedetomidine and Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain",[93],"2024-11-01","2024-03-26",40,[15,201,372,373],"External Oblique Intercostal Plane Block","Post Thoracotomy Pain",[201,15,281],{"nctId":376,"briefTitle":377,"status":106,"phases":378,"primaryCompletion":368,"completion":379,"start":380,"enrollment":171,"conditions":381,"interventions":383},"NCT06835010","Sevoflurane and Dexmedetomidine's Contrasting Renal Impacts After Non-Cardiac Surgery",[93],"2024-12-17","2024-05-20",[382],"AKI - Acute Kidney Injury",[15,384],"Sevoflurane inhalant product",{"nctId":386,"briefTitle":387,"status":227,"phases":388,"primaryCompletion":389,"completion":389,"start":390,"enrollment":391,"conditions":392,"interventions":395},"NCT07165483","Do Increasing Preoperative Timing of Single Dexmedetomidine Dose Have an Effect on Stress Response of Laryngoscopy and Intubation?",[93],"2026-03-01","2025-09-11",45,[393,15,394,160,323],"Time","Stress Response",[15,15,259],{"nctId":397,"briefTitle":398,"status":106,"phases":399,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":403,"interventions":411},"NCT06994273","Analgesic and Sedative Effect of Fentanyl Versus Dexmedetomidine Infusion in Post-Operative Mechanically Ventilated Children After Open Abdominal Surgeries",[93],"2024-10-01","2023-04-01",54,[404,405,243,15,406,407,408,409,410],"Analgesic","Sedative","Infusion","Postoperative","Mechanical Ventilation","Children","Open Abdominal Surgeries",[243,15],{"nctId":413,"briefTitle":414,"status":153,"phases":415,"primaryCompletion":416,"completion":416,"start":417,"enrollment":171,"conditions":418,"interventions":421},"NCT06738043","Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery",[93],"2027-04-20","2026-04-20",[419,32,420],"Obesity","Bariatric Surgery",[15,201,177],{"nctId":423,"briefTitle":424,"status":106,"phases":425,"primaryCompletion":426,"completion":426,"start":427,"enrollment":171,"conditions":428,"interventions":430},"NCT04730596","Cognitive Dysfunction After Cataract Surgery",[93],"2021-04-15","2021-02-01",[429],"POCD - Postoperative Cognitive Dysfunction",[201,15,431],"Normal saline",{"nctId":433,"briefTitle":434,"status":106,"phases":435,"primaryCompletion":300,"completion":436,"start":437,"enrollment":438,"conditions":439,"interventions":444},"NCT05439564","Intrathecal Morphine Versus Morphine-dexmedetomidine Combination for Postoperative Pain Control After Total Knee Replacement",[93],"2023-01-30","2022-07-01",105,[440,441,442,443],"Intrathecal Morphine","Intrathecal Morphine-dexmedetomidine Combination","Postoperative Pain Control","Total Knee Replacement",[15,445,15],"Morphine",{"nctId":447,"briefTitle":448,"status":227,"phases":449,"primaryCompletion":450,"completion":450,"start":451,"enrollment":452,"conditions":453,"interventions":456},"NCT06133712","Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Pain Relief",[93],"2025-12-01","2023-11-01",135,[454,15,455,117],"Carpal Tunnel","Ozone",[15,455,117],{"nctId":458,"briefTitle":459,"status":460,"phases":461,"primaryCompletion":462,"completion":463,"start":464,"enrollment":289,"conditions":465,"interventions":467},"NCT07302815","Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries","ACTIVE_NOT_RECRUITING",[93],"2026-07-10","2026-07-30","2026-01-10",[466],"Emergence Agitation",[15,259],{"nctId":469,"briefTitle":470,"status":106,"phases":471,"primaryCompletion":472,"completion":472,"start":473,"enrollment":370,"conditions":474,"interventions":477},"NCT06098209","Dexmedetomidine and Propofol in Mechanically Ventilated Patients by Using Salivary Alpha-amylase as a Stress Marker",[93],"2024-04-11","2023-10-24",[15,52,408,475,476],"Salivary Alpha Amylase","Stress",[15,52],{"nctId":479,"briefTitle":480,"status":106,"phases":481,"primaryCompletion":482,"completion":482,"start":483,"enrollment":197,"conditions":484,"interventions":488},"NCT06909305","Effect of Intraarticular Ozone, Prolotherapy or Dexmedetomidine in Pain Limitation in Knee Osteoarthritis",[93],"2023-10-01","2022-10-01",[485,455,486,15,35,487],"Intraarticular","Prolotherapy","Knee Osteoarthritis",[455,489,15],"Dextrose prolotherapy",{"nctId":491,"briefTitle":492,"status":106,"phases":493,"primaryCompletion":494,"completion":494,"start":495,"enrollment":452,"conditions":496,"interventions":500},"NCT04331418","Comparison of Caudal Block Versus Dexmedetomidine Infusion in Pediatric Patients Undergoing Hypospadias Repair Surgery",[93],"2020-10-31","2020-03-28",[497,498,499],"Dexmedetomidine Infusion","Pediatric","Hypospadias Repair Surgery",[15],{"nctId":502,"briefTitle":503,"status":106,"phases":504,"primaryCompletion":505,"completion":505,"start":506,"enrollment":370,"conditions":507,"interventions":510},"NCT06684535","Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain",[93],"2025-07-07","2024-11-14",[15,508,372,509,35],"Adjuvant","Thoracotomy",[15,259],6,{"intervention":221,"totalTrials":513,"cells":514},3,{"EARLY_PHASE1":515,"PHASE1":517,"PHASE2":519,"PHASE3":521,"PHASE4":523,"NA":533},{"trials":516,"activeCount":100},[],{"trials":518,"activeCount":100},[],{"trials":520,"activeCount":100},[],{"trials":522,"activeCount":100},[],{"trials":524,"activeCount":247,"soonestReadout":229},[525,529],{"nctId":214,"briefTitle":215,"status":106,"phases":526,"primaryCompletion":217,"completion":218,"start":219,"enrollment":197,"conditions":527,"interventions":528},[92],[221,15,222],[221,15],{"nctId":225,"briefTitle":226,"status":227,"phases":530,"primaryCompletion":229,"completion":229,"start":219,"enrollment":157,"conditions":531,"interventions":532},[92],[221,231,232,15],[221,15],{"trials":534,"activeCount":247,"soonestReadout":539},[535],{"nctId":536,"briefTitle":537,"status":227,"phases":538,"primaryCompletion":539,"completion":539,"start":540,"enrollment":438,"conditions":541,"interventions":545},"NCT07344467","Oral Melatonin Versus Oral Pregabalin on Postoperative Pain and Anxiety Following Spine Surgery",[93],"2027-06-01","2026-01-17",[542,163,221,32,543,544],"Oral","Anxiety","Spine Surgery",[163,221],{"intervention":547,"totalTrials":247,"cells":548},"Baricitinib",{"EARLY_PHASE1":549,"PHASE1":551,"PHASE2":553,"PHASE3":555,"PHASE4":557,"NA":568},{"trials":550,"activeCount":100},[],{"trials":552,"activeCount":100},[],{"trials":554,"activeCount":100},[],{"trials":556,"activeCount":100},[],{"trials":558,"activeCount":247,"soonestReadout":155},[559],{"nctId":560,"briefTitle":561,"status":153,"phases":562,"primaryCompletion":155,"completion":563,"start":564,"enrollment":184,"conditions":565,"interventions":567},"NCT07357649","Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis",[92],"2026-12","2026-01",[566],"Rheumatoid Arthritis",[547],{"trials":569,"activeCount":100},[],{"intervention":571,"totalTrials":247,"cells":572},"Vitamin K 2",{"EARLY_PHASE1":573,"PHASE1":575,"PHASE2":577,"PHASE3":579,"PHASE4":581,"NA":594},{"trials":574,"activeCount":100},[],{"trials":576,"activeCount":100},[],{"trials":578,"activeCount":100},[],{"trials":580,"activeCount":100},[],{"trials":582,"activeCount":247,"soonestReadout":587},[583],{"nctId":584,"briefTitle":585,"status":227,"phases":586,"primaryCompletion":587,"completion":588,"start":589,"enrollment":590,"conditions":591,"interventions":593},"NCT05942053","Role of Vitamin K2 in Chronic Kidney Disease",[92],"2026-07-14","2026-07-15","2023-07-15",44,[592],"Chronic Kidney Diseases",[571],{"trials":595,"activeCount":100},[],{"intervention":597,"totalTrials":247,"cells":598},"Bortezomib + Lenalidomide + Dexamethasone + Fenofibrate 160 mg",{"EARLY_PHASE1":599,"PHASE1":601,"PHASE2":603,"PHASE3":605,"PHASE4":607,"NA":621},{"trials":600,"activeCount":100},[],{"trials":602,"activeCount":100},[],{"trials":604,"activeCount":100},[],{"trials":606,"activeCount":100},[],{"trials":608,"activeCount":247,"soonestReadout":613},[609],{"nctId":610,"briefTitle":611,"status":227,"phases":612,"primaryCompletion":613,"completion":614,"start":615,"enrollment":590,"conditions":616,"interventions":619},"NCT07025005","Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)",[92],"2026-06-30","2026-09-30","2025-08-30",[617,618],"Peripheral Neuropathy","Multiple Myeloma, Neoplasms",[597,620],"Bortezomib + Lenalidomide + Dexamethasone",{"trials":622,"activeCount":100},[],{"intervention":620,"totalTrials":247,"cells":624},{"EARLY_PHASE1":625,"PHASE1":627,"PHASE2":629,"PHASE3":631,"PHASE4":633,"NA":639},{"trials":626,"activeCount":100},[],{"trials":628,"activeCount":100},[],{"trials":630,"activeCount":100},[],{"trials":632,"activeCount":100},[],{"trials":634,"activeCount":247,"soonestReadout":613},[635],{"nctId":610,"briefTitle":611,"status":227,"phases":636,"primaryCompletion":613,"completion":614,"start":615,"enrollment":590,"conditions":637,"interventions":638},[92],[617,618],[597,620],{"trials":640,"activeCount":100},[],{"intervention":72,"totalTrials":247,"cells":642},{"EARLY_PHASE1":643,"PHASE1":645,"PHASE2":647,"PHASE3":649,"PHASE4":651,"NA":663},{"trials":644,"activeCount":100},[],{"trials":646,"activeCount":100},[],{"trials":648,"activeCount":100},[],{"trials":650,"activeCount":100},[],{"trials":652,"activeCount":247,"soonestReadout":71},[653],{"nctId":69,"briefTitle":70,"status":153,"phases":654,"primaryCompletion":71,"completion":655,"start":656,"enrollment":590,"conditions":657,"interventions":661},[92],"2025-04-10","2024-10-15",[658,659,660],"Rheumatoid Arthritis (RA)","Methotrexate Induced Nephrotoxicity","Methotrexate Adverse Reaction",[72,662],"Empagliflozin 25mg tab",{"trials":664,"activeCount":100},[],{"intervention":662,"totalTrials":247,"cells":666},{"EARLY_PHASE1":667,"PHASE1":669,"PHASE2":671,"PHASE3":673,"PHASE4":675,"NA":681},{"trials":668,"activeCount":100},[],{"trials":670,"activeCount":100},[],{"trials":672,"activeCount":100},[],{"trials":674,"activeCount":100},[],{"trials":676,"activeCount":247,"soonestReadout":71},[677],{"nctId":69,"briefTitle":70,"status":153,"phases":678,"primaryCompletion":71,"completion":655,"start":656,"enrollment":590,"conditions":679,"interventions":680},[92],[658,659,660],[72,662],{"trials":682,"activeCount":100},[],{"intervention":684,"totalTrials":247,"cells":685},"Co-Enzyme Q10",{"EARLY_PHASE1":686,"PHASE1":688,"PHASE2":690,"PHASE3":692,"PHASE4":694,"NA":702},{"trials":687,"activeCount":100},[],{"trials":689,"activeCount":100},[],{"trials":691,"activeCount":100},[],{"trials":693,"activeCount":100},[],{"trials":695,"activeCount":247,"soonestReadout":587},[696],{"nctId":697,"briefTitle":698,"status":227,"phases":699,"primaryCompletion":587,"completion":588,"start":589,"enrollment":590,"conditions":700,"interventions":701},"NCT05942027","Role of Coenzyme Q10 in Chronic Kidney Disease",[92],[592],[684],{"trials":703,"activeCount":100},[],{"intervention":705,"totalTrials":247,"cells":706},"Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy",{"EARLY_PHASE1":707,"PHASE1":709,"PHASE2":711,"PHASE3":713,"PHASE4":715,"NA":729},{"trials":708,"activeCount":100},[],{"trials":710,"activeCount":100},[],{"trials":712,"activeCount":100},[],{"trials":714,"activeCount":100},[],{"trials":716,"activeCount":247,"soonestReadout":721},[717],{"nctId":718,"briefTitle":719,"status":153,"phases":720,"primaryCompletion":721,"completion":722,"start":723,"enrollment":724,"conditions":725,"interventions":727},"NCT07436663","Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC",[92],"2027-11-01","2027-12-01","2026-02-01",150,[726],"Breast Cancer",[705,728],"Sitagliptin",{"trials":730,"activeCount":100},[],{"intervention":728,"totalTrials":247,"cells":732},{"EARLY_PHASE1":733,"PHASE1":735,"PHASE2":737,"PHASE3":739,"PHASE4":741,"NA":747},{"trials":734,"activeCount":100},[],{"trials":736,"activeCount":100},[],{"trials":738,"activeCount":100},[],{"trials":740,"activeCount":100},[],{"trials":742,"activeCount":247,"soonestReadout":721},[743],{"nctId":718,"briefTitle":719,"status":153,"phases":744,"primaryCompletion":721,"completion":722,"start":723,"enrollment":724,"conditions":745,"interventions":746},[92],[726],[705,728],{"trials":748,"activeCount":100},[],{"intervention":750,"totalTrials":247,"cells":751},"ICON resin infiltration Material group in vivo",{"EARLY_PHASE1":752,"PHASE1":754,"PHASE2":756,"PHASE3":758,"PHASE4":760,"NA":778},{"trials":753,"activeCount":100},[],{"trials":755,"activeCount":100},[],{"trials":757,"activeCount":100},[],{"trials":759,"activeCount":100},[],{"trials":761,"activeCount":247,"soonestReadout":766},[762],{"nctId":763,"briefTitle":764,"status":153,"phases":765,"primaryCompletion":766,"completion":767,"start":768,"enrollment":769,"conditions":770,"interventions":774},"NCT06729788","Resin Infiltrate as Pit and Fissure Sealant in Permanent Molars",[92],"2025-11-15","2025-12-24","2025-01-04",86,[771,772,773],"Resin Infiltration","Pit and Fissure Sealant","Permanent Molars",[750,775,776,777],"Resin-based fissure sealant group in vivo","ICON resin infiltration in vitro","Resin-based fissure sealant in vitro",{"trials":779,"activeCount":100},[],{"intervention":775,"totalTrials":247,"cells":781},{"EARLY_PHASE1":782,"PHASE1":784,"PHASE2":786,"PHASE3":788,"PHASE4":790,"NA":796},{"trials":783,"activeCount":100},[],{"trials":785,"activeCount":100},[],{"trials":787,"activeCount":100},[],{"trials":789,"activeCount":100},[],{"trials":791,"activeCount":247,"soonestReadout":766},[792],{"nctId":763,"briefTitle":764,"status":153,"phases":793,"primaryCompletion":766,"completion":767,"start":768,"enrollment":769,"conditions":794,"interventions":795},[92],[771,772,773],[750,775,776,777],{"trials":797,"activeCount":100},[],{"intervention":776,"totalTrials":247,"cells":799},{"EARLY_PHASE1":800,"PHASE1":802,"PHASE2":804,"PHASE3":806,"PHASE4":808,"NA":814},{"trials":801,"activeCount":100},[],{"trials":803,"activeCount":100},[],{"trials":805,"activeCount":100},[],{"trials":807,"activeCount":100},[],{"trials":809,"activeCount":247,"soonestReadout":766},[810],{"nctId":763,"briefTitle":764,"status":153,"phases":811,"primaryCompletion":766,"completion":767,"start":768,"enrollment":769,"conditions":812,"interventions":813},[92],[771,772,773],[750,775,776,777],{"trials":815,"activeCount":100},[],{"intervention":777,"totalTrials":247,"cells":817},{"EARLY_PHASE1":818,"PHASE1":820,"PHASE2":822,"PHASE3":824,"PHASE4":826,"NA":832},{"trials":819,"activeCount":100},[],{"trials":821,"activeCount":100},[],{"trials":823,"activeCount":100},[],{"trials":825,"activeCount":100},[],{"trials":827,"activeCount":247,"soonestReadout":766},[828],{"nctId":763,"briefTitle":764,"status":153,"phases":829,"primaryCompletion":766,"completion":767,"start":768,"enrollment":769,"conditions":830,"interventions":831},[92],[771,772,773],[750,775,776,777],{"trials":833,"activeCount":100},[],{"intervention":835,"totalTrials":247,"cells":836},"Vonoprazan 20 mg versus Pantoprazole 40 mg",{"EARLY_PHASE1":837,"PHASE1":839,"PHASE2":841,"PHASE3":843,"PHASE4":845,"NA":857},{"trials":838,"activeCount":100},[],{"trials":840,"activeCount":100},[],{"trials":842,"activeCount":100},[],{"trials":844,"activeCount":100},[],{"trials":846,"activeCount":247,"soonestReadout":851},[847],{"nctId":848,"briefTitle":849,"status":227,"phases":850,"primaryCompletion":851,"completion":852,"start":853,"enrollment":590,"conditions":854,"interventions":856},"NCT06564246","Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease",[92],"2026-08","2026-10","2024-09-18",[855],"Gastroesophageal Reflux Disease (GERD)",[835],{"trials":858,"activeCount":100},[],{"intervention":860,"totalTrials":247,"cells":861},"Tranexamic Acid and vitamin K",{"EARLY_PHASE1":862,"PHASE1":864,"PHASE2":866,"PHASE3":868,"PHASE4":870,"NA":885},{"trials":863,"activeCount":100},[],{"trials":865,"activeCount":100},[],{"trials":867,"activeCount":100},[],{"trials":869,"activeCount":100},[],{"trials":871,"activeCount":247,"soonestReadout":876},[872],{"nctId":873,"briefTitle":874,"status":227,"phases":875,"primaryCompletion":876,"completion":877,"start":878,"enrollment":879,"conditions":880,"interventions":884},"NCT06881628","Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients",[92],"2025-12-15","2025-12-30","2024-12-02",194,[881,882,883],"Upper Gastrointestinal Bleeding (UGIB)","Variceal Bleeding","Cirrhosis",[860],{"trials":886,"activeCount":100},[],{"intervention":76,"totalTrials":247,"cells":888},{"EARLY_PHASE1":889,"PHASE1":891,"PHASE2":893,"PHASE3":895,"PHASE4":897,"NA":905},{"trials":890,"activeCount":100},[],{"trials":892,"activeCount":100},[],{"trials":894,"activeCount":100},[],{"trials":896,"activeCount":100},[],{"trials":898,"activeCount":247,"soonestReadout":71},[899],{"nctId":74,"briefTitle":75,"status":153,"phases":900,"primaryCompletion":71,"completion":655,"start":901,"enrollment":590,"conditions":902,"interventions":903},[92],"2024-12-10",[658],[76,904],"MTX S.C or IM",{"trials":906,"activeCount":100},[],{"intervention":904,"totalTrials":247,"cells":908},{"EARLY_PHASE1":909,"PHASE1":911,"PHASE2":913,"PHASE3":915,"PHASE4":917,"NA":923},{"trials":910,"activeCount":100},[],{"trials":912,"activeCount":100},[],{"trials":914,"activeCount":100},[],{"trials":916,"activeCount":100},[],{"trials":918,"activeCount":247,"soonestReadout":71},[919],{"nctId":74,"briefTitle":75,"status":153,"phases":920,"primaryCompletion":71,"completion":655,"start":901,"enrollment":590,"conditions":921,"interventions":922},[92],[658],[76,904],{"trials":924,"activeCount":100},[],{"intervention":431,"totalTrials":926,"cells":927},21,{"EARLY_PHASE1":928,"PHASE1":930,"PHASE2":948,"PHASE3":950,"PHASE4":956,"NA":979},{"trials":929,"activeCount":100},[],{"trials":931,"activeCount":100},[932,936],{"nctId":104,"briefTitle":105,"status":106,"phases":933,"primaryCompletion":108,"completion":109,"start":110,"enrollment":111,"conditions":934,"interventions":935},[89],[113,114,115],[117,118,15,119],{"nctId":937,"briefTitle":938,"status":123,"phases":939,"primaryCompletion":940,"completion":941,"start":942,"enrollment":128,"conditions":943,"interventions":945},"NCT04554589","The Off Label Use of Glycopyrrolate in the Adults Intensive Care Unit.",[89],"2021-02-10","2021-04-10","2020-09-14",[944],"Effect of Drugs",[946,947],"Glycopyrrolate 0.2 MG","normal saline",{"trials":949,"activeCount":100},[],{"trials":951,"activeCount":247,"soonestReadout":168},[952],{"nctId":165,"briefTitle":166,"status":153,"phases":953,"primaryCompletion":168,"completion":169,"start":170,"enrollment":171,"conditions":954,"interventions":955},[91],[173,174],[176,15,177],{"trials":957,"activeCount":100},[958,967],{"nctId":959,"briefTitle":960,"status":106,"phases":961,"primaryCompletion":238,"completion":238,"start":962,"enrollment":9,"conditions":963,"interventions":965},"NCT03734042","PRP Intrauterine Infusion in Thawed Embryo Cycles",[92],"2018-12-01",[964],"Evaluations",[966,431],"Platelet rich plasma intrauterine",{"nctId":968,"briefTitle":969,"status":106,"phases":970,"primaryCompletion":971,"completion":972,"start":973,"enrollment":128,"conditions":974,"interventions":977},"NCT04706897","Opioid Sparing Anaesthesia for Prevention of Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgery",[92],"2021-05-25","2021-05-26","2021-01-15",[975,976],"PONV","Opioid Sparing Anaesthesia",[978,431],"Dexmedetomidine, ketamine and lidocaine",{"trials":980,"activeCount":513,"soonestReadout":985},[981,993,1005,1016,1020,1032,1041,1053,1062,1074,1085,1089,1100,1104,1118,1128],{"nctId":982,"briefTitle":983,"status":460,"phases":984,"primaryCompletion":985,"completion":986,"start":987,"enrollment":289,"conditions":988,"interventions":990},"NCT07055828","Nebulized vs. IV Ketamine in Preventing Shivering Post Spinal Anesthesia",[93],"2025-06-27","2025-07-15","2025-05-02",[989],"Post Spinal Anesthesia Shivering",[201,991,177,992],"Intranasal ketamine","Saline Inhalants",{"nctId":994,"briefTitle":995,"status":123,"phases":996,"primaryCompletion":997,"completion":998,"start":999,"enrollment":1000,"conditions":1001,"interventions":1003},"NCT06168708","The Safety and Efficacy of Addition of Gentamicin on Irrigation Fluid in Prevention of Post-Transurethral Resection of the Prostate Infectious Complications.",[93],"2024-06-07","2024-07-07","2023-12-07",220,[1002],"Post-TURP Infectious Complications",[1004,947],"Gentamicin",{"nctId":1006,"briefTitle":1007,"status":106,"phases":1008,"primaryCompletion":1009,"completion":1009,"start":1010,"enrollment":1011,"conditions":1012,"interventions":1014},"NCT06246422","Tranexamic Acid Instillation in Laparoscopic Cholecystectomy",[93],"2022-12-13","2021-12-11",91,[1013],"Postoperative Complications",[1015,431],"Tranexamic Acid 500 MG",{"nctId":315,"briefTitle":316,"status":106,"phases":1017,"primaryCompletion":318,"completion":318,"start":319,"enrollment":171,"conditions":1018,"interventions":1019},[93],[321,15,322,323,324,325,326],[15,177],{"nctId":1021,"briefTitle":1022,"status":106,"phases":1023,"primaryCompletion":1024,"completion":1024,"start":1025,"enrollment":1026,"conditions":1027,"interventions":1031},"NCT04821817","Peribulbar Rocuronium in Adult Strabismus Surgery",[93],"2025-02-09","2021-04-03",52,[1028,1029,1030],"Strabismus","Regional Anesthesia Morbidity","Rocuronium",[431,1030],{"nctId":1033,"briefTitle":1034,"status":106,"phases":1035,"primaryCompletion":1036,"completion":1036,"start":1037,"enrollment":1038,"conditions":1039,"interventions":1040},"NCT04898920","Pre-emptive Dexamethasone in Hip Arthroplasty",[93],"2023-01-28","2021-05-23",83,[32],[431,117],{"nctId":1042,"briefTitle":1043,"status":1044,"phases":1045,"primaryCompletion":1046,"completion":1047,"start":1048,"enrollment":370,"conditions":1049,"interventions":1052},"NCT04336046","Ultrasound Guided Bilateral Erector Spinae Block as Analgesia for Adolescent Idiopathic Scoliosis Correction","SUSPENDED",[93],"2026-01-30","2026-02-27","2025-12-31",[1050,18,1051],"Erector Spinae Block","Scoliosis Idiopathic",[947,281],{"nctId":1054,"briefTitle":1055,"status":106,"phases":1056,"primaryCompletion":1057,"completion":1057,"start":1058,"enrollment":128,"conditions":1059,"interventions":1060},"NCT04160676","Therapy With Hydrocortisone, Ascorbic Acid, Thamine in Patients With Sepsis",[93],"2021-07-26","2019-12-01",[27],[1061,431],"Hydrocortisone, Ascorbic acid, Thiamine",{"nctId":1063,"briefTitle":1064,"status":106,"phases":1065,"primaryCompletion":1066,"completion":1066,"start":1067,"enrollment":157,"conditions":1068,"interventions":1073},"NCT07561801","Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit",[93],"2025-06-01","2024-07-01",[1069,1070,1071,1072],"Pentoxifylline","Contrast Induced Nephropathy","Chronic Kidney Disease","Intensive Care Unit",[1069,431],{"nctId":1075,"briefTitle":1076,"status":106,"phases":1077,"primaryCompletion":1078,"completion":1078,"start":1079,"enrollment":128,"conditions":1080,"interventions":1083},"NCT06634524","Effect of Dexmedetomidine on Gastric Emptying, Assessed by Ultrasound in Laparoscopic Cholecystectomy",[93],"2025-03-01","2024-10-12",[15,1081,30,1082],"Gastric Emptying","Laparoscopic Cholecystectomy",[1084,431],"Dexmeditomidine",{"nctId":413,"briefTitle":414,"status":153,"phases":1086,"primaryCompletion":416,"completion":416,"start":417,"enrollment":171,"conditions":1087,"interventions":1088},[93],[419,32,420],[15,201,177],{"nctId":1090,"briefTitle":1091,"status":106,"phases":1092,"primaryCompletion":1093,"completion":1094,"start":1095,"enrollment":289,"conditions":1096,"interventions":1098},"NCT05225610","Valsalva Manoeuvre and Intravenous Dexmedetomidine on Attenuating Pain During Propofol Injection in Upper GIT Endoscopy",[93],"2022-04-15","2022-09-10","2022-02-19",[1097],"Injection Site Irritation",[1099,119],"Dexmedetomidine Injection [Precedex]",{"nctId":423,"briefTitle":424,"status":106,"phases":1101,"primaryCompletion":426,"completion":426,"start":427,"enrollment":171,"conditions":1102,"interventions":1103},[93],[429],[201,15,431],{"nctId":1105,"briefTitle":1106,"status":227,"phases":1107,"primaryCompletion":1108,"completion":1108,"start":1109,"enrollment":1110,"conditions":1111,"interventions":1115},"NCT07345715","Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy",[93],"2027-07-01","2025-07-01",96,[1112,1113,466,409,1114],"Oral Melatonin","Nebulized Dexmedetomidine","Adenotonsillectomy",[431,1116,1117],"Oral melatonin syrup","Nebulized dexmedetomidine",{"nctId":1119,"briefTitle":1120,"status":106,"phases":1121,"primaryCompletion":1122,"completion":1122,"start":1123,"enrollment":1026,"conditions":1124,"interventions":1126},"NCT05738135","Aminophylline on Recovery in Functional Endoscopic Sinus Surgery Under Dexmedetomidine Hypotensive Anesthesia",[93],"2023-08-25","2023-02-25",[335,15,1125],"Functional Endoscopic Sinus Surgery",[1127,947],"Aminophylline group",{"nctId":1129,"briefTitle":1130,"status":106,"phases":1131,"primaryCompletion":656,"completion":368,"start":1067,"enrollment":1132,"conditions":1133,"interventions":1135},"NCT06614881","Dexmedetomidine Dosage for Postoperative Delirium and Cognitive Function in Elderly TKA Patients",[93],132,[1134],"Post Operative Delirium",[1099,1136,1136,1136,431],"Dexmedetomidine in 0.9 % NaCl 1,000 Mcg\u002F250 mL",{"intervention":1138,"totalTrials":1139,"cells":1140},"Nitazoxanide",7,{"EARLY_PHASE1":1141,"PHASE1":1143,"PHASE2":1145,"PHASE3":1155,"PHASE4":1221,"NA":1223},{"trials":1142,"activeCount":100},[],{"trials":1144,"activeCount":100},[],{"trials":1146,"activeCount":100},[1147],{"nctId":1148,"briefTitle":1149,"status":123,"phases":1150,"primaryCompletion":400,"completion":1151,"start":482,"enrollment":157,"conditions":1152,"interventions":1154},"NCT06010992","Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus",[90],"2025-01-01",[1153],"Diabetes Mellitus, Type 2",[1138],{"trials":1156,"activeCount":513,"soonestReadout":1161},[1157,1168,1178,1189,1198,1209],{"nctId":1158,"briefTitle":1159,"status":227,"phases":1160,"primaryCompletion":1161,"completion":1162,"start":1163,"enrollment":197,"conditions":1164,"interventions":1166},"NCT04161053","Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy",[91],"2028-11","2028-12","2018-11-01",[1165],"Hepatic Encephalopathy",[1167,1138],"Rifaximin",{"nctId":1169,"briefTitle":1170,"status":123,"phases":1171,"primaryCompletion":125,"completion":125,"start":1172,"enrollment":184,"conditions":1173,"interventions":1175},"NCT02621359","A Two Week Nitazoxanidebased Quadruple Regimen",[91],"2015-01",[1174],"Dyspepsia",[1138,1176,47,1177],"Levofloxacin","Omeprazole",{"nctId":1179,"briefTitle":1180,"status":123,"phases":1181,"primaryCompletion":1182,"completion":1183,"start":1184,"enrollment":197,"conditions":1185,"interventions":1187},"NCT04746937","Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis",[91],"2022-03","2022-05","2021-03",[1186],"Spontaneous Bacterial Peritonitis",[1138,1188],"Norfloxacin",{"nctId":1190,"briefTitle":1191,"status":123,"phases":1192,"primaryCompletion":308,"completion":1193,"start":1194,"enrollment":197,"conditions":1195,"interventions":1197},"NCT06049901","Nitazoxanide in Patients With Metastatic Colorectal Cancer",[91],"2026-03","2023-03-01",[1196],"Metastatic Colorectal Cancer",[1138],{"nctId":1199,"briefTitle":1200,"status":227,"phases":1201,"primaryCompletion":1202,"completion":1202,"start":1203,"enrollment":1204,"conditions":1205,"interventions":1208},"NCT04382846","Novel Regimens in COVID-19 Treatment",[91],"2030-12-01","2020-05-08",160,[1206,1207],"COVID","Corona Virus Infection",[1138],{"nctId":1210,"briefTitle":1211,"status":227,"phases":1212,"primaryCompletion":1213,"completion":1202,"start":1214,"enrollment":184,"conditions":1215,"interventions":1217},"NCT04415983","Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children",[91],"2030-10-01","2020-06-01",[1216],"Helicobacter Pylori Infection",[1138,1218,1219,1220],"Clarithromycin","Metronidazole","Proton pump inhibitor",{"trials":1222,"activeCount":100},[],{"trials":1224,"activeCount":100},[],{"intervention":1226,"totalTrials":111,"cells":1227},"Empagliflozin",{"EARLY_PHASE1":1228,"PHASE1":1240,"PHASE2":1242,"PHASE3":1256,"PHASE4":1277,"NA":1279},{"trials":1229,"activeCount":247,"soonestReadout":450},[1230],{"nctId":1231,"briefTitle":1232,"status":227,"phases":1233,"primaryCompletion":450,"completion":1234,"start":1235,"enrollment":197,"conditions":1236,"interventions":1238},"NCT05610956","Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis",[88],"2026-12-01","2023-01-01",[1237],"Ulcerative Colitis",[1226,1239],"conventional treatment",{"trials":1241,"activeCount":100},[],{"trials":1243,"activeCount":247,"soonestReadout":1248},[1244],{"nctId":1245,"briefTitle":1246,"status":227,"phases":1247,"primaryCompletion":1248,"completion":1248,"start":723,"enrollment":1249,"conditions":1250,"interventions":1252},"NCT07372040","Add-on Diuretics in Acute Decompensated Heart Failure",[90],"2027-02-01",66,[1251],"Acute Decompensated Heart Failure",[1253,1254,1255],"empagliflozin","Acetazolamide","metolazone",{"trials":1257,"activeCount":247,"soonestReadout":1262},[1258,1268],{"nctId":1259,"briefTitle":1260,"status":227,"phases":1261,"primaryCompletion":1262,"completion":563,"start":1263,"enrollment":370,"conditions":1264,"interventions":1266},"NCT05669742","Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients",[91],"2026-06","2023-05-25",[1265],"Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics",[1226,1267],"olanzapine",{"nctId":1269,"briefTitle":1270,"status":106,"phases":1271,"primaryCompletion":332,"completion":332,"start":206,"enrollment":1272,"conditions":1273,"interventions":1275},"NCT05373680","Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression",[90,91],118,[1274],"Renal Insufficiency, Chronic",[1276,1226],"Metformin",{"trials":1278,"activeCount":100},[],{"trials":1280,"activeCount":100},[],{"intervention":1282,"totalTrials":513,"cells":1283},"Levodopa Carbidopa",{"EARLY_PHASE1":1284,"PHASE1":1286,"PHASE2":1288,"PHASE3":1301,"PHASE4":1319,"NA":1321},{"trials":1285,"activeCount":100},[],{"trials":1287,"activeCount":100},[],{"trials":1289,"activeCount":247,"soonestReadout":1294},[1290],{"nctId":1291,"briefTitle":1292,"status":227,"phases":1293,"primaryCompletion":1294,"completion":1295,"start":1296,"enrollment":128,"conditions":1297,"interventions":1299},"NCT07246278","Celecoxib in Parkinson Disease as Adjuvant Therapy",[89,90],"2026-11-20","2026-11-28","2025-11-20",[1298],"Parkinson Disease",[1282,1300],"Celecoxib 200mg",{"trials":1302,"activeCount":188,"soonestReadout":1294},[1303,1312],{"nctId":1304,"briefTitle":1305,"status":227,"phases":1306,"primaryCompletion":1294,"completion":1307,"start":1308,"enrollment":197,"conditions":1309,"interventions":1310},"NCT07229664","Vinpocetine in Patients With Parkinsonian Disease",[90,91],"2027-11-20","2025-11-10",[1298],[1282,1311],"Vinpocetine",{"nctId":1313,"briefTitle":1314,"status":227,"phases":1315,"primaryCompletion":1294,"completion":1316,"start":1308,"enrollment":197,"conditions":1317,"interventions":1318},"NCT07229651","Metformin in Parkinson Disease",[90,91],"2027-09-20",[1298],[1282,1276],{"trials":1320,"activeCount":100},[],{"trials":1322,"activeCount":100},[],{"intervention":259,"totalTrials":1324,"cells":1325},11,{"EARLY_PHASE1":1326,"PHASE1":1328,"PHASE2":1330,"PHASE3":1332,"PHASE4":1354,"NA":1368},{"trials":1327,"activeCount":100},[],{"trials":1329,"activeCount":100},[],{"trials":1331,"activeCount":100},[],{"trials":1333,"activeCount":247,"soonestReadout":1349},[1334,1345],{"nctId":1335,"briefTitle":1336,"status":123,"phases":1337,"primaryCompletion":1338,"completion":1339,"start":1340,"enrollment":171,"conditions":1341,"interventions":1343},"NCT04434105","Ultrasound-guided PRP Versus Steroid Injections in Management of Carpal Tunnel Syndrome",[90,91],"2020-11","2020-12","2020-02-01",[1342],"Carpal Tunnel Syndrome",[1344,57,259],"platlet rich plasma",{"nctId":1346,"briefTitle":1347,"status":153,"phases":1348,"primaryCompletion":1349,"completion":1350,"start":85,"enrollment":171,"conditions":1351,"interventions":1353},"NCT06867510","Preoperative Block for Anterior Cervical Spine Surgery",[91],"2026-04-01","2026-08-01",[1352],"Anesthesia, Local",[259],{"trials":1355,"activeCount":100},[1356],{"nctId":1357,"briefTitle":1358,"status":106,"phases":1359,"primaryCompletion":1360,"completion":1360,"start":1361,"enrollment":171,"conditions":1362,"interventions":1365},"NCT06018948","Effect of Two Different Doses of Dexmedetomidine Infusion in Morbidly Obese Patients",[92],"2021-09-30","2019-09-01",[1363,1364,15],"Anesthesia","Obesity, Morbid",[1366,1367,259],"Dexmedetomidine 0.6","Dexmedetomidine 0.3",{"trials":1369,"activeCount":188,"soonestReadout":389},[1370,1374,1387,1399,1403,1416,1420,1424],{"nctId":251,"briefTitle":252,"status":123,"phases":1371,"primaryCompletion":254,"completion":254,"start":255,"enrollment":171,"conditions":1372,"interventions":1373},[93],[15,163,222],[15,258,259],{"nctId":1375,"briefTitle":1376,"status":106,"phases":1377,"primaryCompletion":1378,"completion":1378,"start":1379,"enrollment":197,"conditions":1380,"interventions":1385},"NCT06790732","Preoperative Ultrasound-Guided Peri- Capsular Nerve Group Block on Postoperative Analgesia After Shoulder Arthroscopic Surgery",[93],"2024-05-01","2023-05-01",[1381,1382,1383,24,1384],"Preoperative","Ultrasound-Guided","PeriCapsular Nerve Group Block","Shoulder Arthroscopic Surgery",[259,1386],"Bupivacaine + Dexamethasone",{"nctId":1388,"briefTitle":1389,"status":106,"phases":1390,"primaryCompletion":368,"completion":368,"start":1379,"enrollment":289,"conditions":1391,"interventions":1396},"NCT07366372","Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients",[93],[1392,1393,1394,1395,1072],"Taurolidine","Lock Solution","Prevention","Central Venous Catheter Infection",[259,1397,1398],"Tigecycline and heparin","Taurolidine-citrate-heparin",{"nctId":342,"briefTitle":343,"status":123,"phases":1400,"primaryCompletion":345,"completion":345,"start":346,"enrollment":171,"conditions":1401,"interventions":1402},[93],[15,348,326],[259,15],{"nctId":1404,"briefTitle":1405,"status":106,"phases":1406,"primaryCompletion":1407,"completion":1408,"start":1409,"enrollment":452,"conditions":1410,"interventions":1413},"NCT05774067","Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee Arthroplasty",[93],"2023-06-30","2023-07-30","2022-12-01",[1411,1412],"Norepinephrine, Glypressin, Tourniquet Deflation","Hypotension",[259,1414,1415],"Norepinephrine","glypressin",{"nctId":386,"briefTitle":387,"status":227,"phases":1417,"primaryCompletion":389,"completion":389,"start":390,"enrollment":391,"conditions":1418,"interventions":1419},[93],[393,15,394,160,323],[15,15,259],{"nctId":458,"briefTitle":459,"status":460,"phases":1421,"primaryCompletion":462,"completion":463,"start":464,"enrollment":289,"conditions":1422,"interventions":1423},[93],[466],[15,259],{"nctId":502,"briefTitle":503,"status":106,"phases":1425,"primaryCompletion":505,"completion":505,"start":506,"enrollment":370,"conditions":1426,"interventions":1427},[93],[15,508,372,509,35],[15,259],{"intervention":163,"totalTrials":1429,"cells":1430},5,{"EARLY_PHASE1":1431,"PHASE1":1433,"PHASE2":1435,"PHASE3":1446,"PHASE4":1452,"NA":1454},{"trials":1432,"activeCount":100},[],{"trials":1434,"activeCount":100},[],{"trials":1436,"activeCount":100},[1437],{"nctId":1438,"briefTitle":1439,"status":106,"phases":1440,"primaryCompletion":1441,"completion":1441,"start":1442,"enrollment":391,"conditions":1443,"interventions":1445},"NCT02071160","Melatonin for Neuroprotection Following Perinatal Asphyxia",[89,90],"2013-12","2012-01",[1444],"Perinatal Asphyxia",[163],{"trials":1447,"activeCount":247,"soonestReadout":155},[1448],{"nctId":151,"briefTitle":152,"status":153,"phases":1449,"primaryCompletion":155,"completion":155,"start":156,"enrollment":157,"conditions":1450,"interventions":1451},[90,91],[159,160,161],[15,163],{"trials":1453,"activeCount":100},[],{"trials":1455,"activeCount":188,"soonestReadout":1469},[1456,1465,1475],{"nctId":1457,"briefTitle":1458,"status":106,"phases":1459,"primaryCompletion":1151,"completion":1151,"start":1235,"enrollment":128,"conditions":1460,"interventions":1464},"NCT07090720","Melatonin Effects on the Left Ventricular Function in Neonates With Persistent Pulmonary Hypertension",[93],[163,1461,1462,1463],"Left Ventricular Function","Neonates","Persistent Pulmonary Hypertension",[163],{"nctId":1466,"briefTitle":1467,"status":227,"phases":1468,"primaryCompletion":1469,"completion":1469,"start":1470,"enrollment":452,"conditions":1471,"interventions":1474},"NCT06768580","Effect of Oral Melatonin Versus Intraoperative Lidocaine Infusion on Incidence of Postoperative Delirium in Elderly Patients Undergoing Total Hip Arthroplasty",[93],"2026-10-01","2025-01-15",[1112,1472,360,361,1473],"Lidocaine Infusion","Total Hip Arthroplasty",[163,358],{"nctId":536,"briefTitle":537,"status":227,"phases":1476,"primaryCompletion":539,"completion":539,"start":540,"enrollment":438,"conditions":1477,"interventions":1478},[93],[542,163,221,32,543,544],[163,221],{"intervention":1276,"totalTrials":1480,"cells":1481},8,{"EARLY_PHASE1":1482,"PHASE1":1484,"PHASE2":1486,"PHASE3":1522,"PHASE4":1550,"NA":1552},{"trials":1483,"activeCount":100},[],{"trials":1485,"activeCount":100},[],{"trials":1487,"activeCount":247,"soonestReadout":563},[1488,1496,1504,1513],{"nctId":1489,"briefTitle":1490,"status":106,"phases":1491,"primaryCompletion":1078,"completion":1078,"start":1492,"enrollment":197,"conditions":1493,"interventions":1495},"NCT05553704","Metformin in Patients With Ulcerative Colitis Treated With Mesalamine",[90],"2022-11-01",[1494],"Inflammatory Bowel Diseases",[1276],{"nctId":1497,"briefTitle":1498,"status":106,"phases":1499,"primaryCompletion":1500,"completion":1500,"start":1501,"enrollment":391,"conditions":1502,"interventions":1503},"NCT05053841","Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women",[90],"2015-06","2014-02",[1276,726],[1276],{"nctId":1505,"briefTitle":1506,"status":227,"phases":1507,"primaryCompletion":563,"completion":1508,"start":1509,"enrollment":1510,"conditions":1511,"interventions":1512},"NCT05574387","Metformin as Added on Therapy in Patients With Ulcerative Colitis",[90],"2027-04","2023-01-20",46,[1494],[1276],{"nctId":1514,"briefTitle":1515,"status":106,"phases":1516,"primaryCompletion":1517,"completion":1517,"start":1518,"enrollment":197,"conditions":1519,"interventions":1520},"NCT05781711","Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease",[90],"2025-01-20","2023-01-06",[1298],[1521,1276],"levodopa-carbidopa",{"trials":1523,"activeCount":247,"soonestReadout":1294},[1524,1533,1542,1546],{"nctId":1525,"briefTitle":1526,"status":106,"phases":1527,"primaryCompletion":46,"completion":46,"start":1528,"enrollment":197,"conditions":1529,"interventions":1531},"NCT05722951","Metformin Efficacy and Safety in Epileptic Patients",[91],"2022-10-18",[1530],"Epilepsy",[1532,1276],"Levetiracetam &\u002For sodium valproate",{"nctId":1534,"briefTitle":1535,"status":123,"phases":1536,"primaryCompletion":1537,"completion":1537,"start":1538,"enrollment":197,"conditions":1539,"interventions":1540},"NCT06181422","Metformin and Lactoferrin in Sepsis in Icu",[90,91],"2024-06-09","2024-04",[27],[1276,1541],"Lactoferrin",{"nctId":1269,"briefTitle":1270,"status":106,"phases":1543,"primaryCompletion":332,"completion":332,"start":206,"enrollment":1272,"conditions":1544,"interventions":1545},[90,91],[1274],[1276,1226],{"nctId":1313,"briefTitle":1314,"status":227,"phases":1547,"primaryCompletion":1294,"completion":1316,"start":1308,"enrollment":197,"conditions":1548,"interventions":1549},[90,91],[1298],[1282,1276],{"trials":1551,"activeCount":100},[],{"trials":1553,"activeCount":100},[],{"intervention":1555,"totalTrials":188,"cells":1556},"Fluoxetine",{"EARLY_PHASE1":1557,"PHASE1":1559,"PHASE2":1561,"PHASE3":1573,"PHASE4":1585,"NA":1587},{"trials":1558,"activeCount":100},[],{"trials":1560,"activeCount":100},[],{"trials":1562,"activeCount":247,"soonestReadout":1294},[1563],{"nctId":1564,"briefTitle":1565,"status":227,"phases":1566,"primaryCompletion":1294,"completion":1567,"start":1568,"enrollment":197,"conditions":1569,"interventions":1571},"NCT07239011","Dapagliflozin in Depression",[89,90],"2026-12-20","2025-11-01",[1570],"Depression",[1555,1572],"Dapagliflozin",{"trials":1574,"activeCount":247,"soonestReadout":1579},[1575],{"nctId":1576,"briefTitle":1577,"status":227,"phases":1578,"primaryCompletion":1579,"completion":1580,"start":1078,"enrollment":197,"conditions":1581,"interventions":1583},"NCT06860958","Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients",[91],"2027-03-20","2027-08-20",[1582],"Depressive Disorder, Major",[1555,1584],"Roflumilast",{"trials":1586,"activeCount":100},[],{"trials":1588,"activeCount":100},[],{"intervention":1069,"totalTrials":1590,"cells":1591},9,{"EARLY_PHASE1":1592,"PHASE1":1608,"PHASE2":1610,"PHASE3":1642,"PHASE4":1662,"NA":1683},{"trials":1593,"activeCount":100},[1594],{"nctId":1595,"briefTitle":1596,"status":123,"phases":1597,"primaryCompletion":1598,"completion":1599,"start":1600,"enrollment":1601,"conditions":1602,"interventions":1606},"NCT05590117","Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer",[88],"2023-10-11","2024-10-11","2022-10-11",48,[1603,1604,1605],"Colo-rectal Cancer","Neuropathy;Peripheral","Mucositis",[1069,1607],"FOLFOX-6 regimen",{"trials":1609,"activeCount":100},[],{"trials":1611,"activeCount":247,"soonestReadout":1616},[1612,1622,1633],{"nctId":1613,"briefTitle":1614,"status":227,"phases":1615,"primaryCompletion":1616,"completion":614,"start":1617,"enrollment":1618,"conditions":1619,"interventions":1620},"NCT06998628","Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis",[90],"2026-05-30","2025-06-02",50,[566],[1621,1069],"Methotrexate",{"nctId":1623,"briefTitle":1624,"status":106,"phases":1625,"primaryCompletion":1626,"completion":1627,"start":1628,"enrollment":1629,"conditions":1630,"interventions":1632},"NCT03731741","Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?",[90],"2018-05-03","2018-05-04","2017-11-01",57,[1631],"Anemia of Chronic Kidney Disease",[1069],{"nctId":1634,"briefTitle":1635,"status":106,"phases":1636,"primaryCompletion":1637,"completion":1637,"start":1638,"enrollment":391,"conditions":1639,"interventions":1641},"NCT06944704","Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice",[90],"2025-03-19","2024-04-03",[1640],"Hepatobiliary Disorders",[1069],{"trials":1643,"activeCount":247,"soonestReadout":46},[1644,1652],{"nctId":44,"briefTitle":45,"status":153,"phases":1645,"primaryCompletion":46,"completion":1646,"start":1647,"enrollment":184,"conditions":1648,"interventions":1650},[90,91],"2028-06-20","2023-06-20",[1649],"Sexually Transmitted Diseases",[47,1069,1651],"Nitazoxanide 500Mg Oral",{"nctId":1653,"briefTitle":1654,"status":106,"phases":1655,"primaryCompletion":451,"completion":1656,"start":1657,"enrollment":274,"conditions":1658,"interventions":1660},"NCT06422000","Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis",[91],"2023-12-30","2022-06-30",[1659],"Necrotizing Enterocolitis",[1069,1661],"Probiotic Formula",{"trials":1663,"activeCount":100},[1664,1673],{"nctId":1665,"briefTitle":1666,"status":123,"phases":1667,"primaryCompletion":368,"completion":1668,"start":451,"enrollment":590,"conditions":1669,"interventions":1671},"NCT06115174","Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer",[92],"2024-12-01",[1670],"Metastatic Colorectal Carcinoma",[1069,1672],"Monoclonal antibodies",{"nctId":1674,"briefTitle":1675,"status":106,"phases":1676,"primaryCompletion":1677,"completion":1066,"start":1678,"enrollment":184,"conditions":1679,"interventions":1681},"NCT06265389","Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug",[92],"2024-08-31","2024-03-01",[1680],"Pentoxifylline as an Adjunct Therapy in the Treatment of Pneumonia",[1682],"Pentoxifylline Oral",{"trials":1684,"activeCount":100},[1685],{"nctId":1063,"briefTitle":1064,"status":106,"phases":1686,"primaryCompletion":1066,"completion":1066,"start":1067,"enrollment":157,"conditions":1687,"interventions":1688},[93],[1069,1070,1071,1072],[1069,431],{"intervention":1690,"totalTrials":511,"cells":1691},"Gabapentin",{"EARLY_PHASE1":1692,"PHASE1":1694,"PHASE2":1696,"PHASE3":1698,"PHASE4":1729,"NA":1745},{"trials":1693,"activeCount":100},[],{"trials":1695,"activeCount":100},[],{"trials":1697,"activeCount":100},[],{"trials":1699,"activeCount":247,"soonestReadout":1714},[1700,1710,1719],{"nctId":1701,"briefTitle":1702,"status":123,"phases":1703,"primaryCompletion":125,"completion":125,"start":1704,"enrollment":1705,"conditions":1706,"interventions":1708},"NCT02642484","Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis",[91],"2018-12",200,[1707],"Liver Cirrhosis",[1690,1709],"Calcium Carbonate",{"nctId":1711,"briefTitle":1712,"status":460,"phases":1713,"primaryCompletion":1714,"completion":1715,"start":1407,"enrollment":184,"conditions":1716,"interventions":1717},"NCT05921604","Baclofen Versus Gabapentin in Preventing Postoperative Pain After Laparoscopic Sleeve Gastrectomy",[91],"2025-08-28","2025-10",[114],[1718,1690],"Baclofen 10mg",{"nctId":1720,"briefTitle":1721,"status":106,"phases":1722,"primaryCompletion":1723,"completion":85,"start":483,"enrollment":184,"conditions":1724,"interventions":1727},"NCT05620641","Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy",[91],"2025-02-28",[1725,1726,325],"Post Operative Nausea and Vomiting","Sleeve Gastrectomy",[1728,1690],"Ondansetron 8mg",{"trials":1730,"activeCount":100},[1731],{"nctId":1732,"briefTitle":1733,"status":106,"phases":1734,"primaryCompletion":400,"completion":1735,"start":1067,"enrollment":197,"conditions":1736,"interventions":1743},"NCT06466421","Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis",[92],"2024-12-20",[1737,1738,1739,1740,1741,1742],"Uremic Pruritus","Chronic Kidney Disease-associated Pruritus","Hemodialysis","End-stage Renal Disease","Renal Replacement Therapy","ESRD",[1744,1690],"Fexofenadine",{"trials":1746,"activeCount":247,"soonestReadout":1761},[1747,1757],{"nctId":1748,"briefTitle":1749,"status":106,"phases":1750,"primaryCompletion":1751,"completion":1751,"start":401,"enrollment":1618,"conditions":1752,"interventions":1756},"NCT06112223","Preemptive Oral Gabapentin and Tramadol on Postoperative Pain After Knee Arthroscopy",[93],"2023-09-01",[1690,1753,32,1754,1755],"Tramadol","Knee Arthroscopy","Spinal Anesthesia",[1690,1753],{"nctId":1758,"briefTitle":1759,"status":227,"phases":1760,"primaryCompletion":1761,"completion":1761,"start":1668,"enrollment":274,"conditions":1762,"interventions":1766},"NCT07515456","Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache",[93],"2026-11-01",[1763,1764,1690,1765],"Theophylline","Sumatriptan","Post-Dural Puncture Headache",[1763,1764,1690],{"intervention":1768,"totalTrials":513,"cells":1769},"Conventional treatment",{"EARLY_PHASE1":1770,"PHASE1":1776,"PHASE2":1778,"PHASE3":1780,"PHASE4":1791,"NA":1793},{"trials":1771,"activeCount":247,"soonestReadout":450},[1772],{"nctId":1231,"briefTitle":1232,"status":227,"phases":1773,"primaryCompletion":450,"completion":1234,"start":1235,"enrollment":197,"conditions":1774,"interventions":1775},[88],[1237],[1226,1239],{"trials":1777,"activeCount":100},[],{"trials":1779,"activeCount":100},[],{"trials":1781,"activeCount":247,"soonestReadout":1786},[1782],{"nctId":1783,"briefTitle":1784,"status":153,"phases":1785,"primaryCompletion":1786,"completion":1786,"start":1787,"enrollment":197,"conditions":1788,"interventions":1789},"NCT04345406","Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19",[91],"2029-12-01","2020-04-15",[1206],[1790,1768],"ACEIs",{"trials":1792,"activeCount":100},[],{"trials":1794,"activeCount":100},[1795],{"nctId":1796,"briefTitle":1797,"status":106,"phases":1798,"primaryCompletion":332,"completion":332,"start":401,"enrollment":128,"conditions":1799,"interventions":1805},"NCT06964607","Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction",[],[1800,1801,1802,1803,1804],"Sodium-glucose Cotransporter 2","Inhibitors","Clinical Outcome","Left Ventricule","Acute Myocardial Infarction",[1806,1768],"Sodium-glucose cotransporter-2 Inhibitors",{"intervention":1808,"totalTrials":188,"cells":1809},"Melatonin 10 MG",{"EARLY_PHASE1":1810,"PHASE1":1812,"PHASE2":1814,"PHASE3":1816,"PHASE4":1827,"NA":1829},{"trials":1811,"activeCount":100},[],{"trials":1813,"activeCount":100},[],{"trials":1815,"activeCount":100},[],{"trials":1817,"activeCount":247,"soonestReadout":1822},[1818],{"nctId":1819,"briefTitle":1820,"status":227,"phases":1821,"primaryCompletion":1822,"completion":723,"start":1823,"enrollment":1510,"conditions":1824,"interventions":1826},"NCT06846086","Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy",[91],"2026-01-01","2025-02-20",[1825],"Cardiomyopathies",[1808],{"trials":1828,"activeCount":100},[],{"trials":1830,"activeCount":247,"soonestReadout":1835},[1831],{"nctId":1832,"briefTitle":1833,"status":153,"phases":1834,"primaryCompletion":1835,"completion":1836,"start":1567,"enrollment":1837,"conditions":1838,"interventions":1840},"NCT07334197","Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy",[93],"2029-12-20","2029-12-30",25,[1839],"Ppm, Cardiomyopathy",[1808,1841],"Selenium",{"intervention":1843,"totalTrials":188,"cells":1844},"Proton Pump Inhibitor",{"EARLY_PHASE1":1845,"PHASE1":1847,"PHASE2":1849,"PHASE3":1851,"PHASE4":1857,"NA":1859},{"trials":1846,"activeCount":100},[],{"trials":1848,"activeCount":100},[],{"trials":1850,"activeCount":100},[],{"trials":1852,"activeCount":247,"soonestReadout":1213},[1853],{"nctId":1210,"briefTitle":1211,"status":227,"phases":1854,"primaryCompletion":1213,"completion":1202,"start":1214,"enrollment":184,"conditions":1855,"interventions":1856},[91],[1216],[1138,1218,1219,1220],{"trials":1858,"activeCount":100},[],{"trials":1860,"activeCount":247,"soonestReadout":723},[1861],{"nctId":1862,"briefTitle":1863,"status":227,"phases":1864,"primaryCompletion":723,"completion":723,"start":390,"enrollment":1865,"conditions":1866,"interventions":1870},"NCT07165444","Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection",[93],320,[1867,1843,1868,1869,1216],"Potassium-Competitive Acid Blocker","Bismuth Based Quadruple Therapy","Treatment",[1867,1843],{"intervention":1872,"totalTrials":188,"cells":1873},"Ketotifen",{"EARLY_PHASE1":1874,"PHASE1":1876,"PHASE2":1878,"PHASE3":1880,"PHASE4":1889,"NA":1900},{"trials":1875,"activeCount":100},[],{"trials":1877,"activeCount":100},[],{"trials":1879,"activeCount":100},[],{"trials":1881,"activeCount":247,"soonestReadout":41},[1882],{"nctId":39,"briefTitle":40,"status":227,"phases":1883,"primaryCompletion":41,"completion":1884,"start":1885,"enrollment":1886,"conditions":1887,"interventions":1888},[91],"2025-06","2022-11-09",64,[1604],[42],{"trials":1890,"activeCount":100},[1891],{"nctId":1892,"briefTitle":1893,"status":106,"phases":1894,"primaryCompletion":1078,"completion":1078,"start":1895,"enrollment":197,"conditions":1896,"interventions":1898},"NCT05616442","Ketotifen in Non-Alcoholic Fatty Liver Disease Patients",[92],"2023-05-20",[1897],"Hepatic Disease",[1872,1899],"Vitamin E",{"trials":1901,"activeCount":100},[],{"intervention":1744,"totalTrials":188,"cells":1903},{"EARLY_PHASE1":1904,"PHASE1":1906,"PHASE2":1908,"PHASE3":1910,"PHASE4":1920,"NA":1926},{"trials":1905,"activeCount":100},[],{"trials":1907,"activeCount":100},[],{"trials":1909,"activeCount":100},[],{"trials":1911,"activeCount":247,"soonestReadout":1916},[1912],{"nctId":1913,"briefTitle":1914,"status":227,"phases":1915,"primaryCompletion":1916,"completion":1567,"start":901,"enrollment":1510,"conditions":1917,"interventions":1918},"NCT06785298","Fexofenadine as Adjuvant Therapy in Parkinson Disease",[90,91],"2026-12-10",[1298],[1919,1744],"Levodopa\u002Fcarbidopa",{"trials":1921,"activeCount":100},[1922],{"nctId":1732,"briefTitle":1733,"status":106,"phases":1923,"primaryCompletion":400,"completion":1735,"start":1067,"enrollment":197,"conditions":1924,"interventions":1925},[92],[1737,1738,1739,1740,1741,1742],[1744,1690],{"trials":1927,"activeCount":100},[],{"intervention":1584,"totalTrials":111,"cells":1929},{"EARLY_PHASE1":1930,"PHASE1":1932,"PHASE2":1934,"PHASE3":1936,"PHASE4":1972,"NA":1974},{"trials":1931,"activeCount":100},[],{"trials":1933,"activeCount":100},[],{"trials":1935,"activeCount":100},[],{"trials":1937,"activeCount":247,"soonestReadout":1579},[1938,1947,1957,1968],{"nctId":1939,"briefTitle":1940,"status":106,"phases":1941,"primaryCompletion":1942,"completion":1942,"start":1943,"enrollment":1249,"conditions":1944,"interventions":1946},"NCT04800172","The Possible Effects of Roflumilast on Obesity Related Disorders",[91],"2022-03-31","2021-05-01",[419,1945],"PreDiabetes",[1584],{"nctId":1948,"briefTitle":1949,"status":123,"phases":1950,"primaryCompletion":1951,"completion":1952,"start":1953,"enrollment":1601,"conditions":1954,"interventions":1956},"NCT04755946","Possible Role of Roflumilast in Diabetic Nephropathy",[91],"2021-06-10","2021-07-10","2021-03-10",[1955],"Diabetic Nephropathies",[1584],{"nctId":1958,"briefTitle":1959,"status":106,"phases":1960,"primaryCompletion":1961,"completion":1961,"start":1962,"enrollment":197,"conditions":1963,"interventions":1966},"NCT05369793","Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy",[91],"2023-10-10","2022-08-01",[1964,1965],"Type 2 Diabetes (Adult Onset)","Diabetic Neuropathies",[1967,1584],"Alpha lipoic acid",{"nctId":1576,"briefTitle":1577,"status":227,"phases":1969,"primaryCompletion":1579,"completion":1580,"start":1078,"enrollment":197,"conditions":1970,"interventions":1971},[91],[1582],[1555,1584],{"trials":1973,"activeCount":100},[],{"trials":1975,"activeCount":100},[],{"intervention":1977,"totalTrials":513,"cells":1978},"Allopurinol 300 MG",{"EARLY_PHASE1":1979,"PHASE1":1981,"PHASE2":1983,"PHASE3":1985,"PHASE4":2017,"NA":2019},{"trials":1980,"activeCount":100},[],{"trials":1982,"activeCount":100},[],{"trials":1984,"activeCount":100},[],{"trials":1986,"activeCount":247,"soonestReadout":1991},[1987,1996,2004],{"nctId":1988,"briefTitle":1989,"status":153,"phases":1990,"primaryCompletion":1991,"completion":1991,"start":1992,"enrollment":157,"conditions":1993,"interventions":1994},"NCT07574060","Allopurinol in Depression",[90,91],"2027-05-20","2026-05-20",[1570],[1995,1977],"Sertraline 50 MG",{"nctId":1997,"briefTitle":1998,"status":106,"phases":1999,"primaryCompletion":2000,"completion":1194,"start":2001,"enrollment":184,"conditions":2002,"interventions":2003},"NCT05545670","Allopurinol to Prevent Cirrhosis Related Morbidities",[90,91],"2023-02-15","2022-06-15",[883],[1977],{"nctId":2005,"briefTitle":2006,"status":123,"phases":2007,"primaryCompletion":2008,"completion":2009,"start":2010,"enrollment":724,"conditions":2011,"interventions":2015},"NCT05511766","Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis",[90,91],"2024-04-25","2025-01-30","2022-11-15",[883,1165,2012,2013,2014],"Ascites","Varices","SBP - Spontaneous Bacterial Peritonitis",[1977,2016],"Atorvastatin 20mg",{"trials":2018,"activeCount":100},[],{"trials":2020,"activeCount":100},[],{"intervention":2022,"totalTrials":513,"cells":2023},"Ivermectin",{"EARLY_PHASE1":2024,"PHASE1":2026,"PHASE2":2028,"PHASE3":2040,"PHASE4":2058,"NA":2060},{"trials":2025,"activeCount":100},[],{"trials":2027,"activeCount":100},[],{"trials":2029,"activeCount":100},[2030],{"nctId":2031,"briefTitle":2032,"status":123,"phases":2033,"primaryCompletion":2034,"completion":1339,"start":2035,"enrollment":197,"conditions":2036,"interventions":2038},"NCT04510233","Ivermectin Nasal Spray for COVID19 Patients",[90],"2020-10","2020-09",[2037],"Covid19",[2039,2022],"Ivermectin nasal",{"trials":2041,"activeCount":247,"soonestReadout":1202},[2042,2050],{"nctId":2043,"briefTitle":2044,"status":106,"phases":2045,"primaryCompletion":494,"completion":2046,"start":1214,"enrollment":2047,"conditions":2048,"interventions":2049},"NCT04403555","Ivermectin as a Novel Therapy in COVID-19 Treatment",[90,91],"2020-12-01",164,[1206],[2022],{"nctId":2051,"briefTitle":2052,"status":227,"phases":2053,"primaryCompletion":1202,"completion":1202,"start":2054,"enrollment":2055,"conditions":2056,"interventions":2057},"NCT04351347","The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment",[90,91],"2020-06-16",300,[1206],[2022],{"trials":2059,"activeCount":100},[],{"trials":2061,"activeCount":100},[],{"intervention":2063,"totalTrials":513,"cells":2064},"Nicorandil 10 MG Oral",{"EARLY_PHASE1":2065,"PHASE1":2067,"PHASE2":2069,"PHASE3":2071,"PHASE4":2099,"NA":2101},{"trials":2066,"activeCount":100},[],{"trials":2068,"activeCount":100},[],{"trials":2070,"activeCount":100},[],{"trials":2072,"activeCount":247,"soonestReadout":2095},[2073,2082,2091],{"nctId":2074,"briefTitle":2075,"status":123,"phases":2076,"primaryCompletion":2077,"completion":2077,"start":2078,"enrollment":1510,"conditions":2079,"interventions":2081},"NCT06430125","Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus",[91],"2025-02","2023-02-28",[2080],"Type2 Diabetes Mellitus",[2063],{"nctId":2083,"briefTitle":2084,"status":123,"phases":2085,"primaryCompletion":2086,"completion":56,"start":2087,"enrollment":1510,"conditions":2088,"interventions":2089},"NCT06423729","Effect of Nicorandil in Type 2 Diabetic Obese Patients",[90,91],"2024-12","2024-06-01",[1153],[2090],"Nicorandil 10 MG",{"nctId":2092,"briefTitle":2093,"status":227,"phases":2094,"primaryCompletion":2095,"completion":1508,"start":368,"enrollment":1510,"conditions":2096,"interventions":2098},"NCT07516769","Nicorandil as Anti-inflammatory in Rheumatoid Arthritis",[91],"2027-03",[2097],"Rhumatoid Arthisis",[2063],{"trials":2100,"activeCount":100},[],{"trials":2102,"activeCount":100},[],{"intervention":2104,"totalTrials":188,"cells":2105},"Cefotaxime",{"EARLY_PHASE1":2106,"PHASE1":2108,"PHASE2":2110,"PHASE3":2112,"PHASE4":2132,"NA":2134},{"trials":2107,"activeCount":100},[],{"trials":2109,"activeCount":100},[],{"trials":2111,"activeCount":100},[],{"trials":2113,"activeCount":247,"soonestReadout":2118},[2114,2123],{"nctId":2115,"briefTitle":2116,"status":227,"phases":2117,"primaryCompletion":2118,"completion":2119,"start":962,"enrollment":197,"conditions":2120,"interventions":2121},"NCT04168099","Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis",[91],"2028-12-01","2028-12-30",[1186],[2104,2122],"Gemifloxacin",{"nctId":2124,"briefTitle":2125,"status":123,"phases":2126,"primaryCompletion":2127,"completion":2127,"start":1172,"enrollment":184,"conditions":2128,"interventions":2130},"NCT02443285","Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?",[91],"2019-12",[2129],"Primary Bacterial Peritonitis",[2104,2131],"ceftriaxone",{"trials":2133,"activeCount":100},[],{"trials":2135,"activeCount":100},[],{"intervention":118,"totalTrials":188,"cells":2137},{"EARLY_PHASE1":2138,"PHASE1":2140,"PHASE2":2146,"PHASE3":2148,"PHASE4":2157,"NA":2159},{"trials":2139,"activeCount":100},[],{"trials":2141,"activeCount":100},[2142],{"nctId":104,"briefTitle":105,"status":106,"phases":2143,"primaryCompletion":108,"completion":109,"start":110,"enrollment":111,"conditions":2144,"interventions":2145},[89],[113,114,115],[117,118,15,119],{"trials":2147,"activeCount":100},[],{"trials":2149,"activeCount":247,"soonestReadout":1567},[2150],{"nctId":2151,"briefTitle":2152,"status":227,"phases":2153,"primaryCompletion":1567,"completion":1567,"start":1078,"enrollment":590,"conditions":2154,"interventions":2156},"NCT06861010","Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis",[91],[2155],"Pancreatic Diseases",[118],{"trials":2158,"activeCount":100},[],{"trials":2160,"activeCount":100},[],{"intervention":2162,"totalTrials":188,"cells":2163},"Rosuvastatin 20 Mg Oral",{"EARLY_PHASE1":2164,"PHASE1":2166,"PHASE2":2168,"PHASE3":2170,"PHASE4":2192,"NA":2194},{"trials":2165,"activeCount":100},[],{"trials":2167,"activeCount":100},[],{"trials":2169,"activeCount":100},[],{"trials":2171,"activeCount":247,"soonestReadout":1508},[2172,2182],{"nctId":2173,"briefTitle":2174,"status":153,"phases":2175,"primaryCompletion":1508,"completion":2176,"start":1193,"enrollment":1510,"conditions":2177,"interventions":2179},"NCT07504198","Neuroprotection of Memantine and Rosuvastatin",[90,91],"2027-05",[2178],"Peripheral Nerve Disease",[2180,2181,2162],"Starch Placebo","Memantine",{"nctId":2183,"briefTitle":2184,"status":123,"phases":2185,"primaryCompletion":2186,"completion":1538,"start":2187,"enrollment":1510,"conditions":2188,"interventions":2190},"NCT05731596","Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis",[91],"2024-02","2023-06",[2189],"Nonalcoholic Steatohepatitis",[2162,2191],"Coenzyme Q10 100 MG Oral",{"trials":2193,"activeCount":100},[],{"trials":2195,"activeCount":100},[],{"intervention":2197,"totalTrials":188,"cells":2198},"Alpha Lipoic Acid 600 MG Oral",{"EARLY_PHASE1":2199,"PHASE1":2201,"PHASE2":2203,"PHASE3":2205,"PHASE4":2225,"NA":2227},{"trials":2200,"activeCount":100},[],{"trials":2202,"activeCount":100},[],{"trials":2204,"activeCount":100},[],{"trials":2206,"activeCount":247,"soonestReadout":877},[2207,2216],{"nctId":2208,"briefTitle":2209,"status":153,"phases":2210,"primaryCompletion":877,"completion":1046,"start":615,"enrollment":1249,"conditions":2211,"interventions":2213},"NCT07157722","Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia",[91],[2212],"Beta Thalassemia",[2214,2215,2197],"Iron chelating intervention","N Acetyl cysteine 600mg",{"nctId":2217,"briefTitle":2218,"status":123,"phases":2219,"primaryCompletion":2220,"completion":2221,"start":126,"enrollment":1026,"conditions":2222,"interventions":2224},"NCT05679037","Role of Alpha-lipoic Acid in Diabetes Melitus Type 1",[91],"2024-10","2024-11",[2223],"Diabetes MellitusType 1",[2197],{"trials":2226,"activeCount":100},[],{"trials":2228,"activeCount":100},[],{"intervention":47,"totalTrials":188,"cells":2230},{"EARLY_PHASE1":2231,"PHASE1":2233,"PHASE2":2235,"PHASE3":2237,"PHASE4":2247,"NA":2249},{"trials":2232,"activeCount":100},[],{"trials":2234,"activeCount":100},[],{"trials":2236,"activeCount":100},[],{"trials":2238,"activeCount":247,"soonestReadout":46},[2239,2243],{"nctId":44,"briefTitle":45,"status":153,"phases":2240,"primaryCompletion":46,"completion":1646,"start":1647,"enrollment":184,"conditions":2241,"interventions":2242},[90,91],[1649],[47,1069,1651],{"nctId":1169,"briefTitle":1170,"status":123,"phases":2244,"primaryCompletion":125,"completion":125,"start":1172,"enrollment":184,"conditions":2245,"interventions":2246},[91],[1174],[1138,1176,47,1177],{"trials":2248,"activeCount":100},[],{"trials":2250,"activeCount":100},[],{"intervention":1651,"totalTrials":188,"cells":2252},{"EARLY_PHASE1":2253,"PHASE1":2255,"PHASE2":2257,"PHASE3":2259,"PHASE4":2274,"NA":2276},{"trials":2254,"activeCount":100},[],{"trials":2256,"activeCount":100},[],{"trials":2258,"activeCount":100},[],{"trials":2260,"activeCount":247,"soonestReadout":46},[2261,2265],{"nctId":44,"briefTitle":45,"status":153,"phases":2262,"primaryCompletion":46,"completion":1646,"start":1647,"enrollment":184,"conditions":2263,"interventions":2264},[90,91],[1649],[47,1069,1651],{"nctId":2266,"briefTitle":2267,"status":106,"phases":2268,"primaryCompletion":2269,"completion":401,"start":2270,"enrollment":171,"conditions":2271,"interventions":2272},"NCT05480878","Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis",[91],"2023-03-25","2022-12-02",[566],[1651,2273],"Escitalopram 10mg",{"trials":2275,"activeCount":100},[],{"trials":2277,"activeCount":100},[],{"intervention":1188,"totalTrials":188,"cells":2279},{"EARLY_PHASE1":2280,"PHASE1":2282,"PHASE2":2284,"PHASE3":2286,"PHASE4":2299,"NA":2301},{"trials":2281,"activeCount":100},[],{"trials":2283,"activeCount":100},[],{"trials":2285,"activeCount":100},[],{"trials":2287,"activeCount":247,"soonestReadout":2118},[2288,2295],{"nctId":2289,"briefTitle":2290,"status":227,"phases":2291,"primaryCompletion":2118,"completion":2118,"start":962,"enrollment":128,"conditions":2292,"interventions":2293},"NCT04161768","Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis",[91],[1186],[1188,2294],"Itopride",{"nctId":1179,"briefTitle":1180,"status":123,"phases":2296,"primaryCompletion":1182,"completion":1183,"start":1184,"enrollment":197,"conditions":2297,"interventions":2298},[91],[1186],[1138,1188],{"trials":2300,"activeCount":100},[],{"trials":2302,"activeCount":100},[],{"intervention":2122,"totalTrials":247,"cells":2304},{"EARLY_PHASE1":2305,"PHASE1":2307,"PHASE2":2309,"PHASE3":2311,"PHASE4":2317,"NA":2319},{"trials":2306,"activeCount":100},[],{"trials":2308,"activeCount":100},[],{"trials":2310,"activeCount":100},[],{"trials":2312,"activeCount":247,"soonestReadout":2118},[2313],{"nctId":2115,"briefTitle":2116,"status":227,"phases":2314,"primaryCompletion":2118,"completion":2119,"start":962,"enrollment":197,"conditions":2315,"interventions":2316},[91],[1186],[2104,2122],{"trials":2318,"activeCount":100},[],{"trials":2320,"activeCount":100},[],{"intervention":2322,"totalTrials":247,"cells":2323},"Dapagliflozin placebo",{"EARLY_PHASE1":2324,"PHASE1":2326,"PHASE2":2328,"PHASE3":2330,"PHASE4":2343,"NA":2345},{"trials":2325,"activeCount":100},[],{"trials":2327,"activeCount":100},[],{"trials":2329,"activeCount":100},[],{"trials":2331,"activeCount":247,"soonestReadout":2336},[2332],{"nctId":2333,"briefTitle":2334,"status":153,"phases":2335,"primaryCompletion":2336,"completion":1567,"start":2337,"enrollment":274,"conditions":2338,"interventions":2341},"NCT06750458","Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients",[91],"2026-10-20","2025-08-20",[2339,2340,117],"Glioma","Dapagliflozin (Forxiga)",[2322,2342],"DexamethasoneGroup III",{"trials":2344,"activeCount":100},[],{"trials":2346,"activeCount":100},[],{"intervention":2342,"totalTrials":247,"cells":2348},{"EARLY_PHASE1":2349,"PHASE1":2351,"PHASE2":2353,"PHASE3":2355,"PHASE4":2361,"NA":2363},{"trials":2350,"activeCount":100},[],{"trials":2352,"activeCount":100},[],{"trials":2354,"activeCount":100},[],{"trials":2356,"activeCount":247,"soonestReadout":2336},[2357],{"nctId":2333,"briefTitle":2334,"status":153,"phases":2358,"primaryCompletion":2336,"completion":1567,"start":2337,"enrollment":274,"conditions":2359,"interventions":2360},[91],[2339,2340,117],[2322,2342],{"trials":2362,"activeCount":100},[],{"trials":2364,"activeCount":100},[],{"intervention":2180,"totalTrials":247,"cells":2366},{"EARLY_PHASE1":2367,"PHASE1":2369,"PHASE2":2371,"PHASE3":2373,"PHASE4":2379,"NA":2381},{"trials":2368,"activeCount":100},[],{"trials":2370,"activeCount":100},[],{"trials":2372,"activeCount":100},[],{"trials":2374,"activeCount":247,"soonestReadout":1508},[2375],{"nctId":2173,"briefTitle":2174,"status":153,"phases":2376,"primaryCompletion":1508,"completion":2176,"start":1193,"enrollment":1510,"conditions":2377,"interventions":2378},[90,91],[2178],[2180,2181,2162],{"trials":2380,"activeCount":100},[],{"trials":2382,"activeCount":100},[],{"intervention":2181,"totalTrials":247,"cells":2384},{"EARLY_PHASE1":2385,"PHASE1":2387,"PHASE2":2389,"PHASE3":2391,"PHASE4":2397,"NA":2399},{"trials":2386,"activeCount":100},[],{"trials":2388,"activeCount":100},[],{"trials":2390,"activeCount":100},[],{"trials":2392,"activeCount":247,"soonestReadout":1508},[2393],{"nctId":2173,"briefTitle":2174,"status":153,"phases":2394,"primaryCompletion":1508,"completion":2176,"start":1193,"enrollment":1510,"conditions":2395,"interventions":2396},[90,91],[2178],[2180,2181,2162],{"trials":2398,"activeCount":100},[],{"trials":2400,"activeCount":100},[],{"intervention":1267,"totalTrials":247,"cells":2402},{"EARLY_PHASE1":2403,"PHASE1":2405,"PHASE2":2407,"PHASE3":2409,"PHASE4":2415,"NA":2417},{"trials":2404,"activeCount":100},[],{"trials":2406,"activeCount":100},[],{"trials":2408,"activeCount":100},[],{"trials":2410,"activeCount":247,"soonestReadout":1262},[2411],{"nctId":1259,"briefTitle":1260,"status":227,"phases":2412,"primaryCompletion":1262,"completion":563,"start":1263,"enrollment":370,"conditions":2413,"interventions":2414},[91],[1265],[1226,1267],{"trials":2416,"activeCount":100},[],{"trials":2418,"activeCount":100},[],{"intervention":1167,"totalTrials":247,"cells":2420},{"EARLY_PHASE1":2421,"PHASE1":2423,"PHASE2":2425,"PHASE3":2427,"PHASE4":2433,"NA":2435},{"trials":2422,"activeCount":100},[],{"trials":2424,"activeCount":100},[],{"trials":2426,"activeCount":100},[],{"trials":2428,"activeCount":247,"soonestReadout":1161},[2429],{"nctId":1158,"briefTitle":1159,"status":227,"phases":2430,"primaryCompletion":1161,"completion":1162,"start":1163,"enrollment":197,"conditions":2431,"interventions":2432},[91],[1165],[1167,1138],{"trials":2434,"activeCount":100},[],{"trials":2436,"activeCount":100},[],{"intervention":2214,"totalTrials":247,"cells":2438},{"EARLY_PHASE1":2439,"PHASE1":2441,"PHASE2":2443,"PHASE3":2445,"PHASE4":2451,"NA":2453},{"trials":2440,"activeCount":100},[],{"trials":2442,"activeCount":100},[],{"trials":2444,"activeCount":100},[],{"trials":2446,"activeCount":247,"soonestReadout":877},[2447],{"nctId":2208,"briefTitle":2209,"status":153,"phases":2448,"primaryCompletion":877,"completion":1046,"start":615,"enrollment":1249,"conditions":2449,"interventions":2450},[91],[2212],[2214,2215,2197],{"trials":2452,"activeCount":100},[],{"trials":2454,"activeCount":100},[],{"intervention":2215,"totalTrials":247,"cells":2456},{"EARLY_PHASE1":2457,"PHASE1":2459,"PHASE2":2461,"PHASE3":2463,"PHASE4":2469,"NA":2471},{"trials":2458,"activeCount":100},[],{"trials":2460,"activeCount":100},[],{"trials":2462,"activeCount":100},[],{"trials":2464,"activeCount":247,"soonestReadout":877},[2465],{"nctId":2208,"briefTitle":2209,"status":153,"phases":2466,"primaryCompletion":877,"completion":1046,"start":615,"enrollment":1249,"conditions":2467,"interventions":2468},[91],[2212],[2214,2215,2197],{"trials":2470,"activeCount":100},[],{"trials":2472,"activeCount":100},[],{"intervention":2474,"totalTrials":247,"cells":2475},"Sulfasalazine",{"EARLY_PHASE1":2476,"PHASE1":2478,"PHASE2":2480,"PHASE3":2482,"PHASE4":2492,"NA":2494},{"trials":2477,"activeCount":100},[],{"trials":2479,"activeCount":100},[],{"trials":2481,"activeCount":100},[],{"trials":2483,"activeCount":247,"soonestReadout":2488},[2484],{"nctId":2485,"briefTitle":2486,"status":227,"phases":2487,"primaryCompletion":2488,"completion":2489,"start":1751,"enrollment":1618,"conditions":2490,"interventions":2491},"NCT06134388","Sulfasalazine in Patients With Metastatic Colorectal Cancer",[91],"2025-09","2026-09",[1196],[2474],{"trials":2493,"activeCount":100},[],{"trials":2495,"activeCount":100},[],{"intervention":1995,"totalTrials":247,"cells":2497},{"EARLY_PHASE1":2498,"PHASE1":2500,"PHASE2":2502,"PHASE3":2504,"PHASE4":2510,"NA":2512},{"trials":2499,"activeCount":100},[],{"trials":2501,"activeCount":100},[],{"trials":2503,"activeCount":100},[],{"trials":2505,"activeCount":247,"soonestReadout":1991},[2506],{"nctId":1988,"briefTitle":1989,"status":153,"phases":2507,"primaryCompletion":1991,"completion":1991,"start":1992,"enrollment":157,"conditions":2508,"interventions":2509},[90,91],[1570],[1995,1977],{"trials":2511,"activeCount":100},[],{"trials":2513,"activeCount":100},[],{"intervention":1311,"totalTrials":247,"cells":2515},{"EARLY_PHASE1":2516,"PHASE1":2518,"PHASE2":2520,"PHASE3":2522,"PHASE4":2528,"NA":2530},{"trials":2517,"activeCount":100},[],{"trials":2519,"activeCount":100},[],{"trials":2521,"activeCount":100},[],{"trials":2523,"activeCount":247,"soonestReadout":1294},[2524],{"nctId":1304,"briefTitle":1305,"status":227,"phases":2525,"primaryCompletion":1294,"completion":1307,"start":1308,"enrollment":197,"conditions":2526,"interventions":2527},[90,91],[1298],[1282,1311],{"trials":2529,"activeCount":100},[],{"trials":2531,"activeCount":100},[],{"intervention":2533,"totalTrials":247,"cells":2534},"pentoxyifylline",{"EARLY_PHASE1":2535,"PHASE1":2537,"PHASE2":2539,"PHASE3":2541,"PHASE4":2554,"NA":2556},{"trials":2536,"activeCount":100},[],{"trials":2538,"activeCount":100},[],{"trials":2540,"activeCount":100},[],{"trials":2542,"activeCount":247,"soonestReadout":1202},[2543],{"nctId":2544,"briefTitle":2545,"status":227,"phases":2546,"primaryCompletion":1202,"completion":2547,"start":2548,"enrollment":197,"conditions":2549,"interventions":2551},"NCT04217733","Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome",[91],"2030-12-30","2019-11-01",[2550],"IBS - Irritable Bowel Syndrome",[2533,2552,2553],"Mebeverine","ethosuximide",{"trials":2555,"activeCount":100},[],{"trials":2557,"activeCount":100},[],{"intervention":2552,"totalTrials":247,"cells":2559},{"EARLY_PHASE1":2560,"PHASE1":2562,"PHASE2":2564,"PHASE3":2566,"PHASE4":2572,"NA":2574},{"trials":2561,"activeCount":100},[],{"trials":2563,"activeCount":100},[],{"trials":2565,"activeCount":100},[],{"trials":2567,"activeCount":247,"soonestReadout":1202},[2568],{"nctId":2544,"briefTitle":2545,"status":227,"phases":2569,"primaryCompletion":1202,"completion":2547,"start":2548,"enrollment":197,"conditions":2570,"interventions":2571},[91],[2550],[2533,2552,2553],{"trials":2573,"activeCount":100},[],{"trials":2575,"activeCount":100},[],{"intervention":2553,"totalTrials":247,"cells":2577},{"EARLY_PHASE1":2578,"PHASE1":2580,"PHASE2":2582,"PHASE3":2584,"PHASE4":2590,"NA":2592},{"trials":2579,"activeCount":100},[],{"trials":2581,"activeCount":100},[],{"trials":2583,"activeCount":100},[],{"trials":2585,"activeCount":247,"soonestReadout":1202},[2586],{"nctId":2544,"briefTitle":2545,"status":227,"phases":2587,"primaryCompletion":1202,"completion":2547,"start":2548,"enrollment":197,"conditions":2588,"interventions":2589},[91],[2550],[2533,2552,2553],{"trials":2591,"activeCount":100},[],{"trials":2593,"activeCount":100},[],{"intervention":2595,"totalTrials":247,"cells":2596},"Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers",{"EARLY_PHASE1":2597,"PHASE1":2599,"PHASE2":2601,"PHASE3":2603,"PHASE4":2612,"NA":2614},{"trials":2598,"activeCount":100},[],{"trials":2600,"activeCount":100},[],{"trials":2602,"activeCount":100},[],{"trials":2604,"activeCount":247,"soonestReadout":1884},[2605],{"nctId":2606,"briefTitle":2607,"status":227,"phases":2608,"primaryCompletion":1884,"completion":1884,"start":1657,"enrollment":1249,"conditions":2609,"interventions":2611},"NCT05576818","Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease",[91],[2610],"Parkinson's Disease",[2595],{"trials":2613,"activeCount":100},[],{"trials":2615,"activeCount":100},[],{"intervention":1919,"totalTrials":247,"cells":2617},{"EARLY_PHASE1":2618,"PHASE1":2620,"PHASE2":2622,"PHASE3":2624,"PHASE4":2630,"NA":2632},{"trials":2619,"activeCount":100},[],{"trials":2621,"activeCount":100},[],{"trials":2623,"activeCount":100},[],{"trials":2625,"activeCount":247,"soonestReadout":1916},[2626],{"nctId":1913,"briefTitle":1914,"status":227,"phases":2627,"primaryCompletion":1916,"completion":1567,"start":901,"enrollment":1510,"conditions":2628,"interventions":2629},[90,91],[1298],[1919,1744],{"trials":2631,"activeCount":100},[],{"trials":2633,"activeCount":100},[],{"intervention":2294,"totalTrials":247,"cells":2635},{"EARLY_PHASE1":2636,"PHASE1":2638,"PHASE2":2640,"PHASE3":2642,"PHASE4":2648,"NA":2650},{"trials":2637,"activeCount":100},[],{"trials":2639,"activeCount":100},[],{"trials":2641,"activeCount":100},[],{"trials":2643,"activeCount":247,"soonestReadout":2118},[2644],{"nctId":2289,"briefTitle":2290,"status":227,"phases":2645,"primaryCompletion":2118,"completion":2118,"start":962,"enrollment":128,"conditions":2646,"interventions":2647},[91],[1186],[1188,2294],{"trials":2649,"activeCount":100},[],{"trials":2651,"activeCount":100},[],{"intervention":2653,"totalTrials":247,"cells":2654},"Dantrolene",{"EARLY_PHASE1":2655,"PHASE1":2657,"PHASE2":2659,"PHASE3":2661,"PHASE4":2674,"NA":2676},{"trials":2656,"activeCount":100},[],{"trials":2658,"activeCount":100},[],{"trials":2660,"activeCount":100},[],{"trials":2662,"activeCount":247,"soonestReadout":2667},[2663],{"nctId":2664,"briefTitle":2665,"status":153,"phases":2666,"primaryCompletion":2667,"completion":2668,"start":2669,"enrollment":2670,"conditions":2671,"interventions":2673},"NCT06966843","Dantrolene in Statin-induced Myopathy",[90,91],"2029-01","2030-03","2027-10",23,[2672],"Statins Induced Myopathy",[2653],{"trials":2675,"activeCount":100},[],{"trials":2677,"activeCount":100},[],{"intervention":2679,"totalTrials":247,"cells":2680},"Duloxetine",{"EARLY_PHASE1":2681,"PHASE1":2683,"PHASE2":2685,"PHASE3":2687,"PHASE4":2697,"NA":2699},{"trials":2682,"activeCount":100},[],{"trials":2684,"activeCount":100},[],{"trials":2686,"activeCount":100},[],{"trials":2688,"activeCount":247,"soonestReadout":2693},[2689],{"nctId":2690,"briefTitle":2691,"status":227,"phases":2692,"primaryCompletion":2693,"completion":462,"start":71,"enrollment":590,"conditions":2694,"interventions":2696},"NCT06860984","Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis",[91],"2026-06-20",[2695],"Biliary Disease",[2679],{"trials":2698,"activeCount":100},[],{"trials":2700,"activeCount":100},[],{"intervention":2702,"totalTrials":247,"cells":2703},"Cyanocobalamin 1000 Mcg Oral",{"EARLY_PHASE1":2704,"PHASE1":2706,"PHASE2":2708,"PHASE3":2710,"PHASE4":2721,"NA":2723},{"trials":2705,"activeCount":100},[],{"trials":2707,"activeCount":100},[],{"trials":2709,"activeCount":100},[],{"trials":2711,"activeCount":247,"soonestReadout":2119},[2712],{"nctId":2713,"briefTitle":2714,"status":153,"phases":2715,"primaryCompletion":2119,"completion":1836,"start":2716,"enrollment":2670,"conditions":2717,"interventions":2719},"NCT06966856","This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week",[91],"2026-12-30",[2718],"Hypovitaminosis b 12",[2702,2720],"Cyanocobalamin 1000 Mcg Sublingual",{"trials":2722,"activeCount":100},[],{"trials":2724,"activeCount":100},[],{"intervention":2720,"totalTrials":247,"cells":2726},{"EARLY_PHASE1":2727,"PHASE1":2729,"PHASE2":2731,"PHASE3":2733,"PHASE4":2739,"NA":2741},{"trials":2728,"activeCount":100},[],{"trials":2730,"activeCount":100},[],{"trials":2732,"activeCount":100},[],{"trials":2734,"activeCount":247,"soonestReadout":2119},[2735],{"nctId":2713,"briefTitle":2714,"status":153,"phases":2736,"primaryCompletion":2119,"completion":1836,"start":2716,"enrollment":2670,"conditions":2737,"interventions":2738},[91],[2718],[2702,2720],{"trials":2740,"activeCount":100},[],{"trials":2742,"activeCount":100},[],{"intervention":2744,"totalTrials":247,"cells":2745},"Vardenafil 5 Mg Oral",{"EARLY_PHASE1":2746,"PHASE1":2748,"PHASE2":2750,"PHASE3":2752,"PHASE4":2761,"NA":2763},{"trials":2747,"activeCount":100},[],{"trials":2749,"activeCount":100},[],{"trials":2751,"activeCount":100},[],{"trials":2753,"activeCount":247,"soonestReadout":1109},[2754],{"nctId":2755,"briefTitle":2756,"status":227,"phases":2757,"primaryCompletion":1109,"completion":1109,"start":2087,"enrollment":724,"conditions":2758,"interventions":2760},"NCT06491108","Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia",[91],[2759],"Enlarged Prostate With Lower Urinary Tract Symptoms",[2744],{"trials":2762,"activeCount":100},[],{"trials":2764,"activeCount":100},[],{"intervention":2766,"totalTrials":247,"cells":2767},"Bupivacaine + Magnesium sulfate",{"EARLY_PHASE1":2768,"PHASE1":2770,"PHASE2":2772,"PHASE3":2774,"PHASE4":2787,"NA":2789},{"trials":2769,"activeCount":100},[],{"trials":2771,"activeCount":100},[],{"trials":2773,"activeCount":100},[],{"trials":2775,"activeCount":247,"soonestReadout":2780},[2776],{"nctId":2777,"briefTitle":2778,"status":227,"phases":2779,"primaryCompletion":2780,"completion":2781,"start":2782,"enrollment":157,"conditions":2783,"interventions":2785},"NCT06956950","Magnesium Sulfate in Addition to Bupivacaine in Ultrasound-guided Transmuscular Quadratus Lumborum Block for Post-Operative Analgesia After Total Hip Arthroplasty",[90,91],"2025-10-09","2025-11","2025-05",[2784],"Pain Score Reduction",[2766,2786],"Bupivacaine + saline",{"trials":2788,"activeCount":100},[],{"trials":2790,"activeCount":100},[],{"intervention":2786,"totalTrials":247,"cells":2792},{"EARLY_PHASE1":2793,"PHASE1":2795,"PHASE2":2797,"PHASE3":2799,"PHASE4":2805,"NA":2807},{"trials":2794,"activeCount":100},[],{"trials":2796,"activeCount":100},[],{"trials":2798,"activeCount":100},[],{"trials":2800,"activeCount":247,"soonestReadout":2780},[2801],{"nctId":2777,"briefTitle":2778,"status":227,"phases":2802,"primaryCompletion":2780,"completion":2781,"start":2782,"enrollment":157,"conditions":2803,"interventions":2804},[90,91],[2784],[2766,2786],{"trials":2806,"activeCount":100},[],{"trials":2808,"activeCount":100},[],{"intervention":2810,"totalTrials":247,"cells":2811},"zinc sulfate",{"EARLY_PHASE1":2812,"PHASE1":2814,"PHASE2":2816,"PHASE3":2818,"PHASE4":2830,"NA":2832},{"trials":2813,"activeCount":100},[],{"trials":2815,"activeCount":100},[],{"trials":2817,"activeCount":100},[],{"trials":2819,"activeCount":247,"soonestReadout":155},[2820],{"nctId":2821,"briefTitle":2822,"status":153,"phases":2823,"primaryCompletion":155,"completion":852,"start":723,"enrollment":2824,"conditions":2825,"interventions":2827},"NCT07275827","Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection",[91],88,[2826],"HELICOBACTER PYLORI INFECTIONS",[2810,2828,2829],"Vonoprazan + amoxicillin + clarithromycin","proton pump inhibitor + amoxicillin",{"trials":2831,"activeCount":100},[],{"trials":2833,"activeCount":100},[],{"intervention":2828,"totalTrials":247,"cells":2835},{"EARLY_PHASE1":2836,"PHASE1":2838,"PHASE2":2840,"PHASE3":2842,"PHASE4":2848,"NA":2850},{"trials":2837,"activeCount":100},[],{"trials":2839,"activeCount":100},[],{"trials":2841,"activeCount":100},[],{"trials":2843,"activeCount":247,"soonestReadout":155},[2844],{"nctId":2821,"briefTitle":2822,"status":153,"phases":2845,"primaryCompletion":155,"completion":852,"start":723,"enrollment":2824,"conditions":2846,"interventions":2847},[91],[2826],[2810,2828,2829],{"trials":2849,"activeCount":100},[],{"trials":2851,"activeCount":100},[],{"intervention":2829,"totalTrials":247,"cells":2853},{"EARLY_PHASE1":2854,"PHASE1":2856,"PHASE2":2858,"PHASE3":2860,"PHASE4":2866,"NA":2868},{"trials":2855,"activeCount":100},[],{"trials":2857,"activeCount":100},[],{"trials":2859,"activeCount":100},[],{"trials":2861,"activeCount":247,"soonestReadout":155},[2862],{"nctId":2821,"briefTitle":2822,"status":153,"phases":2863,"primaryCompletion":155,"completion":852,"start":723,"enrollment":2824,"conditions":2864,"interventions":2865},[91],[2826],[2810,2828,2829],{"trials":2867,"activeCount":100},[],{"trials":2869,"activeCount":100},[],{"intervention":2871,"totalTrials":247,"cells":2872},"propranolol",{"EARLY_PHASE1":2873,"PHASE1":2875,"PHASE2":2877,"PHASE3":2879,"PHASE4":2892,"NA":2894},{"trials":2874,"activeCount":100},[],{"trials":2876,"activeCount":100},[],{"trials":2878,"activeCount":100},[],{"trials":2880,"activeCount":247,"soonestReadout":2885},[2881],{"nctId":2882,"briefTitle":2883,"status":153,"phases":2884,"primaryCompletion":2885,"completion":2885,"start":2885,"enrollment":197,"conditions":2886,"interventions":2890},"NCT06870370","Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI",[91],"2025-09-20",[2887,2888,1072,2889],"Traumatic Brain Injury (TBI) Patients","Intracranial Pressure","Mortality",[2871,2891],"normal saline IV",{"trials":2893,"activeCount":100},[],{"trials":2895,"activeCount":100},[],{"intervention":2891,"totalTrials":247,"cells":2897},{"EARLY_PHASE1":2898,"PHASE1":2900,"PHASE2":2902,"PHASE3":2904,"PHASE4":2910,"NA":2912},{"trials":2899,"activeCount":100},[],{"trials":2901,"activeCount":100},[],{"trials":2903,"activeCount":100},[],{"trials":2905,"activeCount":247,"soonestReadout":2885},[2906],{"nctId":2882,"briefTitle":2883,"status":153,"phases":2907,"primaryCompletion":2885,"completion":2885,"start":2885,"enrollment":197,"conditions":2908,"interventions":2909},[91],[2887,2888,1072,2889],[2871,2891],{"trials":2911,"activeCount":100},[],{"trials":2913,"activeCount":100},[],{"intervention":1790,"totalTrials":247,"cells":2915},{"EARLY_PHASE1":2916,"PHASE1":2918,"PHASE2":2920,"PHASE3":2922,"PHASE4":2928,"NA":2930},{"trials":2917,"activeCount":100},[],{"trials":2919,"activeCount":100},[],{"trials":2921,"activeCount":100},[],{"trials":2923,"activeCount":247,"soonestReadout":1786},[2924],{"nctId":1783,"briefTitle":1784,"status":153,"phases":2925,"primaryCompletion":1786,"completion":1786,"start":1787,"enrollment":197,"conditions":2926,"interventions":2927},[91],[1206],[1790,1768],{"trials":2929,"activeCount":100},[],{"trials":2931,"activeCount":100},[],{"intervention":1718,"totalTrials":247,"cells":2933},{"EARLY_PHASE1":2934,"PHASE1":2936,"PHASE2":2938,"PHASE3":2940,"PHASE4":2946,"NA":2948},{"trials":2935,"activeCount":100},[],{"trials":2937,"activeCount":100},[],{"trials":2939,"activeCount":100},[],{"trials":2941,"activeCount":247,"soonestReadout":1714},[2942],{"nctId":1711,"briefTitle":1712,"status":460,"phases":2943,"primaryCompletion":1714,"completion":1715,"start":1407,"enrollment":184,"conditions":2944,"interventions":2945},[91],[114],[1718,1690],{"trials":2947,"activeCount":100},[],{"trials":2949,"activeCount":100},[],{"intervention":1218,"totalTrials":247,"cells":2951},{"EARLY_PHASE1":2952,"PHASE1":2954,"PHASE2":2956,"PHASE3":2958,"PHASE4":2964,"NA":2966},{"trials":2953,"activeCount":100},[],{"trials":2955,"activeCount":100},[],{"trials":2957,"activeCount":100},[],{"trials":2959,"activeCount":247,"soonestReadout":1213},[2960],{"nctId":1210,"briefTitle":1211,"status":227,"phases":2961,"primaryCompletion":1213,"completion":1202,"start":1214,"enrollment":184,"conditions":2962,"interventions":2963},[91],[1216],[1138,1218,1219,1220],{"trials":2965,"activeCount":100},[],{"trials":2967,"activeCount":100},[],{"intervention":1219,"totalTrials":247,"cells":2969},{"EARLY_PHASE1":2970,"PHASE1":2972,"PHASE2":2974,"PHASE3":2976,"PHASE4":2982,"NA":2984},{"trials":2971,"activeCount":100},[],{"trials":2973,"activeCount":100},[],{"trials":2975,"activeCount":100},[],{"trials":2977,"activeCount":247,"soonestReadout":1213},[2978],{"nctId":1210,"briefTitle":1211,"status":227,"phases":2979,"primaryCompletion":1213,"completion":1202,"start":1214,"enrollment":184,"conditions":2980,"interventions":2981},[91],[1216],[1138,1218,1219,1220],{"trials":2983,"activeCount":100},[],{"trials":2985,"activeCount":100},[],{"intervention":176,"totalTrials":188,"cells":2987},{"EARLY_PHASE1":2988,"PHASE1":2990,"PHASE2":2992,"PHASE3":2994,"PHASE4":3000,"NA":3002},{"trials":2989,"activeCount":100},[],{"trials":2991,"activeCount":100},[],{"trials":2993,"activeCount":100},[],{"trials":2995,"activeCount":247,"soonestReadout":168},[2996],{"nctId":165,"briefTitle":166,"status":153,"phases":2997,"primaryCompletion":168,"completion":169,"start":170,"enrollment":171,"conditions":2998,"interventions":2999},[91],[173,174],[176,15,177],{"trials":3001,"activeCount":100},[],{"trials":3003,"activeCount":100},[3004],{"nctId":270,"briefTitle":271,"status":106,"phases":3005,"primaryCompletion":61,"completion":61,"start":273,"enrollment":274,"conditions":3006,"interventions":3007},[93],[15,276,277,278,24,279],[281,15,176],{"intervention":3009,"totalTrials":1139,"cells":3010},"Mesalamine",{"EARLY_PHASE1":3011,"PHASE1":3020,"PHASE2":3022,"PHASE3":3058,"PHASE4":3067,"NA":3069},{"trials":3012,"activeCount":247,"soonestReadout":614},[3013],{"nctId":3014,"briefTitle":3015,"status":153,"phases":3016,"primaryCompletion":614,"completion":2716,"start":51,"enrollment":1510,"conditions":3017,"interventions":3018},"NCT06525974","Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine",[88],[1237],[3019,3009],"Febuxostat",{"trials":3021,"activeCount":100},[],{"trials":3023,"activeCount":188,"soonestReadout":2782},[3024,3032,3040,3051],{"nctId":3025,"briefTitle":3026,"status":106,"phases":3027,"primaryCompletion":1066,"completion":1066,"start":3028,"enrollment":402,"conditions":3029,"interventions":3030},"NCT05567068","Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis",[90],"2023-02-01",[1494],[3031,3009],"Atorvastatin 80mg",{"nctId":3033,"briefTitle":3034,"status":106,"phases":3035,"primaryCompletion":254,"completion":1735,"start":3036,"enrollment":197,"conditions":3037,"interventions":3038},"NCT05781698","Repurposing Fenofibrate in Modulating mTOR\u002FNLRP3 Inflammasome in Patients With Ulcerative Colitis",[90],"2023-03-20",[1494],[3009,3039],"Fenofibrate",{"nctId":3041,"briefTitle":3042,"status":227,"phases":3043,"primaryCompletion":3044,"completion":2095,"start":3045,"enrollment":590,"conditions":3046,"interventions":3048},"NCT07333716","Desloratadine in Patients With Ulcerative Colitis",[90],"2027-02","2026-01-26",[3047,1237],"Ulcerative Colitis (UC)",[3049,3050],"Desloratadine","mesalamine",{"nctId":3052,"briefTitle":3053,"status":227,"phases":3054,"primaryCompletion":2782,"completion":1884,"start":61,"enrollment":590,"conditions":3055,"interventions":3056},"NCT06213857","Beneficial Effect of Silymarin in Ulcerative Colitis",[90],[1237],[3009,3057],"Azathioprine",{"trials":3059,"activeCount":100},[3060],{"nctId":3061,"briefTitle":3062,"status":106,"phases":3063,"primaryCompletion":2885,"completion":2885,"start":2078,"enrollment":197,"conditions":3064,"interventions":3065},"NCT05753267","Fenofibrate in Ulcerative Colitis",[90,91],[1494],[3009,3066],"Fenofibrate 160mg",{"trials":3068,"activeCount":100},[],{"trials":3070,"activeCount":100},[3071],{"nctId":3072,"briefTitle":3073,"status":106,"phases":3074,"primaryCompletion":1378,"completion":1378,"start":206,"enrollment":157,"conditions":3075,"interventions":3078},"NCT07180186","Microbiota and Probiotic Therapy in Ulcerative Colitis Patients",[],[3076,3077,1237],"Microbiota","Probiotic Therapy",[3009,3079,3080],"Probiotics","Mesalamine and probiotics",{"intervention":3082,"totalTrials":111,"cells":3083},"Silymarin",{"EARLY_PHASE1":3084,"PHASE1":3086,"PHASE2":3088,"PHASE3":3105,"PHASE4":3127,"NA":3129},{"trials":3085,"activeCount":100},[],{"trials":3087,"activeCount":100},[],{"trials":3089,"activeCount":188,"soonestReadout":1616},[3090,3098],{"nctId":3091,"briefTitle":3092,"status":153,"phases":3093,"primaryCompletion":1508,"completion":3094,"start":3095,"enrollment":1249,"conditions":3096,"interventions":3097},"NCT07572552","Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With Sepsis",[90],"2028-04","2026-05",[27],[3039,3082],{"nctId":3099,"briefTitle":3100,"status":227,"phases":3101,"primaryCompletion":1616,"completion":1616,"start":3102,"enrollment":1618,"conditions":3103,"interventions":3104},"NCT07001150","Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease",[90],"2025-05-10",[1298],[1521,3082],{"trials":3106,"activeCount":100},[3107,3120],{"nctId":3108,"briefTitle":3109,"status":123,"phases":3110,"primaryCompletion":3111,"completion":3112,"start":3113,"enrollment":3114,"conditions":3115,"interventions":3119},"NCT05595109","Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients",[90,91],"2023-04-28","2024-10-28","2022-10-28",56,[726,617,3116,3117,3118],"Cardiac Toxicities","Hepatic Toxicity","Cognitive Impairment",[3082],{"nctId":3121,"briefTitle":3122,"status":123,"phases":3123,"primaryCompletion":2221,"completion":2086,"start":3124,"enrollment":1886,"conditions":3125,"interventions":3126},"NCT05631041","Effect of Silymarin in Metastatic Colorectal Cancer Patients",[91],"2022-12-31",[1196],[3082],{"trials":3128,"activeCount":100},[],{"trials":3130,"activeCount":100},[],{"intervention":3132,"totalTrials":188,"cells":3133},"vit E",{"EARLY_PHASE1":3134,"PHASE1":3136,"PHASE2":3138,"PHASE3":3163,"PHASE4":3165,"NA":3167},{"trials":3135,"activeCount":100},[],{"trials":3137,"activeCount":100},[],{"trials":3139,"activeCount":188,"soonestReadout":1616},[3140,3151],{"nctId":3141,"briefTitle":3142,"status":460,"phases":3143,"primaryCompletion":1616,"completion":3144,"start":3145,"enrollment":157,"conditions":3146,"interventions":3149},"NCT05574036","Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia",[90],"2026-12-25","2022-08-25",[3147,3148],"Non Alcoholic Steatohepatitis","Hyperuricemia",[3150,3132],"Febuxostat 80 MG Oral",{"nctId":3152,"briefTitle":3153,"status":460,"phases":3154,"primaryCompletion":3155,"completion":2716,"start":3156,"enrollment":3157,"conditions":3158,"interventions":3160},"NCT05573204","Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis",[90],"2026-10-25","2021-09-01",59,[3159],"Non-alcoholic Steatohepatitis",[3161,3162],"Obeticholic Acid Oral","Vit E",{"trials":3164,"activeCount":100},[],{"trials":3166,"activeCount":100},[],{"trials":3168,"activeCount":100},[],{"intervention":3170,"totalTrials":513,"cells":3171},"Vitamin D",{"EARLY_PHASE1":3172,"PHASE1":3174,"PHASE2":3176,"PHASE3":3193,"PHASE4":3195,"NA":3217},{"trials":3173,"activeCount":100},[],{"trials":3175,"activeCount":100},[],{"trials":3177,"activeCount":247,"soonestReadout":1567},[3178],{"nctId":3179,"briefTitle":3180,"status":227,"phases":3181,"primaryCompletion":1567,"completion":1567,"start":3182,"enrollment":1249,"conditions":3183,"interventions":3187},"NCT07293910","Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection",[90],"2026-02-15",[2826,3184,3185,3186],"Helicobacter Infection","Helicobacter Pylori Gastrointestinal Tract Infection","Helicobacter Pylori Infected Patients",[3188,3170,3189,3190,3191,3192],"Vonoparazan","Probiotic","Amoxicillin","Clarithromycin 500 mg","Proton Pump Inhibitor (PPI) Therapy",{"trials":3194,"activeCount":100},[],{"trials":3196,"activeCount":100},[3197,3207],{"nctId":3198,"briefTitle":3199,"status":106,"phases":3200,"primaryCompletion":3201,"completion":1942,"start":3202,"enrollment":3203,"conditions":3204,"interventions":3206},"NCT03898934","Vitamin D Supplementation in PCOS Patients",[92],"2022-03-30","2019-04-01",170,[3205],"PCOS",[3170],{"nctId":3208,"briefTitle":3209,"status":106,"phases":3210,"primaryCompletion":3211,"completion":3212,"start":3213,"enrollment":590,"conditions":3214,"interventions":3216},"NCT07241247","Evaluation the of Role of Vitamin D Supplement on Tumor Response, Inflammation and Apoptosis in Patients With Stage II or III Colorectal Cancer Receiving Chemotherapy.",[92],"2025-06-10","2025-10-10","2024-07-31",[3215,1603],"Vitamin D on Tumor Response and Inflammatory Markers",[3170],{"trials":3218,"activeCount":100},[],{"intervention":1661,"totalTrials":513,"cells":3220},{"EARLY_PHASE1":3221,"PHASE1":3223,"PHASE2":3225,"PHASE3":3235,"PHASE4":3250,"NA":3252},{"trials":3222,"activeCount":100},[],{"trials":3224,"activeCount":100},[],{"trials":3226,"activeCount":247,"soonestReadout":3231},[3227],{"nctId":3228,"briefTitle":3229,"status":153,"phases":3230,"primaryCompletion":3231,"completion":1109,"start":1067,"enrollment":590,"conditions":3232,"interventions":3234},"NCT06449508","The Effectiveness of Probiotics in Neonatal Jaundice",[89,90],"2025-06-20",[3233],"Jaundice, Neonatal",[1661],{"trials":3236,"activeCount":100},[3237,3246],{"nctId":3238,"briefTitle":3239,"status":123,"phases":3240,"primaryCompletion":3241,"completion":1884,"start":1657,"enrollment":171,"conditions":3242,"interventions":3244},"NCT05682807","Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia",[91],"2024-06",[3243],"Bronchopulmonary Dysplasia",[3245,1661],"Caffeine",{"nctId":1653,"briefTitle":1654,"status":106,"phases":3247,"primaryCompletion":451,"completion":1656,"start":1657,"enrollment":274,"conditions":3248,"interventions":3249},[91],[1659],[1069,1661],{"trials":3251,"activeCount":100},[],{"trials":3253,"activeCount":100},[],{"intervention":3255,"totalTrials":513,"cells":3256},"Pentoxifylline 400 MG",{"EARLY_PHASE1":3257,"PHASE1":3259,"PHASE2":3261,"PHASE3":3279,"PHASE4":3291,"NA":3293},{"trials":3258,"activeCount":100},[],{"trials":3260,"activeCount":100},[],{"trials":3262,"activeCount":247,"soonestReadout":3275},[3263,3271],{"nctId":3264,"briefTitle":3265,"status":106,"phases":3266,"primaryCompletion":3267,"completion":3267,"start":3268,"enrollment":1618,"conditions":3269,"interventions":3270},"NCT05558761","Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis",[90],"2024-04-20","2022-10-10",[1494],[3255],{"nctId":3272,"briefTitle":3273,"status":227,"phases":3274,"primaryCompletion":3275,"completion":3275,"start":3276,"enrollment":590,"conditions":3277,"interventions":3278},"NCT05575505","Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.",[90],"2026-02","2023-02-02",[1494],[3255],{"trials":3280,"activeCount":100},[3281],{"nctId":3282,"briefTitle":3283,"status":106,"phases":3284,"primaryCompletion":1194,"completion":1751,"start":3285,"enrollment":171,"conditions":3286,"interventions":3288},"NCT05487755","Investigational and Comparative Study in the Management of Diabetic Nephropathy",[91],"2022-02-01",[3287],"Diabetic Nephropathy Type 2",[3289,3290],"Tadalafil 20Mg Oral","Pentoxifylline 400 MG Oral",{"trials":3292,"activeCount":100},[],{"trials":3294,"activeCount":100},[],{"intervention":1300,"totalTrials":188,"cells":3296},{"EARLY_PHASE1":3297,"PHASE1":3299,"PHASE2":3301,"PHASE3":3307,"PHASE4":3321,"NA":3323},{"trials":3298,"activeCount":100},[],{"trials":3300,"activeCount":100},[],{"trials":3302,"activeCount":247,"soonestReadout":1294},[3303],{"nctId":1291,"briefTitle":1292,"status":227,"phases":3304,"primaryCompletion":1294,"completion":1295,"start":1296,"enrollment":128,"conditions":3305,"interventions":3306},[89,90],[1298],[1282,1300],{"trials":3308,"activeCount":100},[3309],{"nctId":3310,"briefTitle":3311,"status":123,"phases":3312,"primaryCompletion":332,"completion":85,"start":3313,"enrollment":590,"conditions":3314,"interventions":3319},"NCT05327751","Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer",[91],"2022-04-01",[3315,3316,3317,3318],"Hand and Foot Syndrome","Erythrodysesthesia Syndrome","HFS","Colorectal Cancer",[1300,3320],"Capecitabine-based chemotherapy",{"trials":3322,"activeCount":100},[],{"trials":3324,"activeCount":100},[],{"intervention":1621,"totalTrials":188,"cells":3326},{"EARLY_PHASE1":3327,"PHASE1":3329,"PHASE2":3331,"PHASE3":3337,"PHASE4":3346,"NA":3348},{"trials":3328,"activeCount":100},[],{"trials":3330,"activeCount":100},[],{"trials":3332,"activeCount":247,"soonestReadout":1616},[3333],{"nctId":1613,"briefTitle":1614,"status":227,"phases":3334,"primaryCompletion":1616,"completion":614,"start":1617,"enrollment":1618,"conditions":3335,"interventions":3336},[90],[566],[1621,1069],{"trials":3338,"activeCount":100},[3339],{"nctId":3340,"briefTitle":3341,"status":123,"phases":3342,"primaryCompletion":368,"completion":368,"start":483,"enrollment":157,"conditions":3343,"interventions":3344},"NCT05594680","Cilostazol and Methotrexate in Rheumatoid Arthritis",[91],[566],[3345,1621],"Cilostazol",{"trials":3347,"activeCount":100},[],{"trials":3349,"activeCount":100},[],{"intervention":3345,"totalTrials":188,"cells":3351},{"EARLY_PHASE1":3352,"PHASE1":3354,"PHASE2":3356,"PHASE3":3365,"PHASE4":3371,"NA":3373},{"trials":3353,"activeCount":100},[],{"trials":3355,"activeCount":100},[],{"trials":3357,"activeCount":247,"soonestReadout":1294},[3358],{"nctId":3359,"briefTitle":3360,"status":227,"phases":3361,"primaryCompletion":1294,"completion":1294,"start":1568,"enrollment":1618,"conditions":3362,"interventions":3364},"NCT07238985","Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease",[89,90],[3363],"Fatty Liver",[3345],{"trials":3366,"activeCount":100},[3367],{"nctId":3340,"briefTitle":3341,"status":123,"phases":3368,"primaryCompletion":368,"completion":368,"start":483,"enrollment":157,"conditions":3369,"interventions":3370},[91],[566],[3345,1621],{"trials":3372,"activeCount":100},[],{"trials":3374,"activeCount":100},[],{"intervention":3376,"totalTrials":188,"cells":3377},"Zinc",{"EARLY_PHASE1":3378,"PHASE1":3380,"PHASE2":3382,"PHASE3":3395,"PHASE4":3409,"NA":3411},{"trials":3379,"activeCount":100},[],{"trials":3381,"activeCount":100},[],{"trials":3383,"activeCount":247,"soonestReadout":3388},[3384],{"nctId":3385,"briefTitle":3386,"status":153,"phases":3387,"primaryCompletion":3388,"completion":2489,"start":3389,"enrollment":590,"conditions":3390,"interventions":3393},"NCT07145268","Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy",[90],"2026-09-01","2025-09-01",[3391,3392],"Liver Fibroses","HBV (Hepatitis B Virus)",[3394,3376],"Entecavir",{"trials":3396,"activeCount":100},[3397],{"nctId":3398,"briefTitle":3399,"status":106,"phases":3400,"primaryCompletion":3401,"completion":3402,"start":3403,"enrollment":3404,"conditions":3405,"interventions":3406},"NCT04447534","Zinc With Chloroquine\u002FHydroxychloroquine in Treatment of COVID-19",[91],"2020-07-15","2020-08-15","2020-06-23",191,[1206],[3407,3408],"Chloroquine or hydroxychloroquine","zinc",{"trials":3410,"activeCount":100},[],{"trials":3412,"activeCount":100},[],{"intervention":3039,"totalTrials":513,"cells":3414},{"EARLY_PHASE1":3415,"PHASE1":3417,"PHASE2":3419,"PHASE3":3439,"PHASE4":3441,"NA":3443},{"trials":3416,"activeCount":100},[],{"trials":3418,"activeCount":100},[],{"trials":3420,"activeCount":247,"soonestReadout":1508},[3421,3425,3435],{"nctId":3033,"briefTitle":3034,"status":106,"phases":3422,"primaryCompletion":254,"completion":1735,"start":3036,"enrollment":197,"conditions":3423,"interventions":3424},[90],[1494],[3009,3039],{"nctId":3426,"briefTitle":3427,"status":106,"phases":3428,"primaryCompletion":1151,"completion":1151,"start":3429,"enrollment":590,"conditions":3430,"interventions":3432},"NCT06155331","Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients",[90],"2023-12-01",[3431],"Breast Cancer Stage 2 and 3",[3039,3433,3434],"Doxorubicin","Cyclophosphamide",{"nctId":3091,"briefTitle":3092,"status":153,"phases":3436,"primaryCompletion":1508,"completion":3094,"start":3095,"enrollment":1249,"conditions":3437,"interventions":3438},[90],[27],[3039,3082],{"trials":3440,"activeCount":100},[],{"trials":3442,"activeCount":100},[],{"trials":3444,"activeCount":100},[],{"intervention":3446,"totalTrials":188,"cells":3447},"Dapagliflozin 10mg Tab",{"EARLY_PHASE1":3448,"PHASE1":3450,"PHASE2":3452,"PHASE3":3472,"PHASE4":3474,"NA":3476},{"trials":3449,"activeCount":100},[],{"trials":3451,"activeCount":100},[],{"trials":3453,"activeCount":247,"soonestReadout":1469},[3454,3464],{"nctId":3455,"briefTitle":3456,"status":106,"phases":3457,"primaryCompletion":3458,"completion":1735,"start":3459,"enrollment":274,"conditions":3460,"interventions":3462},"NCT05792540","Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders",[90],"2024-11-20","2023-06-06",[3461],"Depressive Disorder",[3463,3446,3031],"Fluoxetine 20 mg",{"nctId":3465,"briefTitle":3466,"status":227,"phases":3467,"primaryCompletion":1469,"completion":1469,"start":3468,"enrollment":1510,"conditions":3469,"interventions":3471},"NCT06427226","Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity",[90],"2024-10-31",[3470,726],"Doxorubicin Induced Cardiomyopathy",[3446],{"trials":3473,"activeCount":100},[],{"trials":3475,"activeCount":100},[],{"trials":3477,"activeCount":100},[],{"intervention":3433,"totalTrials":188,"cells":3479},{"EARLY_PHASE1":3480,"PHASE1":3482,"PHASE2":3484,"PHASE3":3499,"PHASE4":3501,"NA":3503},{"trials":3481,"activeCount":100},[],{"trials":3483,"activeCount":100},[],{"trials":3485,"activeCount":247,"soonestReadout":3494},[3486,3490],{"nctId":3426,"briefTitle":3427,"status":106,"phases":3487,"primaryCompletion":1151,"completion":1151,"start":3429,"enrollment":590,"conditions":3488,"interventions":3489},[90],[3431],[3039,3433,3434],{"nctId":3491,"briefTitle":3492,"status":153,"phases":3493,"primaryCompletion":3494,"completion":3044,"start":3275,"enrollment":3495,"conditions":3496,"interventions":3497},"NCT07370506","Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients",[89,90],"2027-01",36,[726,3470],[3498,3433],"Telmisartan",{"trials":3500,"activeCount":100},[],{"trials":3502,"activeCount":100},[],{"trials":3504,"activeCount":100},[],{"intervention":1521,"totalTrials":188,"cells":3506},{"EARLY_PHASE1":3507,"PHASE1":3509,"PHASE2":3511,"PHASE3":3521,"PHASE4":3523,"NA":3525},{"trials":3508,"activeCount":100},[],{"trials":3510,"activeCount":100},[],{"trials":3512,"activeCount":247,"soonestReadout":1616},[3513,3517],{"nctId":3099,"briefTitle":3100,"status":227,"phases":3514,"primaryCompletion":1616,"completion":1616,"start":3102,"enrollment":1618,"conditions":3515,"interventions":3516},[90],[1298],[1521,3082],{"nctId":1514,"briefTitle":1515,"status":106,"phases":3518,"primaryCompletion":1517,"completion":1517,"start":1518,"enrollment":197,"conditions":3519,"interventions":3520},[90],[1298],[1521,1276],{"trials":3522,"activeCount":100},[],{"trials":3524,"activeCount":100},[],{"trials":3526,"activeCount":100},[],{"intervention":3528,"totalTrials":247,"cells":3529},"Erdosteine",{"EARLY_PHASE1":3530,"PHASE1":3532,"PHASE2":3534,"PHASE3":3542,"PHASE4":3544,"NA":3546},{"trials":3531,"activeCount":100},[],{"trials":3533,"activeCount":100},[],{"trials":3535,"activeCount":247,"soonestReadout":1294},[3536],{"nctId":3537,"briefTitle":3538,"status":227,"phases":3539,"primaryCompletion":1294,"completion":1294,"start":1296,"enrollment":1618,"conditions":3540,"interventions":3541},"NCT07242222","Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease",[89,90],[3363],[3528],{"trials":3543,"activeCount":100},[],{"trials":3545,"activeCount":100},[],{"trials":3547,"activeCount":100},[],{"intervention":3549,"totalTrials":247,"cells":3550},"L-Carnitine Tartrate",{"EARLY_PHASE1":3551,"PHASE1":3553,"PHASE2":3555,"PHASE3":3565,"PHASE4":3567,"NA":3569},{"trials":3552,"activeCount":100},[],{"trials":3554,"activeCount":100},[],{"trials":3556,"activeCount":247,"soonestReadout":1350},[3557],{"nctId":3558,"briefTitle":3559,"status":227,"phases":3560,"primaryCompletion":1350,"completion":1761,"start":3561,"enrollment":1510,"conditions":3562,"interventions":3564},"NCT07108777","L-Carnitine Protective Effect in Nephrotoxicity",[90],"2025-08-10",[3563],"Nephrotoxicity",[3549],{"trials":3566,"activeCount":100},[],{"trials":3568,"activeCount":100},[],{"trials":3570,"activeCount":100},[],{"intervention":3188,"totalTrials":247,"cells":3572},{"EARLY_PHASE1":3573,"PHASE1":3575,"PHASE2":3577,"PHASE3":3583,"PHASE4":3585,"NA":3587},{"trials":3574,"activeCount":100},[],{"trials":3576,"activeCount":100},[],{"trials":3578,"activeCount":247,"soonestReadout":1567},[3579],{"nctId":3179,"briefTitle":3180,"status":227,"phases":3580,"primaryCompletion":1567,"completion":1567,"start":3182,"enrollment":1249,"conditions":3581,"interventions":3582},[90],[2826,3184,3185,3186],[3188,3170,3189,3190,3191,3192],{"trials":3584,"activeCount":100},[],{"trials":3586,"activeCount":100},[],{"trials":3588,"activeCount":100},[],{"intervention":3189,"totalTrials":247,"cells":3590},{"EARLY_PHASE1":3591,"PHASE1":3593,"PHASE2":3595,"PHASE3":3601,"PHASE4":3603,"NA":3605},{"trials":3592,"activeCount":100},[],{"trials":3594,"activeCount":100},[],{"trials":3596,"activeCount":247,"soonestReadout":1567},[3597],{"nctId":3179,"briefTitle":3180,"status":227,"phases":3598,"primaryCompletion":1567,"completion":1567,"start":3182,"enrollment":1249,"conditions":3599,"interventions":3600},[90],[2826,3184,3185,3186],[3188,3170,3189,3190,3191,3192],{"trials":3602,"activeCount":100},[],{"trials":3604,"activeCount":100},[],{"trials":3606,"activeCount":100},[],{"intervention":3190,"totalTrials":247,"cells":3608},{"EARLY_PHASE1":3609,"PHASE1":3611,"PHASE2":3613,"PHASE3":3619,"PHASE4":3621,"NA":3623},{"trials":3610,"activeCount":100},[],{"trials":3612,"activeCount":100},[],{"trials":3614,"activeCount":247,"soonestReadout":1567},[3615],{"nctId":3179,"briefTitle":3180,"status":227,"phases":3616,"primaryCompletion":1567,"completion":1567,"start":3182,"enrollment":1249,"conditions":3617,"interventions":3618},[90],[2826,3184,3185,3186],[3188,3170,3189,3190,3191,3192],{"trials":3620,"activeCount":100},[],{"trials":3622,"activeCount":100},[],{"trials":3624,"activeCount":100},[],{"intervention":3191,"totalTrials":247,"cells":3626},{"EARLY_PHASE1":3627,"PHASE1":3629,"PHASE2":3631,"PHASE3":3637,"PHASE4":3639,"NA":3641},{"trials":3628,"activeCount":100},[],{"trials":3630,"activeCount":100},[],{"trials":3632,"activeCount":247,"soonestReadout":1567},[3633],{"nctId":3179,"briefTitle":3180,"status":227,"phases":3634,"primaryCompletion":1567,"completion":1567,"start":3182,"enrollment":1249,"conditions":3635,"interventions":3636},[90],[2826,3184,3185,3186],[3188,3170,3189,3190,3191,3192],{"trials":3638,"activeCount":100},[],{"trials":3640,"activeCount":100},[],{"trials":3642,"activeCount":100},[],{"intervention":3192,"totalTrials":247,"cells":3644},{"EARLY_PHASE1":3645,"PHASE1":3647,"PHASE2":3649,"PHASE3":3655,"PHASE4":3657,"NA":3659},{"trials":3646,"activeCount":100},[],{"trials":3648,"activeCount":100},[],{"trials":3650,"activeCount":247,"soonestReadout":1567},[3651],{"nctId":3179,"briefTitle":3180,"status":227,"phases":3652,"primaryCompletion":1567,"completion":1567,"start":3182,"enrollment":1249,"conditions":3653,"interventions":3654},[90],[2826,3184,3185,3186],[3188,3170,3189,3190,3191,3192],{"trials":3656,"activeCount":100},[],{"trials":3658,"activeCount":100},[],{"trials":3660,"activeCount":100},[],{"intervention":3150,"totalTrials":247,"cells":3662},{"EARLY_PHASE1":3663,"PHASE1":3665,"PHASE2":3667,"PHASE3":3673,"PHASE4":3675,"NA":3677},{"trials":3664,"activeCount":100},[],{"trials":3666,"activeCount":100},[],{"trials":3668,"activeCount":247,"soonestReadout":1616},[3669],{"nctId":3141,"briefTitle":3142,"status":460,"phases":3670,"primaryCompletion":1616,"completion":3144,"start":3145,"enrollment":157,"conditions":3671,"interventions":3672},[90],[3147,3148],[3150,3132],{"trials":3674,"activeCount":100},[],{"trials":3676,"activeCount":100},[],{"trials":3678,"activeCount":100},[],{"intervention":3680,"totalTrials":247,"cells":3681},"Pentoxifylline 400mg plus chemotherapy",{"EARLY_PHASE1":3682,"PHASE1":3684,"PHASE2":3686,"PHASE3":3696,"PHASE4":3698,"NA":3700},{"trials":3683,"activeCount":100},[],{"trials":3685,"activeCount":100},[],{"trials":3687,"activeCount":247,"soonestReadout":3095},[3688],{"nctId":3689,"briefTitle":3690,"status":227,"phases":3691,"primaryCompletion":3095,"completion":563,"start":3692,"enrollment":1510,"conditions":3693,"interventions":3695},"NCT07137793","Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients",[90],"2025-05-25",[3694,726],"Doxorubicin Induced Cardiotoxicity",[3680],{"trials":3697,"activeCount":100},[],{"trials":3699,"activeCount":100},[],{"trials":3701,"activeCount":100},[],{"intervention":1572,"totalTrials":247,"cells":3703},{"EARLY_PHASE1":3704,"PHASE1":3706,"PHASE2":3708,"PHASE3":3714,"PHASE4":3716,"NA":3718},{"trials":3705,"activeCount":100},[],{"trials":3707,"activeCount":100},[],{"trials":3709,"activeCount":247,"soonestReadout":1294},[3710],{"nctId":1564,"briefTitle":1565,"status":227,"phases":3711,"primaryCompletion":1294,"completion":1567,"start":1568,"enrollment":197,"conditions":3712,"interventions":3713},[89,90],[1570],[1555,1572],{"trials":3715,"activeCount":100},[],{"trials":3717,"activeCount":100},[],{"trials":3719,"activeCount":100},[],{"intervention":3049,"totalTrials":247,"cells":3721},{"EARLY_PHASE1":3722,"PHASE1":3724,"PHASE2":3726,"PHASE3":3732,"PHASE4":3734,"NA":3736},{"trials":3723,"activeCount":100},[],{"trials":3725,"activeCount":100},[],{"trials":3727,"activeCount":247,"soonestReadout":3044},[3728],{"nctId":3041,"briefTitle":3042,"status":227,"phases":3729,"primaryCompletion":3044,"completion":2095,"start":3045,"enrollment":590,"conditions":3730,"interventions":3731},[90],[3047,1237],[3049,3050],{"trials":3733,"activeCount":100},[],{"trials":3735,"activeCount":100},[],{"trials":3737,"activeCount":100},[],{"intervention":3739,"totalTrials":247,"cells":3740},"Cabergoline",{"EARLY_PHASE1":3741,"PHASE1":3743,"PHASE2":3745,"PHASE3":3755,"PHASE4":3757,"NA":3759},{"trials":3742,"activeCount":100},[],{"trials":3744,"activeCount":100},[],{"trials":3746,"activeCount":247,"soonestReadout":2336},[3747],{"nctId":3748,"briefTitle":3749,"status":227,"phases":3750,"primaryCompletion":2336,"completion":1294,"start":3751,"enrollment":724,"conditions":3752,"interventions":3754},"NCT07043322","Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome",[90],"2025-06-30",[3753],"Gynecologic Disease",[3739],{"trials":3756,"activeCount":100},[],{"trials":3758,"activeCount":100},[],{"trials":3760,"activeCount":100},[],{"intervention":1254,"totalTrials":247,"cells":3762},{"EARLY_PHASE1":3763,"PHASE1":3765,"PHASE2":3767,"PHASE3":3773,"PHASE4":3775,"NA":3777},{"trials":3764,"activeCount":100},[],{"trials":3766,"activeCount":100},[],{"trials":3768,"activeCount":247,"soonestReadout":1248},[3769],{"nctId":1245,"briefTitle":1246,"status":227,"phases":3770,"primaryCompletion":1248,"completion":1248,"start":723,"enrollment":1249,"conditions":3771,"interventions":3772},[90],[1251],[1253,1254,1255],{"trials":3774,"activeCount":100},[],{"trials":3776,"activeCount":100},[],{"trials":3778,"activeCount":100},[],{"intervention":1255,"totalTrials":247,"cells":3780},{"EARLY_PHASE1":3781,"PHASE1":3783,"PHASE2":3785,"PHASE3":3791,"PHASE4":3793,"NA":3795},{"trials":3782,"activeCount":100},[],{"trials":3784,"activeCount":100},[],{"trials":3786,"activeCount":247,"soonestReadout":1248},[3787],{"nctId":1245,"briefTitle":1246,"status":227,"phases":3788,"primaryCompletion":1248,"completion":1248,"start":723,"enrollment":1249,"conditions":3789,"interventions":3790},[90],[1251],[1253,1254,1255],{"trials":3792,"activeCount":100},[],{"trials":3794,"activeCount":100},[],{"trials":3796,"activeCount":100},[],{"intervention":3798,"totalTrials":247,"cells":3799},"sodium valproate",{"EARLY_PHASE1":3800,"PHASE1":3802,"PHASE2":3804,"PHASE3":3817,"PHASE4":3819,"NA":3821},{"trials":3801,"activeCount":100},[],{"trials":3803,"activeCount":100},[],{"trials":3805,"activeCount":247,"soonestReadout":3810},[3806],{"nctId":3807,"briefTitle":3808,"status":460,"phases":3809,"primaryCompletion":3810,"completion":3811,"start":3812,"enrollment":3813,"conditions":3814,"interventions":3816},"NCT07487675","Evaluation of Intravenous Sodium Valproate on Interleukin-6 Levels in Patients With TMJ Disc Displacement",[90],"2025-05-06","2026-05-06","2024-09-29",10,[3815],"Temporomandibular Joint Internal Derangement (ADWR)",[3798],{"trials":3818,"activeCount":100},[],{"trials":3820,"activeCount":100},[],{"trials":3822,"activeCount":100},[],{"intervention":3161,"totalTrials":247,"cells":3824},{"EARLY_PHASE1":3825,"PHASE1":3827,"PHASE2":3829,"PHASE3":3835,"PHASE4":3837,"NA":3839},{"trials":3826,"activeCount":100},[],{"trials":3828,"activeCount":100},[],{"trials":3830,"activeCount":247,"soonestReadout":3155},[3831],{"nctId":3152,"briefTitle":3153,"status":460,"phases":3832,"primaryCompletion":3155,"completion":2716,"start":3156,"enrollment":3157,"conditions":3833,"interventions":3834},[90],[3159],[3161,3162],{"trials":3836,"activeCount":100},[],{"trials":3838,"activeCount":100},[],{"trials":3840,"activeCount":100},[],{"intervention":3057,"totalTrials":247,"cells":3842},{"EARLY_PHASE1":3843,"PHASE1":3845,"PHASE2":3847,"PHASE3":3853,"PHASE4":3855,"NA":3857},{"trials":3844,"activeCount":100},[],{"trials":3846,"activeCount":100},[],{"trials":3848,"activeCount":247,"soonestReadout":2782},[3849],{"nctId":3052,"briefTitle":3053,"status":227,"phases":3850,"primaryCompletion":2782,"completion":1884,"start":61,"enrollment":590,"conditions":3851,"interventions":3852},[90],[1237],[3009,3057],{"trials":3854,"activeCount":100},[],{"trials":3856,"activeCount":100},[],{"trials":3858,"activeCount":100},[],{"intervention":3394,"totalTrials":247,"cells":3860},{"EARLY_PHASE1":3861,"PHASE1":3863,"PHASE2":3865,"PHASE3":3871,"PHASE4":3873,"NA":3875},{"trials":3862,"activeCount":100},[],{"trials":3864,"activeCount":100},[],{"trials":3866,"activeCount":247,"soonestReadout":3388},[3867],{"nctId":3385,"briefTitle":3386,"status":153,"phases":3868,"primaryCompletion":3388,"completion":2489,"start":3389,"enrollment":590,"conditions":3869,"interventions":3870},[90],[3391,3392],[3394,3376],{"trials":3872,"activeCount":100},[],{"trials":3874,"activeCount":100},[],{"trials":3876,"activeCount":100},[],{"intervention":3878,"totalTrials":247,"cells":3879},"Carbocysteine 375 MG",{"EARLY_PHASE1":3880,"PHASE1":3882,"PHASE2":3884,"PHASE3":3893,"PHASE4":3895,"NA":3897},{"trials":3881,"activeCount":100},[],{"trials":3883,"activeCount":100},[],{"trials":3885,"activeCount":247,"soonestReadout":1579},[3886],{"nctId":3887,"briefTitle":3888,"status":227,"phases":3889,"primaryCompletion":1579,"completion":416,"start":1078,"enrollment":1510,"conditions":3890,"interventions":3892},"NCT06863376","Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients",[90],[3891],"Non-Alcoholic Fatty Liver Disease",[3878],{"trials":3894,"activeCount":100},[],{"trials":3896,"activeCount":100},[],{"trials":3898,"activeCount":100},[],{"intervention":3498,"totalTrials":247,"cells":3900},{"EARLY_PHASE1":3901,"PHASE1":3903,"PHASE2":3905,"PHASE3":3911,"PHASE4":3913,"NA":3915},{"trials":3902,"activeCount":100},[],{"trials":3904,"activeCount":100},[],{"trials":3906,"activeCount":247,"soonestReadout":3494},[3907],{"nctId":3491,"briefTitle":3492,"status":153,"phases":3908,"primaryCompletion":3494,"completion":3044,"start":3275,"enrollment":3495,"conditions":3909,"interventions":3910},[89,90],[726,3470],[3498,3433],{"trials":3912,"activeCount":100},[],{"trials":3914,"activeCount":100},[],{"trials":3916,"activeCount":100},[],{"intervention":3918,"totalTrials":247,"cells":3919},"phenol neurolysis",{"EARLY_PHASE1":3920,"PHASE1":3922,"PHASE2":3935,"PHASE3":3937,"PHASE4":3939,"NA":3941},{"trials":3921,"activeCount":100},[],{"trials":3923,"activeCount":247,"soonestReadout":3928},[3924],{"nctId":3925,"briefTitle":3926,"status":153,"phases":3927,"primaryCompletion":3928,"completion":3929,"start":1078,"enrollment":438,"conditions":3930,"interventions":3933},"NCT06798038","Comparison of the Efficacy of Chemical Genicular Nerve Neurolysis Using Alcohol or Phenol Versus Radiofrequency Ablation Under Ultrasound Guidance for Pain Management in Patients With Knee Osteoarthritis",[89],"2027-02-28","2027-03-01",[3931,3932,487],"Assessment of Pain Intensity Using 10-point Numerical Rating Scale (NRS-10)(9)Immediately After Intervention , 1 Week,1month,3 Months,6months and One Year","Assessment of Knee Function Using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)",[3918,3934],"alcohol neurolysis",{"trials":3936,"activeCount":100},[],{"trials":3938,"activeCount":100},[],{"trials":3940,"activeCount":100},[],{"trials":3942,"activeCount":100},[],{"intervention":3934,"totalTrials":247,"cells":3944},{"EARLY_PHASE1":3945,"PHASE1":3947,"PHASE2":3953,"PHASE3":3955,"PHASE4":3957,"NA":3959},{"trials":3946,"activeCount":100},[],{"trials":3948,"activeCount":247,"soonestReadout":3928},[3949],{"nctId":3925,"briefTitle":3926,"status":153,"phases":3950,"primaryCompletion":3928,"completion":3929,"start":1078,"enrollment":438,"conditions":3951,"interventions":3952},[89],[3931,3932,487],[3918,3934],{"trials":3954,"activeCount":100},[],{"trials":3956,"activeCount":100},[],{"trials":3958,"activeCount":100},[],{"trials":3960,"activeCount":100},[],{"intervention":3019,"totalTrials":247,"cells":3962},{"EARLY_PHASE1":3963,"PHASE1":3969,"PHASE2":3971,"PHASE3":3973,"PHASE4":3975,"NA":3977},{"trials":3964,"activeCount":247,"soonestReadout":614},[3965],{"nctId":3014,"briefTitle":3015,"status":153,"phases":3966,"primaryCompletion":614,"completion":2716,"start":51,"enrollment":1510,"conditions":3967,"interventions":3968},[88],[1237],[3019,3009],{"trials":3970,"activeCount":100},[],{"trials":3972,"activeCount":100},[],{"trials":3974,"activeCount":100},[],{"trials":3976,"activeCount":100},[],{"trials":3978,"activeCount":100},[],{"intervention":3980,"totalTrials":247,"cells":3981},"Intravitreal injection of aflibercept 8 mg",{"EARLY_PHASE1":3982,"PHASE1":3996,"PHASE2":3998,"PHASE3":4000,"PHASE4":4002,"NA":4004},{"trials":3983,"activeCount":247,"soonestReadout":3988},[3984],{"nctId":3985,"briefTitle":3986,"status":153,"phases":3987,"primaryCompletion":3988,"completion":3989,"start":3990,"enrollment":197,"conditions":3991,"interventions":3995},"NCT06879301","Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients",[88],"2025-11-19","2025-12-19","2025-10-19",[3992,3993,3994],"Diabetic Macular Edema (DME)","Retinal Vein Occlusion (RVO)","Myopic Choroidal Neovascularisation",[3980],{"trials":3997,"activeCount":100},[],{"trials":3999,"activeCount":100},[],{"trials":4001,"activeCount":100},[],{"trials":4003,"activeCount":100},[],{"trials":4005,"activeCount":100},[],{"intervention":81,"totalTrials":247,"cells":4007},{"EARLY_PHASE1":4008,"PHASE1":4016,"PHASE2":4018,"PHASE3":4020,"PHASE4":4022,"NA":4024},{"trials":4009,"activeCount":247,"soonestReadout":80},[4010],{"nctId":78,"briefTitle":79,"status":153,"phases":4011,"primaryCompletion":80,"completion":80,"start":1470,"enrollment":197,"conditions":4012,"interventions":4014},[88],[4013],"Borderline Personality Disorder",[81,4015],"matched placebo",{"trials":4017,"activeCount":100},[],{"trials":4019,"activeCount":100},[],{"trials":4021,"activeCount":100},[],{"trials":4023,"activeCount":100},[],{"trials":4025,"activeCount":100},[],{"intervention":4015,"totalTrials":247,"cells":4027},{"EARLY_PHASE1":4028,"PHASE1":4034,"PHASE2":4036,"PHASE3":4038,"PHASE4":4040,"NA":4042},{"trials":4029,"activeCount":247,"soonestReadout":80},[4030],{"nctId":78,"briefTitle":79,"status":153,"phases":4031,"primaryCompletion":80,"completion":80,"start":1470,"enrollment":197,"conditions":4032,"interventions":4033},[88],[4013],[81,4015],{"trials":4035,"activeCount":100},[],{"trials":4037,"activeCount":100},[],{"trials":4039,"activeCount":100},[],{"trials":4041,"activeCount":100},[],{"trials":4043,"activeCount":100},[],{"intervention":4045,"totalTrials":247,"cells":4046},"Atomoxetine",{"EARLY_PHASE1":4047,"PHASE1":4058,"PHASE2":4060,"PHASE3":4062,"PHASE4":4064,"NA":4066},{"trials":4048,"activeCount":247,"soonestReadout":615},[4049],{"nctId":4050,"briefTitle":4051,"status":153,"phases":4052,"primaryCompletion":615,"completion":4053,"start":1723,"enrollment":184,"conditions":4054,"interventions":4057},"NCT06841666","Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study",[88],"2025-09-05",[4055,4056],"ADHD","Primary Nocturnal Enuresis",[4045],{"trials":4059,"activeCount":100},[],{"trials":4061,"activeCount":100},[],{"trials":4063,"activeCount":100},[],{"trials":4065,"activeCount":100},[],{"trials":4067,"activeCount":100},[],{"intervention":52,"totalTrials":1480,"cells":4069},{"EARLY_PHASE1":4070,"PHASE1":4072,"PHASE2":4074,"PHASE3":4076,"PHASE4":4082,"NA":4084},{"trials":4071,"activeCount":100},[],{"trials":4073,"activeCount":100},[],{"trials":4075,"activeCount":100},[],{"trials":4077,"activeCount":100},[4078],{"nctId":179,"briefTitle":180,"status":123,"phases":4079,"primaryCompletion":182,"completion":182,"start":183,"enrollment":184,"conditions":4080,"interventions":4081},[91],[186],[52,15],{"trials":4083,"activeCount":100},[],{"trials":4085,"activeCount":188,"soonestReadout":51},[4086,4095,4108,4118,4128,4138,4142],{"nctId":4087,"briefTitle":4088,"status":227,"phases":4089,"primaryCompletion":1248,"completion":1248,"start":61,"enrollment":171,"conditions":4090,"interventions":4093},"NCT07062367","Sevoflurane With or Without Intravenous Lidocaine Infusion Versus Propofol Anesthesia on Intracranial Pressure and Cerebral Oxygenation During Laparoscopic Hysterectomy",[93],[62,358,52,2888,4091,4092],"Cerebral Oxygenation","Laparoscopic Hysterectomy",[52,4094,62],"Sevoflurane plus lidocaine",{"nctId":4096,"briefTitle":4097,"status":123,"phases":4098,"primaryCompletion":1194,"completion":1194,"start":1962,"enrollment":197,"conditions":4099,"interventions":4104},"NCT05442905","Quadratus Lumborum Versus Transversus Abdominis Plane Block Versus Caudal Block for Postoperative Analgesia After Pediatric Inguinal Hernia : Double-Blinded Randomized Trial",[93],[4100,4101,4102,32,4103],"Quadratus Lumborum Block","Transversus Abdominis Plane Block","Caudal Block","Inguinal Hernia",[4105,4106,4107],"propofol","Atracurium Besylate","sevoflurane",{"nctId":4109,"briefTitle":4110,"status":106,"phases":4111,"primaryCompletion":4112,"completion":4112,"start":4113,"enrollment":4114,"conditions":4115,"interventions":4117},"NCT05596227","Ultrasound Guided Erector Spinae Block vs Thoracolumbar Interfascial Plane Block",[93],"2024-09-20","2022-10-20",180,[18,4116],"Lumbar Spine Disease",[52,243,1030,62],{"nctId":49,"briefTitle":50,"status":227,"phases":4119,"primaryCompletion":51,"completion":51,"start":4120,"enrollment":4121,"conditions":4122,"interventions":4126},[93],"2024-07-20",62,[4123,52,4124,4125],"Clonidine","Sedation","Colonoscopy",[52,4127],"Propofol combined with clonidine",{"nctId":4129,"briefTitle":4130,"status":106,"phases":4131,"primaryCompletion":4132,"completion":4132,"start":368,"enrollment":197,"conditions":4133,"interventions":4135},"NCT07580768","Sedation With Dexmedetomidine or Midazolam in Combination With Propofol for Removal of Double-J Ureteral Stent",[93],"2025-10-01",[4124,15,209,52,4134],"Double-J Ureteral Stent",[52,4136,4137],"Propofol and Dexmedetomidine","Propofol and Midazolam",{"nctId":469,"briefTitle":470,"status":106,"phases":4139,"primaryCompletion":472,"completion":472,"start":473,"enrollment":370,"conditions":4140,"interventions":4141},[93],[15,52,408,475,476],[15,52],{"nctId":4143,"briefTitle":4144,"status":123,"phases":4145,"primaryCompletion":4146,"completion":4146,"start":4147,"enrollment":4148,"conditions":4149,"interventions":4152},"NCT05543109","Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block",[93],"2023-02-10","2022-09-29",85,[4150,4151],"Pain, Postoperative","Hip Dysplasia",[243,52,1030,62,4153],"Ropivacaine",{"intervention":201,"totalTrials":1480,"cells":4155},{"EARLY_PHASE1":4156,"PHASE1":4158,"PHASE2":4160,"PHASE3":4162,"PHASE4":4164,"NA":4179},{"trials":4157,"activeCount":100},[],{"trials":4159,"activeCount":100},[],{"trials":4161,"activeCount":100},[],{"trials":4163,"activeCount":100},[],{"trials":4165,"activeCount":100},[4166,4170],{"nctId":192,"briefTitle":193,"status":106,"phases":4167,"primaryCompletion":195,"completion":195,"start":196,"enrollment":197,"conditions":4168,"interventions":4169},[92],[199],[15,201],{"nctId":4171,"briefTitle":4172,"status":123,"phases":4173,"primaryCompletion":51,"completion":51,"start":4174,"enrollment":274,"conditions":4175,"interventions":4178},"NCT05997134","Three Regimens of Ketamine Infusion in Complex Regional Pain Syndrome",[92],"2023-08-30",[4176,4177],"Ketamine Infusion","Complex Regional Pain Syndromes",[201,201,201],{"trials":4180,"activeCount":188,"soonestReadout":985},[4181,4185,4189,4199,4203,4207],{"nctId":982,"briefTitle":983,"status":460,"phases":4182,"primaryCompletion":985,"completion":986,"start":987,"enrollment":289,"conditions":4183,"interventions":4184},[93],[989],[201,991,177,992],{"nctId":365,"briefTitle":366,"status":106,"phases":4186,"primaryCompletion":368,"completion":368,"start":369,"enrollment":370,"conditions":4187,"interventions":4188},[93],[15,201,372,373],[201,15,281],{"nctId":4190,"briefTitle":4191,"status":106,"phases":4192,"primaryCompletion":723,"completion":723,"start":1109,"enrollment":157,"conditions":4193,"interventions":4198},"NCT07526454","Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder",[93],[4194,4195,4196,4197],"Electroconvulsive Therapy","Intravenous Ketamine","Treatment-Resistant","Major Depressive Disorder",[4194,201],{"nctId":413,"briefTitle":414,"status":153,"phases":4200,"primaryCompletion":416,"completion":416,"start":417,"enrollment":171,"conditions":4201,"interventions":4202},[93],[419,32,420],[15,201,177],{"nctId":423,"briefTitle":424,"status":106,"phases":4204,"primaryCompletion":426,"completion":426,"start":427,"enrollment":171,"conditions":4205,"interventions":4206},[93],[429],[201,15,431],{"nctId":4208,"briefTitle":4209,"status":106,"phases":4210,"primaryCompletion":4211,"completion":4211,"start":4212,"enrollment":1618,"conditions":4213,"interventions":4214},"NCT07138781","Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain",[93],"2026-02-17","2025-08-23",[201,508,372,509,35],[201,4215],"29 ml bupivacaine 0.25% + 1 ml saline",{"intervention":62,"totalTrials":511,"cells":4217},{"EARLY_PHASE1":4218,"PHASE1":4220,"PHASE2":4222,"PHASE3":4224,"PHASE4":4226,"NA":4228},{"trials":4219,"activeCount":100},[],{"trials":4221,"activeCount":100},[],{"trials":4223,"activeCount":100},[],{"trials":4225,"activeCount":100},[],{"trials":4227,"activeCount":100},[],{"trials":4229,"activeCount":188,"soonestReadout":61},[4230,4234,4238,4245,4249,4260],{"nctId":4087,"briefTitle":4088,"status":227,"phases":4231,"primaryCompletion":1248,"completion":1248,"start":61,"enrollment":171,"conditions":4232,"interventions":4233},[93],[62,358,52,2888,4091,4092],[52,4094,62],{"nctId":4096,"briefTitle":4097,"status":123,"phases":4235,"primaryCompletion":1194,"completion":1194,"start":1962,"enrollment":197,"conditions":4236,"interventions":4237},[93],[4100,4101,4102,32,4103],[4105,4106,4107],{"nctId":59,"briefTitle":60,"status":227,"phases":4239,"primaryCompletion":61,"completion":61,"start":309,"enrollment":157,"conditions":4240,"interventions":4243},[93],[62,4124,4241,4242],"Awake Fiberoptic Intubation","Difficult Airway",[62,4244],"2% Xylocaine",{"nctId":4109,"briefTitle":4110,"status":106,"phases":4246,"primaryCompletion":4112,"completion":4112,"start":4113,"enrollment":4114,"conditions":4247,"interventions":4248},[93],[18,4116],[52,243,1030,62],{"nctId":4250,"briefTitle":4251,"status":106,"phases":4252,"primaryCompletion":4253,"completion":4254,"start":4255,"enrollment":4256,"conditions":4257,"interventions":4259},"NCT03726580","Evaluation of Neurotoxic Effect of Sevoflurane-Based AnaesthesiaGuided by Short-Term Olfactory Identification",[],"2018-09-01","2018-10-01","2017-03-01",600,[4258],"Neurotoxic Effect of Sevoflurane-Based Anaesthesia",[62],{"nctId":4143,"briefTitle":4144,"status":123,"phases":4261,"primaryCompletion":4146,"completion":4146,"start":4147,"enrollment":4148,"conditions":4262,"interventions":4263},[93],[4150,4151],[243,52,1030,62,4153],{"intervention":4265,"totalTrials":1429,"cells":4266},"Ondansetron lozenge",{"EARLY_PHASE1":4267,"PHASE1":4269,"PHASE2":4271,"PHASE3":4273,"PHASE4":4275,"NA":4277},{"trials":4268,"activeCount":100},[],{"trials":4270,"activeCount":100},[],{"trials":4272,"activeCount":100},[],{"trials":4274,"activeCount":100},[],{"trials":4276,"activeCount":100},[],{"trials":4278,"activeCount":188,"soonestReadout":3388},[4279,4291,4301,4308,4317],{"nctId":4280,"briefTitle":4281,"status":227,"phases":4282,"primaryCompletion":1469,"completion":1469,"start":4283,"enrollment":171,"conditions":4284,"interventions":4289},"NCT07511491","Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section",[93],"2026-04-11",[118,4285,4286,1394,4287,4288],"Lozenge","Intravenous","Shivering","Cesarean Section",[4265,4290],"Ondansetron intravenous",{"nctId":4292,"briefTitle":4293,"status":106,"phases":4294,"primaryCompletion":4295,"completion":4295,"start":4296,"enrollment":128,"conditions":4297,"interventions":4300},"NCT06423820","Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Pediatrics Undergoing Squint Surgeries",[93],"2025-01-23","2024-05-21",[4298,113,211,4299],"Ondansetron Lozenge","Squint",[4265],{"nctId":4302,"briefTitle":4303,"status":106,"phases":4304,"primaryCompletion":3812,"completion":3812,"start":4296,"enrollment":197,"conditions":4305,"interventions":4307},"NCT06423807","Preoperative Ondansetron Lozenge for Prevention of Post-Spinal Shivering in Caesarean Section",[93],[4298,4306,4288],"Post-Spinal Shivering",[4265],{"nctId":4309,"briefTitle":4310,"status":227,"phases":4311,"primaryCompletion":3388,"completion":3388,"start":4312,"enrollment":4313,"conditions":4314,"interventions":4316},"NCT07489742","Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy",[93],"2026-03-25",210,[118,4285,4286,4287,4315],"Tonsillectomy",[4265,4290],{"nctId":4318,"briefTitle":4319,"status":106,"phases":4320,"primaryCompletion":4321,"completion":4321,"start":4322,"enrollment":274,"conditions":4323,"interventions":4325},"NCT06254131","Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section",[93],"2024-10-05","2024-02-10",[4298,113,4324],"Caesarean Section",[4265,4326],"Ondansetron IV",{"intervention":358,"totalTrials":111,"cells":4328},{"EARLY_PHASE1":4329,"PHASE1":4331,"PHASE2":4333,"PHASE3":4335,"PHASE4":4337,"NA":4339},{"trials":4330,"activeCount":100},[],{"trials":4332,"activeCount":100},[],{"trials":4334,"activeCount":100},[],{"trials":4336,"activeCount":100},[],{"trials":4338,"activeCount":100},[],{"trials":4340,"activeCount":188,"soonestReadout":1469},[4341,4351,4355,4366],{"nctId":4342,"briefTitle":4343,"status":106,"phases":4344,"primaryCompletion":4345,"completion":4345,"start":3028,"enrollment":1249,"conditions":4346,"interventions":4349},"NCT05690087","Lidocaine Infusion on Optic Nerve Sheath Diameter in Laparoscopic Hysterectomy in Trendelenburg Position",[93],"2024-01-01",[358,4347,4092,4348],"Optic Nerve Sheath Diameter","Trendelenburg",[358,4350],"sodium chloride 0.9% solution",{"nctId":351,"briefTitle":352,"status":227,"phases":4352,"primaryCompletion":354,"completion":354,"start":355,"enrollment":184,"conditions":4353,"interventions":4354},[93],[357,358,15,359,360,361,362],[358,15],{"nctId":4356,"briefTitle":4357,"status":106,"phases":4358,"primaryCompletion":4359,"completion":4359,"start":4360,"enrollment":452,"conditions":4361,"interventions":4365},"NCT06643832","Modulation of Propofol Injection Pain by Rubbing and Distraction",[93],"2025-02-17","2024-10-16",[4362,35,4363,4364],"Propofol Injection","Rubbing","Distraction",[358],{"nctId":1466,"briefTitle":1467,"status":227,"phases":4367,"primaryCompletion":1469,"completion":1469,"start":1470,"enrollment":452,"conditions":4368,"interventions":4369},[93],[1112,1472,360,361,1473],[163,358],{"intervention":4371,"totalTrials":513,"cells":4372},"Erector spinae plane block",{"EARLY_PHASE1":4373,"PHASE1":4375,"PHASE2":4377,"PHASE3":4379,"PHASE4":4381,"NA":4383},{"trials":4374,"activeCount":100},[],{"trials":4376,"activeCount":100},[],{"trials":4378,"activeCount":100},[],{"trials":4380,"activeCount":100},[],{"trials":4382,"activeCount":100},[],{"trials":4384,"activeCount":188,"soonestReadout":2693},[4385,4397,4409],{"nctId":4386,"briefTitle":4387,"status":106,"phases":4388,"primaryCompletion":368,"completion":368,"start":1409,"enrollment":171,"conditions":4389,"interventions":4393},"NCT06913140","Preoperative Ultrasound Guided Thoracic Erector Spinae Plane Block Versus Costoclavicular Block for Shoulder Arthroscopy",[93],[1381,30,4390,4391,4392],"Thoracic Erector Spinae Plane Block","Costoclavicular Block","Shoulder Arthroscopy",[4394,4395,4396],"Erector Spinae plane Block","Costoclavicular block","Control group",{"nctId":4398,"briefTitle":4399,"status":227,"phases":4400,"primaryCompletion":2693,"completion":1567,"start":4401,"enrollment":1249,"conditions":4402,"interventions":4407},"NCT06870383","Erector Spinae Block Versus Combined Pecto-intercostal and Recto-intercostal Fascial Plane Block in Cardiac Surgery",[93],"2025-03-20",[21,4403,4404,4405,4406],"Pecto-intercostal Fascial Plane Block","Recto-intercostal Fascial Plane Block","Cardiac","Surgery",[4371,4408],"Combined Pecto-intercostal and recto-intercostal fascial plane block",{"nctId":4410,"briefTitle":4411,"status":227,"phases":4412,"primaryCompletion":614,"completion":614,"start":4413,"enrollment":197,"conditions":4414,"interventions":4418},"NCT06947642","Ultrasound-guided Pectoral Nerve Blocks, Thoracic Erector Spinae Plane Block and Serratus Anterior Plane Block for Breast Surgery",[93],"2025-04-30",[30,4415,4390,4416,4417],"Pectoral Nerve Blocks","Serratus Anterior Plane Block","Breast Surgery",[4419,4371,4420],"Pectoral nerve block","Serratus anterior plane block",{"intervention":4290,"totalTrials":188,"cells":4422},{"EARLY_PHASE1":4423,"PHASE1":4425,"PHASE2":4427,"PHASE3":4429,"PHASE4":4431,"NA":4433},{"trials":4424,"activeCount":100},[],{"trials":4426,"activeCount":100},[],{"trials":4428,"activeCount":100},[],{"trials":4430,"activeCount":100},[],{"trials":4432,"activeCount":100},[],{"trials":4434,"activeCount":188,"soonestReadout":3388},[4435,4439],{"nctId":4280,"briefTitle":4281,"status":227,"phases":4436,"primaryCompletion":1469,"completion":1469,"start":4283,"enrollment":171,"conditions":4437,"interventions":4438},[93],[118,4285,4286,1394,4287,4288],[4265,4290],{"nctId":4309,"briefTitle":4310,"status":227,"phases":4440,"primaryCompletion":3388,"completion":3388,"start":4312,"enrollment":4313,"conditions":4441,"interventions":4442},[93],[118,4285,4286,4287,4315],[4265,4290],{"intervention":117,"totalTrials":111,"cells":4444},{"EARLY_PHASE1":4445,"PHASE1":4456,"PHASE2":4462,"PHASE3":4464,"PHASE4":4466,"NA":4468},{"trials":4446,"activeCount":100},[4447],{"nctId":4448,"briefTitle":4449,"status":123,"phases":4450,"primaryCompletion":4451,"completion":4452,"start":126,"enrollment":171,"conditions":4453,"interventions":4455},"NCT05687981","The Analgesic Efficacy of Two Bupivacaine Concentrations for Combined Ilioinguinal and Iliohypogastric Nerve Block in Postherniorrhaphy Pain",[88],"2023-12","2024-01",[4454],"Hernia, Inguinal",[281,117],{"trials":4457,"activeCount":100},[4458],{"nctId":104,"briefTitle":105,"status":106,"phases":4459,"primaryCompletion":108,"completion":109,"start":110,"enrollment":111,"conditions":4460,"interventions":4461},[89],[113,114,115],[117,118,15,119],{"trials":4463,"activeCount":100},[],{"trials":4465,"activeCount":100},[],{"trials":4467,"activeCount":100},[],{"trials":4469,"activeCount":247,"soonestReadout":450},[4470,4474],{"nctId":1033,"briefTitle":1034,"status":106,"phases":4471,"primaryCompletion":1036,"completion":1036,"start":1037,"enrollment":1038,"conditions":4472,"interventions":4473},[93],[32],[431,117],{"nctId":447,"briefTitle":448,"status":227,"phases":4475,"primaryCompletion":450,"completion":450,"start":451,"enrollment":452,"conditions":4476,"interventions":4477},[93],[454,15,455,117],[15,455,117],{"intervention":445,"totalTrials":111,"cells":4479},{"EARLY_PHASE1":4480,"PHASE1":4482,"PHASE2":4484,"PHASE3":4486,"PHASE4":4488,"NA":4490},{"trials":4481,"activeCount":100},[],{"trials":4483,"activeCount":100},[],{"trials":4485,"activeCount":100},[],{"trials":4487,"activeCount":100},[],{"trials":4489,"activeCount":100},[],{"trials":4491,"activeCount":247,"soonestReadout":1234},[4492,4500,4504,4515],{"nctId":4493,"briefTitle":4494,"status":106,"phases":4495,"primaryCompletion":4283,"completion":4283,"start":4132,"enrollment":197,"conditions":4496,"interventions":4499},"NCT07201272","Transversalis Fascia Plane Block Versus Intrathecal Morphine for Postoperative Analgesia in Total Abdominal Hysterectomy",[93],[4497,440,24,4498],"Transversalis Fascia Plane Block","Total Abdominal Hysterectomy",[445],{"nctId":433,"briefTitle":434,"status":106,"phases":4501,"primaryCompletion":300,"completion":436,"start":437,"enrollment":438,"conditions":4502,"interventions":4503},[93],[440,441,442,443],[15,445,15],{"nctId":4505,"briefTitle":4506,"status":106,"phases":4507,"primaryCompletion":4508,"completion":4508,"start":4509,"enrollment":370,"conditions":4510,"interventions":4514},"NCT06331143","Analgesic Efficacy of Mid-Transverse Process to Pleura (MTP) Block and Intrathecal Morphine in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion",[93],"2026-01-04","2024-03-28",[4511,440,4512,4513],"Mid-Transverse Process Block","Idiopathic Scoliosis","Posterior Spinal Fusion",[445],{"nctId":4516,"briefTitle":4517,"status":227,"phases":4518,"primaryCompletion":1234,"completion":1234,"start":4519,"enrollment":370,"conditions":4520,"interventions":4523},"NCT06820190","Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion",[93],"2025-02-12",[4521,4522,4512,4513],"Multiple Mid-Transverse Process to Pleura","PCA",[445],{"intervention":57,"totalTrials":513,"cells":4525},{"EARLY_PHASE1":4526,"PHASE1":4528,"PHASE2":4530,"PHASE3":4532,"PHASE4":4538,"NA":4540},{"trials":4527,"activeCount":100},[],{"trials":4529,"activeCount":100},[],{"trials":4531,"activeCount":100},[],{"trials":4533,"activeCount":100},[4534],{"nctId":1335,"briefTitle":1336,"status":123,"phases":4535,"primaryCompletion":1338,"completion":1339,"start":1340,"enrollment":171,"conditions":4536,"interventions":4537},[90,91],[1342],[1344,57,259],{"trials":4539,"activeCount":100},[],{"trials":4541,"activeCount":247,"soonestReadout":56},[4542,4546],{"nctId":54,"briefTitle":55,"status":227,"phases":4543,"primaryCompletion":56,"completion":308,"start":309,"enrollment":157,"conditions":4544,"interventions":4545},[93],[311],[57,313,15],{"nctId":4547,"briefTitle":4548,"status":106,"phases":4549,"primaryCompletion":299,"completion":299,"start":4550,"enrollment":197,"conditions":4551,"interventions":4554},"NCT06798025","Three Different Modalities for Treatment of Inflammatory Punctal Stenosis",[93],"2023-07-20",[4552,1869,4553],"Modalities","Inflammatory Punctal Stenosis",[4555,4556],"Punctal dilation and topical medication","Triamcinolone acetonide",{"intervention":4558,"totalTrials":188,"cells":4559},"Intrathecal dexmedetomidine",{"EARLY_PHASE1":4560,"PHASE1":4562,"PHASE2":4564,"PHASE3":4566,"PHASE4":4568,"NA":4583},{"trials":4561,"activeCount":100},[],{"trials":4563,"activeCount":100},[],{"trials":4565,"activeCount":100},[],{"trials":4567,"activeCount":100},[],{"trials":4569,"activeCount":100},[4570],{"nctId":4571,"briefTitle":4572,"status":123,"phases":4573,"primaryCompletion":4574,"completion":4575,"start":4576,"enrollment":274,"conditions":4577,"interventions":4580},"NCT04618965","Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate",[92],"2021-04-26","2021-06-26","2020-11-01",[15,4578,4286,4579],"Transurethral Resection of Prostate","Intrathecal",[4581,4558,4582],"control group","Intravenous dexmedetomidine",{"trials":4584,"activeCount":247,"soonestReadout":389},[4585],{"nctId":4586,"briefTitle":4587,"status":227,"phases":4588,"primaryCompletion":389,"completion":389,"start":4589,"enrollment":1618,"conditions":4590,"interventions":4592},"NCT07170267","Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section",[93],"2025-09-13",[4497,4591,4288],"Intrathecal Dexmedetomidine",[4558],{"intervention":4594,"totalTrials":188,"cells":4595},"General anesthesia",{"EARLY_PHASE1":4596,"PHASE1":4598,"PHASE2":4600,"PHASE3":4602,"PHASE4":4604,"NA":4606},{"trials":4597,"activeCount":100},[],{"trials":4599,"activeCount":100},[],{"trials":4601,"activeCount":100},[],{"trials":4603,"activeCount":100},[],{"trials":4605,"activeCount":100},[],{"trials":4607,"activeCount":247,"soonestReadout":1761},[4608,4620],{"nctId":4609,"briefTitle":4610,"status":106,"phases":4611,"primaryCompletion":1517,"completion":1517,"start":4612,"enrollment":289,"conditions":4613,"interventions":4618},"NCT06909396","Stress Response and Hemodynamic Changes Associated With Intrathecal Anesthesia Versus Caudal Epidural Anesthesia in Infants Undergoing Laparoscopic Inguinal Herniorrhaphy",[93],"2023-06-01",[394,322,4614,4615,4616,4617],"Intrathecal Anesthesia","Caudal Epidural Anesthesia","Infants","Laparoscopic Inguinal Herniorrhaphy",[4594,4614,4619],"Caudal block",{"nctId":4621,"briefTitle":4622,"status":227,"phases":4623,"primaryCompletion":1761,"completion":1761,"start":1668,"enrollment":289,"conditions":4624,"interventions":4629},"NCT06904703","Pericapsular Nerve Group and Lumbar Erector Spinae Plane Blocks for Geriatrics Undergoing Total Hip Arthroplasty",[93],[4625,4626,4627,1473,4628],"Pericapsular Nerve","Lumbar Erector Spinae Plane Blocks","Geriatrics","General Anesthesia",[4594,4630,4630],"Bupivacaine 0.5%",{"intervention":4632,"totalTrials":188,"cells":4633},"Calcitonin",{"EARLY_PHASE1":4634,"PHASE1":4636,"PHASE2":4638,"PHASE3":4640,"PHASE4":4642,"NA":4644},{"trials":4635,"activeCount":100},[],{"trials":4637,"activeCount":100},[],{"trials":4639,"activeCount":100},[],{"trials":4641,"activeCount":100},[],{"trials":4643,"activeCount":100},[],{"trials":4645,"activeCount":247,"soonestReadout":4659},[4646,4655],{"nctId":4647,"briefTitle":4648,"status":106,"phases":4649,"primaryCompletion":4650,"completion":4650,"start":4651,"enrollment":197,"conditions":4652,"interventions":4654},"NCT02115360","Epidural Calcitonin in Lower Limb Amputation",[93],"2016-08","2014-04",[4653],"Amputation Stumps",[4632,243],{"nctId":4656,"briefTitle":4657,"status":227,"phases":4658,"primaryCompletion":4659,"completion":4660,"start":1379,"enrollment":4661,"conditions":4662,"interventions":4665},"NCT05805683","Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury",[93],"2027-05-01","2028-05-01",126,[4632,4663,4664],"Neuropathic Pain","Spinal Cord Injury",[4632],{"intervention":321,"totalTrials":188,"cells":4667},{"EARLY_PHASE1":4668,"PHASE1":4670,"PHASE2":4672,"PHASE3":4674,"PHASE4":4676,"NA":4678},{"trials":4669,"activeCount":100},[],{"trials":4671,"activeCount":100},[],{"trials":4673,"activeCount":100},[],{"trials":4675,"activeCount":100},[],{"trials":4677,"activeCount":100},[],{"trials":4679,"activeCount":247,"soonestReadout":563},[4680,4690],{"nctId":4681,"briefTitle":4682,"status":123,"phases":4683,"primaryCompletion":1378,"completion":1378,"start":4684,"enrollment":1618,"conditions":4685,"interventions":4688},"NCT06088875","Nebulization Versus Spray-as-You-Go Airway Topical Anesthesia Using Dexmedetomidine and Lidocaine Mixture During Awake Flexible Fiberoptic Intubation in Temporomandibular Ankylosis",[93],"2023-10-18",[321,4686,15,358,4687],"Spray-as-You-Go","Temporomandibular Ankylosis",[321,4689],"Spray-as-you-go",{"nctId":4691,"briefTitle":4692,"status":153,"phases":4693,"primaryCompletion":563,"completion":3494,"start":564,"enrollment":4694,"conditions":4695,"interventions":4698},"NCT07286409","Nebulized Furosemide, Heparin, Hypertonic Saline in Mechanically Ventilated Acute Respiratory Distress Syndrome Adult Patients",[93],344,[4696,4697],"Respiratory Distress Syndrome","Mechanical Ventilation Complication",[4699],"nebulization",{"intervention":1113,"totalTrials":188,"cells":4701},{"EARLY_PHASE1":4702,"PHASE1":4704,"PHASE2":4706,"PHASE3":4708,"PHASE4":4710,"NA":4712},{"trials":4703,"activeCount":100},[],{"trials":4705,"activeCount":100},[],{"trials":4707,"activeCount":100},[],{"trials":4709,"activeCount":100},[],{"trials":4711,"activeCount":100},[],{"trials":4713,"activeCount":247,"soonestReadout":1108},[4714,4722],{"nctId":4715,"briefTitle":4716,"status":106,"phases":4717,"primaryCompletion":4718,"completion":4719,"start":451,"enrollment":1618,"conditions":4720,"interventions":4721},"NCT06470854","Effect of Nebulized Dexmedetomidine on Post-dural Puncture Headache",[93],"2024-02-20","2024-03-22",[1765],[1113],{"nctId":1105,"briefTitle":1106,"status":227,"phases":4723,"primaryCompletion":1108,"completion":1108,"start":1109,"enrollment":1110,"conditions":4724,"interventions":4725},[93],[1112,1113,466,409,1114],[431,1116,1117],{"intervention":455,"totalTrials":188,"cells":4727},{"EARLY_PHASE1":4728,"PHASE1":4730,"PHASE2":4732,"PHASE3":4734,"PHASE4":4736,"NA":4738},{"trials":4729,"activeCount":100},[],{"trials":4731,"activeCount":100},[],{"trials":4733,"activeCount":100},[],{"trials":4735,"activeCount":100},[],{"trials":4737,"activeCount":100},[],{"trials":4739,"activeCount":247,"soonestReadout":450},[4740,4744],{"nctId":447,"briefTitle":448,"status":227,"phases":4741,"primaryCompletion":450,"completion":450,"start":451,"enrollment":452,"conditions":4742,"interventions":4743},[93],[454,15,455,117],[15,455,117],{"nctId":479,"briefTitle":480,"status":106,"phases":4745,"primaryCompletion":482,"completion":482,"start":483,"enrollment":197,"conditions":4746,"interventions":4747},[93],[485,455,486,15,35,487],[455,489,15],{"intervention":4094,"totalTrials":247,"cells":4749},{"EARLY_PHASE1":4750,"PHASE1":4752,"PHASE2":4754,"PHASE3":4756,"PHASE4":4758,"NA":4760},{"trials":4751,"activeCount":100},[],{"trials":4753,"activeCount":100},[],{"trials":4755,"activeCount":100},[],{"trials":4757,"activeCount":100},[],{"trials":4759,"activeCount":100},[],{"trials":4761,"activeCount":247,"soonestReadout":1248},[4762],{"nctId":4087,"briefTitle":4088,"status":227,"phases":4763,"primaryCompletion":1248,"completion":1248,"start":61,"enrollment":171,"conditions":4764,"interventions":4765},[93],[62,358,52,2888,4091,4092],[52,4094,62],{"intervention":4767,"totalTrials":247,"cells":4768},"Losartan 50mg Tab",{"EARLY_PHASE1":4769,"PHASE1":4771,"PHASE2":4773,"PHASE3":4775,"PHASE4":4777,"NA":4779},{"trials":4770,"activeCount":100},[],{"trials":4772,"activeCount":100},[],{"trials":4774,"activeCount":100},[],{"trials":4776,"activeCount":100},[],{"trials":4778,"activeCount":100},[],{"trials":4780,"activeCount":247,"soonestReadout":4785},[4781],{"nctId":4782,"briefTitle":4783,"status":227,"phases":4784,"primaryCompletion":4785,"completion":4786,"start":4120,"enrollment":171,"conditions":4787,"interventions":4789},"NCT06539806","Clinical Study Evaluating the Effect of Losartan",[93],"2026-08-10","2026-08-20",[4788],"Pancreatic Cancer",[4767],{"intervention":4791,"totalTrials":247,"cells":4792},"Superficial Cervical Plexus Block",{"EARLY_PHASE1":4793,"PHASE1":4795,"PHASE2":4797,"PHASE3":4799,"PHASE4":4801,"NA":4803},{"trials":4794,"activeCount":100},[],{"trials":4796,"activeCount":100},[],{"trials":4798,"activeCount":100},[],{"trials":4800,"activeCount":100},[],{"trials":4802,"activeCount":100},[],{"trials":4804,"activeCount":247,"soonestReadout":4809},[4805],{"nctId":4806,"briefTitle":4807,"status":227,"phases":4808,"primaryCompletion":4809,"completion":4809,"start":1823,"enrollment":197,"conditions":4810,"interventions":4814},"NCT06831604","Superficial Cervical Plexus Block With Either Clavipectoral Fascial Plane Block or Interscalene Brachial Block for Clavicle Surgeries Anesthesia",[93],"2026-07-01",[30,4791,4811,4812,4813],"Clavipectoral Fascial Plane Block","Interscalene Brachial Block","Clavicle Surgeries",[4791,4791],{"intervention":991,"totalTrials":247,"cells":4816},{"EARLY_PHASE1":4817,"PHASE1":4819,"PHASE2":4821,"PHASE3":4823,"PHASE4":4825,"NA":4827},{"trials":4818,"activeCount":100},[],{"trials":4820,"activeCount":100},[],{"trials":4822,"activeCount":100},[],{"trials":4824,"activeCount":100},[],{"trials":4826,"activeCount":100},[],{"trials":4828,"activeCount":247,"soonestReadout":985},[4829],{"nctId":982,"briefTitle":983,"status":460,"phases":4830,"primaryCompletion":985,"completion":986,"start":987,"enrollment":289,"conditions":4831,"interventions":4832},[93],[989],[201,991,177,992],{"intervention":992,"totalTrials":247,"cells":4834},{"EARLY_PHASE1":4835,"PHASE1":4837,"PHASE2":4839,"PHASE3":4841,"PHASE4":4843,"NA":4845},{"trials":4836,"activeCount":100},[],{"trials":4838,"activeCount":100},[],{"trials":4840,"activeCount":100},[],{"trials":4842,"activeCount":100},[],{"trials":4844,"activeCount":100},[],{"trials":4846,"activeCount":247,"soonestReadout":985},[4847],{"nctId":982,"briefTitle":983,"status":460,"phases":4848,"primaryCompletion":985,"completion":986,"start":987,"enrollment":289,"conditions":4849,"interventions":4850},[93],[989],[201,991,177,992],{"intervention":67,"totalTrials":247,"cells":4852},{"EARLY_PHASE1":4853,"PHASE1":4855,"PHASE2":4857,"PHASE3":4859,"PHASE4":4861,"NA":4863},{"trials":4854,"activeCount":100},[],{"trials":4856,"activeCount":100},[],{"trials":4858,"activeCount":100},[],{"trials":4860,"activeCount":100},[],{"trials":4862,"activeCount":100},[],{"trials":4864,"activeCount":247,"soonestReadout":66},[4865],{"nctId":64,"briefTitle":65,"status":4866,"phases":4867,"primaryCompletion":66,"completion":4868,"start":4869,"enrollment":197,"conditions":4870,"interventions":4872},"ENROLLING_BY_INVITATION",[93],"2025-12-10","2025-01-10",[4871],"Hypertension",[67,4873],"3% plain mepivacaine HCL",{"intervention":4873,"totalTrials":247,"cells":4875},{"EARLY_PHASE1":4876,"PHASE1":4878,"PHASE2":4880,"PHASE3":4882,"PHASE4":4884,"NA":4886},{"trials":4877,"activeCount":100},[],{"trials":4879,"activeCount":100},[],{"trials":4881,"activeCount":100},[],{"trials":4883,"activeCount":100},[],{"trials":4885,"activeCount":100},[],{"trials":4887,"activeCount":247,"soonestReadout":66},[4888],{"nctId":64,"briefTitle":65,"status":4866,"phases":4889,"primaryCompletion":66,"completion":4868,"start":4869,"enrollment":197,"conditions":4890,"interventions":4891},[93],[4871],[67,4873],{"intervention":1841,"totalTrials":247,"cells":4893},{"EARLY_PHASE1":4894,"PHASE1":4896,"PHASE2":4898,"PHASE3":4900,"PHASE4":4902,"NA":4904},{"trials":4895,"activeCount":100},[],{"trials":4897,"activeCount":100},[],{"trials":4899,"activeCount":100},[],{"trials":4901,"activeCount":100},[],{"trials":4903,"activeCount":100},[],{"trials":4905,"activeCount":247,"soonestReadout":1835},[4906],{"nctId":1832,"briefTitle":1833,"status":153,"phases":4907,"primaryCompletion":1835,"completion":1836,"start":1567,"enrollment":1837,"conditions":4908,"interventions":4909},[93],[1839],[1808,1841],{"intervention":313,"totalTrials":247,"cells":4911},{"EARLY_PHASE1":4912,"PHASE1":4914,"PHASE2":4916,"PHASE3":4918,"PHASE4":4920,"NA":4922},{"trials":4913,"activeCount":100},[],{"trials":4915,"activeCount":100},[],{"trials":4917,"activeCount":100},[],{"trials":4919,"activeCount":100},[],{"trials":4921,"activeCount":100},[],{"trials":4923,"activeCount":247,"soonestReadout":56},[4924],{"nctId":54,"briefTitle":55,"status":227,"phases":4925,"primaryCompletion":56,"completion":308,"start":309,"enrollment":157,"conditions":4926,"interventions":4927},[93],[311],[57,313,15],{"intervention":4929,"totalTrials":247,"cells":4930},"Botulinium Toxin-A",{"EARLY_PHASE1":4931,"PHASE1":4933,"PHASE2":4935,"PHASE3":4937,"PHASE4":4939,"NA":4941},{"trials":4932,"activeCount":100},[],{"trials":4934,"activeCount":100},[],{"trials":4936,"activeCount":100},[],{"trials":4938,"activeCount":100},[],{"trials":4940,"activeCount":100},[],{"trials":4942,"activeCount":247,"soonestReadout":1234},[4943],{"nctId":4944,"briefTitle":4945,"status":227,"phases":4946,"primaryCompletion":1234,"completion":1234,"start":1066,"enrollment":1886,"conditions":4947,"interventions":4951},"NCT07523477","Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis",[93],[4948,4929,409,4949,4950],"Local Injection","Dysfunctional Voiding","Refractory Nocturnal Eneuresis",[4929],{"intervention":1763,"totalTrials":247,"cells":4953},{"EARLY_PHASE1":4954,"PHASE1":4956,"PHASE2":4958,"PHASE3":4960,"PHASE4":4962,"NA":4964},{"trials":4955,"activeCount":100},[],{"trials":4957,"activeCount":100},[],{"trials":4959,"activeCount":100},[],{"trials":4961,"activeCount":100},[],{"trials":4963,"activeCount":100},[],{"trials":4965,"activeCount":247,"soonestReadout":1761},[4966],{"nctId":1758,"briefTitle":1759,"status":227,"phases":4967,"primaryCompletion":1761,"completion":1761,"start":1668,"enrollment":274,"conditions":4968,"interventions":4969},[93],[1763,1764,1690,1765],[1763,1764,1690],{"intervention":1764,"totalTrials":247,"cells":4971},{"EARLY_PHASE1":4972,"PHASE1":4974,"PHASE2":4976,"PHASE3":4978,"PHASE4":4980,"NA":4982},{"trials":4973,"activeCount":100},[],{"trials":4975,"activeCount":100},[],{"trials":4977,"activeCount":100},[],{"trials":4979,"activeCount":100},[],{"trials":4981,"activeCount":100},[],{"trials":4983,"activeCount":247,"soonestReadout":1761},[4984],{"nctId":1758,"briefTitle":1759,"status":227,"phases":4985,"primaryCompletion":1761,"completion":1761,"start":1668,"enrollment":274,"conditions":4986,"interventions":4987},[93],[1763,1764,1690,1765],[1763,1764,1690],{"intervention":4989,"totalTrials":247,"cells":4990},"Intranasal Midazolam",{"EARLY_PHASE1":4991,"PHASE1":4993,"PHASE2":4995,"PHASE3":4997,"PHASE4":4999,"NA":5001},{"trials":4992,"activeCount":100},[],{"trials":4994,"activeCount":100},[],{"trials":4996,"activeCount":100},[],{"trials":4998,"activeCount":100},[],{"trials":5000,"activeCount":100},[],{"trials":5002,"activeCount":247,"soonestReadout":851},[5003],{"nctId":5004,"briefTitle":5005,"status":460,"phases":5006,"primaryCompletion":851,"completion":852,"start":1822,"enrollment":5007,"conditions":5008,"interventions":5011},"NCT07498387","Management of Catatonic Features in Adolescents With Profound Autism",[93],30,[5009,5010],"Autism Spectrum Disorder","Catatonia",[4989,5012],"Oral Clonazepam",{"intervention":5012,"totalTrials":247,"cells":5014},{"EARLY_PHASE1":5015,"PHASE1":5017,"PHASE2":5019,"PHASE3":5021,"PHASE4":5023,"NA":5025},{"trials":5016,"activeCount":100},[],{"trials":5018,"activeCount":100},[],{"trials":5020,"activeCount":100},[],{"trials":5022,"activeCount":100},[],{"trials":5024,"activeCount":100},[],{"trials":5026,"activeCount":247,"soonestReadout":851},[5027],{"nctId":5004,"briefTitle":5005,"status":460,"phases":5028,"primaryCompletion":851,"completion":852,"start":1822,"enrollment":5007,"conditions":5029,"interventions":5030},[93],[5009,5010],[4989,5012],{"intervention":4244,"totalTrials":247,"cells":5032},{"EARLY_PHASE1":5033,"PHASE1":5035,"PHASE2":5037,"PHASE3":5039,"PHASE4":5041,"NA":5043},{"trials":5034,"activeCount":100},[],{"trials":5036,"activeCount":100},[],{"trials":5038,"activeCount":100},[],{"trials":5040,"activeCount":100},[],{"trials":5042,"activeCount":100},[],{"trials":5044,"activeCount":247,"soonestReadout":61},[5045],{"nctId":59,"briefTitle":60,"status":227,"phases":5046,"primaryCompletion":61,"completion":61,"start":309,"enrollment":157,"conditions":5047,"interventions":5048},[93],[62,4124,4241,4242],[62,4244],{"intervention":5050,"totalTrials":247,"cells":5051},"Perineural ondansetron",{"EARLY_PHASE1":5052,"PHASE1":5054,"PHASE2":5056,"PHASE3":5058,"PHASE4":5060,"NA":5062},{"trials":5053,"activeCount":100},[],{"trials":5055,"activeCount":100},[],{"trials":5057,"activeCount":100},[],{"trials":5059,"activeCount":100},[],{"trials":5061,"activeCount":100},[],{"trials":5063,"activeCount":247,"soonestReadout":5068},[5064],{"nctId":5065,"briefTitle":5066,"status":227,"phases":5067,"primaryCompletion":5068,"completion":5069,"start":5070,"enrollment":5071,"conditions":5072,"interventions":5075},"NCT06810882","Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy",[93],"2027-02-16","2027-02-17","2025-02-16",482,[118,5073,5074],"Laparoscopic","Gastrectomy",[5050,5076],"Intravenous ondansetron",{"intervention":5076,"totalTrials":247,"cells":5078},{"EARLY_PHASE1":5079,"PHASE1":5081,"PHASE2":5083,"PHASE3":5085,"PHASE4":5087,"NA":5089},{"trials":5080,"activeCount":100},[],{"trials":5082,"activeCount":100},[],{"trials":5084,"activeCount":100},[],{"trials":5086,"activeCount":100},[],{"trials":5088,"activeCount":100},[],{"trials":5090,"activeCount":247,"soonestReadout":5068},[5091],{"nctId":5065,"briefTitle":5066,"status":227,"phases":5092,"primaryCompletion":5068,"completion":5069,"start":5070,"enrollment":5071,"conditions":5093,"interventions":5094},[93],[118,5073,5074],[5050,5076],{"intervention":5096,"totalTrials":247,"cells":5097},"Group F",{"EARLY_PHASE1":5098,"PHASE1":5100,"PHASE2":5102,"PHASE3":5104,"PHASE4":5106,"NA":5108},{"trials":5099,"activeCount":100},[],{"trials":5101,"activeCount":100},[],{"trials":5103,"activeCount":100},[],{"trials":5105,"activeCount":100},[],{"trials":5107,"activeCount":100},[],{"trials":5109,"activeCount":247,"soonestReadout":3275},[5110],{"nctId":5111,"briefTitle":5112,"status":153,"phases":5113,"primaryCompletion":3275,"completion":3275,"start":5114,"enrollment":197,"conditions":5115,"interventions":5118},"NCT07114263","Study of The Analgesic Profile of Two Adjuvants Added to Low Dose Hyperbaric Bupivacaine Versus One Adjuvant in Patients Undergoing Anal Surgery Using Spinal Anesthesia",[93],"2025-08",[5116,404,5117],"Spinal Anesthesia Administration","Anorectal Surgery",[5096,5119,5120],"Group D :Dexmedetomidine group","Group DF :Fentanyl and Dexmedetomidine group",{"intervention":5119,"totalTrials":247,"cells":5122},{"EARLY_PHASE1":5123,"PHASE1":5125,"PHASE2":5127,"PHASE3":5129,"PHASE4":5131,"NA":5133},{"trials":5124,"activeCount":100},[],{"trials":5126,"activeCount":100},[],{"trials":5128,"activeCount":100},[],{"trials":5130,"activeCount":100},[],{"trials":5132,"activeCount":100},[],{"trials":5134,"activeCount":247,"soonestReadout":3275},[5135],{"nctId":5111,"briefTitle":5112,"status":153,"phases":5136,"primaryCompletion":3275,"completion":3275,"start":5114,"enrollment":197,"conditions":5137,"interventions":5138},[93],[5116,404,5117],[5096,5119,5120],{"intervention":5120,"totalTrials":247,"cells":5140},{"EARLY_PHASE1":5141,"PHASE1":5143,"PHASE2":5145,"PHASE3":5147,"PHASE4":5149,"NA":5151},{"trials":5142,"activeCount":100},[],{"trials":5144,"activeCount":100},[],{"trials":5146,"activeCount":100},[],{"trials":5148,"activeCount":100},[],{"trials":5150,"activeCount":100},[],{"trials":5152,"activeCount":247,"soonestReadout":3275},[5153],{"nctId":5111,"briefTitle":5112,"status":153,"phases":5154,"primaryCompletion":3275,"completion":3275,"start":5114,"enrollment":197,"conditions":5155,"interventions":5156},[93],[5116,404,5117],[5096,5119,5120],{"intervention":4127,"totalTrials":247,"cells":5158},{"EARLY_PHASE1":5159,"PHASE1":5161,"PHASE2":5163,"PHASE3":5165,"PHASE4":5167,"NA":5169},{"trials":5160,"activeCount":100},[],{"trials":5162,"activeCount":100},[],{"trials":5164,"activeCount":100},[],{"trials":5166,"activeCount":100},[],{"trials":5168,"activeCount":100},[],{"trials":5170,"activeCount":247,"soonestReadout":51},[5171],{"nctId":49,"briefTitle":50,"status":227,"phases":5172,"primaryCompletion":51,"completion":51,"start":4120,"enrollment":4121,"conditions":5173,"interventions":5174},[93],[4123,52,4124,4125],[52,4127],{"intervention":5176,"totalTrials":247,"cells":5177},"4-L split-dose polyethylene glycol and Bisacodyl + Docusate sodium.",{"EARLY_PHASE1":5178,"PHASE1":5180,"PHASE2":5182,"PHASE3":5184,"PHASE4":5186,"NA":5188},{"trials":5179,"activeCount":100},[],{"trials":5181,"activeCount":100},[],{"trials":5183,"activeCount":100},[],{"trials":5185,"activeCount":100},[],{"trials":5187,"activeCount":100},[],{"trials":5189,"activeCount":247,"soonestReadout":1349},[5190],{"nctId":5191,"briefTitle":5192,"status":227,"phases":5193,"primaryCompletion":1349,"completion":5194,"start":85,"enrollment":5195,"conditions":5196,"interventions":5198},"NCT07328880","4-L Split-dose Polyethylene Glycol and Bisacodyl and Docusate Sodium Regimen Versus 2-L Split-dose Polyethylene Glycol Plus Oral Simethicone Regimen for Bowel Preparation Before Colonoscopy",[93],"2026-04-26",450,[5197],"Colonoscopy Preparation",[5176,5199,5200],"2-L split-dose polyethylene glycol plus Oral Simethicone regimen .","2-L split-dose polyethylene glycol regimen",{"intervention":5199,"totalTrials":247,"cells":5202},{"EARLY_PHASE1":5203,"PHASE1":5205,"PHASE2":5207,"PHASE3":5209,"PHASE4":5211,"NA":5213},{"trials":5204,"activeCount":100},[],{"trials":5206,"activeCount":100},[],{"trials":5208,"activeCount":100},[],{"trials":5210,"activeCount":100},[],{"trials":5212,"activeCount":100},[],{"trials":5214,"activeCount":247,"soonestReadout":1349},[5215],{"nctId":5191,"briefTitle":5192,"status":227,"phases":5216,"primaryCompletion":1349,"completion":5194,"start":85,"enrollment":5195,"conditions":5217,"interventions":5218},[93],[5197],[5176,5199,5200],{"intervention":5200,"totalTrials":247,"cells":5220},{"EARLY_PHASE1":5221,"PHASE1":5223,"PHASE2":5225,"PHASE3":5227,"PHASE4":5229,"NA":5231},{"trials":5222,"activeCount":100},[],{"trials":5224,"activeCount":100},[],{"trials":5226,"activeCount":100},[],{"trials":5228,"activeCount":100},[],{"trials":5230,"activeCount":100},[],{"trials":5232,"activeCount":247,"soonestReadout":1349},[5233],{"nctId":5191,"briefTitle":5192,"status":227,"phases":5234,"primaryCompletion":1349,"completion":5194,"start":85,"enrollment":5195,"conditions":5235,"interventions":5236},[93],[5197],[5176,5199,5200],{"intervention":4630,"totalTrials":247,"cells":5238},{"EARLY_PHASE1":5239,"PHASE1":5241,"PHASE2":5243,"PHASE3":5245,"PHASE4":5247,"NA":5249},{"trials":5240,"activeCount":100},[],{"trials":5242,"activeCount":100},[],{"trials":5244,"activeCount":100},[],{"trials":5246,"activeCount":100},[],{"trials":5248,"activeCount":100},[],{"trials":5250,"activeCount":247,"soonestReadout":1761},[5251],{"nctId":4621,"briefTitle":4622,"status":227,"phases":5252,"primaryCompletion":1761,"completion":1761,"start":1668,"enrollment":289,"conditions":5253,"interventions":5254},[93],[4625,4626,4627,1473,4628],[4594,4630,4630],{"intervention":4408,"totalTrials":247,"cells":5256},{"EARLY_PHASE1":5257,"PHASE1":5259,"PHASE2":5261,"PHASE3":5263,"PHASE4":5265,"NA":5267},{"trials":5258,"activeCount":100},[],{"trials":5260,"activeCount":100},[],{"trials":5262,"activeCount":100},[],{"trials":5264,"activeCount":100},[],{"trials":5266,"activeCount":100},[],{"trials":5268,"activeCount":247,"soonestReadout":2693},[5269],{"nctId":4398,"briefTitle":4399,"status":227,"phases":5270,"primaryCompletion":2693,"completion":1567,"start":4401,"enrollment":1249,"conditions":5271,"interventions":5272},[93],[21,4403,4404,4405,4406],[4371,4408],{"intervention":5274,"totalTrials":247,"cells":5275},"Bupivacaine methylene blue",{"EARLY_PHASE1":5276,"PHASE1":5278,"PHASE2":5280,"PHASE3":5282,"PHASE4":5284,"NA":5286},{"trials":5277,"activeCount":100},[],{"trials":5279,"activeCount":100},[],{"trials":5281,"activeCount":100},[],{"trials":5283,"activeCount":100},[],{"trials":5285,"activeCount":100},[],{"trials":5287,"activeCount":247,"soonestReadout":1350},[5288],{"nctId":5289,"briefTitle":5290,"status":227,"phases":5291,"primaryCompletion":1350,"completion":4659,"start":1379,"enrollment":5292,"conditions":5293,"interventions":5297},"NCT05830630","Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery",[93],72,[5294,5295,5296],"Perineural","Methylene Blue","Lower Limb Amputation",[5274,5298],"bupivacaine saline",{"intervention":5298,"totalTrials":247,"cells":5300},{"EARLY_PHASE1":5301,"PHASE1":5303,"PHASE2":5305,"PHASE3":5307,"PHASE4":5309,"NA":5311},{"trials":5302,"activeCount":100},[],{"trials":5304,"activeCount":100},[],{"trials":5306,"activeCount":100},[],{"trials":5308,"activeCount":100},[],{"trials":5310,"activeCount":100},[],{"trials":5312,"activeCount":247,"soonestReadout":1350},[5313],{"nctId":5289,"briefTitle":5290,"status":227,"phases":5314,"primaryCompletion":1350,"completion":4659,"start":1379,"enrollment":5292,"conditions":5315,"interventions":5316},[93],[5294,5295,5296],[5274,5298],{"intervention":5318,"totalTrials":247,"cells":5319},"Standard Allergic Rhinitis Treatment",{"EARLY_PHASE1":5320,"PHASE1":5322,"PHASE2":5324,"PHASE3":5326,"PHASE4":5328,"NA":5330},{"trials":5321,"activeCount":100},[],{"trials":5323,"activeCount":100},[],{"trials":5325,"activeCount":100},[],{"trials":5327,"activeCount":100},[],{"trials":5329,"activeCount":100},[],{"trials":5331,"activeCount":247,"soonestReadout":5336},[5332],{"nctId":5333,"briefTitle":5334,"status":227,"phases":5335,"primaryCompletion":5336,"completion":318,"start":5337,"enrollment":289,"conditions":5338,"interventions":5341},"NCT07115342","Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis",[93],"2025-10-30","2025-08-01",[5339,5340],"Allergic Rhinitis","Allergic Rhinitis (AR)",[5318],{"intervention":5343,"totalTrials":247,"cells":5344},"Chlorhexidine Oral Care",{"EARLY_PHASE1":5345,"PHASE1":5347,"PHASE2":5349,"PHASE3":5351,"PHASE4":5353,"NA":5355},{"trials":5346,"activeCount":100},[],{"trials":5348,"activeCount":100},[],{"trials":5350,"activeCount":100},[],{"trials":5352,"activeCount":100},[],{"trials":5354,"activeCount":100},[],{"trials":5356,"activeCount":247,"soonestReadout":1822},[5357],{"nctId":5358,"briefTitle":5359,"status":460,"phases":5360,"primaryCompletion":1822,"completion":1193,"start":332,"enrollment":128,"conditions":5361,"interventions":5363},"NCT07482007","Oropharyngeal Care With Colostrum, Chlorohexidine and Sodium Bicarbonate in Preventing Ventilator-associated Pneumonia in Preterm Neonates",[93],[5362],"Ventilator-Associated Pneumonia",[5343],{"intervention":4419,"totalTrials":247,"cells":5365},{"EARLY_PHASE1":5366,"PHASE1":5368,"PHASE2":5370,"PHASE3":5372,"PHASE4":5374,"NA":5376},{"trials":5367,"activeCount":100},[],{"trials":5369,"activeCount":100},[],{"trials":5371,"activeCount":100},[],{"trials":5373,"activeCount":100},[],{"trials":5375,"activeCount":100},[],{"trials":5377,"activeCount":247,"soonestReadout":614},[5378],{"nctId":4410,"briefTitle":4411,"status":227,"phases":5379,"primaryCompletion":614,"completion":614,"start":4413,"enrollment":197,"conditions":5380,"interventions":5381},[93],[30,4415,4390,4416,4417],[4419,4371,4420],{"intervention":4420,"totalTrials":247,"cells":5383},{"EARLY_PHASE1":5384,"PHASE1":5386,"PHASE2":5388,"PHASE3":5390,"PHASE4":5392,"NA":5394},{"trials":5385,"activeCount":100},[],{"trials":5387,"activeCount":100},[],{"trials":5389,"activeCount":100},[],{"trials":5391,"activeCount":100},[],{"trials":5393,"activeCount":100},[],{"trials":5395,"activeCount":247,"soonestReadout":614},[5396],{"nctId":4410,"briefTitle":4411,"status":227,"phases":5397,"primaryCompletion":614,"completion":614,"start":4413,"enrollment":197,"conditions":5398,"interventions":5399},[93],[30,4415,4390,4416,4417],[4419,4371,4420],{"intervention":5401,"totalTrials":247,"cells":5402},"L-thyroxine",{"EARLY_PHASE1":5403,"PHASE1":5405,"PHASE2":5407,"PHASE3":5409,"PHASE4":5411,"NA":5413},{"trials":5404,"activeCount":100},[],{"trials":5406,"activeCount":100},[],{"trials":5408,"activeCount":100},[],{"trials":5410,"activeCount":100},[],{"trials":5412,"activeCount":100},[],{"trials":5414,"activeCount":247,"soonestReadout":5419},[5415],{"nctId":5416,"briefTitle":5417,"status":227,"phases":5418,"primaryCompletion":5419,"completion":5419,"start":5420,"enrollment":370,"conditions":5421,"interventions":5425},"NCT07393165","Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism",[93],"2026-05-01","2025-05-24",[5422,5423,409,5424],"Levothyroxine","Cardiac Function","Subclinical Hypothyroidism",[5401],{"intervention":5427,"totalTrials":247,"cells":5428},"Perineural injection with 5% dextrose (D5W).",{"EARLY_PHASE1":5429,"PHASE1":5431,"PHASE2":5433,"PHASE3":5435,"PHASE4":5437,"NA":5439},{"trials":5430,"activeCount":100},[],{"trials":5432,"activeCount":100},[],{"trials":5434,"activeCount":100},[],{"trials":5436,"activeCount":100},[],{"trials":5438,"activeCount":100},[],{"trials":5440,"activeCount":247,"soonestReadout":5445},[5441],{"nctId":5442,"briefTitle":5443,"status":153,"phases":5444,"primaryCompletion":5445,"completion":5445,"start":463,"enrollment":438,"conditions":5446,"interventions":5450},"NCT07498998","Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome",[93],"2026-08-30",[5447,5448,35,5449],"Carpal Tunnel Syndrome (CTS)","Glucocorticoid","Dextrose",[5427,5451,5452],"Local ozone","Local glucocorticoid injection (dexamethasone).",{"intervention":5451,"totalTrials":247,"cells":5454},{"EARLY_PHASE1":5455,"PHASE1":5457,"PHASE2":5459,"PHASE3":5461,"PHASE4":5463,"NA":5465},{"trials":5456,"activeCount":100},[],{"trials":5458,"activeCount":100},[],{"trials":5460,"activeCount":100},[],{"trials":5462,"activeCount":100},[],{"trials":5464,"activeCount":100},[],{"trials":5466,"activeCount":247,"soonestReadout":5445},[5467],{"nctId":5442,"briefTitle":5443,"status":153,"phases":5468,"primaryCompletion":5445,"completion":5445,"start":463,"enrollment":438,"conditions":5469,"interventions":5470},[93],[5447,5448,35,5449],[5427,5451,5452],{"intervention":5452,"totalTrials":247,"cells":5472},{"EARLY_PHASE1":5473,"PHASE1":5475,"PHASE2":5477,"PHASE3":5479,"PHASE4":5481,"NA":5483},{"trials":5474,"activeCount":100},[],{"trials":5476,"activeCount":100},[],{"trials":5478,"activeCount":100},[],{"trials":5480,"activeCount":100},[],{"trials":5482,"activeCount":100},[],{"trials":5484,"activeCount":247,"soonestReadout":5445},[5485],{"nctId":5442,"briefTitle":5443,"status":153,"phases":5486,"primaryCompletion":5445,"completion":5445,"start":463,"enrollment":438,"conditions":5487,"interventions":5488},[93],[5447,5448,35,5449],[5427,5451,5452],{"intervention":86,"totalTrials":247,"cells":5490},{"EARLY_PHASE1":5491,"PHASE1":5493,"PHASE2":5495,"PHASE3":5497,"PHASE4":5499,"NA":5501},{"trials":5492,"activeCount":100},[],{"trials":5494,"activeCount":100},[],{"trials":5496,"activeCount":100},[],{"trials":5498,"activeCount":100},[],{"trials":5500,"activeCount":100},[],{"trials":5502,"activeCount":247,"soonestReadout":85},[5503],{"nctId":83,"briefTitle":84,"status":227,"phases":5504,"primaryCompletion":85,"completion":85,"start":482,"enrollment":197,"conditions":5505,"interventions":5506},[93],[1237,3047],[86,5507],"\"Mesalamine\" and \"Placebo\"",{"intervention":5507,"totalTrials":247,"cells":5509},{"EARLY_PHASE1":5510,"PHASE1":5512,"PHASE2":5514,"PHASE3":5516,"PHASE4":5518,"NA":5520},{"trials":5511,"activeCount":100},[],{"trials":5513,"activeCount":100},[],{"trials":5515,"activeCount":100},[],{"trials":5517,"activeCount":100},[],{"trials":5519,"activeCount":100},[],{"trials":5521,"activeCount":247,"soonestReadout":85},[5522],{"nctId":83,"briefTitle":84,"status":227,"phases":5523,"primaryCompletion":85,"completion":85,"start":482,"enrollment":197,"conditions":5524,"interventions":5525},[93],[1237,3047],[86,5507],{"intervention":1116,"totalTrials":247,"cells":5527},{"EARLY_PHASE1":5528,"PHASE1":5530,"PHASE2":5532,"PHASE3":5534,"PHASE4":5536,"NA":5538},{"trials":5529,"activeCount":100},[],{"trials":5531,"activeCount":100},[],{"trials":5533,"activeCount":100},[],{"trials":5535,"activeCount":100},[],{"trials":5537,"activeCount":100},[],{"trials":5539,"activeCount":247,"soonestReadout":1108},[5540],{"nctId":1105,"briefTitle":1106,"status":227,"phases":5541,"primaryCompletion":1108,"completion":1108,"start":1109,"enrollment":1110,"conditions":5542,"interventions":5543},[93],[1112,1113,466,409,1114],[431,1116,1117],{"intervention":1867,"totalTrials":247,"cells":5545},{"EARLY_PHASE1":5546,"PHASE1":5548,"PHASE2":5550,"PHASE3":5552,"PHASE4":5554,"NA":5556},{"trials":5547,"activeCount":100},[],{"trials":5549,"activeCount":100},[],{"trials":5551,"activeCount":100},[],{"trials":5553,"activeCount":100},[],{"trials":5555,"activeCount":100},[],{"trials":5557,"activeCount":247,"soonestReadout":723},[5558],{"nctId":1862,"briefTitle":1863,"status":227,"phases":5559,"primaryCompletion":723,"completion":723,"start":390,"enrollment":1865,"conditions":5560,"interventions":5561},[93],[1867,1843,1868,1869,1216],[1867,1843],{"intervention":5563,"totalTrials":247,"cells":5564},"Rhomboid intercostal plane block",{"EARLY_PHASE1":5565,"PHASE1":5567,"PHASE2":5569,"PHASE3":5571,"PHASE4":5573,"NA":5575},{"trials":5566,"activeCount":100},[],{"trials":5568,"activeCount":100},[],{"trials":5570,"activeCount":100},[],{"trials":5572,"activeCount":100},[],{"trials":5574,"activeCount":100},[],{"trials":5576,"activeCount":247,"soonestReadout":5581},[5577],{"nctId":5578,"briefTitle":5579,"status":227,"phases":5580,"primaryCompletion":5581,"completion":5581,"start":4345,"enrollment":197,"conditions":5582,"interventions":5585},"NCT06654635","Ultrasound Guided Rhomboid Intercostal Plane Block Versus Thoracic Erector Spinae Plane Block in Upper Abdominal Surgery",[93],"2025-05-01",[30,5583,4390,5584],"Rhomboid Intercostal Plane Block","Upper Abdominal Surgery",[5563],{"intervention":5587,"totalTrials":247,"cells":5588},"oral coenzymeQ10",{"EARLY_PHASE1":5589,"PHASE1":5591,"PHASE2":5593,"PHASE3":5595,"PHASE4":5597,"NA":5599},{"trials":5590,"activeCount":100},[],{"trials":5592,"activeCount":100},[],{"trials":5594,"activeCount":100},[],{"trials":5596,"activeCount":100},[],{"trials":5598,"activeCount":100},[],{"trials":5600,"activeCount":247,"soonestReadout":5605},[5601],{"nctId":5602,"briefTitle":5603,"status":153,"phases":5604,"primaryCompletion":5605,"completion":5606,"start":1048,"enrollment":289,"conditions":5607,"interventions":5609},"NCT07317440","Coenzyme Q10 in Pediatric Community-Acquired Pneumonia",[93],"2026-06-01","2026-12-31",[5608],"Community Acquired Pneumonia",[5587],{"intervention":5611,"totalTrials":247,"cells":5612},"Mebendazole",{"EARLY_PHASE1":5613,"PHASE1":5615,"PHASE2":5617,"PHASE3":5619,"PHASE4":5621,"NA":5623},{"trials":5614,"activeCount":100},[],{"trials":5616,"activeCount":100},[],{"trials":5618,"activeCount":100},[],{"trials":5620,"activeCount":100},[],{"trials":5622,"activeCount":100},[],{"trials":5624,"activeCount":247,"soonestReadout":155},[5625],{"nctId":5626,"briefTitle":5627,"status":227,"phases":5628,"primaryCompletion":155,"completion":3095,"start":3267,"enrollment":1510,"conditions":5629,"interventions":5630},"NCT06335160","Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine",[93],[1237],[5611],{"intervention":5632,"totalTrials":247,"cells":5633},"Group 1",{"EARLY_PHASE1":5634,"PHASE1":5636,"PHASE2":5638,"PHASE3":5640,"PHASE4":5642,"NA":5644},{"trials":5635,"activeCount":100},[],{"trials":5637,"activeCount":100},[],{"trials":5639,"activeCount":100},[],{"trials":5641,"activeCount":100},[],{"trials":5643,"activeCount":100},[],{"trials":5645,"activeCount":247,"soonestReadout":5445},[5646],{"nctId":5647,"briefTitle":5648,"status":153,"phases":5649,"primaryCompletion":5445,"completion":5445,"start":5650,"enrollment":171,"conditions":5651,"interventions":5654},"NCT07349459","Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin",[93],"2026-04-30",[163,5652,5653,3433],"Breast Cancer Patients Diagnosed","Vitamin D Concentration",[5632,5655,5656],"Group 2: Vitamin D group","Group 3: melatonin group",{"intervention":5655,"totalTrials":247,"cells":5658},{"EARLY_PHASE1":5659,"PHASE1":5661,"PHASE2":5663,"PHASE3":5665,"PHASE4":5667,"NA":5669},{"trials":5660,"activeCount":100},[],{"trials":5662,"activeCount":100},[],{"trials":5664,"activeCount":100},[],{"trials":5666,"activeCount":100},[],{"trials":5668,"activeCount":100},[],{"trials":5670,"activeCount":247,"soonestReadout":5445},[5671],{"nctId":5647,"briefTitle":5648,"status":153,"phases":5672,"primaryCompletion":5445,"completion":5445,"start":5650,"enrollment":171,"conditions":5673,"interventions":5674},[93],[163,5652,5653,3433],[5632,5655,5656],{"intervention":5656,"totalTrials":247,"cells":5676},{"EARLY_PHASE1":5677,"PHASE1":5679,"PHASE2":5681,"PHASE3":5683,"PHASE4":5685,"NA":5687},{"trials":5678,"activeCount":100},[],{"trials":5680,"activeCount":100},[],{"trials":5682,"activeCount":100},[],{"trials":5684,"activeCount":100},[],{"trials":5686,"activeCount":100},[],{"trials":5688,"activeCount":247,"soonestReadout":5445},[5689],{"nctId":5647,"briefTitle":5648,"status":153,"phases":5690,"primaryCompletion":5445,"completion":5445,"start":5650,"enrollment":171,"conditions":5691,"interventions":5692},[93],[163,5652,5653,3433],[5632,5655,5656],{"intervention":5694,"totalTrials":247,"cells":5695},"Fluticasone \u002F Long-Acting Beta-2 Agonist Combination",{"EARLY_PHASE1":5696,"PHASE1":5698,"PHASE2":5700,"PHASE3":5702,"PHASE4":5704,"NA":5706},{"trials":5697,"activeCount":100},[],{"trials":5699,"activeCount":100},[],{"trials":5701,"activeCount":100},[],{"trials":5703,"activeCount":100},[],{"trials":5705,"activeCount":100},[],{"trials":5707,"activeCount":247,"soonestReadout":5605},[5708],{"nctId":5709,"briefTitle":5710,"status":153,"phases":5711,"primaryCompletion":5605,"completion":5712,"start":1822,"enrollment":171,"conditions":5713,"interventions":5714},"NCT07315555","Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma",[93],"2026-10-31",[5608],[5694],{"intervention":5716,"totalTrials":247,"cells":5717},"Systemic Methotrexate",{"EARLY_PHASE1":5718,"PHASE1":5720,"PHASE2":5722,"PHASE3":5724,"PHASE4":5726,"NA":5728},{"trials":5719,"activeCount":100},[],{"trials":5721,"activeCount":100},[],{"trials":5723,"activeCount":100},[],{"trials":5725,"activeCount":100},[],{"trials":5727,"activeCount":100},[],{"trials":5729,"activeCount":247,"soonestReadout":1109},[5730],{"nctId":5731,"briefTitle":5732,"status":227,"phases":5733,"primaryCompletion":1109,"completion":1109,"start":5734,"enrollment":96,"conditions":5735,"interventions":5739},"NCT06554470","Local vs Systemic Methotrexate in Management of Uterine Ectopic Pregnancy",[93],"2024-08-15",[5736,5737,1621,5738],"Local","Systemic","Uterine Ectopic Pregnancy",[5716,5740],"Local Methotrexate",{"intervention":5740,"totalTrials":247,"cells":5742},{"EARLY_PHASE1":5743,"PHASE1":5745,"PHASE2":5747,"PHASE3":5749,"PHASE4":5751,"NA":5753},{"trials":5744,"activeCount":100},[],{"trials":5746,"activeCount":100},[],{"trials":5748,"activeCount":100},[],{"trials":5750,"activeCount":100},[],{"trials":5752,"activeCount":100},[],{"trials":5754,"activeCount":247,"soonestReadout":1109},[5755],{"nctId":5731,"briefTitle":5732,"status":227,"phases":5756,"primaryCompletion":1109,"completion":1109,"start":5734,"enrollment":96,"conditions":5757,"interventions":5758},[93],[5736,5737,1621,5738],[5716,5740],{"intervention":5760,"totalTrials":247,"cells":5761},"Adalimumab",{"EARLY_PHASE1":5762,"PHASE1":5764,"PHASE2":5766,"PHASE3":5768,"PHASE4":5770,"NA":5772},{"trials":5763,"activeCount":100},[],{"trials":5765,"activeCount":100},[],{"trials":5767,"activeCount":100},[],{"trials":5769,"activeCount":100},[],{"trials":5771,"activeCount":100},[],{"trials":5773,"activeCount":247,"soonestReadout":2716},[5774],{"nctId":5775,"briefTitle":5776,"status":153,"phases":5777,"primaryCompletion":2716,"completion":2716,"start":2716,"enrollment":197,"conditions":5778,"interventions":5782},"NCT07398651","Apremilast and Adalimumab in Psoriatic Arthritis Patients",[93],[5779,5780,5781],"Psoriatic Arthritis","Ultrasound Assessment","TNF",[5760,5783],"Apremilast",{"intervention":5783,"totalTrials":247,"cells":5785},{"EARLY_PHASE1":5786,"PHASE1":5788,"PHASE2":5790,"PHASE3":5792,"PHASE4":5794,"NA":5796},{"trials":5787,"activeCount":100},[],{"trials":5789,"activeCount":100},[],{"trials":5791,"activeCount":100},[],{"trials":5793,"activeCount":100},[],{"trials":5795,"activeCount":100},[],{"trials":5797,"activeCount":247,"soonestReadout":2716},[5798],{"nctId":5775,"briefTitle":5776,"status":153,"phases":5799,"primaryCompletion":2716,"completion":2716,"start":2716,"enrollment":197,"conditions":5800,"interventions":5801},[93],[5779,5780,5781],[5760,5783],{"intervention":5803,"totalTrials":247,"cells":5804},"Micronized purified flavonoid fraction",{"EARLY_PHASE1":5805,"PHASE1":5807,"PHASE2":5809,"PHASE3":5811,"PHASE4":5813,"NA":5815},{"trials":5806,"activeCount":100},[],{"trials":5808,"activeCount":100},[],{"trials":5810,"activeCount":100},[],{"trials":5812,"activeCount":100},[],{"trials":5814,"activeCount":100},[],{"trials":5816,"activeCount":247,"soonestReadout":4132},[5817],{"nctId":5818,"briefTitle":5819,"status":227,"phases":5820,"primaryCompletion":4132,"completion":4132,"start":5821,"enrollment":370,"conditions":5822,"interventions":5825},"NCT06560294","Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome",[93],"2024-08-17",[5823,5824],"Glue Embolization","Pelvic Congestion Syndrome",[5803],{"intervention":5827,"totalTrials":513,"cells":5828},"Sofosbuvir",{"EARLY_PHASE1":5829,"PHASE1":5831,"PHASE2":5833,"PHASE3":5835,"PHASE4":5856,"NA":5872},{"trials":5830,"activeCount":100},[],{"trials":5832,"activeCount":100},[],{"trials":5834,"activeCount":100},[],{"trials":5836,"activeCount":100},[5837,5845],{"nctId":5838,"briefTitle":5839,"status":123,"phases":5840,"primaryCompletion":5841,"completion":941,"start":239,"enrollment":184,"conditions":5842,"interventions":5843},"NCT04497649","Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients",[90,91],"2021-04-01",[2037],[5827,5844],"Daclatasvir",{"nctId":5846,"briefTitle":5847,"status":123,"phases":5848,"primaryCompletion":5849,"completion":5850,"start":5851,"enrollment":197,"conditions":5852,"interventions":5853},"NCT04460443","Sofosbuvir in Treatment of COVID 19",[90,91],"2021-08-01","2021-08-31","2020-08-01",[1206],[5854,5855,5844],"sofosbuvir","Sofosbuvir ledipsavir",{"trials":5857,"activeCount":100},[5858],{"nctId":5859,"briefTitle":5860,"status":106,"phases":5861,"primaryCompletion":1704,"completion":2127,"start":1172,"enrollment":5862,"conditions":5863,"interventions":5865},"NCT02992457","Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection",[92],10000,[5864],"Hepatitis C",[5827,5866,5867,5868,5844,5869,5870,5871],"Ribavirin","Pegylated-interferon alfa-2a","Simeprevir","Ritaprevir, paritaprevir, ombetasvir","Sofosbuvir and Ledipasvir","Salvage therapy",{"trials":5873,"activeCount":100},[],{"intervention":5844,"totalTrials":513,"cells":5875},{"EARLY_PHASE1":5876,"PHASE1":5878,"PHASE2":5880,"PHASE3":5882,"PHASE4":5892,"NA":5898},{"trials":5877,"activeCount":100},[],{"trials":5879,"activeCount":100},[],{"trials":5881,"activeCount":100},[],{"trials":5883,"activeCount":100},[5884,5888],{"nctId":5838,"briefTitle":5839,"status":123,"phases":5885,"primaryCompletion":5841,"completion":941,"start":239,"enrollment":184,"conditions":5886,"interventions":5887},[90,91],[2037],[5827,5844],{"nctId":5846,"briefTitle":5847,"status":123,"phases":5889,"primaryCompletion":5849,"completion":5850,"start":5851,"enrollment":197,"conditions":5890,"interventions":5891},[90,91],[1206],[5854,5855,5844],{"trials":5893,"activeCount":100},[5894],{"nctId":5859,"briefTitle":5860,"status":106,"phases":5895,"primaryCompletion":1704,"completion":2127,"start":1172,"enrollment":5862,"conditions":5896,"interventions":5897},[92],[5864],[5827,5866,5867,5868,5844,5869,5870,5871],{"trials":5899,"activeCount":100},[],{"intervention":5901,"totalTrials":188,"cells":5902},"Letrozole 2.5mg",{"EARLY_PHASE1":5903,"PHASE1":5905,"PHASE2":5907,"PHASE3":5909,"PHASE4":5919,"NA":5934},{"trials":5904,"activeCount":100},[],{"trials":5906,"activeCount":100},[],{"trials":5908,"activeCount":100},[],{"trials":5910,"activeCount":100},[5911],{"nctId":5912,"briefTitle":5913,"status":123,"phases":5914,"primaryCompletion":5915,"completion":2220,"start":1492,"enrollment":370,"conditions":5916,"interventions":5917},"NCT05523609","Vitamin D and Calcium Supplementation in Breast Cancer",[90,91],"2024-09",[726],[5901,5918],"Letrozole + vitamin D3 and calcium",{"trials":5920,"activeCount":100},[5921],{"nctId":5922,"briefTitle":5923,"status":106,"phases":5924,"primaryCompletion":5925,"completion":5925,"start":5926,"enrollment":157,"conditions":5927,"interventions":5932},"NCT04834791","Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance",[92],"2019-10-31","2019-03-01",[5928,5929,5930,5931],"Clomiphene Citrate Resistance","Ovulation Induction","Letrozole","Gonadotropins",[5901,5933],"Gonadotropin",{"trials":5935,"activeCount":100},[],{"intervention":5937,"totalTrials":188,"cells":5938},"Metoclopramide",{"EARLY_PHASE1":5939,"PHASE1":5941,"PHASE2":5943,"PHASE3":5955,"PHASE4":5957,"NA":5969},{"trials":5940,"activeCount":100},[],{"trials":5942,"activeCount":100},[],{"trials":5944,"activeCount":100},[5945],{"nctId":5946,"briefTitle":5947,"status":106,"phases":5948,"primaryCompletion":5949,"completion":5950,"start":1093,"enrollment":171,"conditions":5951,"interventions":5953},"NCT05342818","Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron",[90],"2022-07-30","2022-10-17",[5952],"Delayed Gastric Emptying",[5954,1728,5937],"Neostigmine",{"trials":5956,"activeCount":100},[],{"trials":5958,"activeCount":100},[5959],{"nctId":5960,"briefTitle":5961,"status":106,"phases":5962,"primaryCompletion":5963,"completion":5963,"start":5964,"enrollment":128,"conditions":5965,"interventions":5968},"NCT05641051","Metoclopramide on Gastric Emptying in Mechanically Ventilated Patients",[92],"2023-06-16","2022-12-14",[1081,5966,5967,5937],"Mechanically Ventilation","Randomized Controlled Trial",[5937],{"trials":5970,"activeCount":100},[],{"intervention":5933,"totalTrials":188,"cells":5972},{"EARLY_PHASE1":5973,"PHASE1":5975,"PHASE2":5977,"PHASE3":5979,"PHASE4":5981,"NA":5997},{"trials":5974,"activeCount":100},[],{"trials":5976,"activeCount":100},[],{"trials":5978,"activeCount":100},[],{"trials":5980,"activeCount":100},[],{"trials":5982,"activeCount":100},[5983,5987],{"nctId":5922,"briefTitle":5923,"status":106,"phases":5984,"primaryCompletion":5925,"completion":5925,"start":5926,"enrollment":157,"conditions":5985,"interventions":5986},[92],[5928,5929,5930,5931],[5901,5933],{"nctId":5988,"briefTitle":5989,"status":123,"phases":5990,"primaryCompletion":5991,"completion":5991,"start":5992,"enrollment":1705,"conditions":5993,"interventions":5995},"NCT04754243","New Protocol in Unexplained Infertility",[92],"2024-12-31","2021-03-01",[5994],"Unexplained Infertility",[5933,5996],"Standard protocol in IUI",{"trials":5998,"activeCount":100},[],{"intervention":1899,"totalTrials":188,"cells":6000},{"EARLY_PHASE1":6001,"PHASE1":6003,"PHASE2":6005,"PHASE3":6016,"PHASE4":6018,"NA":6024},{"trials":6002,"activeCount":100},[],{"trials":6004,"activeCount":100},[],{"trials":6006,"activeCount":100},[6007],{"nctId":6008,"briefTitle":6009,"status":106,"phases":6010,"primaryCompletion":4112,"completion":656,"start":3313,"enrollment":6011,"conditions":6012,"interventions":6014},"NCT06677788","Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH",[90],55,[6013],"Non-Alcoholic Steatohepatitis (NASH)",[6015,1899],"Roflumilast 500 Mcg Oral",{"trials":6017,"activeCount":100},[],{"trials":6019,"activeCount":100},[6020],{"nctId":1892,"briefTitle":1893,"status":106,"phases":6021,"primaryCompletion":1078,"completion":1078,"start":1895,"enrollment":197,"conditions":6022,"interventions":6023},[92],[1897],[1872,1899],{"trials":6025,"activeCount":100},[],{"intervention":244,"totalTrials":188,"cells":6027},{"EARLY_PHASE1":6028,"PHASE1":6030,"PHASE2":6032,"PHASE3":6034,"PHASE4":6036,"NA":6053},{"trials":6029,"activeCount":100},[],{"trials":6031,"activeCount":100},[],{"trials":6033,"activeCount":100},[],{"trials":6035,"activeCount":100},[],{"trials":6037,"activeCount":100},[6038,6049],{"nctId":6039,"briefTitle":6040,"status":106,"phases":6041,"primaryCompletion":6042,"completion":6042,"start":4174,"enrollment":197,"conditions":6043,"interventions":6047},"NCT06011746","Adding Ketamine to Levobupivacaine in Paravertebral Block in Thoracotomy",[92],"2024-01-26",[201,244,6044,6045,6046],"Paravertebral Block","Acute Pain","Chronic Pain",[6048,244],"Ketamine + Levobupivacaine",{"nctId":235,"briefTitle":236,"status":106,"phases":6050,"primaryCompletion":238,"completion":238,"start":239,"enrollment":171,"conditions":6051,"interventions":6052},[92],[241,242,15,243,244],[246,15,243],{"trials":6054,"activeCount":100},[],{"intervention":6056,"totalTrials":188,"cells":6057},"Placebos",{"EARLY_PHASE1":6058,"PHASE1":6060,"PHASE2":6062,"PHASE3":6064,"PHASE4":6066,"NA":6090},{"trials":6059,"activeCount":100},[],{"trials":6061,"activeCount":100},[],{"trials":6063,"activeCount":100},[],{"trials":6065,"activeCount":100},[],{"trials":6067,"activeCount":100},[6068,6078],{"nctId":6069,"briefTitle":6070,"status":106,"phases":6071,"primaryCompletion":6072,"completion":6072,"start":1361,"enrollment":6073,"conditions":6074,"interventions":6076},"NCT04048226","Dexmedetomidine-Ketamine Infusion in Breast Surgeries",[92],"2024-03-20",103,[6075],"Total Intravenous Anesthesia",[6056,6077],"Dexmedetomidine +Ketamine",{"nctId":6079,"briefTitle":6080,"status":106,"phases":6081,"primaryCompletion":6082,"completion":6082,"start":6083,"enrollment":6084,"conditions":6085,"interventions":6088},"NCT03930212","Progesterone Supplementation in Threatened Abortion",[92],"2018-12-31","2018-01-01",190,[6086,6087],"Threatened Abortion","Progesterone Resistance",[6089,6056],"Progesterone",{"trials":6091,"activeCount":100},[],{"intervention":6093,"totalTrials":247,"cells":6094},"oral melatonin",{"EARLY_PHASE1":6095,"PHASE1":6097,"PHASE2":6099,"PHASE3":6101,"PHASE4":6103,"NA":6114},{"trials":6096,"activeCount":100},[],{"trials":6098,"activeCount":100},[],{"trials":6100,"activeCount":100},[],{"trials":6102,"activeCount":100},[],{"trials":6104,"activeCount":100},[6105],{"nctId":6106,"briefTitle":6107,"status":106,"phases":6108,"primaryCompletion":4253,"completion":4253,"start":6109,"enrollment":197,"conditions":6110,"interventions":6112},"NCT03631901","Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures",[92],"2017-04-01",[6111],"Febrile Seizures",[6093,6113],"oral diazepam",{"trials":6115,"activeCount":100},[],{"intervention":6113,"totalTrials":247,"cells":6117},{"EARLY_PHASE1":6118,"PHASE1":6120,"PHASE2":6122,"PHASE3":6124,"PHASE4":6126,"NA":6132},{"trials":6119,"activeCount":100},[],{"trials":6121,"activeCount":100},[],{"trials":6123,"activeCount":100},[],{"trials":6125,"activeCount":100},[],{"trials":6127,"activeCount":100},[6128],{"nctId":6106,"briefTitle":6107,"status":106,"phases":6129,"primaryCompletion":4253,"completion":4253,"start":6109,"enrollment":197,"conditions":6130,"interventions":6131},[92],[6111],[6093,6113],{"trials":6133,"activeCount":100},[],{"intervention":6135,"totalTrials":247,"cells":6136},"Opioid-sparing based anesthesia",{"EARLY_PHASE1":6137,"PHASE1":6139,"PHASE2":6141,"PHASE3":6143,"PHASE4":6145,"NA":6158},{"trials":6138,"activeCount":100},[],{"trials":6140,"activeCount":100},[],{"trials":6142,"activeCount":100},[],{"trials":6144,"activeCount":100},[],{"trials":6146,"activeCount":100},[6147],{"nctId":6148,"briefTitle":6149,"status":123,"phases":6150,"primaryCompletion":6151,"completion":6151,"start":6152,"enrollment":5292,"conditions":6153,"interventions":6156},"NCT05962671","Opioid-sparing Versus Sevoflurane Anesthesia on Early Postoperative Hypoventilation in Laparoscopic Bariatric Surgery",[92],"2024-03-30","2023-08-10",[1363,6154,6155,420],"Hypoventilation","Opioid Use",[6135,6157],"Sevoflurane-based anesthesia",{"trials":6159,"activeCount":100},[],{"intervention":6157,"totalTrials":247,"cells":6161},{"EARLY_PHASE1":6162,"PHASE1":6164,"PHASE2":6166,"PHASE3":6168,"PHASE4":6170,"NA":6176},{"trials":6163,"activeCount":100},[],{"trials":6165,"activeCount":100},[],{"trials":6167,"activeCount":100},[],{"trials":6169,"activeCount":100},[],{"trials":6171,"activeCount":100},[6172],{"nctId":6148,"briefTitle":6149,"status":123,"phases":6173,"primaryCompletion":6151,"completion":6151,"start":6152,"enrollment":5292,"conditions":6174,"interventions":6175},[92],[1363,6154,6155,420],[6135,6157],{"trials":6177,"activeCount":100},[],{"intervention":6179,"totalTrials":247,"cells":6180},"Roflumilast 500 MCG Oral Tablet [DALIRESP]",{"EARLY_PHASE1":6181,"PHASE1":6183,"PHASE2":6185,"PHASE3":6187,"PHASE4":6189,"NA":6200},{"trials":6182,"activeCount":100},[],{"trials":6184,"activeCount":100},[],{"trials":6186,"activeCount":100},[],{"trials":6188,"activeCount":100},[],{"trials":6190,"activeCount":100},[6191],{"nctId":6192,"briefTitle":6193,"status":106,"phases":6194,"primaryCompletion":6195,"completion":6196,"start":3028,"enrollment":1026,"conditions":6197,"interventions":6198},"NCT05684484","Role of Roflumilast in Ulcerative Colitis",[92],"2024-04-15","2024-09-15",[1237],[6179,6199],"amino salicylic acid",{"trials":6201,"activeCount":100},[],{"intervention":6199,"totalTrials":247,"cells":6203},{"EARLY_PHASE1":6204,"PHASE1":6206,"PHASE2":6208,"PHASE3":6210,"PHASE4":6212,"NA":6218},{"trials":6205,"activeCount":100},[],{"trials":6207,"activeCount":100},[],{"trials":6209,"activeCount":100},[],{"trials":6211,"activeCount":100},[],{"trials":6213,"activeCount":100},[6214],{"nctId":6192,"briefTitle":6193,"status":106,"phases":6215,"primaryCompletion":6195,"completion":6196,"start":3028,"enrollment":1026,"conditions":6216,"interventions":6217},[92],[1237],[6179,6199],{"trials":6219,"activeCount":100},[],{"intervention":1366,"totalTrials":247,"cells":6221},{"EARLY_PHASE1":6222,"PHASE1":6224,"PHASE2":6226,"PHASE3":6228,"PHASE4":6230,"NA":6236},{"trials":6223,"activeCount":100},[],{"trials":6225,"activeCount":100},[],{"trials":6227,"activeCount":100},[],{"trials":6229,"activeCount":100},[],{"trials":6231,"activeCount":100},[6232],{"nctId":1357,"briefTitle":1358,"status":106,"phases":6233,"primaryCompletion":1360,"completion":1360,"start":1361,"enrollment":171,"conditions":6234,"interventions":6235},[92],[1363,1364,15],[1366,1367,259],{"trials":6237,"activeCount":100},[],{"intervention":1367,"totalTrials":247,"cells":6239},{"EARLY_PHASE1":6240,"PHASE1":6242,"PHASE2":6244,"PHASE3":6246,"PHASE4":6248,"NA":6254},{"trials":6241,"activeCount":100},[],{"trials":6243,"activeCount":100},[],{"trials":6245,"activeCount":100},[],{"trials":6247,"activeCount":100},[],{"trials":6249,"activeCount":100},[6250],{"nctId":1357,"briefTitle":1358,"status":106,"phases":6251,"primaryCompletion":1360,"completion":1360,"start":1361,"enrollment":171,"conditions":6252,"interventions":6253},[92],[1363,1364,15],[1366,1367,259],{"trials":6255,"activeCount":100},[],{"intervention":6257,"totalTrials":247,"cells":6258},"Levetiracetam",{"EARLY_PHASE1":6259,"PHASE1":6261,"PHASE2":6263,"PHASE3":6265,"PHASE4":6267,"NA":6280},{"trials":6260,"activeCount":100},[],{"trials":6262,"activeCount":100},[],{"trials":6264,"activeCount":100},[],{"trials":6266,"activeCount":100},[],{"trials":6268,"activeCount":100},[6269],{"nctId":6270,"briefTitle":6271,"status":123,"phases":6272,"primaryCompletion":1340,"completion":5851,"start":6273,"enrollment":197,"conditions":6274,"interventions":6279},"NCT04176887","Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus",[92],"2019-01-01",[6275,6276,6277,6278],"Comparison","the Efficacy of Levetireacetam","Phenytoin","Management of Pediatric Status Epilepticus",[6257,6277],{"trials":6281,"activeCount":100},[],{"intervention":6277,"totalTrials":247,"cells":6283},{"EARLY_PHASE1":6284,"PHASE1":6286,"PHASE2":6288,"PHASE3":6290,"PHASE4":6292,"NA":6298},{"trials":6285,"activeCount":100},[],{"trials":6287,"activeCount":100},[],{"trials":6289,"activeCount":100},[],{"trials":6291,"activeCount":100},[],{"trials":6293,"activeCount":100},[6294],{"nctId":6270,"briefTitle":6271,"status":123,"phases":6295,"primaryCompletion":1340,"completion":5851,"start":6273,"enrollment":197,"conditions":6296,"interventions":6297},[92],[6275,6276,6277,6278],[6257,6277],{"trials":6299,"activeCount":100},[],{"intervention":6301,"totalTrials":247,"cells":6302},"Norfloxacin 400 MG",{"EARLY_PHASE1":6303,"PHASE1":6305,"PHASE2":6307,"PHASE3":6309,"PHASE4":6311,"NA":6323},{"trials":6304,"activeCount":100},[],{"trials":6306,"activeCount":100},[],{"trials":6308,"activeCount":100},[],{"trials":6310,"activeCount":100},[],{"trials":6312,"activeCount":100},[6313],{"nctId":6314,"briefTitle":6315,"status":106,"phases":6316,"primaryCompletion":6317,"completion":3285,"start":5992,"enrollment":171,"conditions":6318,"interventions":6320},"NCT06827756","Comparative Study of Secondary Prophylaxis for SBP",[92],"2021-12-01",[1186,6319,2012],"Cirrhoses, Liver",[6301,6321,6322],"Nitazoxanide 500 MG","Colistin",{"trials":6324,"activeCount":100},[],{"intervention":6321,"totalTrials":247,"cells":6326},{"EARLY_PHASE1":6327,"PHASE1":6329,"PHASE2":6331,"PHASE3":6333,"PHASE4":6335,"NA":6341},{"trials":6328,"activeCount":100},[],{"trials":6330,"activeCount":100},[],{"trials":6332,"activeCount":100},[],{"trials":6334,"activeCount":100},[],{"trials":6336,"activeCount":100},[6337],{"nctId":6314,"briefTitle":6315,"status":106,"phases":6338,"primaryCompletion":6317,"completion":3285,"start":5992,"enrollment":171,"conditions":6339,"interventions":6340},[92],[1186,6319,2012],[6301,6321,6322],{"trials":6342,"activeCount":100},[],{"intervention":6322,"totalTrials":247,"cells":6344},{"EARLY_PHASE1":6345,"PHASE1":6347,"PHASE2":6349,"PHASE3":6351,"PHASE4":6353,"NA":6359},{"trials":6346,"activeCount":100},[],{"trials":6348,"activeCount":100},[],{"trials":6350,"activeCount":100},[],{"trials":6352,"activeCount":100},[],{"trials":6354,"activeCount":100},[6355],{"nctId":6314,"briefTitle":6315,"status":106,"phases":6356,"primaryCompletion":6317,"completion":3285,"start":5992,"enrollment":171,"conditions":6357,"interventions":6358},[92],[1186,6319,2012],[6301,6321,6322],{"trials":6360,"activeCount":100},[],{"intervention":6362,"totalTrials":247,"cells":6363},"Meperdine",{"EARLY_PHASE1":6364,"PHASE1":6366,"PHASE2":6368,"PHASE3":6370,"PHASE4":6372,"NA":6381},{"trials":6365,"activeCount":100},[],{"trials":6367,"activeCount":100},[],{"trials":6369,"activeCount":100},[],{"trials":6371,"activeCount":100},[],{"trials":6373,"activeCount":100},[6374],{"nctId":6375,"briefTitle":6376,"status":106,"phases":6377,"primaryCompletion":6378,"completion":6378,"start":4651,"enrollment":171,"conditions":6379,"interventions":6380},"NCT02128451","The Value of Adding Either Meperdine or Fentanyl to Clonidine-bupivacaine",[92],"2014-10",[4653],[6362,243],{"trials":6382,"activeCount":100},[],{"intervention":6384,"totalTrials":247,"cells":6385},"Ergocalciferol 1.25 mg",{"EARLY_PHASE1":6386,"PHASE1":6388,"PHASE2":6390,"PHASE3":6392,"PHASE4":6394,"NA":6407},{"trials":6387,"activeCount":100},[],{"trials":6389,"activeCount":100},[],{"trials":6391,"activeCount":100},[],{"trials":6393,"activeCount":100},[],{"trials":6395,"activeCount":100},[6396],{"nctId":6397,"briefTitle":6398,"status":106,"phases":6399,"primaryCompletion":6400,"completion":6401,"start":6402,"enrollment":6403,"conditions":6404,"interventions":6406},"NCT04472481","Vitamin D Effect in Rheumatoid Arthritis.",[92],"2019-12-22","2020-03-22","2019-09-06",20,[6405],"Active Rheumatoid Arthritis",[6384],{"trials":6408,"activeCount":100},[],{"intervention":6410,"totalTrials":247,"cells":6411},"Budesonide\u002FFormoterol combination 160\u002F4.5 mcg, 2 inhalations bid",{"EARLY_PHASE1":6412,"PHASE1":6414,"PHASE2":6416,"PHASE3":6418,"PHASE4":6420,"NA":6434},{"trials":6413,"activeCount":100},[],{"trials":6415,"activeCount":100},[],{"trials":6417,"activeCount":100},[],{"trials":6419,"activeCount":100},[],{"trials":6421,"activeCount":100},[6422],{"nctId":6423,"briefTitle":6424,"status":106,"phases":6425,"primaryCompletion":6426,"completion":6427,"start":6428,"enrollment":391,"conditions":6429,"interventions":6431},"NCT04520230","Three Treatment of Chronic Obstructive Pulmonary Disease Patients",[92],"2019-12-30","2019-12-31","2014-10-31",[6430],"COPD",[6410,6432,6433],"Tiotropium 18 mcg capsule inhaled once daily + Budesonide","Formoterol\u002FTiotropium",{"trials":6435,"activeCount":100},[],{"intervention":6432,"totalTrials":247,"cells":6437},{"EARLY_PHASE1":6438,"PHASE1":6440,"PHASE2":6442,"PHASE3":6444,"PHASE4":6446,"NA":6452},{"trials":6439,"activeCount":100},[],{"trials":6441,"activeCount":100},[],{"trials":6443,"activeCount":100},[],{"trials":6445,"activeCount":100},[],{"trials":6447,"activeCount":100},[6448],{"nctId":6423,"briefTitle":6424,"status":106,"phases":6449,"primaryCompletion":6426,"completion":6427,"start":6428,"enrollment":391,"conditions":6450,"interventions":6451},[92],[6430],[6410,6432,6433],{"trials":6453,"activeCount":100},[],{"intervention":6433,"totalTrials":247,"cells":6455},{"EARLY_PHASE1":6456,"PHASE1":6458,"PHASE2":6460,"PHASE3":6462,"PHASE4":6464,"NA":6470},{"trials":6457,"activeCount":100},[],{"trials":6459,"activeCount":100},[],{"trials":6461,"activeCount":100},[],{"trials":6463,"activeCount":100},[],{"trials":6465,"activeCount":100},[6466],{"nctId":6423,"briefTitle":6424,"status":106,"phases":6467,"primaryCompletion":6426,"completion":6427,"start":6428,"enrollment":391,"conditions":6468,"interventions":6469},[92],[6430],[6410,6432,6433],{"trials":6471,"activeCount":100},[],{"intervention":6473,"totalTrials":247,"cells":6474},"Biodentine",{"EARLY_PHASE1":6475,"PHASE1":6477,"PHASE2":6479,"PHASE3":6481,"PHASE4":6483,"NA":6495},{"trials":6476,"activeCount":100},[],{"trials":6478,"activeCount":100},[],{"trials":6480,"activeCount":100},[],{"trials":6482,"activeCount":100},[],{"trials":6484,"activeCount":100},[6485],{"nctId":6486,"briefTitle":6487,"status":106,"phases":6488,"primaryCompletion":482,"completion":482,"start":436,"enrollment":6489,"conditions":6490,"interventions":6493},"NCT06020911","Indirect Pulp Capping Using Biodentine and Theracal Light-cured in Primary Molars",[92],17,[6491,6473,6492],"Pulp Caping","Theracal",[6473,6494],"Theracal light cured",{"trials":6496,"activeCount":100},[],{"intervention":6494,"totalTrials":247,"cells":6498},{"EARLY_PHASE1":6499,"PHASE1":6501,"PHASE2":6503,"PHASE3":6505,"PHASE4":6507,"NA":6513},{"trials":6500,"activeCount":100},[],{"trials":6502,"activeCount":100},[],{"trials":6504,"activeCount":100},[],{"trials":6506,"activeCount":100},[],{"trials":6508,"activeCount":100},[6509],{"nctId":6486,"briefTitle":6487,"status":106,"phases":6510,"primaryCompletion":482,"completion":482,"start":436,"enrollment":6489,"conditions":6511,"interventions":6512},[92],[6491,6473,6492],[6473,6494],{"trials":6514,"activeCount":100},[],{"intervention":6516,"totalTrials":247,"cells":6517},"Methylprednisolone eyedrops",{"EARLY_PHASE1":6518,"PHASE1":6520,"PHASE2":6522,"PHASE3":6524,"PHASE4":6526,"NA":6538},{"trials":6519,"activeCount":100},[],{"trials":6521,"activeCount":100},[],{"trials":6523,"activeCount":100},[],{"trials":6525,"activeCount":100},[],{"trials":6527,"activeCount":100},[6528],{"nctId":6529,"briefTitle":6530,"status":106,"phases":6531,"primaryCompletion":6532,"completion":6533,"start":6534,"enrollment":128,"conditions":6535,"interventions":6537},"NCT04318652","OCT Guided Punctal Stenosis Management",[92],"2019-09-05","2019-09-20","2018-09-02",[6536],"Epiphora Due to Insufficient Drainage",[6516],{"trials":6539,"activeCount":100},[],{"intervention":6541,"totalTrials":247,"cells":6542},"Intralipid, 20% Intravenous Emulsion",{"EARLY_PHASE1":6543,"PHASE1":6545,"PHASE2":6547,"PHASE3":6549,"PHASE4":6551,"NA":6563},{"trials":6544,"activeCount":100},[],{"trials":6546,"activeCount":100},[],{"trials":6548,"activeCount":100},[],{"trials":6550,"activeCount":100},[],{"trials":6552,"activeCount":100},[6553],{"nctId":6554,"briefTitle":6555,"status":6556,"phases":6557,"primaryCompletion":6558,"completion":6558,"start":182,"enrollment":100,"conditions":6559,"interventions":6561},"NCT04274803","Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?","WITHDRAWN",[92],"2021-05-31",[6560],"Antiphospholipid Syndrome in Pregnancy",[6541,6562],"Conventional therapy of antiphospholipis syndrome",{"trials":6564,"activeCount":100},[],{"intervention":6562,"totalTrials":247,"cells":6566},{"EARLY_PHASE1":6567,"PHASE1":6569,"PHASE2":6571,"PHASE3":6573,"PHASE4":6575,"NA":6581},{"trials":6568,"activeCount":100},[],{"trials":6570,"activeCount":100},[],{"trials":6572,"activeCount":100},[],{"trials":6574,"activeCount":100},[],{"trials":6576,"activeCount":100},[6577],{"nctId":6554,"briefTitle":6555,"status":6556,"phases":6578,"primaryCompletion":6558,"completion":6558,"start":182,"enrollment":100,"conditions":6579,"interventions":6580},[92],[6560],[6541,6562],{"trials":6582,"activeCount":100},[],{"intervention":966,"totalTrials":247,"cells":6584},{"EARLY_PHASE1":6585,"PHASE1":6587,"PHASE2":6589,"PHASE3":6591,"PHASE4":6593,"NA":6599},{"trials":6586,"activeCount":100},[],{"trials":6588,"activeCount":100},[],{"trials":6590,"activeCount":100},[],{"trials":6592,"activeCount":100},[],{"trials":6594,"activeCount":100},[6595],{"nctId":959,"briefTitle":960,"status":106,"phases":6596,"primaryCompletion":238,"completion":238,"start":962,"enrollment":9,"conditions":6597,"interventions":6598},[92],[964],[966,431],{"trials":6600,"activeCount":100},[],{"intervention":978,"totalTrials":247,"cells":6602},{"EARLY_PHASE1":6603,"PHASE1":6605,"PHASE2":6607,"PHASE3":6609,"PHASE4":6611,"NA":6617},{"trials":6604,"activeCount":100},[],{"trials":6606,"activeCount":100},[],{"trials":6608,"activeCount":100},[],{"trials":6610,"activeCount":100},[],{"trials":6612,"activeCount":100},[6613],{"nctId":968,"briefTitle":969,"status":106,"phases":6614,"primaryCompletion":971,"completion":972,"start":973,"enrollment":128,"conditions":6615,"interventions":6616},[92],[975,976],[978,431],{"trials":6618,"activeCount":100},[],{"intervention":6620,"totalTrials":247,"cells":6621},"Octreotide",{"EARLY_PHASE1":6622,"PHASE1":6624,"PHASE2":6626,"PHASE3":6628,"PHASE4":6630,"NA":6642},{"trials":6623,"activeCount":100},[],{"trials":6625,"activeCount":100},[],{"trials":6627,"activeCount":100},[],{"trials":6629,"activeCount":100},[],{"trials":6631,"activeCount":100},[6632],{"nctId":6633,"briefTitle":6634,"status":123,"phases":6635,"primaryCompletion":2187,"completion":6636,"start":6637,"enrollment":6638,"conditions":6639,"interventions":6641},"NCT05199038","Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study",[92],"2023-11","2022-06",184,[6640],"Esophageal Varices",[6620],{"trials":6643,"activeCount":100},[],{"intervention":6645,"totalTrials":247,"cells":6646},"Isotretinoin ,silymarin",{"EARLY_PHASE1":6647,"PHASE1":6649,"PHASE2":6651,"PHASE3":6653,"PHASE4":6655,"NA":6664},{"trials":6648,"activeCount":100},[],{"trials":6650,"activeCount":100},[],{"trials":6652,"activeCount":100},[],{"trials":6654,"activeCount":100},[],{"trials":6656,"activeCount":100},[6657],{"nctId":6658,"briefTitle":6659,"status":123,"phases":6660,"primaryCompletion":451,"completion":4345,"start":1235,"enrollment":274,"conditions":6661,"interventions":6663},"NCT05666765","Comparison Between Isotretinoin, Silymarin and Both in the Treatment of Acne Vulgaris",[92],[6662],"Acne Vulgaris",[6645],{"trials":6665,"activeCount":100},[],{"intervention":6048,"totalTrials":247,"cells":6667},{"EARLY_PHASE1":6668,"PHASE1":6670,"PHASE2":6672,"PHASE3":6674,"PHASE4":6676,"NA":6682},{"trials":6669,"activeCount":100},[],{"trials":6671,"activeCount":100},[],{"trials":6673,"activeCount":100},[],{"trials":6675,"activeCount":100},[],{"trials":6677,"activeCount":100},[6678],{"nctId":6039,"briefTitle":6040,"status":106,"phases":6679,"primaryCompletion":6042,"completion":6042,"start":4174,"enrollment":197,"conditions":6680,"interventions":6681},[92],[201,244,6044,6045,6046],[6048,244],{"trials":6683,"activeCount":100},[],{"intervention":6685,"totalTrials":247,"cells":6686},"Amino Acid",{"EARLY_PHASE1":6687,"PHASE1":6689,"PHASE2":6691,"PHASE3":6693,"PHASE4":6695,"NA":6705},{"trials":6688,"activeCount":100},[],{"trials":6690,"activeCount":100},[],{"trials":6692,"activeCount":100},[],{"trials":6694,"activeCount":100},[],{"trials":6696,"activeCount":100},[6697],{"nctId":6698,"briefTitle":6699,"status":106,"phases":6700,"primaryCompletion":1657,"completion":1657,"start":6701,"enrollment":157,"conditions":6702,"interventions":6704},"NCT05877989","Evaluation of Effectiveness of Combining High Protein Intake With Early Physical Exercise During Critical Illness",[92],"2021-07-01",[6703],"Muscle Weakness",[6685],{"trials":6706,"activeCount":100},[],{"intervention":6708,"totalTrials":247,"cells":6709},"hCG",{"EARLY_PHASE1":6710,"PHASE1":6712,"PHASE2":6714,"PHASE3":6716,"PHASE4":6718,"NA":6731},{"trials":6711,"activeCount":100},[],{"trials":6713,"activeCount":100},[],{"trials":6715,"activeCount":100},[],{"trials":6717,"activeCount":100},[],{"trials":6719,"activeCount":100},[6720],{"nctId":6721,"briefTitle":6722,"status":106,"phases":6723,"primaryCompletion":6724,"completion":6724,"start":6725,"enrollment":6726,"conditions":6727,"interventions":6729},"NCT03580031","Booster Dose of HCG for Unruptured Follicle in Non IVF\u002FICSI Cycles",[92],"2021-01-01","2018-08-01",110,[6728],"LUF - Luteinised Unruptured Follicle Syndrome",[6708,6730],"Saline Solution",{"trials":6732,"activeCount":100},[],{"intervention":6730,"totalTrials":247,"cells":6734},{"EARLY_PHASE1":6735,"PHASE1":6737,"PHASE2":6739,"PHASE3":6741,"PHASE4":6743,"NA":6749},{"trials":6736,"activeCount":100},[],{"trials":6738,"activeCount":100},[],{"trials":6740,"activeCount":100},[],{"trials":6742,"activeCount":100},[],{"trials":6744,"activeCount":100},[6745],{"nctId":6721,"briefTitle":6722,"status":106,"phases":6746,"primaryCompletion":6724,"completion":6724,"start":6725,"enrollment":6726,"conditions":6747,"interventions":6748},[92],[6728],[6708,6730],{"trials":6750,"activeCount":100},[],{"intervention":1672,"totalTrials":247,"cells":6752},{"EARLY_PHASE1":6753,"PHASE1":6755,"PHASE2":6757,"PHASE3":6759,"PHASE4":6761,"NA":6767},{"trials":6754,"activeCount":100},[],{"trials":6756,"activeCount":100},[],{"trials":6758,"activeCount":100},[],{"trials":6760,"activeCount":100},[],{"trials":6762,"activeCount":100},[6763],{"nctId":1665,"briefTitle":1666,"status":123,"phases":6764,"primaryCompletion":368,"completion":1668,"start":451,"enrollment":590,"conditions":6765,"interventions":6766},[92],[1670],[1069,1672],{"trials":6768,"activeCount":100},[],{"intervention":6770,"totalTrials":247,"cells":6771},"Lumbar Erector spinae plane block",{"EARLY_PHASE1":6772,"PHASE1":6774,"PHASE2":6776,"PHASE3":6778,"PHASE4":6780,"NA":6791},{"trials":6773,"activeCount":100},[],{"trials":6775,"activeCount":100},[],{"trials":6777,"activeCount":100},[],{"trials":6779,"activeCount":100},[],{"trials":6781,"activeCount":100},[6782],{"nctId":6783,"briefTitle":6784,"status":123,"phases":6785,"primaryCompletion":3429,"completion":3429,"start":6786,"enrollment":274,"conditions":6787,"interventions":6788},"NCT05905510","Lumbar Erector Spinae Plane Block and Fascia Iliaca Compartment Block After Total Hip Arthroplasty",[92],"2023-06-15",[18],[6770,6789,6790],"Fascia iliaca compartment block","spinal anesthesia plane block",{"trials":6792,"activeCount":100},[],{"intervention":6789,"totalTrials":247,"cells":6794},{"EARLY_PHASE1":6795,"PHASE1":6797,"PHASE2":6799,"PHASE3":6801,"PHASE4":6803,"NA":6809},{"trials":6796,"activeCount":100},[],{"trials":6798,"activeCount":100},[],{"trials":6800,"activeCount":100},[],{"trials":6802,"activeCount":100},[],{"trials":6804,"activeCount":100},[6805],{"nctId":6783,"briefTitle":6784,"status":123,"phases":6806,"primaryCompletion":3429,"completion":3429,"start":6786,"enrollment":274,"conditions":6807,"interventions":6808},[92],[18],[6770,6789,6790],{"trials":6810,"activeCount":100},[],{"intervention":6790,"totalTrials":247,"cells":6812},{"EARLY_PHASE1":6813,"PHASE1":6815,"PHASE2":6817,"PHASE3":6819,"PHASE4":6821,"NA":6827},{"trials":6814,"activeCount":100},[],{"trials":6816,"activeCount":100},[],{"trials":6818,"activeCount":100},[],{"trials":6820,"activeCount":100},[],{"trials":6822,"activeCount":100},[6823],{"nctId":6783,"briefTitle":6784,"status":123,"phases":6824,"primaryCompletion":3429,"completion":3429,"start":6786,"enrollment":274,"conditions":6825,"interventions":6826},[92],[18],[6770,6789,6790],{"trials":6828,"activeCount":100},[],{"intervention":6830,"totalTrials":247,"cells":6831},"Dexmedetomidine group",{"EARLY_PHASE1":6832,"PHASE1":6834,"PHASE2":6836,"PHASE3":6838,"PHASE4":6840,"NA":6851},{"trials":6833,"activeCount":100},[],{"trials":6835,"activeCount":100},[],{"trials":6837,"activeCount":100},[],{"trials":6839,"activeCount":100},[],{"trials":6841,"activeCount":100},[6842],{"nctId":6843,"briefTitle":6844,"status":123,"phases":6845,"primaryCompletion":6846,"completion":6846,"start":6847,"enrollment":157,"conditions":6848,"interventions":6850},"NCT05639777","Intranasal Dexmedetomidine in Children Undergoing Adenotonsillectomy Suffering From Mild Upper Respiratory Tract Infection",[92],"2023-05-15","2022-12-06",[15,1114,6849],"Respiratory Tract Infections",[6830],{"trials":6852,"activeCount":100},[],{"intervention":6854,"totalTrials":247,"cells":6855},"Dexmedetomidine Ketamine",{"EARLY_PHASE1":6856,"PHASE1":6858,"PHASE2":6860,"PHASE3":6862,"PHASE4":6864,"NA":6875},{"trials":6857,"activeCount":100},[],{"trials":6859,"activeCount":100},[],{"trials":6861,"activeCount":100},[],{"trials":6863,"activeCount":100},[],{"trials":6865,"activeCount":100},[6866],{"nctId":6867,"briefTitle":6868,"status":106,"phases":6869,"primaryCompletion":6870,"completion":6870,"start":1361,"enrollment":171,"conditions":6871,"interventions":6874},"NCT04048200","The Effect of Opioid Free Anesthesia in Bariatric Surgeries",[92],"2020-06-15",[6872,6873],"Adverse Effect of Drugs and Medicaments in Therapeutic Use","Adverse Effects in the Therapeutic Use of Anaesthetics",[243,6854],{"trials":6876,"activeCount":100},[],{"intervention":4582,"totalTrials":247,"cells":6878},{"EARLY_PHASE1":6879,"PHASE1":6881,"PHASE2":6883,"PHASE3":6885,"PHASE4":6887,"NA":6893},{"trials":6880,"activeCount":100},[],{"trials":6882,"activeCount":100},[],{"trials":6884,"activeCount":100},[],{"trials":6886,"activeCount":100},[],{"trials":6888,"activeCount":100},[6889],{"nctId":4571,"briefTitle":4572,"status":123,"phases":6890,"primaryCompletion":4574,"completion":4575,"start":4576,"enrollment":274,"conditions":6891,"interventions":6892},[92],[15,4578,4286,4579],[4581,4558,4582],{"trials":6894,"activeCount":100},[],{"intervention":6896,"totalTrials":247,"cells":6897},"gabapentin 1200 mg",{"EARLY_PHASE1":6898,"PHASE1":6900,"PHASE2":6902,"PHASE3":6904,"PHASE4":6906,"NA":6916},{"trials":6899,"activeCount":100},[],{"trials":6901,"activeCount":100},[],{"trials":6903,"activeCount":100},[],{"trials":6905,"activeCount":100},[],{"trials":6907,"activeCount":100},[6908],{"nctId":6909,"briefTitle":6910,"status":106,"phases":6911,"primaryCompletion":5581,"completion":318,"start":1668,"enrollment":171,"conditions":6912,"interventions":6915},"NCT06254183","Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG)",[92],[6913,6914],"Acute Kidney Injury","Obesity (BMI > 35)",[6896],{"trials":6917,"activeCount":100},[],{"intervention":6919,"totalTrials":247,"cells":6920},"Montelukast",{"EARLY_PHASE1":6921,"PHASE1":6923,"PHASE2":6925,"PHASE3":6927,"PHASE4":6929,"NA":6939},{"trials":6922,"activeCount":100},[],{"trials":6924,"activeCount":100},[],{"trials":6926,"activeCount":100},[],{"trials":6928,"activeCount":100},[],{"trials":6930,"activeCount":100},[6931],{"nctId":6932,"briefTitle":6933,"status":106,"phases":6934,"primaryCompletion":6935,"completion":6935,"start":6936,"enrollment":590,"conditions":6937,"interventions":6938},"NCT04537780","Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH)",[92],"2020-08-30","2019-08-20",[3147],[6919],{"trials":6940,"activeCount":100},[],{"intervention":6942,"totalTrials":247,"cells":6943},"Simvastatin",{"EARLY_PHASE1":6944,"PHASE1":6946,"PHASE2":6948,"PHASE3":6950,"PHASE4":6952,"NA":6963},{"trials":6945,"activeCount":100},[],{"trials":6947,"activeCount":100},[],{"trials":6949,"activeCount":100},[],{"trials":6951,"activeCount":100},[],{"trials":6953,"activeCount":100},[6954],{"nctId":6955,"briefTitle":6956,"status":106,"phases":6957,"primaryCompletion":6958,"completion":6958,"start":6959,"enrollment":370,"conditions":6960,"interventions":6962},"NCT02994485","Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin",[92],"2018-02","2016-10",[6961],"Portal Hypertension",[6942],{"trials":6964,"activeCount":100},[],{"intervention":5867,"totalTrials":247,"cells":6966},{"EARLY_PHASE1":6967,"PHASE1":6969,"PHASE2":6971,"PHASE3":6973,"PHASE4":6975,"NA":6981},{"trials":6968,"activeCount":100},[],{"trials":6970,"activeCount":100},[],{"trials":6972,"activeCount":100},[],{"trials":6974,"activeCount":100},[],{"trials":6976,"activeCount":100},[6977],{"nctId":5859,"briefTitle":5860,"status":106,"phases":6978,"primaryCompletion":1704,"completion":2127,"start":1172,"enrollment":5862,"conditions":6979,"interventions":6980},[92],[5864],[5827,5866,5867,5868,5844,5869,5870,5871],{"trials":6982,"activeCount":100},[],{"intervention":5868,"totalTrials":247,"cells":6984},{"EARLY_PHASE1":6985,"PHASE1":6987,"PHASE2":6989,"PHASE3":6991,"PHASE4":6993,"NA":6999},{"trials":6986,"activeCount":100},[],{"trials":6988,"activeCount":100},[],{"trials":6990,"activeCount":100},[],{"trials":6992,"activeCount":100},[],{"trials":6994,"activeCount":100},[6995],{"nctId":5859,"briefTitle":5860,"status":106,"phases":6996,"primaryCompletion":1704,"completion":2127,"start":1172,"enrollment":5862,"conditions":6997,"interventions":6998},[92],[5864],[5827,5866,5867,5868,5844,5869,5870,5871],{"trials":7000,"activeCount":100},[],{"intervention":5869,"totalTrials":247,"cells":7002},{"EARLY_PHASE1":7003,"PHASE1":7005,"PHASE2":7007,"PHASE3":7009,"PHASE4":7011,"NA":7017},{"trials":7004,"activeCount":100},[],{"trials":7006,"activeCount":100},[],{"trials":7008,"activeCount":100},[],{"trials":7010,"activeCount":100},[],{"trials":7012,"activeCount":100},[7013],{"nctId":5859,"briefTitle":5860,"status":106,"phases":7014,"primaryCompletion":1704,"completion":2127,"start":1172,"enrollment":5862,"conditions":7015,"interventions":7016},[92],[5864],[5827,5866,5867,5868,5844,5869,5870,5871],{"trials":7018,"activeCount":100},[],{"intervention":5870,"totalTrials":247,"cells":7020},{"EARLY_PHASE1":7021,"PHASE1":7023,"PHASE2":7025,"PHASE3":7027,"PHASE4":7029,"NA":7035},{"trials":7022,"activeCount":100},[],{"trials":7024,"activeCount":100},[],{"trials":7026,"activeCount":100},[],{"trials":7028,"activeCount":100},[],{"trials":7030,"activeCount":100},[7031],{"nctId":5859,"briefTitle":5860,"status":106,"phases":7032,"primaryCompletion":1704,"completion":2127,"start":1172,"enrollment":5862,"conditions":7033,"interventions":7034},[92],[5864],[5827,5866,5867,5868,5844,5869,5870,5871],{"trials":7036,"activeCount":100},[],{"intervention":5871,"totalTrials":247,"cells":7038},{"EARLY_PHASE1":7039,"PHASE1":7041,"PHASE2":7043,"PHASE3":7045,"PHASE4":7047,"NA":7053},{"trials":7040,"activeCount":100},[],{"trials":7042,"activeCount":100},[],{"trials":7044,"activeCount":100},[],{"trials":7046,"activeCount":100},[],{"trials":7048,"activeCount":100},[7049],{"nctId":5859,"briefTitle":5860,"status":106,"phases":7050,"primaryCompletion":1704,"completion":2127,"start":1172,"enrollment":5862,"conditions":7051,"interventions":7052},[92],[5864],[5827,5866,5867,5868,5844,5869,5870,5871],{"trials":7054,"activeCount":100},[],{"intervention":7056,"totalTrials":247,"cells":7057},"Intermittent boluses of Cisatracurium",{"EARLY_PHASE1":7058,"PHASE1":7060,"PHASE2":7062,"PHASE3":7064,"PHASE4":7066,"NA":7079},{"trials":7059,"activeCount":100},[],{"trials":7061,"activeCount":100},[],{"trials":7063,"activeCount":100},[],{"trials":7065,"activeCount":100},[],{"trials":7067,"activeCount":100},[7068],{"nctId":7069,"briefTitle":7070,"status":123,"phases":7071,"primaryCompletion":5949,"completion":7072,"start":7073,"enrollment":197,"conditions":7074,"interventions":7077},"NCT05153525","Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS",[92],"2022-08-05","2022-01-06",[7075,7076],"Respiratory Distress Syndrome, Pediatric","Acute Lung Injury\u002FAcute Respiratory Distress Syndrome (ARDS)",[7056,7078],"Intravenous infusion of Cisatracurium for 24 hours",{"trials":7080,"activeCount":100},[],{"intervention":7078,"totalTrials":247,"cells":7082},{"EARLY_PHASE1":7083,"PHASE1":7085,"PHASE2":7087,"PHASE3":7089,"PHASE4":7091,"NA":7097},{"trials":7084,"activeCount":100},[],{"trials":7086,"activeCount":100},[],{"trials":7088,"activeCount":100},[],{"trials":7090,"activeCount":100},[],{"trials":7092,"activeCount":100},[7093],{"nctId":7069,"briefTitle":7070,"status":123,"phases":7094,"primaryCompletion":5949,"completion":7072,"start":7073,"enrollment":197,"conditions":7095,"interventions":7096},[92],[7075,7076],[7056,7078],{"trials":7098,"activeCount":100},[],{"intervention":5996,"totalTrials":247,"cells":7100},{"EARLY_PHASE1":7101,"PHASE1":7103,"PHASE2":7105,"PHASE3":7107,"PHASE4":7109,"NA":7115},{"trials":7102,"activeCount":100},[],{"trials":7104,"activeCount":100},[],{"trials":7106,"activeCount":100},[],{"trials":7108,"activeCount":100},[],{"trials":7110,"activeCount":100},[7111],{"nctId":5988,"briefTitle":5989,"status":123,"phases":7112,"primaryCompletion":5991,"completion":5991,"start":5992,"enrollment":1705,"conditions":7113,"interventions":7114},[92],[5994],[5933,5996],{"trials":7116,"activeCount":100},[],{"intervention":6077,"totalTrials":247,"cells":7118},{"EARLY_PHASE1":7119,"PHASE1":7121,"PHASE2":7123,"PHASE3":7125,"PHASE4":7127,"NA":7133},{"trials":7120,"activeCount":100},[],{"trials":7122,"activeCount":100},[],{"trials":7124,"activeCount":100},[],{"trials":7126,"activeCount":100},[],{"trials":7128,"activeCount":100},[7129],{"nctId":6069,"briefTitle":6070,"status":106,"phases":7130,"primaryCompletion":6072,"completion":6072,"start":1361,"enrollment":6073,"conditions":7131,"interventions":7132},[92],[6075],[6056,6077],{"trials":7134,"activeCount":100},[],{"intervention":7136,"totalTrials":247,"cells":7137},"Cinacalcet",{"EARLY_PHASE1":7138,"PHASE1":7140,"PHASE2":7142,"PHASE3":7144,"PHASE4":7146,"NA":7158},{"trials":7139,"activeCount":100},[],{"trials":7141,"activeCount":100},[],{"trials":7143,"activeCount":100},[],{"trials":7145,"activeCount":100},[],{"trials":7147,"activeCount":100},[7148],{"nctId":7149,"briefTitle":7150,"status":106,"phases":7151,"primaryCompletion":7152,"completion":7152,"start":7153,"enrollment":7154,"conditions":7155,"interventions":7157},"NCT05926570","Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular Hemodialysis",[92],"2024-01-22","2023-08-05",35,[7156],"Drug Effect",[7136],{"trials":7159,"activeCount":100},[],{"intervention":7161,"totalTrials":247,"cells":7162},"Ultrasound guided Stellate ganglion block",{"EARLY_PHASE1":7163,"PHASE1":7165,"PHASE2":7167,"PHASE3":7169,"PHASE4":7171,"NA":7183},{"trials":7164,"activeCount":100},[],{"trials":7166,"activeCount":100},[],{"trials":7168,"activeCount":100},[],{"trials":7170,"activeCount":100},[],{"trials":7172,"activeCount":100},[7173],{"nctId":7174,"briefTitle":7175,"status":123,"phases":7176,"primaryCompletion":2087,"completion":2087,"start":7177,"enrollment":171,"conditions":7178,"interventions":7181},"NCT05970146","Cervical Epidural and Stellate Ganglion Block in Upper Limb Complex Regional Pain Syndrome",[92],"2023-08-01",[7179,7180,4177],"Stellate Ganglion Block","Cervical Epidural",[7161,7182],"unilateral cervical epidural",{"trials":7184,"activeCount":100},[],{"intervention":7182,"totalTrials":247,"cells":7186},{"EARLY_PHASE1":7187,"PHASE1":7189,"PHASE2":7191,"PHASE3":7193,"PHASE4":7195,"NA":7201},{"trials":7188,"activeCount":100},[],{"trials":7190,"activeCount":100},[],{"trials":7192,"activeCount":100},[],{"trials":7194,"activeCount":100},[],{"trials":7196,"activeCount":100},[7197],{"nctId":7174,"briefTitle":7175,"status":123,"phases":7198,"primaryCompletion":2087,"completion":2087,"start":7177,"enrollment":171,"conditions":7199,"interventions":7200},[92],[7179,7180,4177],[7161,7182],{"trials":7202,"activeCount":100},[],{"intervention":7204,"totalTrials":247,"cells":7205},"Ledipasvir 90 MG \u002F Sofosbuvir 400 MG [Harvoni]",{"EARLY_PHASE1":7206,"PHASE1":7208,"PHASE2":7210,"PHASE3":7212,"PHASE4":7214,"NA":7224},{"trials":7207,"activeCount":100},[],{"trials":7209,"activeCount":100},[],{"trials":7211,"activeCount":100},[],{"trials":7213,"activeCount":100},[],{"trials":7215,"activeCount":100},[7216],{"nctId":7217,"briefTitle":7218,"status":106,"phases":7219,"primaryCompletion":6082,"completion":5926,"start":7220,"enrollment":1618,"conditions":7221,"interventions":7223},"NCT03961828","Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus",[92],"2017-10-01",[7222,5864],"Beta-Thalassemia",[7204],{"trials":7225,"activeCount":100},[],{"intervention":6089,"totalTrials":247,"cells":7227},{"EARLY_PHASE1":7228,"PHASE1":7230,"PHASE2":7232,"PHASE3":7234,"PHASE4":7236,"NA":7242},{"trials":7229,"activeCount":100},[],{"trials":7231,"activeCount":100},[],{"trials":7233,"activeCount":100},[],{"trials":7235,"activeCount":100},[],{"trials":7237,"activeCount":100},[7238],{"nctId":6079,"briefTitle":6080,"status":106,"phases":7239,"primaryCompletion":6082,"completion":6082,"start":6083,"enrollment":6084,"conditions":7240,"interventions":7241},[92],[6086,6087],[6089,6056],{"trials":7243,"activeCount":100},[],{"intervention":7245,"totalTrials":247,"cells":7246},"Control Rx",{"EARLY_PHASE1":7247,"PHASE1":7249,"PHASE2":7251,"PHASE3":7253,"PHASE4":7255,"NA":7269},{"trials":7248,"activeCount":100},[],{"trials":7250,"activeCount":100},[],{"trials":7252,"activeCount":100},[],{"trials":7254,"activeCount":100},[],{"trials":7256,"activeCount":100},[7257],{"nctId":7258,"briefTitle":7259,"status":123,"phases":7260,"primaryCompletion":7261,"completion":7262,"start":7263,"enrollment":171,"conditions":7264,"interventions":7268},"NCT04656821","Erector Spinae Block Versus Thoracic Paravertebral Block for Acute Thoracic Herpes Zoster",[92],"2021-06-06","2021-06-20","2020-12-05",[7265,21,7266,7267],"Acute Thoracic Herpes Zoster","Thoracic Paravertebral Block","Pain Relief",[7245],{"trials":7270,"activeCount":100},[],{"intervention":7272,"totalTrials":247,"cells":7273},"zolmitriptanee",{"EARLY_PHASE1":7274,"PHASE1":7276,"PHASE2":7278,"PHASE3":7280,"PHASE4":7282,"NA":7293},{"trials":7275,"activeCount":100},[],{"trials":7277,"activeCount":100},[],{"trials":7279,"activeCount":100},[],{"trials":7281,"activeCount":100},[],{"trials":7283,"activeCount":100},[7284],{"nctId":7285,"briefTitle":7286,"status":123,"phases":7287,"primaryCompletion":4345,"completion":4345,"start":1235,"enrollment":171,"conditions":7288,"interventions":7290},"NCT06089356","Zolmitriptane as Prophylaxis for Chilhood Migraine",[92],[7289],"Migraine",[7272,7291,7292],"topiramate","Valproate",{"trials":7294,"activeCount":100},[],{"intervention":7291,"totalTrials":247,"cells":7296},{"EARLY_PHASE1":7297,"PHASE1":7299,"PHASE2":7301,"PHASE3":7303,"PHASE4":7305,"NA":7311},{"trials":7298,"activeCount":100},[],{"trials":7300,"activeCount":100},[],{"trials":7302,"activeCount":100},[],{"trials":7304,"activeCount":100},[],{"trials":7306,"activeCount":100},[7307],{"nctId":7285,"briefTitle":7286,"status":123,"phases":7308,"primaryCompletion":4345,"completion":4345,"start":1235,"enrollment":171,"conditions":7309,"interventions":7310},[92],[7289],[7272,7291,7292],{"trials":7312,"activeCount":100},[],{"intervention":7292,"totalTrials":247,"cells":7314},{"EARLY_PHASE1":7315,"PHASE1":7317,"PHASE2":7319,"PHASE3":7321,"PHASE4":7323,"NA":7329},{"trials":7316,"activeCount":100},[],{"trials":7318,"activeCount":100},[],{"trials":7320,"activeCount":100},[],{"trials":7322,"activeCount":100},[],{"trials":7324,"activeCount":100},[7325],{"nctId":7285,"briefTitle":7286,"status":123,"phases":7326,"primaryCompletion":4345,"completion":4345,"start":1235,"enrollment":171,"conditions":7327,"interventions":7328},[92],[7289],[7272,7291,7292],{"trials":7330,"activeCount":100},[],{"intervention":1709,"totalTrials":513,"cells":7332},{"EARLY_PHASE1":7333,"PHASE1":7335,"PHASE2":7337,"PHASE3":7339,"PHASE4":7360,"NA":7362},{"trials":7334,"activeCount":100},[],{"trials":7336,"activeCount":100},[],{"trials":7338,"activeCount":100},[],{"trials":7340,"activeCount":100},[7341,7348,7352],{"nctId":7342,"briefTitle":7343,"status":123,"phases":7344,"primaryCompletion":1339,"completion":1339,"start":6109,"enrollment":1705,"conditions":7345,"interventions":7346},"NCT02642874","Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients",[91],[1707],[7347,1709],"Methocarbamol",{"nctId":1701,"briefTitle":1702,"status":123,"phases":7349,"primaryCompletion":125,"completion":125,"start":1704,"enrollment":1705,"conditions":7350,"interventions":7351},[91],[1707],[1690,1709],{"nctId":7353,"briefTitle":7354,"status":123,"phases":7355,"primaryCompletion":2127,"completion":2127,"start":7356,"enrollment":1705,"conditions":7357,"interventions":7358},"NCT02642861","Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis",[91],"2018-10",[1707],[7359,1709],"Cyclobenzaprine",{"trials":7361,"activeCount":100},[],{"trials":7363,"activeCount":100},[],{"intervention":7365,"totalTrials":513,"cells":7366},"Diosmin",{"EARLY_PHASE1":7367,"PHASE1":7369,"PHASE2":7371,"PHASE3":7373,"PHASE4":7395,"NA":7397},{"trials":7368,"activeCount":100},[],{"trials":7370,"activeCount":100},[],{"trials":7372,"activeCount":100},[],{"trials":7374,"activeCount":100},[7375,7381,7388],{"nctId":7376,"briefTitle":7377,"status":123,"phases":7378,"primaryCompletion":6636,"completion":2221,"start":219,"enrollment":197,"conditions":7379,"interventions":7380},"NCT05626166","the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis",[91],[1237],[7365],{"nctId":7382,"briefTitle":7383,"status":123,"phases":7384,"primaryCompletion":3241,"completion":1884,"start":1657,"enrollment":590,"conditions":7385,"interventions":7387},"NCT05670457","Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer",[91],[7386],"Non-bleeding Peptic Ulcer",[7365],{"nctId":7389,"briefTitle":7390,"status":123,"phases":7391,"primaryCompletion":1961,"completion":3211,"start":7392,"enrollment":1601,"conditions":7393,"interventions":7394},"NCT05942547","the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.",[91],"2023-07-10",[3147],[7365],{"trials":7396,"activeCount":100},[],{"trials":7398,"activeCount":100},[],{"intervention":2016,"totalTrials":188,"cells":7400},{"EARLY_PHASE1":7401,"PHASE1":7403,"PHASE2":7405,"PHASE3":7407,"PHASE4":7420,"NA":7422},{"trials":7402,"activeCount":100},[],{"trials":7404,"activeCount":100},[],{"trials":7406,"activeCount":100},[],{"trials":7408,"activeCount":100},[7409,7416],{"nctId":7410,"briefTitle":7411,"status":106,"phases":7412,"primaryCompletion":1123,"completion":1123,"start":2001,"enrollment":184,"conditions":7413,"interventions":7415},"NCT05563389","Statin Impact on Hepatic Decompensation",[90,91],[7414],"Quality of Life",[2016],{"nctId":2005,"briefTitle":2006,"status":123,"phases":7417,"primaryCompletion":2008,"completion":2009,"start":2010,"enrollment":724,"conditions":7418,"interventions":7419},[90,91],[883,1165,2012,2013,2014],[1977,2016],{"trials":7421,"activeCount":100},[],{"trials":7423,"activeCount":100},[],{"intervention":1728,"totalTrials":188,"cells":7425},{"EARLY_PHASE1":7426,"PHASE1":7428,"PHASE2":7430,"PHASE3":7436,"PHASE4":7442,"NA":7444},{"trials":7427,"activeCount":100},[],{"trials":7429,"activeCount":100},[],{"trials":7431,"activeCount":100},[7432],{"nctId":5946,"briefTitle":5947,"status":106,"phases":7433,"primaryCompletion":5949,"completion":5950,"start":1093,"enrollment":171,"conditions":7434,"interventions":7435},[90],[5952],[5954,1728,5937],{"trials":7437,"activeCount":100},[7438],{"nctId":1720,"briefTitle":1721,"status":106,"phases":7439,"primaryCompletion":1723,"completion":85,"start":483,"enrollment":184,"conditions":7440,"interventions":7441},[91],[1725,1726,325],[1728,1690],{"trials":7443,"activeCount":100},[],{"trials":7445,"activeCount":100},[],{"intervention":7447,"totalTrials":188,"cells":7448},"Allopurinol",{"EARLY_PHASE1":7449,"PHASE1":7451,"PHASE2":7453,"PHASE3":7461,"PHASE4":7471,"NA":7473},{"trials":7450,"activeCount":100},[],{"trials":7452,"activeCount":100},[],{"trials":7454,"activeCount":100},[7455],{"nctId":7456,"briefTitle":7457,"status":106,"phases":7458,"primaryCompletion":1678,"completion":1678,"start":4612,"enrollment":184,"conditions":7459,"interventions":7460},"NCT07033533","Allopurinol and Pathogenesis of Cirrhosis",[89,90],[6319],[7447],{"trials":7462,"activeCount":100},[7463],{"nctId":7464,"briefTitle":7465,"status":106,"phases":7466,"primaryCompletion":7467,"completion":1194,"start":2001,"enrollment":184,"conditions":7468,"interventions":7470},"NCT05828836","Allopurinol and Quality of Life in Liver Cirrhosis",[90,91],"2023-01-15",[7469],"Cirrhosis, Liver",[7447],{"trials":7472,"activeCount":100},[],{"trials":7474,"activeCount":100},[],{"intervention":7476,"totalTrials":188,"cells":7477},"Chloroquine or Hydroxychloroquine",{"EARLY_PHASE1":7478,"PHASE1":7480,"PHASE2":7482,"PHASE3":7484,"PHASE4":7499,"NA":7501},{"trials":7479,"activeCount":100},[],{"trials":7481,"activeCount":100},[],{"trials":7483,"activeCount":100},[],{"trials":7485,"activeCount":100},[7486,7495],{"nctId":7487,"briefTitle":7488,"status":106,"phases":7489,"primaryCompletion":1214,"completion":239,"start":7490,"enrollment":879,"conditions":7491,"interventions":7494},"NCT04353336","Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment",[90,91],"2020-03-23",[7492,7493],"COVID-19","Coronavirus Infection",[7476],{"nctId":3398,"briefTitle":3399,"status":106,"phases":7496,"primaryCompletion":3401,"completion":3402,"start":3403,"enrollment":3404,"conditions":7497,"interventions":7498},[91],[1206],[3407,3408],{"trials":7500,"activeCount":100},[],{"trials":7502,"activeCount":100},[],{"intervention":3245,"totalTrials":247,"cells":7504},{"EARLY_PHASE1":7505,"PHASE1":7507,"PHASE2":7509,"PHASE3":7511,"PHASE4":7517,"NA":7519},{"trials":7506,"activeCount":100},[],{"trials":7508,"activeCount":100},[],{"trials":7510,"activeCount":100},[],{"trials":7512,"activeCount":100},[7513],{"nctId":3238,"briefTitle":3239,"status":123,"phases":7514,"primaryCompletion":3241,"completion":1884,"start":1657,"enrollment":171,"conditions":7515,"interventions":7516},[91],[3243],[3245,1661],{"trials":7518,"activeCount":100},[],{"trials":7520,"activeCount":100},[],{"intervention":7522,"totalTrials":247,"cells":7523},"Ivermectin plus Nitazoxanide",{"EARLY_PHASE1":7524,"PHASE1":7526,"PHASE2":7528,"PHASE3":7530,"PHASE4":7539,"NA":7541},{"trials":7525,"activeCount":100},[],{"trials":7527,"activeCount":100},[],{"trials":7529,"activeCount":100},[],{"trials":7531,"activeCount":100},[7532],{"nctId":7533,"briefTitle":7534,"status":123,"phases":7535,"primaryCompletion":2034,"completion":1339,"start":7536,"enrollment":184,"conditions":7537,"interventions":7538},"NCT04360356","Ivermectin and Nitazoxanide Combination Therapy for COVID-19",[90,91],"2020-05",[7492],[7522],{"trials":7540,"activeCount":100},[],{"trials":7542,"activeCount":100},[],{"intervention":2131,"totalTrials":247,"cells":7544},{"EARLY_PHASE1":7545,"PHASE1":7547,"PHASE2":7549,"PHASE3":7551,"PHASE4":7557,"NA":7559},{"trials":7546,"activeCount":100},[],{"trials":7548,"activeCount":100},[],{"trials":7550,"activeCount":100},[],{"trials":7552,"activeCount":100},[7553],{"nctId":2124,"briefTitle":2125,"status":123,"phases":7554,"primaryCompletion":2127,"completion":2127,"start":1172,"enrollment":184,"conditions":7555,"interventions":7556},[91],[2129],[2104,2131],{"trials":7558,"activeCount":100},[],{"trials":7560,"activeCount":100},[],{"intervention":5918,"totalTrials":247,"cells":7562},{"EARLY_PHASE1":7563,"PHASE1":7565,"PHASE2":7567,"PHASE3":7569,"PHASE4":7575,"NA":7577},{"trials":7564,"activeCount":100},[],{"trials":7566,"activeCount":100},[],{"trials":7568,"activeCount":100},[],{"trials":7570,"activeCount":100},[7571],{"nctId":5912,"briefTitle":5913,"status":123,"phases":7572,"primaryCompletion":5915,"completion":2220,"start":1492,"enrollment":370,"conditions":7573,"interventions":7574},[90,91],[726],[5901,5918],{"trials":7576,"activeCount":100},[],{"trials":7578,"activeCount":100},[],{"intervention":7580,"totalTrials":247,"cells":7581},"Niclosamide",{"EARLY_PHASE1":7582,"PHASE1":7584,"PHASE2":7586,"PHASE3":7588,"PHASE4":7596,"NA":7598},{"trials":7583,"activeCount":100},[],{"trials":7585,"activeCount":100},[],{"trials":7587,"activeCount":100},[],{"trials":7589,"activeCount":100},[7590],{"nctId":7591,"briefTitle":7592,"status":106,"phases":7593,"primaryCompletion":3313,"completion":3313,"start":1340,"enrollment":197,"conditions":7594,"interventions":7595},"NCT04317430","Niclosamide Role in Diabetic Nephropathy",[91],[1955],[7580],{"trials":7597,"activeCount":100},[],{"trials":7599,"activeCount":100},[],{"intervention":1532,"totalTrials":247,"cells":7601},{"EARLY_PHASE1":7602,"PHASE1":7604,"PHASE2":7606,"PHASE3":7608,"PHASE4":7614,"NA":7616},{"trials":7603,"activeCount":100},[],{"trials":7605,"activeCount":100},[],{"trials":7607,"activeCount":100},[],{"trials":7609,"activeCount":100},[7610],{"nctId":1525,"briefTitle":1526,"status":106,"phases":7611,"primaryCompletion":46,"completion":46,"start":1528,"enrollment":197,"conditions":7612,"interventions":7613},[91],[1530],[1532,1276],{"trials":7615,"activeCount":100},[],{"trials":7617,"activeCount":100},[],{"intervention":3320,"totalTrials":247,"cells":7619},{"EARLY_PHASE1":7620,"PHASE1":7622,"PHASE2":7624,"PHASE3":7626,"PHASE4":7632,"NA":7634},{"trials":7621,"activeCount":100},[],{"trials":7623,"activeCount":100},[],{"trials":7625,"activeCount":100},[],{"trials":7627,"activeCount":100},[7628],{"nctId":3310,"briefTitle":3311,"status":123,"phases":7629,"primaryCompletion":332,"completion":85,"start":3313,"enrollment":590,"conditions":7630,"interventions":7631},[91],[3315,3316,3317,3318],[1300,3320],{"trials":7633,"activeCount":100},[],{"trials":7635,"activeCount":100},[],{"intervention":7637,"totalTrials":247,"cells":7638},"Pioglitazone 30mg",{"EARLY_PHASE1":7639,"PHASE1":7641,"PHASE2":7643,"PHASE3":7645,"PHASE4":7656,"NA":7658},{"trials":7640,"activeCount":100},[],{"trials":7642,"activeCount":100},[],{"trials":7644,"activeCount":100},[],{"trials":7646,"activeCount":100},[7647],{"nctId":7648,"briefTitle":7649,"status":123,"phases":7650,"primaryCompletion":7651,"completion":2221,"start":7652,"enrollment":3114,"conditions":7653,"interventions":7654},"NCT05605158","Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis",[91],"2023-05","2022-11",[3147],[7637,7655],"Empagliflozin 10 MG",{"trials":7657,"activeCount":100},[],{"trials":7659,"activeCount":100},[],{"intervention":7655,"totalTrials":247,"cells":7661},{"EARLY_PHASE1":7662,"PHASE1":7664,"PHASE2":7666,"PHASE3":7668,"PHASE4":7674,"NA":7676},{"trials":7663,"activeCount":100},[],{"trials":7665,"activeCount":100},[],{"trials":7667,"activeCount":100},[],{"trials":7669,"activeCount":100},[7670],{"nctId":7648,"briefTitle":7649,"status":123,"phases":7671,"primaryCompletion":7651,"completion":2221,"start":7652,"enrollment":3114,"conditions":7672,"interventions":7673},[91],[3147],[7637,7655],{"trials":7675,"activeCount":100},[],{"trials":7677,"activeCount":100},[],{"intervention":7679,"totalTrials":247,"cells":7680},"use concentrated growth factor.",{"EARLY_PHASE1":7681,"PHASE1":7683,"PHASE2":7685,"PHASE3":7687,"PHASE4":7699,"NA":7701},{"trials":7682,"activeCount":100},[],{"trials":7684,"activeCount":100},[],{"trials":7686,"activeCount":100},[],{"trials":7688,"activeCount":100},[7689],{"nctId":7690,"briefTitle":7691,"status":106,"phases":7692,"primaryCompletion":7693,"completion":7694,"start":7695,"enrollment":3813,"conditions":7696,"interventions":7698},"NCT06880965","Effect of Concentrated Growth Factors on Short Implant-Supported Overdentures",[90,91],"2024-11-25","2024-12-04","2023-08-24",[7697],"Partially Edentulous Patients",[7679],{"trials":7700,"activeCount":100},[],{"trials":7702,"activeCount":100},[],{"intervention":5855,"totalTrials":247,"cells":7704},{"EARLY_PHASE1":7705,"PHASE1":7707,"PHASE2":7709,"PHASE3":7711,"PHASE4":7717,"NA":7719},{"trials":7706,"activeCount":100},[],{"trials":7708,"activeCount":100},[],{"trials":7710,"activeCount":100},[],{"trials":7712,"activeCount":100},[7713],{"nctId":5846,"briefTitle":5847,"status":123,"phases":7714,"primaryCompletion":5849,"completion":5850,"start":5851,"enrollment":197,"conditions":7715,"interventions":7716},[90,91],[1206],[5854,5855,5844],{"trials":7718,"activeCount":100},[],{"trials":7720,"activeCount":100},[],{"intervention":7347,"totalTrials":247,"cells":7722},{"EARLY_PHASE1":7723,"PHASE1":7725,"PHASE2":7727,"PHASE3":7729,"PHASE4":7735,"NA":7737},{"trials":7724,"activeCount":100},[],{"trials":7726,"activeCount":100},[],{"trials":7728,"activeCount":100},[],{"trials":7730,"activeCount":100},[7731],{"nctId":7342,"briefTitle":7343,"status":123,"phases":7732,"primaryCompletion":1339,"completion":1339,"start":6109,"enrollment":1705,"conditions":7733,"interventions":7734},[91],[1707],[7347,1709],{"trials":7736,"activeCount":100},[],{"trials":7738,"activeCount":100},[],{"intervention":7740,"totalTrials":247,"cells":7741},"Metformin Hcl 500Mg Tab",{"EARLY_PHASE1":7742,"PHASE1":7744,"PHASE2":7746,"PHASE3":7748,"PHASE4":7756,"NA":7758},{"trials":7743,"activeCount":100},[],{"trials":7745,"activeCount":100},[],{"trials":7747,"activeCount":100},[],{"trials":7749,"activeCount":100},[7750],{"nctId":7751,"briefTitle":7752,"status":106,"phases":7753,"primaryCompletion":109,"completion":1093,"start":427,"enrollment":1618,"conditions":7754,"interventions":7755},"NCT05638893","Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients",[90,91],[487],[7740],{"trials":7757,"activeCount":100},[],{"trials":7759,"activeCount":100},[],{"intervention":7761,"totalTrials":247,"cells":7762},"Lansoprazole",{"EARLY_PHASE1":7763,"PHASE1":7765,"PHASE2":7767,"PHASE3":7769,"PHASE4":7778,"NA":7780},{"trials":7764,"activeCount":100},[],{"trials":7766,"activeCount":100},[],{"trials":7768,"activeCount":100},[],{"trials":7770,"activeCount":100},[7771],{"nctId":7772,"briefTitle":7773,"status":106,"phases":7774,"primaryCompletion":7775,"completion":7775,"start":1951,"enrollment":1249,"conditions":7776,"interventions":7777},"NCT04874935","The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer",[91],"2022-11-05",[726],[7761],{"trials":7779,"activeCount":100},[],{"trials":7781,"activeCount":100},[],{"intervention":1344,"totalTrials":247,"cells":7783},{"EARLY_PHASE1":7784,"PHASE1":7786,"PHASE2":7788,"PHASE3":7790,"PHASE4":7796,"NA":7798},{"trials":7785,"activeCount":100},[],{"trials":7787,"activeCount":100},[],{"trials":7789,"activeCount":100},[],{"trials":7791,"activeCount":100},[7792],{"nctId":1335,"briefTitle":1336,"status":123,"phases":7793,"primaryCompletion":1338,"completion":1339,"start":1340,"enrollment":171,"conditions":7794,"interventions":7795},[90,91],[1342],[1344,57,259],{"trials":7797,"activeCount":100},[],{"trials":7799,"activeCount":100},[],{"intervention":7801,"totalTrials":247,"cells":7802},"injection of Botulinum type A",{"EARLY_PHASE1":7803,"PHASE1":7805,"PHASE2":7807,"PHASE3":7809,"PHASE4":7818,"NA":7820},{"trials":7804,"activeCount":100},[],{"trials":7806,"activeCount":100},[],{"trials":7808,"activeCount":100},[],{"trials":7810,"activeCount":100},[7811],{"nctId":7812,"briefTitle":7813,"status":106,"phases":7814,"primaryCompletion":615,"completion":877,"start":7177,"enrollment":157,"conditions":7815,"interventions":7817},"NCT07543315","Low Versus High Dose OnabotulinumtoxinA for Chronic Anal Fissure",[91],[7816],"Chronic Anal Fissure",[7801],{"trials":7819,"activeCount":100},[],{"trials":7821,"activeCount":100},[],{"intervention":3066,"totalTrials":247,"cells":7823},{"EARLY_PHASE1":7824,"PHASE1":7826,"PHASE2":7828,"PHASE3":7830,"PHASE4":7836,"NA":7838},{"trials":7825,"activeCount":100},[],{"trials":7827,"activeCount":100},[],{"trials":7829,"activeCount":100},[],{"trials":7831,"activeCount":100},[7832],{"nctId":3061,"briefTitle":3062,"status":106,"phases":7833,"primaryCompletion":2885,"completion":2885,"start":2078,"enrollment":197,"conditions":7834,"interventions":7835},[90,91],[1494],[3009,3066],{"trials":7837,"activeCount":100},[],{"trials":7839,"activeCount":100},[],{"intervention":1541,"totalTrials":247,"cells":7841},{"EARLY_PHASE1":7842,"PHASE1":7844,"PHASE2":7846,"PHASE3":7848,"PHASE4":7854,"NA":7856},{"trials":7843,"activeCount":100},[],{"trials":7845,"activeCount":100},[],{"trials":7847,"activeCount":100},[],{"trials":7849,"activeCount":100},[7850],{"nctId":1534,"briefTitle":1535,"status":123,"phases":7851,"primaryCompletion":1537,"completion":1537,"start":1538,"enrollment":197,"conditions":7852,"interventions":7853},[90,91],[27],[1276,1541],{"trials":7855,"activeCount":100},[],{"trials":7857,"activeCount":100},[],{"intervention":2191,"totalTrials":247,"cells":7859},{"EARLY_PHASE1":7860,"PHASE1":7862,"PHASE2":7864,"PHASE3":7866,"PHASE4":7872,"NA":7874},{"trials":7861,"activeCount":100},[],{"trials":7863,"activeCount":100},[],{"trials":7865,"activeCount":100},[],{"trials":7867,"activeCount":100},[7868],{"nctId":2183,"briefTitle":2184,"status":123,"phases":7869,"primaryCompletion":2186,"completion":1538,"start":2187,"enrollment":1510,"conditions":7870,"interventions":7871},[91],[2189],[2162,2191],{"trials":7873,"activeCount":100},[],{"trials":7875,"activeCount":100},[],{"intervention":7877,"totalTrials":247,"cells":7878},"Rosuvastatin 20mg",{"EARLY_PHASE1":7879,"PHASE1":7881,"PHASE2":7883,"PHASE3":7885,"PHASE4":7896,"NA":7898},{"trials":7880,"activeCount":100},[],{"trials":7882,"activeCount":100},[],{"trials":7884,"activeCount":100},[],{"trials":7886,"activeCount":100},[7887],{"nctId":7888,"briefTitle":7889,"status":106,"phases":7890,"primaryCompletion":7891,"completion":7891,"start":7892,"enrollment":1618,"conditions":7893,"interventions":7895},"NCT05338723","Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients",[91],"2023-09-15","2020-09-15",[7894,726],"Chemotherapy-induced Cardiotoxicity",[7877],{"trials":7897,"activeCount":100},[],{"trials":7899,"activeCount":100},[],{"intervention":7901,"totalTrials":247,"cells":7902},"Remdesivir",{"EARLY_PHASE1":7903,"PHASE1":7905,"PHASE2":7907,"PHASE3":7909,"PHASE4":7917,"NA":7919},{"trials":7904,"activeCount":100},[],{"trials":7906,"activeCount":100},[],{"trials":7908,"activeCount":100},[],{"trials":7910,"activeCount":100},[7911],{"nctId":7912,"briefTitle":7913,"status":106,"phases":7914,"primaryCompletion":2046,"completion":2046,"start":2054,"enrollment":1705,"conditions":7915,"interventions":7916},"NCT04345419","Remdesivir Efficacy in Coronavirus Disease",[90,91],[1206],[7901],{"trials":7918,"activeCount":100},[],{"trials":7920,"activeCount":100},[],{"intervention":7922,"totalTrials":247,"cells":7923},"Isotretinoin Only Product in Oral Dose Form",{"EARLY_PHASE1":7924,"PHASE1":7926,"PHASE2":7928,"PHASE3":7930,"PHASE4":7940,"NA":7942},{"trials":7925,"activeCount":100},[],{"trials":7927,"activeCount":100},[],{"trials":7929,"activeCount":100},[],{"trials":7931,"activeCount":100},[7932],{"nctId":7933,"briefTitle":7934,"status":123,"phases":7935,"primaryCompletion":7936,"completion":7937,"start":2046,"enrollment":2055,"conditions":7938,"interventions":7939},"NCT04361422","Isotretinoin in Treatment of COVID-19",[91],"2021-08","2021-12",[7492],[7922],{"trials":7941,"activeCount":100},[],{"trials":7943,"activeCount":100},[],{"intervention":7359,"totalTrials":247,"cells":7945},{"EARLY_PHASE1":7946,"PHASE1":7948,"PHASE2":7950,"PHASE3":7952,"PHASE4":7958,"NA":7960},{"trials":7947,"activeCount":100},[],{"trials":7949,"activeCount":100},[],{"trials":7951,"activeCount":100},[],{"trials":7953,"activeCount":100},[7954],{"nctId":7353,"briefTitle":7354,"status":123,"phases":7955,"primaryCompletion":2127,"completion":2127,"start":7356,"enrollment":1705,"conditions":7956,"interventions":7957},[91],[1707],[7359,1709],{"trials":7959,"activeCount":100},[],{"trials":7961,"activeCount":100},[],{"intervention":7963,"totalTrials":247,"cells":7964},"Zinc Supplement",{"EARLY_PHASE1":7965,"PHASE1":7967,"PHASE2":7969,"PHASE3":7971,"PHASE4":7979,"NA":7981},{"trials":7966,"activeCount":100},[],{"trials":7968,"activeCount":100},[],{"trials":7970,"activeCount":100},[],{"trials":7972,"activeCount":100},[7973],{"nctId":7974,"briefTitle":7975,"status":106,"phases":7976,"primaryCompletion":1235,"completion":4174,"start":1962,"enrollment":1618,"conditions":7977,"interventions":7978},"NCT05465434","Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.",[91],[5864],[7963],{"trials":7980,"activeCount":100},[],{"trials":7982,"activeCount":100},[],{"intervention":7984,"totalTrials":247,"cells":7985},"Ursodeoxycholic acid",{"EARLY_PHASE1":7986,"PHASE1":7988,"PHASE2":7990,"PHASE3":7992,"PHASE4":8003,"NA":8005},{"trials":7987,"activeCount":100},[],{"trials":7989,"activeCount":100},[],{"trials":7991,"activeCount":100},[],{"trials":7993,"activeCount":100},[7994],{"nctId":7995,"briefTitle":7996,"status":123,"phases":7997,"primaryCompletion":7998,"completion":7999,"start":8000,"enrollment":2824,"conditions":8001,"interventions":8002},"NCT05902468","Ursodeoxycholic Acid as add-on Therapy in Type 2 Diabetes Mellitus",[90,91],"2024-06-28","2024-11-28","2023-06-28",[1153],[7984],{"trials":8004,"activeCount":100},[],{"trials":8006,"activeCount":100},[],{"intervention":8008,"totalTrials":247,"cells":8009},"L_carnitine",{"EARLY_PHASE1":8010,"PHASE1":8012,"PHASE2":8014,"PHASE3":8016,"PHASE4":8029,"NA":8031},{"trials":8011,"activeCount":100},[],{"trials":8013,"activeCount":100},[],{"trials":8015,"activeCount":100},[],{"trials":8017,"activeCount":100},[8018],{"nctId":8019,"briefTitle":8020,"status":123,"phases":8021,"primaryCompletion":8022,"completion":8023,"start":8024,"enrollment":590,"conditions":8025,"interventions":8027},"NCT05584956","Clinical Study to Evaluate the Possible Efficacy and Safety of L- Carnitine and Sildenafil in Children Having Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity",[91],"2023-07-08","2024-07-08","2022-07-08",[8026],"Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity",[8008,8028],"Sildenafil",{"trials":8030,"activeCount":100},[],{"trials":8032,"activeCount":100},[],{"intervention":8028,"totalTrials":247,"cells":8034},{"EARLY_PHASE1":8035,"PHASE1":8037,"PHASE2":8039,"PHASE3":8041,"PHASE4":8047,"NA":8049},{"trials":8036,"activeCount":100},[],{"trials":8038,"activeCount":100},[],{"trials":8040,"activeCount":100},[],{"trials":8042,"activeCount":100},[8043],{"nctId":8019,"briefTitle":8020,"status":123,"phases":8044,"primaryCompletion":8022,"completion":8023,"start":8024,"enrollment":590,"conditions":8045,"interventions":8046},[91],[8026],[8008,8028],{"trials":8048,"activeCount":100},[],{"trials":8050,"activeCount":100},[],{"intervention":1176,"totalTrials":247,"cells":8052},{"EARLY_PHASE1":8053,"PHASE1":8055,"PHASE2":8057,"PHASE3":8059,"PHASE4":8065,"NA":8067},{"trials":8054,"activeCount":100},[],{"trials":8056,"activeCount":100},[],{"trials":8058,"activeCount":100},[],{"trials":8060,"activeCount":100},[8061],{"nctId":1169,"briefTitle":1170,"status":123,"phases":8062,"primaryCompletion":125,"completion":125,"start":1172,"enrollment":184,"conditions":8063,"interventions":8064},[91],[1174],[1138,1176,47,1177],{"trials":8066,"activeCount":100},[],{"trials":8068,"activeCount":100},[],{"intervention":1177,"totalTrials":247,"cells":8070},{"EARLY_PHASE1":8071,"PHASE1":8073,"PHASE2":8075,"PHASE3":8077,"PHASE4":8083,"NA":8085},{"trials":8072,"activeCount":100},[],{"trials":8074,"activeCount":100},[],{"trials":8076,"activeCount":100},[],{"trials":8078,"activeCount":100},[8079],{"nctId":1169,"briefTitle":1170,"status":123,"phases":8080,"primaryCompletion":125,"completion":125,"start":1172,"enrollment":184,"conditions":8081,"interventions":8082},[91],[1174],[1138,1176,47,1177],{"trials":8084,"activeCount":100},[],{"trials":8086,"activeCount":100},[],{"intervention":3289,"totalTrials":247,"cells":8088},{"EARLY_PHASE1":8089,"PHASE1":8091,"PHASE2":8093,"PHASE3":8095,"PHASE4":8101,"NA":8103},{"trials":8090,"activeCount":100},[],{"trials":8092,"activeCount":100},[],{"trials":8094,"activeCount":100},[],{"trials":8096,"activeCount":100},[8097],{"nctId":3282,"briefTitle":3283,"status":106,"phases":8098,"primaryCompletion":1194,"completion":1751,"start":3285,"enrollment":171,"conditions":8099,"interventions":8100},[91],[3287],[3289,3290],{"trials":8102,"activeCount":100},[],{"trials":8104,"activeCount":100},[],{"intervention":8106,"totalTrials":247,"cells":8107},"Triamcinolone Acetonide 40mg\u002FmL",{"EARLY_PHASE1":8108,"PHASE1":8110,"PHASE2":8112,"PHASE3":8114,"PHASE4":8127,"NA":8129},{"trials":8109,"activeCount":100},[],{"trials":8111,"activeCount":100},[],{"trials":8113,"activeCount":100},[],{"trials":8115,"activeCount":100},[8116],{"nctId":8117,"briefTitle":8118,"status":106,"phases":8119,"primaryCompletion":8120,"completion":8121,"start":8122,"enrollment":197,"conditions":8123,"interventions":8125},"NCT05567081","Efficacy of Ultrasound-Guided PRP Versus Corticosteroid Injection in Patients With Ulnar Neuropathy at Elbow",[90,91],"2022-04-21","2022-07-11","2021-06-01",[8124],"Ulnar Neuropathy at Elbow",[8106,8126],"PRP",{"trials":8128,"activeCount":100},[],{"trials":8130,"activeCount":100},[],{"intervention":8126,"totalTrials":247,"cells":8132},{"EARLY_PHASE1":8133,"PHASE1":8135,"PHASE2":8137,"PHASE3":8139,"PHASE4":8145,"NA":8147},{"trials":8134,"activeCount":100},[],{"trials":8136,"activeCount":100},[],{"trials":8138,"activeCount":100},[],{"trials":8140,"activeCount":100},[8141],{"nctId":8117,"briefTitle":8118,"status":106,"phases":8142,"primaryCompletion":8120,"completion":8121,"start":8122,"enrollment":197,"conditions":8143,"interventions":8144},[90,91],[8124],[8106,8126],{"trials":8146,"activeCount":100},[],{"trials":8148,"activeCount":100},[],{"intervention":2273,"totalTrials":247,"cells":8150},{"EARLY_PHASE1":8151,"PHASE1":8153,"PHASE2":8155,"PHASE3":8157,"PHASE4":8163,"NA":8165},{"trials":8152,"activeCount":100},[],{"trials":8154,"activeCount":100},[],{"trials":8156,"activeCount":100},[],{"trials":8158,"activeCount":100},[8159],{"nctId":2266,"briefTitle":2267,"status":106,"phases":8160,"primaryCompletion":2269,"completion":401,"start":2270,"enrollment":171,"conditions":8161,"interventions":8162},[91],[566],[1651,2273],{"trials":8164,"activeCount":100},[],{"trials":8166,"activeCount":100},[],{"intervention":8168,"totalTrials":247,"cells":8169},"L-Arginine",{"EARLY_PHASE1":8170,"PHASE1":8172,"PHASE2":8174,"PHASE3":8176,"PHASE4":8186,"NA":8188},{"trials":8171,"activeCount":100},[],{"trials":8173,"activeCount":100},[],{"trials":8175,"activeCount":100},[],{"trials":8177,"activeCount":100},[8178],{"nctId":8179,"briefTitle":8180,"status":106,"phases":8181,"primaryCompletion":400,"completion":400,"start":8182,"enrollment":1618,"conditions":8183,"interventions":8185},"NCT05470998","L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity",[91],"2022-07-25",[8184],"Sickle Cell Disease",[8168],{"trials":8187,"activeCount":100},[],{"trials":8189,"activeCount":100},[],{"intervention":1967,"totalTrials":247,"cells":8191},{"EARLY_PHASE1":8192,"PHASE1":8194,"PHASE2":8196,"PHASE3":8198,"PHASE4":8204,"NA":8206},{"trials":8193,"activeCount":100},[],{"trials":8195,"activeCount":100},[],{"trials":8197,"activeCount":100},[],{"trials":8199,"activeCount":100},[8200],{"nctId":1958,"briefTitle":1959,"status":106,"phases":8201,"primaryCompletion":1961,"completion":1961,"start":1962,"enrollment":197,"conditions":8202,"interventions":8203},[91],[1964,1965],[1967,1584],{"trials":8205,"activeCount":100},[],{"trials":8207,"activeCount":100},[],{"intervention":8209,"totalTrials":247,"cells":8210},"Fexofenadine Pill",{"EARLY_PHASE1":8211,"PHASE1":8213,"PHASE2":8215,"PHASE3":8217,"PHASE4":8227,"NA":8229},{"trials":8212,"activeCount":100},[],{"trials":8214,"activeCount":100},[],{"trials":8216,"activeCount":100},[],{"trials":8218,"activeCount":100},[8219],{"nctId":8220,"briefTitle":8221,"status":106,"phases":8222,"primaryCompletion":3285,"completion":3285,"start":8223,"enrollment":197,"conditions":8224,"interventions":8226},"NCT04224428","Role of Fexofenadine in Diabetic Kidney Disease",[91],"2020-01-01",[8225],"Diabetic Kidney Disease",[8209],{"trials":8228,"activeCount":100},[],{"trials":8230,"activeCount":100},[],{"intervention":8232,"totalTrials":247,"cells":8233},"large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP",{"EARLY_PHASE1":8234,"PHASE1":8236,"PHASE2":8238,"PHASE3":8240,"PHASE4":8251,"NA":8253},{"trials":8235,"activeCount":100},[],{"trials":8237,"activeCount":100},[],{"trials":8239,"activeCount":100},[],{"trials":8241,"activeCount":100},[8242],{"nctId":8243,"briefTitle":8244,"status":123,"phases":8245,"primaryCompletion":2046,"completion":8246,"start":8247,"enrollment":3813,"conditions":8248,"interventions":8250},"NCT04744623","Clinical Evaluation of New Treatment Strategy of Mucous Membrane Pemphigoid Using Large Dose of Prednisolone Plus Intra-lesional of Triamcinolone Acetonide Followed by Combination of Mycophenolate Mofetil, Dapsone and Low Dose Prednisolone",[90,91],"2021-11-04","2020-09-30",[8249],"Benign Mucous Membrane Pemphigoid",[8232],{"trials":8252,"activeCount":100},[],{"trials":8254,"activeCount":100},[],{"intervention":8256,"totalTrials":247,"cells":8257},"L-Carnitine 500Mg Oral",{"EARLY_PHASE1":8258,"PHASE1":8260,"PHASE2":8262,"PHASE3":8264,"PHASE4":8276,"NA":8278},{"trials":8259,"activeCount":100},[],{"trials":8261,"activeCount":100},[],{"trials":8263,"activeCount":100},[],{"trials":8265,"activeCount":100},[8266],{"nctId":8267,"briefTitle":8268,"status":123,"phases":8269,"primaryCompletion":8270,"completion":8270,"start":8271,"enrollment":1249,"conditions":8272,"interventions":8274},"NCT05632549","The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma",[91],"2024-08-08","2022-08-08",[8273],"Moderate Persistent Asthma",[8256,8275],"Biotin",{"trials":8277,"activeCount":100},[],{"trials":8279,"activeCount":100},[],{"intervention":8275,"totalTrials":247,"cells":8281},{"EARLY_PHASE1":8282,"PHASE1":8284,"PHASE2":8286,"PHASE3":8288,"PHASE4":8294,"NA":8296},{"trials":8283,"activeCount":100},[],{"trials":8285,"activeCount":100},[],{"trials":8287,"activeCount":100},[],{"trials":8289,"activeCount":100},[8290],{"nctId":8267,"briefTitle":8268,"status":123,"phases":8291,"primaryCompletion":8270,"completion":8270,"start":8271,"enrollment":1249,"conditions":8292,"interventions":8293},[91],[8273],[8256,8275],{"trials":8295,"activeCount":100},[],{"trials":8297,"activeCount":100},[],{"intervention":8299,"totalTrials":247,"cells":8300},"Hydroxychloroquine plus Nitazoxanide",{"EARLY_PHASE1":8301,"PHASE1":8303,"PHASE2":8305,"PHASE3":8307,"PHASE4":8315,"NA":8317},{"trials":8302,"activeCount":100},[],{"trials":8304,"activeCount":100},[],{"trials":8306,"activeCount":100},[],{"trials":8308,"activeCount":100},[8309],{"nctId":8310,"briefTitle":8311,"status":123,"phases":8312,"primaryCompletion":2034,"completion":1339,"start":7536,"enrollment":184,"conditions":8313,"interventions":8314},"NCT04361318","Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19",[90,91],[7492],[8299],{"trials":8316,"activeCount":100},[],{"trials":8318,"activeCount":100},[],{"intervention":8320,"totalTrials":247,"cells":8321},"Favipiravir",{"EARLY_PHASE1":8322,"PHASE1":8324,"PHASE2":8326,"PHASE3":8328,"PHASE4":8340,"NA":8342},{"trials":8323,"activeCount":100},[],{"trials":8325,"activeCount":100},[],{"trials":8327,"activeCount":100},[],{"trials":8329,"activeCount":100},[8330],{"nctId":8331,"briefTitle":8332,"status":106,"phases":8333,"primaryCompletion":8334,"completion":8334,"start":8335,"enrollment":8336,"conditions":8337,"interventions":8338},"NCT04351295","Efficacy of Faviprevir in COVID-19 Treatment",[90,91],"2020-09-28","2020-04-20",92,[1206],[8320,8339],"Chloroquine",{"trials":8341,"activeCount":100},[],{"trials":8343,"activeCount":100},[],{"intervention":8345,"totalTrials":247,"cells":8346},"Ibuprofen 400 mg.",{"EARLY_PHASE1":8347,"PHASE1":8349,"PHASE2":8351,"PHASE3":8353,"PHASE4":8367,"NA":8369},{"trials":8348,"activeCount":100},[],{"trials":8350,"activeCount":100},[],{"trials":8352,"activeCount":100},[],{"trials":8354,"activeCount":100},[8355],{"nctId":8356,"briefTitle":8357,"status":123,"phases":8358,"primaryCompletion":8359,"completion":8360,"start":8361,"enrollment":8362,"conditions":8363,"interventions":8365},"NCT06006663","Effect of Hebal and Synthetic Medicamentss on Enterococcus Feacalis",[90,91],"2023-10-05","2023-12-10","2023-08-26",32,[8364],"Effective Intracanal Medicaments Against Enterococcus Faecalis",[8345,8366],"modified triple antibiotic paste",{"trials":8368,"activeCount":100},[],{"trials":8370,"activeCount":100},[],{"intervention":8366,"totalTrials":247,"cells":8372},{"EARLY_PHASE1":8373,"PHASE1":8375,"PHASE2":8377,"PHASE3":8379,"PHASE4":8385,"NA":8387},{"trials":8374,"activeCount":100},[],{"trials":8376,"activeCount":100},[],{"trials":8378,"activeCount":100},[],{"trials":8380,"activeCount":100},[8381],{"nctId":8356,"briefTitle":8357,"status":123,"phases":8382,"primaryCompletion":8359,"completion":8360,"start":8361,"enrollment":8362,"conditions":8383,"interventions":8384},[90,91],[8364],[8345,8366],{"trials":8386,"activeCount":100},[],{"trials":8388,"activeCount":100},[],{"intervention":3031,"totalTrials":513,"cells":8390},{"EARLY_PHASE1":8391,"PHASE1":8393,"PHASE2":8395,"PHASE3":8411,"PHASE4":8413,"NA":8415},{"trials":8392,"activeCount":100},[],{"trials":8394,"activeCount":100},[],{"trials":8396,"activeCount":100},[8397,8401,8405],{"nctId":3025,"briefTitle":3026,"status":106,"phases":8398,"primaryCompletion":1066,"completion":1066,"start":3028,"enrollment":402,"conditions":8399,"interventions":8400},[90],[1494],[3031,3009],{"nctId":3455,"briefTitle":3456,"status":106,"phases":8402,"primaryCompletion":3458,"completion":1735,"start":3459,"enrollment":274,"conditions":8403,"interventions":8404},[90],[3461],[3463,3446,3031],{"nctId":8406,"briefTitle":8407,"status":106,"phases":8408,"primaryCompletion":368,"completion":368,"start":1409,"enrollment":1618,"conditions":8409,"interventions":8410},"NCT05561062","Atorvastatin in Patients With Ulcerative Colitis",[90],[1494],[3031],{"trials":8412,"activeCount":100},[],{"trials":8414,"activeCount":100},[],{"trials":8416,"activeCount":100},[],{"intervention":8418,"totalTrials":188,"cells":8419},"Ursodeoxycholic acid (UDCA) 500 mg",{"EARLY_PHASE1":8420,"PHASE1":8422,"PHASE2":8424,"PHASE3":8443,"PHASE4":8445,"NA":8447},{"trials":8421,"activeCount":100},[],{"trials":8423,"activeCount":100},[],{"trials":8425,"activeCount":100},[8426,8436],{"nctId":8427,"briefTitle":8428,"status":106,"phases":8429,"primaryCompletion":8430,"completion":8431,"start":8432,"enrollment":171,"conditions":8433,"interventions":8434},"NCT04834557","Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis",[90],"2022-05-18","2022-09-30","2021-11-01",[566],[8435,8418],"Digoxin 0.25 mg",{"nctId":8437,"briefTitle":8438,"status":106,"phases":8439,"primaryCompletion":8440,"completion":298,"start":1379,"enrollment":197,"conditions":8441,"interventions":8442},"NCT05973370","Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis",[90],"2023-11-30",[566],[8418],{"trials":8444,"activeCount":100},[],{"trials":8446,"activeCount":100},[],{"trials":8448,"activeCount":100},[],{"intervention":8450,"totalTrials":247,"cells":8451},"use of basil extract gel in treatment of aphthus ulcer",{"EARLY_PHASE1":8452,"PHASE1":8454,"PHASE2":8456,"PHASE3":8465,"PHASE4":8467,"NA":8469},{"trials":8453,"activeCount":100},[],{"trials":8455,"activeCount":100},[],{"trials":8457,"activeCount":100},[8458],{"nctId":8459,"briefTitle":8460,"status":123,"phases":8461,"primaryCompletion":1943,"completion":6317,"start":6724,"enrollment":5007,"conditions":8462,"interventions":8464},"NCT04710888","Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis",[90],[8463],"Oral Ulcer",[8450],{"trials":8466,"activeCount":100},[],{"trials":8468,"activeCount":100},[],{"trials":8470,"activeCount":100},[],{"intervention":8472,"totalTrials":247,"cells":8473},"Alloderm",{"EARLY_PHASE1":8474,"PHASE1":8476,"PHASE2":8478,"PHASE3":8488,"PHASE4":8490,"NA":8492},{"trials":8475,"activeCount":100},[],{"trials":8477,"activeCount":100},[],{"trials":8479,"activeCount":100},[8480],{"nctId":8481,"briefTitle":8482,"status":123,"phases":8483,"primaryCompletion":332,"completion":332,"start":437,"enrollment":3813,"conditions":8484,"interventions":8486},"NCT06241196","Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft",[90],[8485],"Immediate Implant",[8472,8487],"Xenogenic bone membrane shield",{"trials":8489,"activeCount":100},[],{"trials":8491,"activeCount":100},[],{"trials":8493,"activeCount":100},[],{"intervention":8487,"totalTrials":247,"cells":8495},{"EARLY_PHASE1":8496,"PHASE1":8498,"PHASE2":8500,"PHASE3":8506,"PHASE4":8508,"NA":8510},{"trials":8497,"activeCount":100},[],{"trials":8499,"activeCount":100},[],{"trials":8501,"activeCount":100},[8502],{"nctId":8481,"briefTitle":8482,"status":123,"phases":8503,"primaryCompletion":332,"completion":332,"start":437,"enrollment":3813,"conditions":8504,"interventions":8505},[90],[8485],[8472,8487],{"trials":8507,"activeCount":100},[],{"trials":8509,"activeCount":100},[],{"trials":8511,"activeCount":100},[],{"intervention":8513,"totalTrials":247,"cells":8514},"dexmedetomidine as adjuvant with bupivacaine",{"EARLY_PHASE1":8515,"PHASE1":8517,"PHASE2":8519,"PHASE3":8531,"PHASE4":8533,"NA":8535},{"trials":8516,"activeCount":100},[],{"trials":8518,"activeCount":100},[],{"trials":8520,"activeCount":100},[8521],{"nctId":8522,"briefTitle":8523,"status":106,"phases":8524,"primaryCompletion":8525,"completion":8525,"start":8526,"enrollment":197,"conditions":8527,"interventions":8529},"NCT05369468","Dexmetomidine With Erector Spinae Plane Block in Cholecystectomy",[89,90],"2022-11-10","2020-01-22",[8528],"Dexmedtomidine in Erector Spinae Block for Laparscopic Cholecystectomy",[8513,8530],"Bupivacain only",{"trials":8532,"activeCount":100},[],{"trials":8534,"activeCount":100},[],{"trials":8536,"activeCount":100},[],{"intervention":8530,"totalTrials":247,"cells":8538},{"EARLY_PHASE1":8539,"PHASE1":8541,"PHASE2":8543,"PHASE3":8549,"PHASE4":8551,"NA":8553},{"trials":8540,"activeCount":100},[],{"trials":8542,"activeCount":100},[],{"trials":8544,"activeCount":100},[8545],{"nctId":8522,"briefTitle":8523,"status":106,"phases":8546,"primaryCompletion":8525,"completion":8525,"start":8526,"enrollment":197,"conditions":8547,"interventions":8548},[89,90],[8528],[8513,8530],{"trials":8550,"activeCount":100},[],{"trials":8552,"activeCount":100},[],{"trials":8554,"activeCount":100},[],{"intervention":3463,"totalTrials":247,"cells":8556},{"EARLY_PHASE1":8557,"PHASE1":8559,"PHASE2":8561,"PHASE3":8567,"PHASE4":8569,"NA":8571},{"trials":8558,"activeCount":100},[],{"trials":8560,"activeCount":100},[],{"trials":8562,"activeCount":100},[8563],{"nctId":3455,"briefTitle":3456,"status":106,"phases":8564,"primaryCompletion":3458,"completion":1735,"start":3459,"enrollment":274,"conditions":8565,"interventions":8566},[90],[3461],[3463,3446,3031],{"trials":8568,"activeCount":100},[],{"trials":8570,"activeCount":100},[],{"trials":8572,"activeCount":100},[],{"intervention":8435,"totalTrials":247,"cells":8574},{"EARLY_PHASE1":8575,"PHASE1":8577,"PHASE2":8579,"PHASE3":8585,"PHASE4":8587,"NA":8589},{"trials":8576,"activeCount":100},[],{"trials":8578,"activeCount":100},[],{"trials":8580,"activeCount":100},[8581],{"nctId":8427,"briefTitle":8428,"status":106,"phases":8582,"primaryCompletion":8430,"completion":8431,"start":8432,"enrollment":171,"conditions":8583,"interventions":8584},[90],[566],[8435,8418],{"trials":8586,"activeCount":100},[],{"trials":8588,"activeCount":100},[],{"trials":8590,"activeCount":100},[],{"intervention":8592,"totalTrials":247,"cells":8593},"Empagliflozin 25 MG",{"EARLY_PHASE1":8594,"PHASE1":8596,"PHASE2":8598,"PHASE3":8609,"PHASE4":8611,"NA":8613},{"trials":8595,"activeCount":100},[],{"trials":8597,"activeCount":100},[],{"trials":8599,"activeCount":100},[8600],{"nctId":8601,"briefTitle":8602,"status":106,"phases":8603,"primaryCompletion":7177,"completion":8604,"start":8605,"enrollment":1618,"conditions":8606,"interventions":8608},"NCT05977465","Empagliflozin in Treatment of Peripheral Diabetic Neuropathy",[89,90],"2023-08-03","2022-01-20",[8607],"Diabetic Neuropathy Peripheral",[8592],{"trials":8610,"activeCount":100},[],{"trials":8612,"activeCount":100},[],{"trials":8614,"activeCount":100},[],{"intervention":8616,"totalTrials":247,"cells":8617},"Tacrolimus ointment",{"EARLY_PHASE1":8618,"PHASE1":8620,"PHASE2":8622,"PHASE3":8633,"PHASE4":8635,"NA":8637},{"trials":8619,"activeCount":100},[],{"trials":8621,"activeCount":100},[],{"trials":8623,"activeCount":100},[8624],{"nctId":8625,"briefTitle":8626,"status":106,"phases":8627,"primaryCompletion":8628,"completion":8628,"start":3113,"enrollment":184,"conditions":8629,"interventions":8631},"NCT05607901","A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone",[90],"2023-11-20",[8630],"Dermatologic Disease",[8616,8632],"Hydrocortisone 1% cream",{"trials":8634,"activeCount":100},[],{"trials":8636,"activeCount":100},[],{"trials":8638,"activeCount":100},[],{"intervention":8632,"totalTrials":247,"cells":8640},{"EARLY_PHASE1":8641,"PHASE1":8643,"PHASE2":8645,"PHASE3":8651,"PHASE4":8653,"NA":8655},{"trials":8642,"activeCount":100},[],{"trials":8644,"activeCount":100},[],{"trials":8646,"activeCount":100},[8647],{"nctId":8625,"briefTitle":8626,"status":106,"phases":8648,"primaryCompletion":8628,"completion":8628,"start":3113,"enrollment":184,"conditions":8649,"interventions":8650},[90],[8630],[8616,8632],{"trials":8652,"activeCount":100},[],{"trials":8654,"activeCount":100},[],{"trials":8656,"activeCount":100},[],{"intervention":3434,"totalTrials":247,"cells":8658},{"EARLY_PHASE1":8659,"PHASE1":8661,"PHASE2":8663,"PHASE3":8669,"PHASE4":8671,"NA":8673},{"trials":8660,"activeCount":100},[],{"trials":8662,"activeCount":100},[],{"trials":8664,"activeCount":100},[8665],{"nctId":3426,"briefTitle":3427,"status":106,"phases":8666,"primaryCompletion":1151,"completion":1151,"start":3429,"enrollment":590,"conditions":8667,"interventions":8668},[90],[3431],[3039,3433,3434],{"trials":8670,"activeCount":100},[],{"trials":8672,"activeCount":100},[],{"trials":8674,"activeCount":100},[],{"intervention":2039,"totalTrials":247,"cells":8676},{"EARLY_PHASE1":8677,"PHASE1":8679,"PHASE2":8681,"PHASE3":8687,"PHASE4":8689,"NA":8691},{"trials":8678,"activeCount":100},[],{"trials":8680,"activeCount":100},[],{"trials":8682,"activeCount":100},[8683],{"nctId":2031,"briefTitle":2032,"status":123,"phases":8684,"primaryCompletion":2034,"completion":1339,"start":2035,"enrollment":197,"conditions":8685,"interventions":8686},[90],[2037],[2039,2022],{"trials":8688,"activeCount":100},[],{"trials":8690,"activeCount":100},[],{"trials":8692,"activeCount":100},[],{"intervention":8694,"totalTrials":247,"cells":8695},"Rectal Diclofenac",{"EARLY_PHASE1":8696,"PHASE1":8698,"PHASE2":8700,"PHASE3":8713,"PHASE4":8715,"NA":8717},{"trials":8697,"activeCount":100},[],{"trials":8699,"activeCount":100},[],{"trials":8701,"activeCount":100},[8702],{"nctId":8703,"briefTitle":8704,"status":106,"phases":8705,"primaryCompletion":8706,"completion":8707,"start":8708,"enrollment":1510,"conditions":8709,"interventions":8711},"NCT06252441","Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis",[89,90],"2025-05-14","2025-06-25","2024-03-16",[8710],"Post ERCP Pancreatitis",[8694,8712],"Oral N-acetyl cysteine",{"trials":8714,"activeCount":100},[],{"trials":8716,"activeCount":100},[],{"trials":8718,"activeCount":100},[],{"intervention":8712,"totalTrials":247,"cells":8720},{"EARLY_PHASE1":8721,"PHASE1":8723,"PHASE2":8725,"PHASE3":8731,"PHASE4":8733,"NA":8735},{"trials":8722,"activeCount":100},[],{"trials":8724,"activeCount":100},[],{"trials":8726,"activeCount":100},[8727],{"nctId":8703,"briefTitle":8704,"status":106,"phases":8728,"primaryCompletion":8706,"completion":8707,"start":8708,"enrollment":1510,"conditions":8729,"interventions":8730},[89,90],[8710],[8694,8712],{"trials":8732,"activeCount":100},[],{"trials":8734,"activeCount":100},[],{"trials":8736,"activeCount":100},[],{"intervention":5954,"totalTrials":247,"cells":8738},{"EARLY_PHASE1":8739,"PHASE1":8741,"PHASE2":8743,"PHASE3":8749,"PHASE4":8751,"NA":8753},{"trials":8740,"activeCount":100},[],{"trials":8742,"activeCount":100},[],{"trials":8744,"activeCount":100},[8745],{"nctId":5946,"briefTitle":5947,"status":106,"phases":8746,"primaryCompletion":5949,"completion":5950,"start":1093,"enrollment":171,"conditions":8747,"interventions":8748},[90],[5952],[5954,1728,5937],{"trials":8750,"activeCount":100},[],{"trials":8752,"activeCount":100},[],{"trials":8754,"activeCount":100},[],{"intervention":8756,"totalTrials":247,"cells":8757},"Human recombinant erythropoietin",{"EARLY_PHASE1":8758,"PHASE1":8760,"PHASE2":8762,"PHASE3":8775,"PHASE4":8777,"NA":8779},{"trials":8759,"activeCount":100},[],{"trials":8761,"activeCount":100},[],{"trials":8763,"activeCount":100},[8764],{"nctId":8765,"briefTitle":8766,"status":106,"phases":8767,"primaryCompletion":8768,"completion":8769,"start":8770,"enrollment":391,"conditions":8771,"interventions":8773},"NCT00945789","Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)",[89,90],"2008-12","2009-06","2007-10",[8772],"Hypoxic Ischemic Encephalopathy",[8756,8774],"Nitric oxide measurement in the blood",{"trials":8776,"activeCount":100},[],{"trials":8778,"activeCount":100},[],{"trials":8780,"activeCount":100},[],{"intervention":8774,"totalTrials":247,"cells":8782},{"EARLY_PHASE1":8783,"PHASE1":8785,"PHASE2":8787,"PHASE3":8793,"PHASE4":8795,"NA":8797},{"trials":8784,"activeCount":100},[],{"trials":8786,"activeCount":100},[],{"trials":8788,"activeCount":100},[8789],{"nctId":8765,"briefTitle":8766,"status":106,"phases":8790,"primaryCompletion":8768,"completion":8769,"start":8770,"enrollment":391,"conditions":8791,"interventions":8792},[89,90],[8772],[8756,8774],{"trials":8794,"activeCount":100},[],{"trials":8796,"activeCount":100},[],{"trials":8798,"activeCount":100},[],{"intervention":8800,"totalTrials":247,"cells":8801},"NAc",{"EARLY_PHASE1":8802,"PHASE1":8804,"PHASE2":8806,"PHASE3":8817,"PHASE4":8819,"NA":8821},{"trials":8803,"activeCount":100},[],{"trials":8805,"activeCount":100},[],{"trials":8807,"activeCount":100},[8808],{"nctId":8809,"briefTitle":8810,"status":106,"phases":8811,"primaryCompletion":2087,"completion":1151,"start":8812,"enrollment":171,"conditions":8813,"interventions":8815},"NCT05485558","the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy",[90],"2022-09-15",[8814],"Drug Resistant Epilepsy",[8816,8800],"N-acetyl cysteine",{"trials":8818,"activeCount":100},[],{"trials":8820,"activeCount":100},[],{"trials":8822,"activeCount":100},[],{"intervention":8824,"totalTrials":247,"cells":8825},"Ondansetron 4mg + dexmedetomidine 0.5 ug\u002Fkg + normal saline .",{"EARLY_PHASE1":8826,"PHASE1":8828,"PHASE2":8830,"PHASE3":8841,"PHASE4":8843,"NA":8845},{"trials":8827,"activeCount":100},[],{"trials":8829,"activeCount":100},[],{"trials":8831,"activeCount":100},[8832],{"nctId":8833,"briefTitle":8834,"status":123,"phases":8835,"primaryCompletion":8836,"completion":8837,"start":8812,"enrollment":157,"conditions":8838,"interventions":8839},"NCT06017167","Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy",[90],"2023-09","2023-10",[113,1082],[8824,8840],"Ondansetron 4mg + dexamethasone 8mg + normal saline.",{"trials":8842,"activeCount":100},[],{"trials":8844,"activeCount":100},[],{"trials":8846,"activeCount":100},[],{"intervention":8840,"totalTrials":247,"cells":8848},{"EARLY_PHASE1":8849,"PHASE1":8851,"PHASE2":8853,"PHASE3":8859,"PHASE4":8861,"NA":8863},{"trials":8850,"activeCount":100},[],{"trials":8852,"activeCount":100},[],{"trials":8854,"activeCount":100},[8855],{"nctId":8833,"briefTitle":8834,"status":123,"phases":8856,"primaryCompletion":8836,"completion":8837,"start":8812,"enrollment":157,"conditions":8857,"interventions":8858},[90],[113,1082],[8824,8840],{"trials":8860,"activeCount":100},[],{"trials":8862,"activeCount":100},[],{"trials":8864,"activeCount":100},[],{"intervention":145,"totalTrials":247,"cells":8866},{"EARLY_PHASE1":8867,"PHASE1":8869,"PHASE2":8871,"PHASE3":8877,"PHASE4":8879,"NA":8881},{"trials":8868,"activeCount":100},[],{"trials":8870,"activeCount":100},[],{"trials":8872,"activeCount":100},[8873],{"nctId":135,"briefTitle":136,"status":106,"phases":8874,"primaryCompletion":138,"completion":139,"start":140,"enrollment":141,"conditions":8875,"interventions":8876},[90],[143],[145,146,147],{"trials":8878,"activeCount":100},[],{"trials":8880,"activeCount":100},[],{"trials":8882,"activeCount":100},[],{"intervention":147,"totalTrials":247,"cells":8884},{"EARLY_PHASE1":8885,"PHASE1":8887,"PHASE2":8889,"PHASE3":8895,"PHASE4":8897,"NA":8899},{"trials":8886,"activeCount":100},[],{"trials":8888,"activeCount":100},[],{"trials":8890,"activeCount":100},[8891],{"nctId":135,"briefTitle":136,"status":106,"phases":8892,"primaryCompletion":138,"completion":139,"start":140,"enrollment":141,"conditions":8893,"interventions":8894},[90],[143],[145,146,147],{"trials":8896,"activeCount":100},[],{"trials":8898,"activeCount":100},[],{"trials":8900,"activeCount":100},[],{"intervention":8902,"totalTrials":247,"cells":8903},"minimally invasive flap with root contioning by EDTA and growth factor enhanced matrix GEM21S",{"EARLY_PHASE1":8904,"PHASE1":8906,"PHASE2":8908,"PHASE3":8918,"PHASE4":8920,"NA":8922},{"trials":8905,"activeCount":100},[],{"trials":8907,"activeCount":100},[],{"trials":8909,"activeCount":100},[8910],{"nctId":8911,"briefTitle":8912,"status":106,"phases":8913,"primaryCompletion":8914,"completion":8914,"start":6083,"enrollment":926,"conditions":8915,"interventions":8917},"NCT04786327","Minimally Invasive Flap With Platelet Rich Fibrin or Growth Factor Enhanced Matrix in Treatment of Intrabony Defect",[90],"2019-10-01",[8916],"Periodontal Regeneration",[8902],{"trials":8919,"activeCount":100},[],{"trials":8921,"activeCount":100},[],{"trials":8923,"activeCount":100},[],{"intervention":8925,"totalTrials":247,"cells":8926},"Labetalol",{"EARLY_PHASE1":8927,"PHASE1":8929,"PHASE2":8931,"PHASE3":8941,"PHASE4":8943,"NA":8945},{"trials":8928,"activeCount":100},[],{"trials":8930,"activeCount":100},[],{"trials":8932,"activeCount":100},[8933],{"nctId":8934,"briefTitle":8935,"status":123,"phases":8936,"primaryCompletion":3458,"completion":1735,"start":332,"enrollment":370,"conditions":8937,"interventions":8939},"NCT06360601","Intravenous Labetalol Versus Hydralazine in Preeclampsia",[89,90],[8938],"Preeclampsia Severe",[8925,8940],"HydrALAZINE",{"trials":8942,"activeCount":100},[],{"trials":8944,"activeCount":100},[],{"trials":8946,"activeCount":100},[],{"intervention":8940,"totalTrials":247,"cells":8948},{"EARLY_PHASE1":8949,"PHASE1":8951,"PHASE2":8953,"PHASE3":8959,"PHASE4":8961,"NA":8963},{"trials":8950,"activeCount":100},[],{"trials":8952,"activeCount":100},[],{"trials":8954,"activeCount":100},[8955],{"nctId":8934,"briefTitle":8935,"status":123,"phases":8956,"primaryCompletion":3458,"completion":1735,"start":332,"enrollment":370,"conditions":8957,"interventions":8958},[89,90],[8938],[8925,8940],{"trials":8960,"activeCount":100},[],{"trials":8962,"activeCount":100},[],{"trials":8964,"activeCount":100},[],{"intervention":8966,"totalTrials":247,"cells":8967},"N-acetylcysteine",{"EARLY_PHASE1":8968,"PHASE1":8970,"PHASE2":8972,"PHASE3":8983,"PHASE4":8985,"NA":8987},{"trials":8969,"activeCount":100},[],{"trials":8971,"activeCount":100},[],{"trials":8973,"activeCount":100},[8974],{"nctId":8975,"briefTitle":8976,"status":106,"phases":8977,"primaryCompletion":8978,"completion":8978,"start":8979,"enrollment":590,"conditions":8980,"interventions":8982},"NCT06236165","Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice",[90],"2025-01-22","2024-02-14",[8981],"Hepatic and Post Hepatic Jaundice",[8966],{"trials":8984,"activeCount":100},[],{"trials":8986,"activeCount":100},[],{"trials":8988,"activeCount":100},[],{"intervention":8990,"totalTrials":247,"cells":8991},"cisplatin with hydration magnesium",{"EARLY_PHASE1":8992,"PHASE1":8994,"PHASE2":8996,"PHASE3":9008,"PHASE4":9010,"NA":9012},{"trials":8993,"activeCount":100},[],{"trials":8995,"activeCount":100},[],{"trials":8997,"activeCount":100},[8998],{"nctId":8999,"briefTitle":9000,"status":106,"phases":9001,"primaryCompletion":9002,"completion":9003,"start":483,"enrollment":184,"conditions":9004,"interventions":9006},"NCT05586009","Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients",[90],"2025-02-27","2025-03-30",[9005],"Cisplatin Adverse Reaction",[8990,9007],"cisplatin 40 mg\u002Fm²",{"trials":9009,"activeCount":100},[],{"trials":9011,"activeCount":100},[],{"trials":9013,"activeCount":100},[],{"intervention":9007,"totalTrials":247,"cells":9015},{"EARLY_PHASE1":9016,"PHASE1":9018,"PHASE2":9020,"PHASE3":9026,"PHASE4":9028,"NA":9030},{"trials":9017,"activeCount":100},[],{"trials":9019,"activeCount":100},[],{"trials":9021,"activeCount":100},[9022],{"nctId":8999,"briefTitle":9000,"status":106,"phases":9023,"primaryCompletion":9002,"completion":9003,"start":483,"enrollment":184,"conditions":9024,"interventions":9025},[90],[9005],[8990,9007],{"trials":9027,"activeCount":100},[],{"trials":9029,"activeCount":100},[],{"trials":9031,"activeCount":100},[],{"intervention":6015,"totalTrials":247,"cells":9033},{"EARLY_PHASE1":9034,"PHASE1":9036,"PHASE2":9038,"PHASE3":9044,"PHASE4":9046,"NA":9048},{"trials":9035,"activeCount":100},[],{"trials":9037,"activeCount":100},[],{"trials":9039,"activeCount":100},[9040],{"nctId":6008,"briefTitle":6009,"status":106,"phases":9041,"primaryCompletion":4112,"completion":656,"start":3313,"enrollment":6011,"conditions":9042,"interventions":9043},[90],[6013],[6015,1899],{"trials":9045,"activeCount":100},[],{"trials":9047,"activeCount":100},[],{"trials":9049,"activeCount":100},[],{"intervention":9051,"totalTrials":247,"cells":9052},"Cholecalciferol",{"EARLY_PHASE1":9053,"PHASE1":9055,"PHASE2":9057,"PHASE3":9066,"PHASE4":9068,"NA":9070},{"trials":9054,"activeCount":100},[],{"trials":9056,"activeCount":100},[],{"trials":9058,"activeCount":100},[9059],{"nctId":9060,"briefTitle":9061,"status":106,"phases":9062,"primaryCompletion":9063,"completion":9063,"start":4113,"enrollment":184,"conditions":9064,"interventions":9065},"NCT05578404","High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease",[90],"2023-04-20",[3891],[9051],{"trials":9067,"activeCount":100},[],{"trials":9069,"activeCount":100},[],{"trials":9071,"activeCount":100},[],{"intervention":9073,"totalTrials":247,"cells":9074},"Lactobacillus-Based",{"EARLY_PHASE1":9075,"PHASE1":9077,"PHASE2":9079,"PHASE3":9089,"PHASE4":9091,"NA":9093},{"trials":9076,"activeCount":100},[],{"trials":9078,"activeCount":100},[],{"trials":9080,"activeCount":100},[9081],{"nctId":9082,"briefTitle":9083,"status":106,"phases":9084,"primaryCompletion":9085,"completion":61,"start":9086,"enrollment":197,"conditions":9087,"interventions":9088},"NCT05539287","Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy",[90],"2024-08-05","2022-09-25",[8814],[9073],{"trials":9090,"activeCount":100},[],{"trials":9092,"activeCount":100},[],{"trials":9094,"activeCount":100},[],{"intervention":9096,"totalTrials":247,"cells":9097},"human treated dentin matrix",{"EARLY_PHASE1":9098,"PHASE1":9100,"PHASE2":9102,"PHASE3":9114,"PHASE4":9116,"NA":9118},{"trials":9099,"activeCount":100},[],{"trials":9101,"activeCount":100},[],{"trials":9103,"activeCount":100},[9104],{"nctId":9105,"briefTitle":9106,"status":106,"phases":9107,"primaryCompletion":9108,"completion":4684,"start":9109,"enrollment":6403,"conditions":9110,"interventions":9112},"NCT06116695","Tomographic Evaluation of Pulpotomy in Young Permanent Teeth Using Human-treated Dentin Matrix",[89,90],"2023-06-18","2022-01-18",[9111],"Pulpotomy of Young Permanent Molars",[9096,9113],"Mineral Tri-Oxide Aggregate",{"trials":9115,"activeCount":100},[],{"trials":9117,"activeCount":100},[],{"trials":9119,"activeCount":100},[],{"intervention":9113,"totalTrials":247,"cells":9121},{"EARLY_PHASE1":9122,"PHASE1":9124,"PHASE2":9126,"PHASE3":9132,"PHASE4":9134,"NA":9136},{"trials":9123,"activeCount":100},[],{"trials":9125,"activeCount":100},[],{"trials":9127,"activeCount":100},[9128],{"nctId":9105,"briefTitle":9106,"status":106,"phases":9129,"primaryCompletion":9108,"completion":4684,"start":9109,"enrollment":6403,"conditions":9130,"interventions":9131},[89,90],[9111],[9096,9113],{"trials":9133,"activeCount":100},[],{"trials":9135,"activeCount":100},[],{"trials":9137,"activeCount":100},[],{"intervention":9139,"totalTrials":247,"cells":9140},"self assembling peptide p11-4 with fluoride",{"EARLY_PHASE1":9141,"PHASE1":9143,"PHASE2":9156,"PHASE3":9158,"PHASE4":9160,"NA":9162},{"trials":9142,"activeCount":100},[],{"trials":9144,"activeCount":100},[9145],{"nctId":9146,"briefTitle":9147,"status":123,"phases":9148,"primaryCompletion":9149,"completion":9150,"start":9151,"enrollment":1618,"conditions":9152,"interventions":9154},"NCT06358066","The Remineralization of Early Enamel Caries in Permanent Teeth",[89],"2024-11-06","2025-01-06","2024-06-06",[9153],"White Spot Lesion",[9139,9155],"5% sodium fluoride varnish",{"trials":9157,"activeCount":100},[],{"trials":9159,"activeCount":100},[],{"trials":9161,"activeCount":100},[],{"trials":9163,"activeCount":100},[],{"intervention":9155,"totalTrials":247,"cells":9165},{"EARLY_PHASE1":9166,"PHASE1":9168,"PHASE2":9174,"PHASE3":9176,"PHASE4":9178,"NA":9180},{"trials":9167,"activeCount":100},[],{"trials":9169,"activeCount":100},[9170],{"nctId":9146,"briefTitle":9147,"status":123,"phases":9171,"primaryCompletion":9149,"completion":9150,"start":9151,"enrollment":1618,"conditions":9172,"interventions":9173},[89],[9153],[9139,9155],{"trials":9175,"activeCount":100},[],{"trials":9177,"activeCount":100},[],{"trials":9179,"activeCount":100},[],{"trials":9181,"activeCount":100},[],{"intervention":9183,"totalTrials":247,"cells":9184},"Lactobacillus Reuteri Oral Drops",{"EARLY_PHASE1":9185,"PHASE1":9187,"PHASE2":9198,"PHASE3":9200,"PHASE4":9202,"NA":9204},{"trials":9186,"activeCount":100},[],{"trials":9188,"activeCount":100},[9189],{"nctId":9190,"briefTitle":9191,"status":106,"phases":9192,"primaryCompletion":6402,"completion":9193,"start":4253,"enrollment":9194,"conditions":9195,"interventions":9197},"NCT04697199","The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis",[89],"2020-02-06",12,[9196],"Chronic Periodontitis",[9183],{"trials":9199,"activeCount":100},[],{"trials":9201,"activeCount":100},[],{"trials":9203,"activeCount":100},[],{"trials":9205,"activeCount":100},[],{"intervention":946,"totalTrials":247,"cells":9207},{"EARLY_PHASE1":9208,"PHASE1":9210,"PHASE2":9216,"PHASE3":9218,"PHASE4":9220,"NA":9222},{"trials":9209,"activeCount":100},[],{"trials":9211,"activeCount":100},[9212],{"nctId":937,"briefTitle":938,"status":123,"phases":9213,"primaryCompletion":940,"completion":941,"start":942,"enrollment":128,"conditions":9214,"interventions":9215},[89],[944],[946,947],{"trials":9217,"activeCount":100},[],{"trials":9219,"activeCount":100},[],{"trials":9221,"activeCount":100},[],{"trials":9223,"activeCount":100},[],{"intervention":9225,"totalTrials":247,"cells":9226},"Frankincense Extract",{"EARLY_PHASE1":9227,"PHASE1":9229,"PHASE2":9238,"PHASE3":9240,"PHASE4":9242,"NA":9244},{"trials":9228,"activeCount":100},[],{"trials":9230,"activeCount":100},[9231],{"nctId":9232,"briefTitle":9233,"status":106,"phases":9234,"primaryCompletion":5992,"completion":5992,"start":973,"enrollment":5007,"conditions":9235,"interventions":9237},"NCT04705714","Antibacterial and Anti-biofilm Activity of Frankincense Extract Against Porphyromonas Gingivalis",[89],[9236],"Periodontal Diseases",[9225],{"trials":9239,"activeCount":100},[],{"trials":9241,"activeCount":100},[],{"trials":9243,"activeCount":100},[],{"trials":9245,"activeCount":100},[],{"intervention":9247,"totalTrials":247,"cells":9248},"dexmedetomidine 4μg",{"EARLY_PHASE1":9249,"PHASE1":9251,"PHASE2":9262,"PHASE3":9264,"PHASE4":9266,"NA":9268},{"trials":9250,"activeCount":100},[],{"trials":9252,"activeCount":100},[9253],{"nctId":9254,"briefTitle":9255,"status":106,"phases":9256,"primaryCompletion":299,"completion":299,"start":273,"enrollment":171,"conditions":9257,"interventions":9259},"NCT07051512","Effect of Different Doses Of Intrathecal Dexmedetomidine In Combination With Bupivacaine On Spinal Anesthesia",[89],[9258,404,4614],"Spinal Anesthesia Evaluation",[9247,9260,9261],"dexmedetomidine 8 μg","dexmedetomidine 10 μg",{"trials":9263,"activeCount":100},[],{"trials":9265,"activeCount":100},[],{"trials":9267,"activeCount":100},[],{"trials":9269,"activeCount":100},[],{"intervention":9260,"totalTrials":247,"cells":9271},{"EARLY_PHASE1":9272,"PHASE1":9274,"PHASE2":9280,"PHASE3":9282,"PHASE4":9284,"NA":9286},{"trials":9273,"activeCount":100},[],{"trials":9275,"activeCount":100},[9276],{"nctId":9254,"briefTitle":9255,"status":106,"phases":9277,"primaryCompletion":299,"completion":299,"start":273,"enrollment":171,"conditions":9278,"interventions":9279},[89],[9258,404,4614],[9247,9260,9261],{"trials":9281,"activeCount":100},[],{"trials":9283,"activeCount":100},[],{"trials":9285,"activeCount":100},[],{"trials":9287,"activeCount":100},[],{"intervention":9261,"totalTrials":247,"cells":9289},{"EARLY_PHASE1":9290,"PHASE1":9292,"PHASE2":9298,"PHASE3":9300,"PHASE4":9302,"NA":9304},{"trials":9291,"activeCount":100},[],{"trials":9293,"activeCount":100},[9294],{"nctId":9254,"briefTitle":9255,"status":106,"phases":9295,"primaryCompletion":299,"completion":299,"start":273,"enrollment":171,"conditions":9296,"interventions":9297},[89],[9258,404,4614],[9247,9260,9261],{"trials":9299,"activeCount":100},[],{"trials":9301,"activeCount":100},[],{"trials":9303,"activeCount":100},[],{"trials":9305,"activeCount":100},[],{"intervention":9307,"totalTrials":247,"cells":9308},"Vit D",{"EARLY_PHASE1":9309,"PHASE1":9311,"PHASE2":9321,"PHASE3":9323,"PHASE4":9325,"NA":9327},{"trials":9310,"activeCount":100},[],{"trials":9312,"activeCount":100},[9313],{"nctId":9314,"briefTitle":9315,"status":106,"phases":9316,"primaryCompletion":196,"completion":9317,"start":1214,"enrollment":9,"conditions":9318,"interventions":9320},"NCT05167617","Vitamin D Improves Clinical Manifestations in Asthmatic Children",[89],"2021-09-15",[9319],"Asthma in Children",[9307],{"trials":9322,"activeCount":100},[],{"trials":9324,"activeCount":100},[],{"trials":9326,"activeCount":100},[],{"trials":9328,"activeCount":100},[],{"intervention":9330,"totalTrials":247,"cells":9331},"acetyl cysteine 600 mg",{"EARLY_PHASE1":9332,"PHASE1":9334,"PHASE2":9347,"PHASE3":9349,"PHASE4":9351,"NA":9353},{"trials":9333,"activeCount":100},[],{"trials":9335,"activeCount":100},[9336],{"nctId":9337,"briefTitle":9338,"status":106,"phases":9339,"primaryCompletion":9340,"completion":9341,"start":9342,"enrollment":157,"conditions":9343,"interventions":9345},"NCT07097727","Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella",[89],"2024-09-30","2024-10-30","2023-10-30",[9344,408],"Ventilator Associated Pneumonia ( VAP)",[9330,9346],"antibiotics and saline.",{"trials":9348,"activeCount":100},[],{"trials":9350,"activeCount":100},[],{"trials":9352,"activeCount":100},[],{"trials":9354,"activeCount":100},[],{"intervention":9346,"totalTrials":247,"cells":9356},{"EARLY_PHASE1":9357,"PHASE1":9359,"PHASE2":9365,"PHASE3":9367,"PHASE4":9369,"NA":9371},{"trials":9358,"activeCount":100},[],{"trials":9360,"activeCount":100},[9361],{"nctId":9337,"briefTitle":9338,"status":106,"phases":9362,"primaryCompletion":9340,"completion":9341,"start":9342,"enrollment":157,"conditions":9363,"interventions":9364},[89],[9344,408],[9330,9346],{"trials":9366,"activeCount":100},[],{"trials":9368,"activeCount":100},[],{"trials":9370,"activeCount":100},[],{"trials":9372,"activeCount":100},[],{"intervention":9374,"totalTrials":247,"cells":9375},"Ultrasound Guided Bilateral single shot Erector Spinae Plane Block",{"EARLY_PHASE1":9376,"PHASE1":9388,"PHASE2":9390,"PHASE3":9392,"PHASE4":9394,"NA":9396},{"trials":9377,"activeCount":100},[9378],{"nctId":9379,"briefTitle":9380,"status":106,"phases":9381,"primaryCompletion":6083,"completion":4253,"start":9382,"enrollment":370,"conditions":9383,"interventions":9387},"NCT03746418","Effect of Addition of Dexmedetomidine During Ultrasound Guided Bilateral Single Shot Erector Spinae Plane Block in Patients Undergoing Posterior Lumbar Interbody Fusion Under General Anesthesia",[88],"2016-01-01",[9384,9385,9386],"Double Level Lumbar Spondylolisthesis (L3-L5)","Posterior Lumbar Interbody Fusion (PLIF)","Lumbar Fixation Surgery",[9374],{"trials":9389,"activeCount":100},[],{"trials":9391,"activeCount":100},[],{"trials":9393,"activeCount":100},[],{"trials":9395,"activeCount":100},[],{"trials":9397,"activeCount":100},[],{"intervention":9399,"totalTrials":247,"cells":9400},"standard treatment",{"EARLY_PHASE1":9401,"PHASE1":9412,"PHASE2":9414,"PHASE3":9416,"PHASE4":9418,"NA":9420},{"trials":9402,"activeCount":100},[9403],{"nctId":9404,"briefTitle":9405,"status":106,"phases":9406,"primaryCompletion":9407,"completion":9317,"start":6724,"enrollment":9408,"conditions":9409,"interventions":9411},"NCT04724655","Paraffin Oil or Coconut Oil in Acute Aluminum Phosphide Poisoning",[88],"2021-06-30",89,[9410],"Aluminum Phosphide Poisoning",[9399],{"trials":9413,"activeCount":100},[],{"trials":9415,"activeCount":100},[],{"trials":9417,"activeCount":100},[],{"trials":9419,"activeCount":100},[],{"trials":9421,"activeCount":100},[],{"intervention":1607,"totalTrials":247,"cells":9423},{"EARLY_PHASE1":9424,"PHASE1":9430,"PHASE2":9432,"PHASE3":9434,"PHASE4":9436,"NA":9438},{"trials":9425,"activeCount":100},[9426],{"nctId":1595,"briefTitle":1596,"status":123,"phases":9427,"primaryCompletion":1598,"completion":1599,"start":1600,"enrollment":1601,"conditions":9428,"interventions":9429},[88],[1603,1604,1605],[1069,1607],{"trials":9431,"activeCount":100},[],{"trials":9433,"activeCount":100},[],{"trials":9435,"activeCount":100},[],{"trials":9437,"activeCount":100},[],{"trials":9439,"activeCount":100},[],{"intervention":9441,"totalTrials":247,"cells":9442},"intrathecal bupivacaine",{"EARLY_PHASE1":9443,"PHASE1":9455,"PHASE2":9457,"PHASE3":9459,"PHASE4":9461,"NA":9463},{"trials":9444,"activeCount":100},[9445],{"nctId":9446,"briefTitle":9447,"status":106,"phases":9448,"primaryCompletion":9449,"completion":1953,"start":9450,"enrollment":289,"conditions":9451,"interventions":9453},"NCT04718259","The Use of Midazolam as Adjuvant to Bupivacaine Intrathecal Anesthesia for Children Undergoing Lower Abdominal Surgeries.",[88],"2021-02-28","2020-01-18",[18,9452,281,209],"Children, Only",[9441,9454],"midazolam",{"trials":9456,"activeCount":100},[],{"trials":9458,"activeCount":100},[],{"trials":9460,"activeCount":100},[],{"trials":9462,"activeCount":100},[],{"trials":9464,"activeCount":100},[],{"intervention":9466,"totalTrials":247,"cells":9467},"Bilateral Ultrasound Guided Pectoralis Nerve Block.",{"EARLY_PHASE1":9468,"PHASE1":9482,"PHASE2":9484,"PHASE3":9486,"PHASE4":9488,"NA":9490},{"trials":9469,"activeCount":100},[9470],{"nctId":9471,"briefTitle":9472,"status":106,"phases":9473,"primaryCompletion":9474,"completion":9475,"start":9476,"enrollment":370,"conditions":9477,"interventions":9481},"NCT03734848","Bilateral Ultrasound Guided Pectoralis Nerve Block Induces Hemodynamic Stability With Reducing Systemic Stress Response for Off-pump Coronary Artery Bypass Graft",[88],"2018-01","2018-11","2016-01",[9478,9479,9480],"Analgesic Effects","Systemic Stress Response","Hemodynamic Stability",[9466],{"trials":9483,"activeCount":100},[],{"trials":9485,"activeCount":100},[],{"trials":9487,"activeCount":100},[],{"trials":9489,"activeCount":100},[],{"trials":9491,"activeCount":100},[],{"intervention":9493,"totalTrials":247,"cells":9494},"Hesperidin and Diosmin mixture",{"EARLY_PHASE1":9495,"PHASE1":9505,"PHASE2":9507,"PHASE3":9509,"PHASE4":9511,"NA":9513},{"trials":9496,"activeCount":100},[9497],{"nctId":9498,"briefTitle":9499,"status":123,"phases":9500,"primaryCompletion":9501,"completion":9502,"start":239,"enrollment":184,"conditions":9503,"interventions":9504},"NCT04452799","Hesperidin and Diosmin for Treatment of COVID-19",[88],"2020-10-01","2020-10-30",[7493],[9493],{"trials":9506,"activeCount":100},[],{"trials":9508,"activeCount":100},[],{"trials":9510,"activeCount":100},[],{"trials":9512,"activeCount":100},[],{"trials":9514,"activeCount":100},[],{"intervention":9516,"totalTrials":247,"cells":9517},"Triamcinolone Acetonide 40Mg\u002FMl Inj,Susp_#1",{"EARLY_PHASE1":9518,"PHASE1":9527,"PHASE2":9529,"PHASE3":9531,"PHASE4":9533,"NA":9535},{"trials":9519,"activeCount":100},[9520],{"nctId":9521,"briefTitle":9522,"status":123,"phases":9523,"primaryCompletion":1668,"completion":61,"start":1668,"enrollment":184,"conditions":9524,"interventions":9526},"NCT04690608","Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema, CRVO, Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema Following Pars Plana Vitrectomy",[88],[9525],"Retinal Edema",[9516],{"trials":9528,"activeCount":100},[],{"trials":9530,"activeCount":100},[],{"trials":9532,"activeCount":100},[],{"trials":9534,"activeCount":100},[],{"trials":9536,"activeCount":100},[],{"intervention":9538,"totalTrials":247,"cells":9539},"nigella sativ",{"EARLY_PHASE1":9540,"PHASE1":9551,"PHASE2":9553,"PHASE3":9555,"PHASE4":9557,"NA":9559},{"trials":9541,"activeCount":100},[9542],{"nctId":9543,"briefTitle":9544,"status":123,"phases":9545,"primaryCompletion":9546,"completion":9546,"start":9547,"enrollment":128,"conditions":9548,"interventions":9550},"NCT02816957","Benefits of Nigella Sativa in Children With Beta Thalassemia Major",[88],"2017-06","2016-06",[9549],"Nigella Sativa With Beta Thalassemia Major",[9538],{"trials":9552,"activeCount":100},[],{"trials":9554,"activeCount":100},[],{"trials":9556,"activeCount":100},[],{"trials":9558,"activeCount":100},[],{"trials":9560,"activeCount":100},[],{"intervention":9562,"totalTrials":247,"cells":9563},"Ethanol",{"EARLY_PHASE1":9564,"PHASE1":9577,"PHASE2":9579,"PHASE3":9581,"PHASE4":9583,"NA":9585},{"trials":9565,"activeCount":100},[9566],{"nctId":9567,"briefTitle":9568,"status":106,"phases":9569,"primaryCompletion":9570,"completion":9571,"start":9572,"enrollment":9573,"conditions":9574,"interventions":9576},"NCT05470972","Relation Between Ethanol Sclerotherapy for Endometrioma Systemic Immune Milieu",[88],"2021-11-17","2022-05-19","2020-05-21",69,[9575],"Endometriosis",[9562],{"trials":9578,"activeCount":100},[],{"trials":9580,"activeCount":100},[],{"trials":9582,"activeCount":100},[],{"trials":9584,"activeCount":100},[],{"trials":9586,"activeCount":100},[],{"intervention":281,"totalTrials":1324,"cells":9588},{"EARLY_PHASE1":9589,"PHASE1":9595,"PHASE2":9597,"PHASE3":9599,"PHASE4":9601,"NA":9603},{"trials":9590,"activeCount":100},[9591],{"nctId":4448,"briefTitle":4449,"status":123,"phases":9592,"primaryCompletion":4451,"completion":4452,"start":126,"enrollment":171,"conditions":9593,"interventions":9594},[88],[4454],[281,117],{"trials":9596,"activeCount":100},[],{"trials":9598,"activeCount":100},[],{"trials":9600,"activeCount":100},[],{"trials":9602,"activeCount":100},[],{"trials":9604,"activeCount":100},[9605,9609,9618,9627,9636,9640,9648,9652,9664,9672],{"nctId":270,"briefTitle":271,"status":106,"phases":9606,"primaryCompletion":61,"completion":61,"start":273,"enrollment":274,"conditions":9607,"interventions":9608},[93],[15,276,277,278,24,279],[281,15,176],{"nctId":9610,"briefTitle":9611,"status":106,"phases":9612,"primaryCompletion":9613,"completion":9613,"start":473,"enrollment":1249,"conditions":9614,"interventions":9617},"NCT06098105","Laparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block vs Laparoscopic Intraperitoneal Instillation of Local Anesthetic in Pediatrics",[93],"2024-04-21",[5073,30,4101,9615,211,9616],"Laparoscopic Intraperitoneal Instillation","Inguinal Hernia Repair",[281],{"nctId":9619,"briefTitle":9620,"status":123,"phases":9621,"primaryCompletion":9622,"completion":5915,"start":4452,"enrollment":1618,"conditions":9623,"interventions":9626},"NCT05999734","Mid-transverse Process to Pleura Block in Pediatric Thoracotomy",[93],"2024-08",[9624,9625,18],"Ultrasound Guided Block","Pediatric Surgery",[281],{"nctId":9628,"briefTitle":9629,"status":106,"phases":9630,"primaryCompletion":450,"completion":450,"start":9631,"enrollment":370,"conditions":9632,"interventions":9634},"NCT06092073","Bilateral Recto-Intercostal Fascial Plane Block in Epigastric Hernia Repair",[93],"2023-10-21",[4404,9633,18],"Epigastric Hernia",[9635],"bupivacaine",{"nctId":1042,"briefTitle":1043,"status":1044,"phases":9637,"primaryCompletion":1046,"completion":1047,"start":1048,"enrollment":370,"conditions":9638,"interventions":9639},[93],[1050,18,1051],[947,281],{"nctId":9641,"briefTitle":9642,"status":106,"phases":9643,"primaryCompletion":9644,"completion":9644,"start":9645,"enrollment":171,"conditions":9646,"interventions":9647},"NCT05686395","Pain Control After Arthroscopic Shoulder Surgeries",[93],"2024-08-11","2023-01-23",[114],[281],{"nctId":365,"briefTitle":366,"status":106,"phases":9649,"primaryCompletion":368,"completion":368,"start":369,"enrollment":370,"conditions":9650,"interventions":9651},[93],[15,201,372,373],[201,15,281],{"nctId":9653,"briefTitle":9654,"status":106,"phases":9655,"primaryCompletion":9656,"completion":9657,"start":9658,"enrollment":513,"conditions":9659,"interventions":9661},"NCT04963816","Pediatric Postoperative Analgesia With Quadratus Lumborum Block(QLB) And Dexamethasone As An Adjuvant To Bupivacaine.",[93],"2021-10-30","2022-01-10","2021-06-16",[114,4100,498,9660],"Abdominal Surgery",[9662,281,9663],"Dexamethasone Phosphate 4 MG\u002FML Injectable Solution intravenously","Dexamethasone Phosphate 4 MG\u002FML Injectable Solution locally",{"nctId":9665,"briefTitle":9666,"status":106,"phases":9667,"primaryCompletion":9668,"completion":9668,"start":7177,"enrollment":171,"conditions":9669,"interventions":9670},"NCT06825286","Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-Guided Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy",[93],"2024-08-01",[15,281,1382,4100,24,1082],[281,9671],"Bupivacaine and Dexmedetomidinc) group",{"nctId":9673,"briefTitle":9674,"status":123,"phases":9675,"primaryCompletion":3028,"completion":3028,"start":3285,"enrollment":1618,"conditions":9676,"interventions":9679},"NCT05222334","Ultrasound-Guided Extrafascial Versus Intrafascial Interscalene Brachial Plexus Block in Shoulder Arthroscopy",[93],[9677,18,9678],"Arthroscopy","Intrafascial Interscalene Brachial Plexus Block",[281],{"intervention":243,"totalTrials":1480,"cells":9681},{"EARLY_PHASE1":9682,"PHASE1":9684,"PHASE2":9686,"PHASE3":9688,"PHASE4":9690,"NA":9704},{"trials":9683,"activeCount":100},[],{"trials":9685,"activeCount":100},[],{"trials":9687,"activeCount":100},[],{"trials":9689,"activeCount":100},[],{"trials":9691,"activeCount":100},[9692,9696,9700],{"nctId":6375,"briefTitle":6376,"status":106,"phases":9693,"primaryCompletion":6378,"completion":6378,"start":4651,"enrollment":171,"conditions":9694,"interventions":9695},[92],[4653],[6362,243],{"nctId":6867,"briefTitle":6868,"status":106,"phases":9697,"primaryCompletion":6870,"completion":6870,"start":1361,"enrollment":171,"conditions":9698,"interventions":9699},[92],[6872,6873],[243,6854],{"nctId":235,"briefTitle":236,"status":106,"phases":9701,"primaryCompletion":238,"completion":238,"start":239,"enrollment":171,"conditions":9702,"interventions":9703},[92],[241,242,15,243,244],[246,15,243],{"trials":9705,"activeCount":100},[9706,9710,9720,9724,9728],{"nctId":4109,"briefTitle":4110,"status":106,"phases":9707,"primaryCompletion":4112,"completion":4112,"start":4113,"enrollment":4114,"conditions":9708,"interventions":9709},[93],[18,4116],[52,243,1030,62],{"nctId":9711,"briefTitle":9712,"status":106,"phases":9713,"primaryCompletion":9714,"completion":9714,"start":9715,"enrollment":1110,"conditions":9716,"interventions":9718},"NCT04518618","Effect of Intrathecal Naloxone in the Incidence of Pruritis After C.S",[93],"2021-03-07","2020-09-11",[9717],"Pruritis",[243,9719],"Naloxone",{"nctId":397,"briefTitle":398,"status":106,"phases":9721,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":9722,"interventions":9723},[93],[404,405,243,15,406,407,408,409,410],[243,15],{"nctId":4647,"briefTitle":4648,"status":106,"phases":9725,"primaryCompletion":4650,"completion":4650,"start":4651,"enrollment":197,"conditions":9726,"interventions":9727},[93],[4653],[4632,243],{"nctId":4143,"briefTitle":4144,"status":123,"phases":9729,"primaryCompletion":4146,"completion":4146,"start":4147,"enrollment":4148,"conditions":9730,"interventions":9731},[93],[4150,4151],[243,52,1030,62,4153],{"intervention":4396,"totalTrials":111,"cells":9733},{"EARLY_PHASE1":9734,"PHASE1":9736,"PHASE2":9738,"PHASE3":9740,"PHASE4":9742,"NA":9748},{"trials":9735,"activeCount":100},[],{"trials":9737,"activeCount":100},[],{"trials":9739,"activeCount":100},[],{"trials":9741,"activeCount":100},[],{"trials":9743,"activeCount":100},[9744],{"nctId":4571,"briefTitle":4572,"status":123,"phases":9745,"primaryCompletion":4574,"completion":4575,"start":4576,"enrollment":274,"conditions":9746,"interventions":9747},[92],[15,4578,4286,4579],[4581,4558,4582],{"trials":9749,"activeCount":100},[9750,9759,9763],{"nctId":9751,"briefTitle":9752,"status":106,"phases":9753,"primaryCompletion":1067,"completion":1067,"start":273,"enrollment":438,"conditions":9754,"interventions":9756},"NCT06862518","Ultrasound Guided Serratus Anterior Plane Block Versus Thoracic Erector Spinae Plane Block for Post Operative Analgesia in Pediatrics Undergoing Thoracotomy",[93],[30,4416,4390,9755,211,509],"Post Operative Analgesia",[4396,9757,9758],"Serratus Anterior Plane Block (SAPB) group","Erector Spinae Plane Block (ESPB) group",{"nctId":4386,"briefTitle":4387,"status":106,"phases":9760,"primaryCompletion":368,"completion":368,"start":1409,"enrollment":171,"conditions":9761,"interventions":9762},[93],[1381,30,4390,4391,4392],[4394,4395,4396],{"nctId":9764,"briefTitle":9765,"status":123,"phases":9766,"primaryCompletion":9767,"completion":9767,"start":9768,"enrollment":274,"conditions":9769,"interventions":9770},"NCT05525819","Intrathecal Versus Intravenous Dexmedetomidine in Prostate Transurethral Resection",[93],"2023-04-29","2022-09-01",[15,4578,18],[4396,9771,9772],"Intrathecal group","Intravenous group",{"intervention":209,"totalTrials":513,"cells":9774},{"EARLY_PHASE1":9775,"PHASE1":9781,"PHASE2":9783,"PHASE3":9785,"PHASE4":9787,"NA":9793},{"trials":9776,"activeCount":100},[9777],{"nctId":9446,"briefTitle":9447,"status":106,"phases":9778,"primaryCompletion":9449,"completion":1953,"start":9450,"enrollment":289,"conditions":9779,"interventions":9780},[88],[18,9452,281,209],[9441,9454],{"trials":9782,"activeCount":100},[],{"trials":9784,"activeCount":100},[],{"trials":9786,"activeCount":100},[],{"trials":9788,"activeCount":100},[9789],{"nctId":203,"briefTitle":204,"status":106,"phases":9790,"primaryCompletion":206,"completion":206,"start":207,"enrollment":197,"conditions":9791,"interventions":9792},[92],[15,209,210,211],[15,209],{"trials":9794,"activeCount":100},[9795],{"nctId":9796,"briefTitle":9797,"status":123,"phases":9798,"primaryCompletion":9799,"completion":7891,"start":9800,"enrollment":391,"conditions":9801,"interventions":9805},"NCT05476003","Bilateral Ultrasound Guided Superficial Cervical Plexus Block After Thyroid Surgery",[93],"2023-08-15","2022-08-15",[9802,9803,9804],"Bilateral Ultrasound Guided Superficial Cervical Plexus Block","Thyroid Surgery","Enhanced Recovery",[209],{"intervention":1030,"totalTrials":513,"cells":9807},{"EARLY_PHASE1":9808,"PHASE1":9810,"PHASE2":9812,"PHASE3":9814,"PHASE4":9816,"NA":9818},{"trials":9809,"activeCount":100},[],{"trials":9811,"activeCount":100},[],{"trials":9813,"activeCount":100},[],{"trials":9815,"activeCount":100},[],{"trials":9817,"activeCount":100},[],{"trials":9819,"activeCount":100},[9820,9824,9828],{"nctId":1021,"briefTitle":1022,"status":106,"phases":9821,"primaryCompletion":1024,"completion":1024,"start":1025,"enrollment":1026,"conditions":9822,"interventions":9823},[93],[1028,1029,1030],[431,1030],{"nctId":4109,"briefTitle":4110,"status":106,"phases":9825,"primaryCompletion":4112,"completion":4112,"start":4113,"enrollment":4114,"conditions":9826,"interventions":9827},[93],[18,4116],[52,243,1030,62],{"nctId":4143,"briefTitle":4144,"status":123,"phases":9829,"primaryCompletion":4146,"completion":4146,"start":4147,"enrollment":4148,"conditions":9830,"interventions":9831},[93],[4150,4151],[243,52,1030,62,4153],{"intervention":5866,"totalTrials":188,"cells":9833},{"EARLY_PHASE1":9834,"PHASE1":9836,"PHASE2":9838,"PHASE3":9840,"PHASE4":9842,"NA":9848},{"trials":9835,"activeCount":100},[],{"trials":9837,"activeCount":100},[],{"trials":9839,"activeCount":100},[],{"trials":9841,"activeCount":100},[],{"trials":9843,"activeCount":100},[9844],{"nctId":5859,"briefTitle":5860,"status":106,"phases":9845,"primaryCompletion":1704,"completion":2127,"start":1172,"enrollment":5862,"conditions":9846,"interventions":9847},[92],[5864],[5827,5866,5867,5868,5844,5869,5870,5871],{"trials":9849,"activeCount":100},[9850],{"nctId":9851,"briefTitle":9852,"status":123,"phases":9853,"primaryCompletion":9854,"completion":9854,"start":287,"enrollment":5007,"conditions":9855,"interventions":9859},"NCT02261662","Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection",[93],"2014-11",[5864,9856,9857,9858],"Lichen Planus","Vasculitis","Autoimmune Diseases",[5866,9860],"Betamethasone",{"intervention":9862,"totalTrials":188,"cells":9863},"Carvedilol",{"EARLY_PHASE1":9864,"PHASE1":9872,"PHASE2":9874,"PHASE3":9876,"PHASE4":9878,"NA":9880},{"trials":9865,"activeCount":100},[9866],{"nctId":9867,"briefTitle":9868,"status":123,"phases":9869,"primaryCompletion":2220,"completion":2221,"start":2087,"enrollment":157,"conditions":9870,"interventions":9871},"NCT06108518","Clinical Study Evaluating the Effect of Carvedilol in Patients With Active Rheumatoid Arthritis",[88],[566],[9862],{"trials":9873,"activeCount":100},[],{"trials":9875,"activeCount":100},[],{"trials":9877,"activeCount":100},[],{"trials":9879,"activeCount":100},[],{"trials":9881,"activeCount":100},[9882],{"nctId":9883,"briefTitle":9884,"status":123,"phases":9885,"primaryCompletion":8837,"completion":8837,"start":9886,"enrollment":1249,"conditions":9887,"interventions":9891},"NCT05553717","Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy",[93],"2022-10",[9888,9889,9890],"IHD","Gastro-Intestinal Disorder","Aspirin Induced Esophageal Ulcer",[9862],{"intervention":9893,"totalTrials":188,"cells":9894},"Noradrenaline",{"EARLY_PHASE1":9895,"PHASE1":9897,"PHASE2":9899,"PHASE3":9901,"PHASE4":9903,"NA":9905},{"trials":9896,"activeCount":100},[],{"trials":9898,"activeCount":100},[],{"trials":9900,"activeCount":100},[],{"trials":9902,"activeCount":100},[],{"trials":9904,"activeCount":100},[],{"trials":9906,"activeCount":100},[9907,9916],{"nctId":9908,"briefTitle":9909,"status":106,"phases":9910,"primaryCompletion":1678,"completion":1678,"start":273,"enrollment":184,"conditions":9911,"interventions":9915},"NCT07067944","Prophylactic Perioperative Infusion of Ephedrine Versus Noradrenaline in Patients Undergoing Cesarean Delivery Under Spinal Anesthesia",[93],[9912,9913,9893,9914,1755],"Perioperative Infusion","Ephedrine","Cesarean Delivery",[9913,9893],{"nctId":9917,"briefTitle":9918,"status":106,"phases":9919,"primaryCompletion":3028,"completion":9920,"start":1943,"enrollment":1886,"conditions":9921,"interventions":9922},"NCT05774054","The Impact of Early Norepinephrine Administration on Outcomes of Patients With Sepsis-induced Hypotension",[93],"2023-03-10",[1414,27,1412],[9923,9924],"Crystalloid","noradrenaline",{"intervention":1753,"totalTrials":188,"cells":9926},{"EARLY_PHASE1":9927,"PHASE1":9929,"PHASE2":9931,"PHASE3":9941,"PHASE4":9943,"NA":9945},{"trials":9928,"activeCount":100},[],{"trials":9930,"activeCount":100},[],{"trials":9932,"activeCount":100},[9933],{"nctId":9934,"briefTitle":9935,"status":123,"phases":9936,"primaryCompletion":9937,"completion":2034,"start":9938,"enrollment":184,"conditions":9939,"interventions":9940},"NCT04454307","Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients",[89,90],"2020-08","2020-07",[7492],[1753],{"trials":9942,"activeCount":100},[],{"trials":9944,"activeCount":100},[],{"trials":9946,"activeCount":100},[9947],{"nctId":1748,"briefTitle":1749,"status":106,"phases":9948,"primaryCompletion":1751,"completion":1751,"start":401,"enrollment":1618,"conditions":9949,"interventions":9950},[93],[1690,1753,32,1754,1755],[1690,1753],{"intervention":9952,"totalTrials":188,"cells":9953},"Plasma rich fibrin epidural injection by Racz catheter",{"EARLY_PHASE1":9954,"PHASE1":9956,"PHASE2":9958,"PHASE3":9960,"PHASE4":9962,"NA":9964},{"trials":9955,"activeCount":100},[],{"trials":9957,"activeCount":100},[],{"trials":9959,"activeCount":100},[],{"trials":9961,"activeCount":100},[],{"trials":9963,"activeCount":100},[],{"trials":9965,"activeCount":100},[9966,9978],{"nctId":9967,"briefTitle":9968,"status":106,"phases":9969,"primaryCompletion":5336,"completion":5336,"start":9970,"enrollment":197,"conditions":9971,"interventions":9977},"NCT06790745","Plasma Rich Fibrin Epidural Injection by Racz Catheter Versus Epidural Blood Patch in Postdural Puncture Headache",[93],"2025-01-25",[9972,9973,9974,9975,9976],"Plasma Rich Fibrin","Epidural","Racz Catheter","Epidural Blood Patch","Postdural Puncture Headache",[9952],{"nctId":9979,"briefTitle":9980,"status":106,"phases":9981,"primaryCompletion":9982,"completion":9982,"start":9970,"enrollment":197,"conditions":9983,"interventions":9984},"NCT06790758","Plasma Rich Fibrin Epidural Injection by Racz Catheter in Postdural Puncture Headache Guided Optic Nerve Sheath Diameter",[93],"2025-11-23",[9972,9973,9974,9976,4347],[9952],{"intervention":9986,"totalTrials":188,"cells":9987},"L-carnitine",{"EARLY_PHASE1":9988,"PHASE1":9990,"PHASE2":9992,"PHASE3":9994,"PHASE4":10005,"NA":10007},{"trials":9989,"activeCount":100},[],{"trials":9991,"activeCount":100},[],{"trials":9993,"activeCount":100},[],{"trials":9995,"activeCount":100},[9996],{"nctId":9997,"briefTitle":9998,"status":123,"phases":9999,"primaryCompletion":10000,"completion":10001,"start":10002,"enrollment":1510,"conditions":10003,"interventions":10004},"NCT05792527","L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis",[91],"2025-03-05","2026-03-05","2023-03-05",[566],[9986],{"trials":10006,"activeCount":100},[],{"trials":10008,"activeCount":100},[10009],{"nctId":10010,"briefTitle":10011,"status":106,"phases":10012,"primaryCompletion":10013,"completion":10013,"start":6109,"enrollment":724,"conditions":10014,"interventions":10016},"NCT03660293","Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs",[93],"2019-06-01",[10015],"Diabetes Mellitus, Type 1",[10017,10018,9986],"Atorvastatin","Captopril",{"intervention":10020,"totalTrials":188,"cells":10021},"Hyperbaric bupivacaine",{"EARLY_PHASE1":10022,"PHASE1":10024,"PHASE2":10026,"PHASE3":10028,"PHASE4":10030,"NA":10032},{"trials":10023,"activeCount":100},[],{"trials":10025,"activeCount":100},[],{"trials":10027,"activeCount":100},[],{"trials":10029,"activeCount":100},[],{"trials":10031,"activeCount":100},[],{"trials":10033,"activeCount":100},[10034,10045],{"nctId":10035,"briefTitle":10036,"status":106,"phases":10037,"primaryCompletion":1078,"completion":1078,"start":309,"enrollment":171,"conditions":10038,"interventions":10043},"NCT06600048","Spinal Anesthesia by Hyperbaric Prilocaine in Day-Case Perianal Surgery",[93],[1755,10039,10040,10041,10042],"Hyperbaric","Prilocaine","Day-Case","Perianal Surgery",[10044,10020],"Hyperbaric prilocaine",{"nctId":10046,"briefTitle":10047,"status":106,"phases":10048,"primaryCompletion":10049,"completion":10049,"start":1751,"enrollment":1886,"conditions":10050,"interventions":10053},"NCT06667024","Dexmedetomidine as an Intrathecal Adjuvant to Hyperbaric Bupivacaine for Postoperative Analgesia in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction Surgeries",[93],"2024-04-30",[15,4579,508,10051,18,10052],"Hyperbaric Bupivacaine","Arthroscopic Anterior Cruciate Ligament Reconstruction",[10020,10054],"Dexmedetomidine and Hyperbaric bupivacaine",{"intervention":10056,"totalTrials":188,"cells":10057},"Baclofen",{"EARLY_PHASE1":10058,"PHASE1":10060,"PHASE2":10062,"PHASE3":10064,"PHASE4":10075,"NA":10077},{"trials":10059,"activeCount":100},[],{"trials":10061,"activeCount":100},[],{"trials":10063,"activeCount":100},[],{"trials":10065,"activeCount":100},[10066],{"nctId":10067,"briefTitle":10068,"status":106,"phases":10069,"primaryCompletion":10070,"completion":1723,"start":10071,"enrollment":184,"conditions":10072,"interventions":10074},"NCT05516953","Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery",[90,91],"2024-12-28","2022-08-22",[113,10073,325],"Laparoscopic Sleeve Gastrectomy",[10056],{"trials":10076,"activeCount":100},[],{"trials":10078,"activeCount":100},[10079],{"nctId":10080,"briefTitle":10081,"status":123,"phases":10082,"primaryCompletion":9854,"completion":9854,"start":287,"enrollment":184,"conditions":10083,"interventions":10085},"NCT02221570","Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis",[93],[10084,1707],"Muscle Cramps",[10056],{"intervention":8816,"totalTrials":188,"cells":10087},{"EARLY_PHASE1":10088,"PHASE1":10090,"PHASE2":10092,"PHASE3":10098,"PHASE4":10100,"NA":10102},{"trials":10089,"activeCount":100},[],{"trials":10091,"activeCount":100},[],{"trials":10093,"activeCount":100},[10094],{"nctId":8809,"briefTitle":8810,"status":106,"phases":10095,"primaryCompletion":2087,"completion":1151,"start":8812,"enrollment":171,"conditions":10096,"interventions":10097},[90],[8814],[8816,8800],{"trials":10099,"activeCount":100},[],{"trials":10101,"activeCount":100},[],{"trials":10103,"activeCount":100},[10104],{"nctId":10105,"briefTitle":10106,"status":106,"phases":10107,"primaryCompletion":1822,"completion":1822,"start":4345,"enrollment":1510,"conditions":10108,"interventions":10109},"NCT07391163","Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer",[93],[3318],[10110,10111],"N-Acetyl Cysteine","Modified FOLFOX-6 regimen",{"intervention":8339,"totalTrials":188,"cells":10113},{"EARLY_PHASE1":10114,"PHASE1":10116,"PHASE2":10118,"PHASE3":10120,"PHASE4":10126,"NA":10128},{"trials":10115,"activeCount":100},[],{"trials":10117,"activeCount":100},[],{"trials":10119,"activeCount":100},[],{"trials":10121,"activeCount":100},[10122],{"nctId":8331,"briefTitle":8332,"status":106,"phases":10123,"primaryCompletion":8334,"completion":8334,"start":8335,"enrollment":8336,"conditions":10124,"interventions":10125},[90,91],[1206],[8320,8339],{"trials":10127,"activeCount":100},[],{"trials":10129,"activeCount":100},[10130],{"nctId":10131,"briefTitle":10132,"status":123,"phases":10133,"primaryCompletion":10134,"completion":10135,"start":10136,"enrollment":197,"conditions":10137,"interventions":10140},"NCT03687905","Proliferative Lupus Nephritis Treatment With Chloroquine and Hydroxychloroquine",[],"2019-03-31","2019-09-30","2018-09-18",[10138,10139],"Proliferative Nephritis","Chloroquine Retinopathy",[8339,10141],"Hydroxychloroquine",{"intervention":1099,"totalTrials":188,"cells":10143},{"EARLY_PHASE1":10144,"PHASE1":10146,"PHASE2":10148,"PHASE3":10150,"PHASE4":10152,"NA":10154},{"trials":10145,"activeCount":100},[],{"trials":10147,"activeCount":100},[],{"trials":10149,"activeCount":100},[],{"trials":10151,"activeCount":100},[],{"trials":10153,"activeCount":100},[],{"trials":10155,"activeCount":100},[10156,10160],{"nctId":1090,"briefTitle":1091,"status":106,"phases":10157,"primaryCompletion":1093,"completion":1094,"start":1095,"enrollment":289,"conditions":10158,"interventions":10159},[93],[1097],[1099,119],{"nctId":1129,"briefTitle":1130,"status":106,"phases":10161,"primaryCompletion":656,"completion":368,"start":1067,"enrollment":1132,"conditions":10162,"interventions":10163},[93],[1134],[1099,1136,1136,1136,431],{"intervention":10165,"totalTrials":188,"cells":10166},"Medical Treatment",{"EARLY_PHASE1":10167,"PHASE1":10169,"PHASE2":10171,"PHASE3":10173,"PHASE4":10175,"NA":10189},{"trials":10168,"activeCount":100},[],{"trials":10170,"activeCount":100},[],{"trials":10172,"activeCount":100},[],{"trials":10174,"activeCount":100},[],{"trials":10176,"activeCount":100},[10177],{"nctId":10178,"briefTitle":10179,"status":123,"phases":10180,"primaryCompletion":10181,"completion":10182,"start":207,"enrollment":197,"conditions":10183,"interventions":10188},"NCT04657952","Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients",[92],"2021-05-10","2021-05-20",[10184,10185,1765,10186,10187],"Sphenopalatine Ganglion Block","Adrenaline","Orthopedic","Randomized Controlled Study",[10165],{"trials":10190,"activeCount":100},[10191],{"nctId":10192,"briefTitle":10193,"status":106,"phases":10194,"primaryCompletion":10195,"completion":10195,"start":10196,"enrollment":171,"conditions":10197,"interventions":10199},"NCT04546334","Erector Spinae Plane Block in Post-herpetic Neuralgia",[93],"2021-06-19","2020-09-26",[10198],"Postherpetic Neuralgia",[10200],"Medical treatment",{"intervention":1127,"totalTrials":188,"cells":10202},{"EARLY_PHASE1":10203,"PHASE1":10205,"PHASE2":10207,"PHASE3":10209,"PHASE4":10211,"NA":10213},{"trials":10204,"activeCount":100},[],{"trials":10206,"activeCount":100},[],{"trials":10208,"activeCount":100},[],{"trials":10210,"activeCount":100},[],{"trials":10212,"activeCount":100},[],{"trials":10214,"activeCount":100},[10215,10219],{"nctId":1119,"briefTitle":1120,"status":106,"phases":10216,"primaryCompletion":1122,"completion":1122,"start":1123,"enrollment":1026,"conditions":10217,"interventions":10218},[93],[335,15,1125],[1127,947],{"nctId":10220,"briefTitle":10221,"status":106,"phases":10222,"primaryCompletion":9108,"completion":10223,"start":2000,"enrollment":1618,"conditions":10224,"interventions":10226},"NCT05705050","Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy",[93],"2023-06-19",[335,35,10225],"Ureterocopic Lithotripsy",[1127],{"intervention":258,"totalTrials":247,"cells":10228},{"EARLY_PHASE1":10229,"PHASE1":10231,"PHASE2":10233,"PHASE3":10235,"PHASE4":10237,"NA":10239},{"trials":10230,"activeCount":100},[],{"trials":10232,"activeCount":100},[],{"trials":10234,"activeCount":100},[],{"trials":10236,"activeCount":100},[],{"trials":10238,"activeCount":100},[],{"trials":10240,"activeCount":100},[10241],{"nctId":251,"briefTitle":252,"status":123,"phases":10242,"primaryCompletion":254,"completion":254,"start":255,"enrollment":171,"conditions":10243,"interventions":10244},[93],[15,163,222],[15,258,259],{"intervention":10246,"totalTrials":247,"cells":10247},"Direct Acting Antivirals",{"EARLY_PHASE1":10248,"PHASE1":10250,"PHASE2":10252,"PHASE3":10254,"PHASE4":10256,"NA":10258},{"trials":10249,"activeCount":100},[],{"trials":10251,"activeCount":100},[],{"trials":10253,"activeCount":100},[],{"trials":10255,"activeCount":100},[],{"trials":10257,"activeCount":100},[],{"trials":10259,"activeCount":100},[10260],{"nctId":10261,"briefTitle":10262,"status":123,"phases":10263,"primaryCompletion":10264,"completion":5949,"start":10265,"enrollment":1618,"conditions":10266,"interventions":10267},"NCT05372874","Treatment of Hepatitis c by Using Direct-acting Antiviral",[],"2022-07-12","2022-05-06",[5864],[10246],{"intervention":10269,"totalTrials":247,"cells":10270},"Dexmedetomidine 0.5 μg\u002Fkg",{"EARLY_PHASE1":10271,"PHASE1":10273,"PHASE2":10275,"PHASE3":10277,"PHASE4":10279,"NA":10281},{"trials":10272,"activeCount":100},[],{"trials":10274,"activeCount":100},[],{"trials":10276,"activeCount":100},[],{"trials":10278,"activeCount":100},[],{"trials":10280,"activeCount":100},[],{"trials":10282,"activeCount":100},[10283],{"nctId":10284,"briefTitle":10285,"status":106,"phases":10286,"primaryCompletion":10287,"completion":10287,"start":3267,"enrollment":1618,"conditions":10288,"interventions":10290},"NCT06363578","Different Doses of Dexmedetomidine in External Oblique Intercostal Plane Block in Splenectomy",[93],"2025-03-08",[15,372,10289],"Splenectomy",[10269,10291],"Dexmedetomidine 1 μg\u002Fkg",{"intervention":10291,"totalTrials":247,"cells":10293},{"EARLY_PHASE1":10294,"PHASE1":10296,"PHASE2":10298,"PHASE3":10300,"PHASE4":10302,"NA":10304},{"trials":10295,"activeCount":100},[],{"trials":10297,"activeCount":100},[],{"trials":10299,"activeCount":100},[],{"trials":10301,"activeCount":100},[],{"trials":10303,"activeCount":100},[],{"trials":10305,"activeCount":100},[10306],{"nctId":10284,"briefTitle":10285,"status":106,"phases":10307,"primaryCompletion":10287,"completion":10287,"start":3267,"enrollment":1618,"conditions":10308,"interventions":10309},[93],[15,372,10289],[10269,10291],{"intervention":10311,"totalTrials":247,"cells":10312},"Mesna",{"EARLY_PHASE1":10313,"PHASE1":10315,"PHASE2":10317,"PHASE3":10319,"PHASE4":10321,"NA":10323},{"trials":10314,"activeCount":100},[],{"trials":10316,"activeCount":100},[],{"trials":10318,"activeCount":100},[],{"trials":10320,"activeCount":100},[],{"trials":10322,"activeCount":100},[],{"trials":10324,"activeCount":100},[10325],{"nctId":10326,"briefTitle":10327,"status":106,"phases":10328,"primaryCompletion":10329,"completion":10329,"start":1194,"enrollment":197,"conditions":10330,"interventions":10332},"NCT05882604","MESNA Injection for TMJ Internal Derangement",[93],"2024-03-10",[10331],"TMJ Disorder",[10311,10333],"Arthrocentesis with ringer solution",{"intervention":10333,"totalTrials":247,"cells":10335},{"EARLY_PHASE1":10336,"PHASE1":10338,"PHASE2":10340,"PHASE3":10342,"PHASE4":10344,"NA":10346},{"trials":10337,"activeCount":100},[],{"trials":10339,"activeCount":100},[],{"trials":10341,"activeCount":100},[],{"trials":10343,"activeCount":100},[],{"trials":10345,"activeCount":100},[],{"trials":10347,"activeCount":100},[10348],{"nctId":10326,"briefTitle":10327,"status":106,"phases":10349,"primaryCompletion":10329,"completion":10329,"start":1194,"enrollment":197,"conditions":10350,"interventions":10351},[93],[10331],[10311,10333],{"intervention":10353,"totalTrials":247,"cells":10354},"vitamin C group",{"EARLY_PHASE1":10355,"PHASE1":10357,"PHASE2":10359,"PHASE3":10361,"PHASE4":10363,"NA":10365},{"trials":10356,"activeCount":100},[],{"trials":10358,"activeCount":100},[],{"trials":10360,"activeCount":100},[],{"trials":10362,"activeCount":100},[],{"trials":10364,"activeCount":100},[],{"trials":10366,"activeCount":100},[10367],{"nctId":10368,"briefTitle":10369,"status":106,"phases":10370,"primaryCompletion":217,"completion":10371,"start":401,"enrollment":10372,"conditions":10373,"interventions":10376},"NCT05770596","Vitamin C on Acute and Chronic Post Mastectomy Pain",[93],"2025-12-03",204,[10374,10375],"Vitamin C","Post-mastectomy Pain Syndrome",[10353],{"intervention":1004,"totalTrials":247,"cells":10378},{"EARLY_PHASE1":10379,"PHASE1":10381,"PHASE2":10383,"PHASE3":10385,"PHASE4":10387,"NA":10389},{"trials":10380,"activeCount":100},[],{"trials":10382,"activeCount":100},[],{"trials":10384,"activeCount":100},[],{"trials":10386,"activeCount":100},[],{"trials":10388,"activeCount":100},[],{"trials":10390,"activeCount":100},[10391],{"nctId":994,"briefTitle":995,"status":123,"phases":10392,"primaryCompletion":997,"completion":998,"start":999,"enrollment":1000,"conditions":10393,"interventions":10394},[93],[1002],[1004,947],{"intervention":10396,"totalTrials":247,"cells":10397},"Hyaluronic acid",{"EARLY_PHASE1":10398,"PHASE1":10400,"PHASE2":10402,"PHASE3":10404,"PHASE4":10406,"NA":10408},{"trials":10399,"activeCount":100},[],{"trials":10401,"activeCount":100},[],{"trials":10403,"activeCount":100},[],{"trials":10405,"activeCount":100},[],{"trials":10407,"activeCount":100},[],{"trials":10409,"activeCount":100},[10410],{"nctId":10411,"briefTitle":10412,"status":106,"phases":10413,"primaryCompletion":1067,"completion":1067,"start":7177,"enrollment":128,"conditions":10414,"interventions":10419},"NCT06710782","Transcutaneous Pulsed Radiofrequency Application Plus Genicular Nerve Block Versus Intraarticular Hyaluronic Acid Injection for Management of Chronic Pain in Knee Osteoarthritis.",[93],[10415,10416,10417,485,10418,6046,487],"Transcutaneous","Pulsed Radiofrequency","Genicular Nerve Block","Hyaluronic Acid",[10396],{"intervention":10421,"totalTrials":247,"cells":10422},"Topical fluconazole eye drops",{"EARLY_PHASE1":10423,"PHASE1":10425,"PHASE2":10427,"PHASE3":10429,"PHASE4":10431,"NA":10433},{"trials":10424,"activeCount":100},[],{"trials":10426,"activeCount":100},[],{"trials":10428,"activeCount":100},[],{"trials":10430,"activeCount":100},[],{"trials":10432,"activeCount":100},[],{"trials":10434,"activeCount":100},[10435],{"nctId":10436,"briefTitle":10437,"status":106,"phases":10438,"primaryCompletion":1409,"completion":1409,"start":206,"enrollment":370,"conditions":10439,"interventions":10445},"NCT07557966","Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis",[93],[10440,10441,10442,10443,1869,10444],"Safety","Efficacy","Intrastromal Injection","Fluconazole","Fungal Keratitis",[10421,10446],"Intrastromal injection of fluconazole",{"intervention":10446,"totalTrials":247,"cells":10448},{"EARLY_PHASE1":10449,"PHASE1":10451,"PHASE2":10453,"PHASE3":10455,"PHASE4":10457,"NA":10459},{"trials":10450,"activeCount":100},[],{"trials":10452,"activeCount":100},[],{"trials":10454,"activeCount":100},[],{"trials":10456,"activeCount":100},[],{"trials":10458,"activeCount":100},[],{"trials":10460,"activeCount":100},[10461],{"nctId":10436,"briefTitle":10437,"status":106,"phases":10462,"primaryCompletion":1409,"completion":1409,"start":206,"enrollment":370,"conditions":10463,"interventions":10464},[93],[10440,10441,10442,10443,1869,10444],[10421,10446],{"intervention":1015,"totalTrials":247,"cells":10466},{"EARLY_PHASE1":10467,"PHASE1":10469,"PHASE2":10471,"PHASE3":10473,"PHASE4":10475,"NA":10477},{"trials":10468,"activeCount":100},[],{"trials":10470,"activeCount":100},[],{"trials":10472,"activeCount":100},[],{"trials":10474,"activeCount":100},[],{"trials":10476,"activeCount":100},[],{"trials":10478,"activeCount":100},[10479],{"nctId":1006,"briefTitle":1007,"status":106,"phases":10480,"primaryCompletion":1009,"completion":1009,"start":1010,"enrollment":1011,"conditions":10481,"interventions":10482},[93],[1013],[1015,431],{"intervention":9757,"totalTrials":247,"cells":10484},{"EARLY_PHASE1":10485,"PHASE1":10487,"PHASE2":10489,"PHASE3":10491,"PHASE4":10493,"NA":10495},{"trials":10486,"activeCount":100},[],{"trials":10488,"activeCount":100},[],{"trials":10490,"activeCount":100},[],{"trials":10492,"activeCount":100},[],{"trials":10494,"activeCount":100},[],{"trials":10496,"activeCount":100},[10497],{"nctId":9751,"briefTitle":9752,"status":106,"phases":10498,"primaryCompletion":1067,"completion":1067,"start":273,"enrollment":438,"conditions":10499,"interventions":10500},[93],[30,4416,4390,9755,211,509],[4396,9757,9758],{"intervention":9758,"totalTrials":247,"cells":10502},{"EARLY_PHASE1":10503,"PHASE1":10505,"PHASE2":10507,"PHASE3":10509,"PHASE4":10511,"NA":10513},{"trials":10504,"activeCount":100},[],{"trials":10506,"activeCount":100},[],{"trials":10508,"activeCount":100},[],{"trials":10510,"activeCount":100},[],{"trials":10512,"activeCount":100},[],{"trials":10514,"activeCount":100},[10515],{"nctId":9751,"briefTitle":9752,"status":106,"phases":10516,"primaryCompletion":1067,"completion":1067,"start":273,"enrollment":438,"conditions":10517,"interventions":10518},[93],[30,4416,4390,9755,211,509],[4396,9757,9758],{"intervention":10520,"totalTrials":247,"cells":10521},"Hydroxyethyl Starch 130-0.4 60 MG\u002FML [Voluven]",{"EARLY_PHASE1":10522,"PHASE1":10524,"PHASE2":10526,"PHASE3":10528,"PHASE4":10530,"NA":10532},{"trials":10523,"activeCount":100},[],{"trials":10525,"activeCount":100},[],{"trials":10527,"activeCount":100},[],{"trials":10529,"activeCount":100},[],{"trials":10531,"activeCount":100},[],{"trials":10533,"activeCount":100},[10534],{"nctId":10535,"briefTitle":10536,"status":106,"phases":10537,"primaryCompletion":10538,"completion":6151,"start":3401,"enrollment":197,"conditions":10539,"interventions":10541},"NCT04465539","The Potential Therapeutic Role of Hydroxyethyl Starch and Hydrocortisone in Acute Aluminum Phosphide Poisoning",[93],"2024-02-28",[10540],"Potential Therapeutic Role",[10520,10542],"Hydrocortisone",{"intervention":10542,"totalTrials":247,"cells":10544},{"EARLY_PHASE1":10545,"PHASE1":10547,"PHASE2":10549,"PHASE3":10551,"PHASE4":10553,"NA":10555},{"trials":10546,"activeCount":100},[],{"trials":10548,"activeCount":100},[],{"trials":10550,"activeCount":100},[],{"trials":10552,"activeCount":100},[],{"trials":10554,"activeCount":100},[],{"trials":10556,"activeCount":100},[10557],{"nctId":10535,"briefTitle":10536,"status":106,"phases":10558,"primaryCompletion":10538,"completion":6151,"start":3401,"enrollment":197,"conditions":10559,"interventions":10560},[93],[10540],[10520,10542],{"intervention":10562,"totalTrials":247,"cells":10563},"Pharmacotherapy",{"EARLY_PHASE1":10564,"PHASE1":10566,"PHASE2":10568,"PHASE3":10570,"PHASE4":10572,"NA":10574},{"trials":10565,"activeCount":100},[],{"trials":10567,"activeCount":100},[],{"trials":10569,"activeCount":100},[],{"trials":10571,"activeCount":100},[],{"trials":10573,"activeCount":100},[],{"trials":10575,"activeCount":100},[10576],{"nctId":10577,"briefTitle":10578,"status":106,"phases":10579,"primaryCompletion":1378,"completion":1378,"start":3028,"enrollment":370,"conditions":10580,"interventions":10585},"NCT06840912","Electroencephalographic Biofeedback Therapy in Heroin Craving",[93],[10581,10582,10583,10584],"Electroencephalographic","Biofeedback Therapy","Heroin","Craving",[10562],{"intervention":10587,"totalTrials":247,"cells":10588},"Regional Dexamethasone",{"EARLY_PHASE1":10589,"PHASE1":10591,"PHASE2":10593,"PHASE3":10595,"PHASE4":10597,"NA":10599},{"trials":10590,"activeCount":100},[],{"trials":10592,"activeCount":100},[],{"trials":10594,"activeCount":100},[],{"trials":10596,"activeCount":100},[],{"trials":10598,"activeCount":100},[],{"trials":10600,"activeCount":100},[10601],{"nctId":10602,"briefTitle":10603,"status":106,"phases":10604,"primaryCompletion":61,"completion":61,"start":1194,"enrollment":171,"conditions":10605,"interventions":10611},"NCT07074691","Regional and Intravenous Dexamethasone in The Prophylaxis of Rebound Pain After Supraclavicular Block in Upper Limb Surgeries",[93],[10606,4286,117,10607,10608,10609,10610],"Regional","Prophylaxis","Rebound Pain","Supraclavicular Block","Upper Limb Surgeries",[10587,10612],"Intravenous Dexamethasone",{"intervention":10612,"totalTrials":247,"cells":10614},{"EARLY_PHASE1":10615,"PHASE1":10617,"PHASE2":10619,"PHASE3":10621,"PHASE4":10623,"NA":10625},{"trials":10616,"activeCount":100},[],{"trials":10618,"activeCount":100},[],{"trials":10620,"activeCount":100},[],{"trials":10622,"activeCount":100},[],{"trials":10624,"activeCount":100},[],{"trials":10626,"activeCount":100},[10627],{"nctId":10602,"briefTitle":10603,"status":106,"phases":10628,"primaryCompletion":61,"completion":61,"start":1194,"enrollment":171,"conditions":10629,"interventions":10630},[93],[10606,4286,117,10607,10608,10609,10610],[10587,10612],{"intervention":9860,"totalTrials":247,"cells":10632},{"EARLY_PHASE1":10633,"PHASE1":10635,"PHASE2":10637,"PHASE3":10639,"PHASE4":10641,"NA":10643},{"trials":10634,"activeCount":100},[],{"trials":10636,"activeCount":100},[],{"trials":10638,"activeCount":100},[],{"trials":10640,"activeCount":100},[],{"trials":10642,"activeCount":100},[],{"trials":10644,"activeCount":100},[10645],{"nctId":9851,"briefTitle":9852,"status":123,"phases":10646,"primaryCompletion":9854,"completion":9854,"start":287,"enrollment":5007,"conditions":10647,"interventions":10648},[93],[5864,9856,9857,9858],[5866,9860],{"intervention":10650,"totalTrials":247,"cells":10651},"Deferasirox",{"EARLY_PHASE1":10652,"PHASE1":10654,"PHASE2":10656,"PHASE3":10658,"PHASE4":10660,"NA":10662},{"trials":10653,"activeCount":100},[],{"trials":10655,"activeCount":100},[],{"trials":10657,"activeCount":100},[],{"trials":10659,"activeCount":100},[],{"trials":10661,"activeCount":100},[],{"trials":10663,"activeCount":100},[10664],{"nctId":10665,"briefTitle":10666,"status":123,"phases":10667,"primaryCompletion":10668,"completion":10668,"start":10669,"enrollment":197,"conditions":10670,"interventions":10672},"NCT02761395","Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major",[93],"2017-05","2015-11",[10671],"AL-Hijama in Thalassmia Major",[10650],{"intervention":10374,"totalTrials":247,"cells":10674},{"EARLY_PHASE1":10675,"PHASE1":10677,"PHASE2":10679,"PHASE3":10681,"PHASE4":10683,"NA":10685},{"trials":10676,"activeCount":100},[],{"trials":10678,"activeCount":100},[],{"trials":10680,"activeCount":100},[],{"trials":10682,"activeCount":100},[],{"trials":10684,"activeCount":100},[],{"trials":10686,"activeCount":100},[10687],{"nctId":10688,"briefTitle":10689,"status":106,"phases":10690,"primaryCompletion":7177,"completion":7177,"start":3028,"enrollment":1618,"conditions":10691,"interventions":10693},"NCT06780345","Role of Vitamin C Infusion in Postoperative Mechanically Ventilated Neonates With Sepsis",[93],[10374,407,5966,27,10692],"Neonate",[10374],{"intervention":293,"totalTrials":247,"cells":10695},{"EARLY_PHASE1":10696,"PHASE1":10698,"PHASE2":10700,"PHASE3":10702,"PHASE4":10704,"NA":10706},{"trials":10697,"activeCount":100},[],{"trials":10699,"activeCount":100},[],{"trials":10701,"activeCount":100},[],{"trials":10703,"activeCount":100},[],{"trials":10705,"activeCount":100},[],{"trials":10707,"activeCount":100},[10708],{"nctId":283,"briefTitle":284,"status":106,"phases":10709,"primaryCompletion":286,"completion":287,"start":288,"enrollment":289,"conditions":10710,"interventions":10711},[93],[291],[293,15],{"intervention":10713,"totalTrials":247,"cells":10714},"hyperbaric bupivacaine and fentanyl",{"EARLY_PHASE1":10715,"PHASE1":10717,"PHASE2":10719,"PHASE3":10721,"PHASE4":10723,"NA":10725},{"trials":10716,"activeCount":100},[],{"trials":10718,"activeCount":100},[],{"trials":10720,"activeCount":100},[],{"trials":10722,"activeCount":100},[],{"trials":10724,"activeCount":100},[],{"trials":10726,"activeCount":100},[10727],{"nctId":10728,"briefTitle":10729,"status":106,"phases":10730,"primaryCompletion":1678,"completion":1678,"start":483,"enrollment":10731,"conditions":10732,"interventions":10735},"NCT06507397","Dural Puncture Epidural Anesthesia Versus Traditional Spinal Anesthesia for Rigid Cystoscopy",[93],76,[10733,1755,10734],"Dural Puncture Epidural Anesthesia","Rigid Cystoscopy",[10713,10736],"plain bupivacaine and fentanyl",{"intervention":10736,"totalTrials":247,"cells":10738},{"EARLY_PHASE1":10739,"PHASE1":10741,"PHASE2":10743,"PHASE3":10745,"PHASE4":10747,"NA":10749},{"trials":10740,"activeCount":100},[],{"trials":10742,"activeCount":100},[],{"trials":10744,"activeCount":100},[],{"trials":10746,"activeCount":100},[],{"trials":10748,"activeCount":100},[],{"trials":10750,"activeCount":100},[10751],{"nctId":10728,"briefTitle":10729,"status":106,"phases":10752,"primaryCompletion":1678,"completion":1678,"start":483,"enrollment":10731,"conditions":10753,"interventions":10754},[93],[10733,1755,10734],[10713,10736],{"intervention":305,"totalTrials":247,"cells":10756},{"EARLY_PHASE1":10757,"PHASE1":10759,"PHASE2":10761,"PHASE3":10763,"PHASE4":10765,"NA":10767},{"trials":10758,"activeCount":100},[],{"trials":10760,"activeCount":100},[],{"trials":10762,"activeCount":100},[],{"trials":10764,"activeCount":100},[],{"trials":10766,"activeCount":100},[],{"trials":10768,"activeCount":100},[10769],{"nctId":295,"briefTitle":296,"status":123,"phases":10770,"primaryCompletion":298,"completion":299,"start":300,"enrollment":157,"conditions":10771,"interventions":10772},[93],[302,303],[305,15],{"intervention":10774,"totalTrials":247,"cells":10775},"Fentanyl and Bupivacaine",{"EARLY_PHASE1":10776,"PHASE1":10778,"PHASE2":10780,"PHASE3":10782,"PHASE4":10784,"NA":10786},{"trials":10777,"activeCount":100},[],{"trials":10779,"activeCount":100},[],{"trials":10781,"activeCount":100},[],{"trials":10783,"activeCount":100},[],{"trials":10785,"activeCount":100},[],{"trials":10787,"activeCount":100},[10788],{"nctId":10789,"briefTitle":10790,"status":106,"phases":10791,"primaryCompletion":986,"completion":986,"start":4519,"enrollment":171,"conditions":10792,"interventions":10796},"NCT06820203","Premixed, Sequential and Manually Mixed Administration of Intrathecal Fentanyl and Bupivacaine in Cesarean Section",[93],[10793,10794,10795,4579,243,281,4288],"Premixed","Sequential","Manually Mixed",[10774,10774,10774],{"intervention":10798,"totalTrials":247,"cells":10799},"Conventional lumbar steroid injections",{"EARLY_PHASE1":10800,"PHASE1":10802,"PHASE2":10804,"PHASE3":10806,"PHASE4":10808,"NA":10810},{"trials":10801,"activeCount":100},[],{"trials":10803,"activeCount":100},[],{"trials":10805,"activeCount":100},[],{"trials":10807,"activeCount":100},[],{"trials":10809,"activeCount":100},[],{"trials":10811,"activeCount":100},[10812],{"nctId":10813,"briefTitle":10814,"status":106,"phases":10815,"primaryCompletion":10816,"completion":10816,"start":309,"enrollment":197,"conditions":10817,"interventions":10822},"NCT06599723","Racz Catheter Technique Versus Conventional Technique in Lumbar Epidural Steroid Injection for Management of Low Back Pain",[93],"2025-03-06",[9974,10818,10819,9973,10820,10821],"Conventional","Lumbar","Steroid Injection","Low Back Pain",[10798],{"intervention":4106,"totalTrials":247,"cells":10824},{"EARLY_PHASE1":10825,"PHASE1":10827,"PHASE2":10829,"PHASE3":10831,"PHASE4":10833,"NA":10835},{"trials":10826,"activeCount":100},[],{"trials":10828,"activeCount":100},[],{"trials":10830,"activeCount":100},[],{"trials":10832,"activeCount":100},[],{"trials":10834,"activeCount":100},[],{"trials":10836,"activeCount":100},[10837],{"nctId":4096,"briefTitle":4097,"status":123,"phases":10838,"primaryCompletion":1194,"completion":1194,"start":1962,"enrollment":197,"conditions":10839,"interventions":10840},[93],[4100,4101,4102,32,4103],[4105,4106,4107],{"intervention":10842,"totalTrials":247,"cells":10843},"Itraconazole",{"EARLY_PHASE1":10844,"PHASE1":10846,"PHASE2":10848,"PHASE3":10850,"PHASE4":10852,"NA":10854},{"trials":10845,"activeCount":100},[],{"trials":10847,"activeCount":100},[],{"trials":10849,"activeCount":100},[],{"trials":10851,"activeCount":100},[],{"trials":10853,"activeCount":100},[],{"trials":10855,"activeCount":100},[10856],{"nctId":10857,"briefTitle":10858,"status":123,"phases":10859,"primaryCompletion":2220,"completion":2220,"start":9886,"enrollment":1249,"conditions":10860,"interventions":10862},"NCT05591560","Itraconazole in Advanced Ovarian Cancer",[93],[10861],"Ovarian Carcinoma",[10842],{"intervention":10864,"totalTrials":247,"cells":10865},"conventional sepsis therapy alone",{"EARLY_PHASE1":10866,"PHASE1":10868,"PHASE2":10870,"PHASE3":10872,"PHASE4":10874,"NA":10876},{"trials":10867,"activeCount":100},[],{"trials":10869,"activeCount":100},[],{"trials":10871,"activeCount":100},[],{"trials":10873,"activeCount":100},[],{"trials":10875,"activeCount":100},[],{"trials":10877,"activeCount":100},[10878],{"nctId":10879,"briefTitle":10880,"status":106,"phases":10881,"primaryCompletion":10882,"completion":10882,"start":451,"enrollment":1510,"conditions":10883,"interventions":10885},"NCT07074990","Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis",[93],"2024-08-30",[10884],"Sepsis at Intensive Care Unit",[10864,10886],"colchicine 500 mcg oral twice daily plus conventional sepsis therapy.",{"intervention":10886,"totalTrials":247,"cells":10888},{"EARLY_PHASE1":10889,"PHASE1":10891,"PHASE2":10893,"PHASE3":10895,"PHASE4":10897,"NA":10899},{"trials":10890,"activeCount":100},[],{"trials":10892,"activeCount":100},[],{"trials":10894,"activeCount":100},[],{"trials":10896,"activeCount":100},[],{"trials":10898,"activeCount":100},[],{"trials":10900,"activeCount":100},[10901],{"nctId":10879,"briefTitle":10880,"status":106,"phases":10902,"primaryCompletion":10882,"completion":10882,"start":451,"enrollment":1510,"conditions":10903,"interventions":10904},[93],[10884],[10864,10886],{"intervention":1386,"totalTrials":247,"cells":10906},{"EARLY_PHASE1":10907,"PHASE1":10909,"PHASE2":10911,"PHASE3":10913,"PHASE4":10915,"NA":10917},{"trials":10908,"activeCount":100},[],{"trials":10910,"activeCount":100},[],{"trials":10912,"activeCount":100},[],{"trials":10914,"activeCount":100},[],{"trials":10916,"activeCount":100},[],{"trials":10918,"activeCount":100},[10919],{"nctId":1375,"briefTitle":1376,"status":106,"phases":10920,"primaryCompletion":1378,"completion":1378,"start":1379,"enrollment":197,"conditions":10921,"interventions":10922},[93],[1381,1382,1383,24,1384],[259,1386],{"intervention":1397,"totalTrials":247,"cells":10924},{"EARLY_PHASE1":10925,"PHASE1":10927,"PHASE2":10929,"PHASE3":10931,"PHASE4":10933,"NA":10935},{"trials":10926,"activeCount":100},[],{"trials":10928,"activeCount":100},[],{"trials":10930,"activeCount":100},[],{"trials":10932,"activeCount":100},[],{"trials":10934,"activeCount":100},[],{"trials":10936,"activeCount":100},[10937],{"nctId":1388,"briefTitle":1389,"status":106,"phases":10938,"primaryCompletion":368,"completion":368,"start":1379,"enrollment":289,"conditions":10939,"interventions":10940},[93],[1392,1393,1394,1395,1072],[259,1397,1398],{"intervention":1398,"totalTrials":247,"cells":10942},{"EARLY_PHASE1":10943,"PHASE1":10945,"PHASE2":10947,"PHASE3":10949,"PHASE4":10951,"NA":10953},{"trials":10944,"activeCount":100},[],{"trials":10946,"activeCount":100},[],{"trials":10948,"activeCount":100},[],{"trials":10950,"activeCount":100},[],{"trials":10952,"activeCount":100},[],{"trials":10954,"activeCount":100},[10955],{"nctId":1388,"briefTitle":1389,"status":106,"phases":10956,"primaryCompletion":368,"completion":368,"start":1379,"enrollment":289,"conditions":10957,"interventions":10958},[93],[1392,1393,1394,1395,1072],[259,1397,1398],{"intervention":4555,"totalTrials":247,"cells":10960},{"EARLY_PHASE1":10961,"PHASE1":10963,"PHASE2":10965,"PHASE3":10967,"PHASE4":10969,"NA":10971},{"trials":10962,"activeCount":100},[],{"trials":10964,"activeCount":100},[],{"trials":10966,"activeCount":100},[],{"trials":10968,"activeCount":100},[],{"trials":10970,"activeCount":100},[],{"trials":10972,"activeCount":100},[10973],{"nctId":4547,"briefTitle":4548,"status":106,"phases":10974,"primaryCompletion":299,"completion":299,"start":4550,"enrollment":197,"conditions":10975,"interventions":10976},[93],[4552,1869,4553],[4555,4556],{"intervention":340,"totalTrials":247,"cells":10978},{"EARLY_PHASE1":10979,"PHASE1":10981,"PHASE2":10983,"PHASE3":10985,"PHASE4":10987,"NA":10989},{"trials":10980,"activeCount":100},[],{"trials":10982,"activeCount":100},[],{"trials":10984,"activeCount":100},[],{"trials":10986,"activeCount":100},[],{"trials":10988,"activeCount":100},[],{"trials":10990,"activeCount":100},[10991],{"nctId":329,"briefTitle":330,"status":123,"phases":10992,"primaryCompletion":332,"completion":332,"start":333,"enrollment":197,"conditions":10993,"interventions":10994},[93],[335,336,337,326,15,338],[340,15],{"intervention":10996,"totalTrials":247,"cells":10997},"Calcium hydroxylapatite filler",{"EARLY_PHASE1":10998,"PHASE1":11000,"PHASE2":11002,"PHASE3":11004,"PHASE4":11006,"NA":11008},{"trials":10999,"activeCount":100},[],{"trials":11001,"activeCount":100},[],{"trials":11003,"activeCount":100},[],{"trials":11005,"activeCount":100},[],{"trials":11007,"activeCount":100},[],{"trials":11009,"activeCount":100},[11010],{"nctId":11011,"briefTitle":11012,"status":106,"phases":11013,"primaryCompletion":11014,"completion":11014,"start":1235,"enrollment":36,"conditions":11015,"interventions":11020},"NCT07028567","Subcision Followed by Diluted Calcium Hydroxylapatite Injection Versus Subcision Followed by Painting CROSS TCA Technique for the Treatment of Atrophic Acne Scars",[93],"2023-06-22",[11016,11017,11018,11019],"Subcision","Calcium Hydroxylapatite","Trichloroacetic Acid","Atrophic Acne Scar",[10996,11021],"Painting chemical reconstruction of skin scars trichloroacetic acid technique",{"intervention":11021,"totalTrials":247,"cells":11023},{"EARLY_PHASE1":11024,"PHASE1":11026,"PHASE2":11028,"PHASE3":11030,"PHASE4":11032,"NA":11034},{"trials":11025,"activeCount":100},[],{"trials":11027,"activeCount":100},[],{"trials":11029,"activeCount":100},[],{"trials":11031,"activeCount":100},[],{"trials":11033,"activeCount":100},[],{"trials":11035,"activeCount":100},[11036],{"nctId":11011,"briefTitle":11012,"status":106,"phases":11037,"primaryCompletion":11014,"completion":11014,"start":1235,"enrollment":36,"conditions":11038,"interventions":11039},[93],[11016,11017,11018,11019],[10996,11021],{"intervention":1414,"totalTrials":247,"cells":11041},{"EARLY_PHASE1":11042,"PHASE1":11044,"PHASE2":11046,"PHASE3":11048,"PHASE4":11050,"NA":11052},{"trials":11043,"activeCount":100},[],{"trials":11045,"activeCount":100},[],{"trials":11047,"activeCount":100},[],{"trials":11049,"activeCount":100},[],{"trials":11051,"activeCount":100},[],{"trials":11053,"activeCount":100},[11054],{"nctId":1404,"briefTitle":1405,"status":106,"phases":11055,"primaryCompletion":1407,"completion":1408,"start":1409,"enrollment":452,"conditions":11056,"interventions":11057},[93],[1411,1412],[259,1414,1415],{"intervention":1415,"totalTrials":247,"cells":11059},{"EARLY_PHASE1":11060,"PHASE1":11062,"PHASE2":11064,"PHASE3":11066,"PHASE4":11068,"NA":11070},{"trials":11061,"activeCount":100},[],{"trials":11063,"activeCount":100},[],{"trials":11065,"activeCount":100},[],{"trials":11067,"activeCount":100},[],{"trials":11069,"activeCount":100},[],{"trials":11071,"activeCount":100},[11072],{"nctId":1404,"briefTitle":1405,"status":106,"phases":11073,"primaryCompletion":1407,"completion":1408,"start":1409,"enrollment":452,"conditions":11074,"interventions":11075},[93],[1411,1412],[259,1414,1415],{"intervention":11077,"totalTrials":247,"cells":11078},"Low dose of Norepinephrine",{"EARLY_PHASE1":11079,"PHASE1":11081,"PHASE2":11083,"PHASE3":11085,"PHASE4":11087,"NA":11089},{"trials":11080,"activeCount":100},[],{"trials":11082,"activeCount":100},[],{"trials":11084,"activeCount":100},[],{"trials":11086,"activeCount":100},[],{"trials":11088,"activeCount":100},[],{"trials":11090,"activeCount":100},[11091],{"nctId":11092,"briefTitle":11093,"status":123,"phases":11094,"primaryCompletion":332,"completion":332,"start":3429,"enrollment":1705,"conditions":11095,"interventions":11098},"NCT06311903","Norepinephrine in Preperiod of Hypotensive Resuscitation in Hemorrhagic Shock",[93],[1414,11096,11097],"Hemorrhagic Shock","Hypotensive Resuscitation",[11077,11099],"High dose of Norepinephrine",{"intervention":11099,"totalTrials":247,"cells":11101},{"EARLY_PHASE1":11102,"PHASE1":11104,"PHASE2":11106,"PHASE3":11108,"PHASE4":11110,"NA":11112},{"trials":11103,"activeCount":100},[],{"trials":11105,"activeCount":100},[],{"trials":11107,"activeCount":100},[],{"trials":11109,"activeCount":100},[],{"trials":11111,"activeCount":100},[],{"trials":11113,"activeCount":100},[11114],{"nctId":11092,"briefTitle":11093,"status":123,"phases":11115,"primaryCompletion":332,"completion":332,"start":3429,"enrollment":1705,"conditions":11116,"interventions":11117},[93],[1414,11096,11097],[11077,11099],{"intervention":9913,"totalTrials":247,"cells":11119},{"EARLY_PHASE1":11120,"PHASE1":11122,"PHASE2":11124,"PHASE3":11126,"PHASE4":11128,"NA":11130},{"trials":11121,"activeCount":100},[],{"trials":11123,"activeCount":100},[],{"trials":11125,"activeCount":100},[],{"trials":11127,"activeCount":100},[],{"trials":11129,"activeCount":100},[],{"trials":11131,"activeCount":100},[11132],{"nctId":9908,"briefTitle":9909,"status":106,"phases":11133,"primaryCompletion":1678,"completion":1678,"start":273,"enrollment":184,"conditions":11134,"interventions":11135},[93],[9912,9913,9893,9914,1755],[9913,9893],{"intervention":4350,"totalTrials":247,"cells":11137},{"EARLY_PHASE1":11138,"PHASE1":11140,"PHASE2":11142,"PHASE3":11144,"PHASE4":11146,"NA":11148},{"trials":11139,"activeCount":100},[],{"trials":11141,"activeCount":100},[],{"trials":11143,"activeCount":100},[],{"trials":11145,"activeCount":100},[],{"trials":11147,"activeCount":100},[],{"trials":11149,"activeCount":100},[11150],{"nctId":4342,"briefTitle":4343,"status":106,"phases":11151,"primaryCompletion":4345,"completion":4345,"start":3028,"enrollment":1249,"conditions":11152,"interventions":11153},[93],[358,4347,4092,4348],[358,4350],{"intervention":4614,"totalTrials":247,"cells":11155},{"EARLY_PHASE1":11156,"PHASE1":11158,"PHASE2":11160,"PHASE3":11162,"PHASE4":11164,"NA":11166},{"trials":11157,"activeCount":100},[],{"trials":11159,"activeCount":100},[],{"trials":11161,"activeCount":100},[],{"trials":11163,"activeCount":100},[],{"trials":11165,"activeCount":100},[],{"trials":11167,"activeCount":100},[11168],{"nctId":4609,"briefTitle":4610,"status":106,"phases":11169,"primaryCompletion":1517,"completion":1517,"start":4612,"enrollment":289,"conditions":11170,"interventions":11171},[93],[394,322,4614,4615,4616,4617],[4594,4614,4619],{"intervention":4619,"totalTrials":247,"cells":11173},{"EARLY_PHASE1":11174,"PHASE1":11176,"PHASE2":11178,"PHASE3":11180,"PHASE4":11182,"NA":11184},{"trials":11175,"activeCount":100},[],{"trials":11177,"activeCount":100},[],{"trials":11179,"activeCount":100},[],{"trials":11181,"activeCount":100},[],{"trials":11183,"activeCount":100},[],{"trials":11185,"activeCount":100},[11186],{"nctId":4609,"briefTitle":4610,"status":106,"phases":11187,"primaryCompletion":1517,"completion":1517,"start":4612,"enrollment":289,"conditions":11188,"interventions":11189},[93],[394,322,4614,4615,4616,4617],[4594,4614,4619],{"intervention":4395,"totalTrials":247,"cells":11191},{"EARLY_PHASE1":11192,"PHASE1":11194,"PHASE2":11196,"PHASE3":11198,"PHASE4":11200,"NA":11202},{"trials":11193,"activeCount":100},[],{"trials":11195,"activeCount":100},[],{"trials":11197,"activeCount":100},[],{"trials":11199,"activeCount":100},[],{"trials":11201,"activeCount":100},[],{"trials":11203,"activeCount":100},[11204],{"nctId":4386,"briefTitle":4387,"status":106,"phases":11205,"primaryCompletion":368,"completion":368,"start":1409,"enrollment":171,"conditions":11206,"interventions":11207},[93],[1381,30,4390,4391,4392],[4394,4395,4396],{"intervention":11209,"totalTrials":247,"cells":11210},"I.V Paracetamol.",{"EARLY_PHASE1":11211,"PHASE1":11213,"PHASE2":11215,"PHASE3":11217,"PHASE4":11219,"NA":11221},{"trials":11212,"activeCount":100},[],{"trials":11214,"activeCount":100},[],{"trials":11216,"activeCount":100},[],{"trials":11218,"activeCount":100},[],{"trials":11220,"activeCount":100},[],{"trials":11222,"activeCount":100},[11223],{"nctId":11224,"briefTitle":11225,"status":106,"phases":11226,"primaryCompletion":332,"completion":332,"start":482,"enrollment":11227,"conditions":11228,"interventions":11230},"NCT06606015","Noninvasive Hemodynamics Assessment of Preterms With Successful Medical Closure of PDA",[],43,[11229],"Patent Ductus Arteriosus in Preterm Infants",[11209],{"intervention":11232,"totalTrials":247,"cells":11233},"bupivacaine or onabotulinum toxin A injection.",{"EARLY_PHASE1":11234,"PHASE1":11236,"PHASE2":11238,"PHASE3":11240,"PHASE4":11242,"NA":11244},{"trials":11235,"activeCount":100},[],{"trials":11237,"activeCount":100},[],{"trials":11239,"activeCount":100},[],{"trials":11241,"activeCount":100},[],{"trials":11243,"activeCount":100},[],{"trials":11245,"activeCount":100},[11246],{"nctId":11247,"briefTitle":11248,"status":123,"phases":11249,"primaryCompletion":1378,"completion":1378,"start":11250,"enrollment":128,"conditions":11251,"interventions":11254},"NCT06122545","Chronic Migraine Prophylaxis: Ultrasound-Guided Greater Occipital Nerve Block Versus Medical Treatment",[93],"2022-05-01",[11252,10165,11253],"Greater Occipital Nerve Block","Chronic Migraine",[11232],{"intervention":11256,"totalTrials":247,"cells":11257},"corticosteroid, saline, and local anesthetic",{"EARLY_PHASE1":11258,"PHASE1":11260,"PHASE2":11262,"PHASE3":11264,"PHASE4":11266,"NA":11268},{"trials":11259,"activeCount":100},[],{"trials":11261,"activeCount":100},[],{"trials":11263,"activeCount":100},[],{"trials":11265,"activeCount":100},[],{"trials":11267,"activeCount":100},[],{"trials":11269,"activeCount":100},[11270],{"nctId":11271,"briefTitle":11272,"status":106,"phases":11273,"primaryCompletion":11274,"completion":11275,"start":11276,"enrollment":197,"conditions":11277,"interventions":11279},"NCT05194852","Ultrasound-guided Anterior Hydrodilatation in Shoulder Adhesive Capsulitis",[93],"2018-06-30","2018-09-28","2018-01-02",[11278],"Shoulder Capsulitis",[11256],{"intervention":11281,"totalTrials":247,"cells":11282},"Hypertonic saline 3% nebulizer",{"EARLY_PHASE1":11283,"PHASE1":11285,"PHASE2":11287,"PHASE3":11289,"PHASE4":11291,"NA":11293},{"trials":11284,"activeCount":100},[],{"trials":11286,"activeCount":100},[],{"trials":11288,"activeCount":100},[],{"trials":11290,"activeCount":100},[],{"trials":11292,"activeCount":100},[],{"trials":11294,"activeCount":100},[11295],{"nctId":11296,"briefTitle":11297,"status":123,"phases":11298,"primaryCompletion":51,"completion":51,"start":1751,"enrollment":438,"conditions":11299,"interventions":11302},"NCT06226402","Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome",[93],[321,11300,11301],"Hypertonic Saline","Acute Respiratory Distress Syndrome",[11281,11303],"Intravenous hypertonic saline 3%",{"intervention":11303,"totalTrials":247,"cells":11305},{"EARLY_PHASE1":11306,"PHASE1":11308,"PHASE2":11310,"PHASE3":11312,"PHASE4":11314,"NA":11316},{"trials":11307,"activeCount":100},[],{"trials":11309,"activeCount":100},[],{"trials":11311,"activeCount":100},[],{"trials":11313,"activeCount":100},[],{"trials":11315,"activeCount":100},[],{"trials":11317,"activeCount":100},[11318],{"nctId":11296,"briefTitle":11297,"status":123,"phases":11319,"primaryCompletion":51,"completion":51,"start":1751,"enrollment":438,"conditions":11320,"interventions":11321},[93],[321,11300,11301],[11281,11303],{"intervention":11323,"totalTrials":247,"cells":11324},"pharmaceutical treatment only",{"EARLY_PHASE1":11325,"PHASE1":11327,"PHASE2":11329,"PHASE3":11331,"PHASE4":11333,"NA":11335},{"trials":11326,"activeCount":100},[],{"trials":11328,"activeCount":100},[],{"trials":11330,"activeCount":100},[],{"trials":11332,"activeCount":100},[],{"trials":11334,"activeCount":100},[],{"trials":11336,"activeCount":100},[11337],{"nctId":11338,"briefTitle":11339,"status":106,"phases":11340,"primaryCompletion":10882,"completion":10882,"start":4174,"enrollment":8362,"conditions":11341,"interventions":11345},"NCT07618637","Results of Combined Medical and Swallowing Behavioral Readjustment Therapy in Oropharyngeal Dysphagia Management Among Parkinson's Patients",[93],[11342,11343,11344],"Oropharyngeal Dysphagia (OPD)","Parkinson","Swallowing Difficulties",[11323],{"intervention":11347,"totalTrials":247,"cells":11348},"Lumbosacral Erector Spinae Plane Block",{"EARLY_PHASE1":11349,"PHASE1":11351,"PHASE2":11353,"PHASE3":11355,"PHASE4":11357,"NA":11359},{"trials":11350,"activeCount":100},[],{"trials":11352,"activeCount":100},[],{"trials":11354,"activeCount":100},[],{"trials":11356,"activeCount":100},[],{"trials":11358,"activeCount":100},[],{"trials":11360,"activeCount":100},[11361],{"nctId":11362,"briefTitle":11363,"status":106,"phases":11364,"primaryCompletion":11365,"completion":11365,"start":1677,"enrollment":11366,"conditions":11367,"interventions":11374},"NCT06580704","Lumbosacral Erector Spinae Plane Block Versus Psoas Muscle Compartment With Sciatic Nerve Block for Anesthesia for Unilateral Lower Limb Operations in Critically Ill Patients",[93],"2025-03-26",130,[11368,21,11369,11370,1363,11371,11372,11373],"Lumbosacral","Psoas Muscle Compartment Block","Sciatic Nerve Block","Unilateral","Lower Limb","Critically Ill Patients",[11347,11375],"Psoas Muscle Compartment With Sciatic Nerve Block",{"intervention":11375,"totalTrials":247,"cells":11377},{"EARLY_PHASE1":11378,"PHASE1":11380,"PHASE2":11382,"PHASE3":11384,"PHASE4":11386,"NA":11388},{"trials":11379,"activeCount":100},[],{"trials":11381,"activeCount":100},[],{"trials":11383,"activeCount":100},[],{"trials":11385,"activeCount":100},[],{"trials":11387,"activeCount":100},[],{"trials":11389,"activeCount":100},[11390],{"nctId":11362,"briefTitle":11363,"status":106,"phases":11391,"primaryCompletion":11365,"completion":11365,"start":1677,"enrollment":11366,"conditions":11392,"interventions":11393},[93],[11368,21,11369,11370,1363,11371,11372,11373],[11347,11375],{"intervention":11395,"totalTrials":247,"cells":11396},"Spirulina",{"EARLY_PHASE1":11397,"PHASE1":11399,"PHASE2":11401,"PHASE3":11403,"PHASE4":11405,"NA":11407},{"trials":11398,"activeCount":100},[],{"trials":11400,"activeCount":100},[],{"trials":11402,"activeCount":100},[],{"trials":11404,"activeCount":100},[],{"trials":11406,"activeCount":100},[],{"trials":11408,"activeCount":100},[11409],{"nctId":11410,"briefTitle":11411,"status":106,"phases":11412,"primaryCompletion":11413,"completion":11413,"start":11414,"enrollment":370,"conditions":11415,"interventions":11417},"NCT02671695","Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia",[93],"2018-04","2015-04",[11416],"Beta Thalassemia Major",[11395,11418],"Amlodipine",{"intervention":11418,"totalTrials":247,"cells":11420},{"EARLY_PHASE1":11421,"PHASE1":11423,"PHASE2":11425,"PHASE3":11427,"PHASE4":11429,"NA":11431},{"trials":11422,"activeCount":100},[],{"trials":11424,"activeCount":100},[],{"trials":11426,"activeCount":100},[],{"trials":11428,"activeCount":100},[],{"trials":11430,"activeCount":100},[],{"trials":11432,"activeCount":100},[11433],{"nctId":11410,"briefTitle":11411,"status":106,"phases":11434,"primaryCompletion":11413,"completion":11413,"start":11414,"enrollment":370,"conditions":11435,"interventions":11436},[93],[11416],[11395,11418],{"intervention":11438,"totalTrials":247,"cells":11439},"antimicrobial agent",{"EARLY_PHASE1":11440,"PHASE1":11442,"PHASE2":11444,"PHASE3":11446,"PHASE4":11448,"NA":11450},{"trials":11441,"activeCount":100},[],{"trials":11443,"activeCount":100},[],{"trials":11445,"activeCount":100},[],{"trials":11447,"activeCount":100},[],{"trials":11449,"activeCount":100},[],{"trials":11451,"activeCount":100},[11452],{"nctId":11453,"briefTitle":11454,"status":106,"phases":11455,"primaryCompletion":4120,"completion":140,"start":4146,"enrollment":11456,"conditions":11457,"interventions":11459},"NCT06921577","Clinical and Microbial Study of Reinforced 3D Printed Maxillary Denture Base Resin",[93],24,[11458],"Denture Stomatitis",[11438],{"intervention":11461,"totalTrials":247,"cells":11462},"Mild therapeutic hypothermia",{"EARLY_PHASE1":11463,"PHASE1":11465,"PHASE2":11467,"PHASE3":11469,"PHASE4":11471,"NA":11473},{"trials":11464,"activeCount":100},[],{"trials":11466,"activeCount":100},[],{"trials":11468,"activeCount":100},[],{"trials":11470,"activeCount":100},[],{"trials":11472,"activeCount":100},[],{"trials":11474,"activeCount":100},[11475],{"nctId":11476,"briefTitle":11477,"status":106,"phases":11478,"primaryCompletion":483,"completion":483,"start":9501,"enrollment":197,"conditions":11479,"interventions":11484},"NCT06947616","Effect of Mild Therapeutic Hypothermia on the Doses of Vasopressors and Inotropes in Cardiogenic Shock Complicating Acute Myocardial Infarction",[93],[11480,11481,1804,11482,11483],"Mild Therapeutic Hypothermia","Cardiogenic Shock","Vasopressors","Inotropes",[11461],{"intervention":11486,"totalTrials":247,"cells":11487},"Postoperative pain management",{"EARLY_PHASE1":11488,"PHASE1":11490,"PHASE2":11492,"PHASE3":11494,"PHASE4":11496,"NA":11498},{"trials":11489,"activeCount":100},[],{"trials":11491,"activeCount":100},[],{"trials":11493,"activeCount":100},[],{"trials":11495,"activeCount":100},[],{"trials":11497,"activeCount":100},[],{"trials":11499,"activeCount":100},[11500],{"nctId":11501,"briefTitle":11502,"status":123,"phases":11503,"primaryCompletion":3201,"completion":3201,"start":11504,"enrollment":274,"conditions":11505,"interventions":11507},"NCT05142176","Bilateral Erector Spinae Plane Block for Management of Acute Postoperative Pain After Pediatric Cardiac Surgeries Through a Midline Sternotomy",[93],"2022-02-05",[11506],"Cardiac Surgery",[11486],{"intervention":4194,"totalTrials":247,"cells":11509},{"EARLY_PHASE1":11510,"PHASE1":11512,"PHASE2":11514,"PHASE3":11516,"PHASE4":11518,"NA":11520},{"trials":11511,"activeCount":100},[],{"trials":11513,"activeCount":100},[],{"trials":11515,"activeCount":100},[],{"trials":11517,"activeCount":100},[],{"trials":11519,"activeCount":100},[],{"trials":11521,"activeCount":100},[11522],{"nctId":4190,"briefTitle":4191,"status":106,"phases":11523,"primaryCompletion":723,"completion":723,"start":1109,"enrollment":157,"conditions":11524,"interventions":11525},[93],[4194,4195,4196,4197],[4194,201],{"intervention":11527,"totalTrials":247,"cells":11528},"Lidocaine 5% patch with Dexmedetomidine Bupivacaine",{"EARLY_PHASE1":11529,"PHASE1":11531,"PHASE2":11533,"PHASE3":11535,"PHASE4":11537,"NA":11539},{"trials":11530,"activeCount":100},[],{"trials":11532,"activeCount":100},[],{"trials":11534,"activeCount":100},[],{"trials":11536,"activeCount":100},[],{"trials":11538,"activeCount":100},[],{"trials":11540,"activeCount":100},[11541],{"nctId":11542,"briefTitle":11543,"status":106,"phases":11544,"primaryCompletion":11545,"completion":11546,"start":11547,"enrollment":370,"conditions":11548,"interventions":11552},"NCT04322760","Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery",[93],"2017-11-30","2017-12-01","2016-12-01",[15,11549,11550,11551],"Lidocaine 5% Patch","Arthroscopic Knee Surgery","Intra-articular",[11527,11553],"Dexmedetomidine Bupivacaine",{"intervention":11553,"totalTrials":247,"cells":11555},{"EARLY_PHASE1":11556,"PHASE1":11558,"PHASE2":11560,"PHASE3":11562,"PHASE4":11564,"NA":11566},{"trials":11557,"activeCount":100},[],{"trials":11559,"activeCount":100},[],{"trials":11561,"activeCount":100},[],{"trials":11563,"activeCount":100},[],{"trials":11565,"activeCount":100},[],{"trials":11567,"activeCount":100},[11568],{"nctId":11542,"briefTitle":11543,"status":106,"phases":11569,"primaryCompletion":11545,"completion":11546,"start":11547,"enrollment":370,"conditions":11570,"interventions":11571},[93],[15,11549,11550,11551],[11527,11553],{"intervention":1061,"totalTrials":247,"cells":11573},{"EARLY_PHASE1":11574,"PHASE1":11576,"PHASE2":11578,"PHASE3":11580,"PHASE4":11582,"NA":11584},{"trials":11575,"activeCount":100},[],{"trials":11577,"activeCount":100},[],{"trials":11579,"activeCount":100},[],{"trials":11581,"activeCount":100},[],{"trials":11583,"activeCount":100},[],{"trials":11585,"activeCount":100},[11586],{"nctId":1054,"briefTitle":1055,"status":106,"phases":11587,"primaryCompletion":1057,"completion":1057,"start":1058,"enrollment":128,"conditions":11588,"interventions":11589},[93],[27],[1061,431],{"intervention":11591,"totalTrials":247,"cells":11592},"Continuing Ramipril",{"EARLY_PHASE1":11593,"PHASE1":11595,"PHASE2":11597,"PHASE3":11599,"PHASE4":11601,"NA":11603},{"trials":11594,"activeCount":100},[],{"trials":11596,"activeCount":100},[],{"trials":11598,"activeCount":100},[],{"trials":11600,"activeCount":100},[],{"trials":11602,"activeCount":100},[],{"trials":11604,"activeCount":100},[11605],{"nctId":11606,"briefTitle":11607,"status":106,"phases":11608,"primaryCompletion":1066,"completion":1066,"start":345,"enrollment":590,"conditions":11609,"interventions":11612},"NCT07184918","Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography",[93],[11610,11611,6913],"Contrast-Induced Nephropathy","Coronary Angiography",[11591,11613],"Withholding Ramipril",{"intervention":11613,"totalTrials":247,"cells":11615},{"EARLY_PHASE1":11616,"PHASE1":11618,"PHASE2":11620,"PHASE3":11622,"PHASE4":11624,"NA":11626},{"trials":11617,"activeCount":100},[],{"trials":11619,"activeCount":100},[],{"trials":11621,"activeCount":100},[],{"trials":11623,"activeCount":100},[],{"trials":11625,"activeCount":100},[],{"trials":11627,"activeCount":100},[11628],{"nctId":11606,"briefTitle":11607,"status":106,"phases":11629,"primaryCompletion":1066,"completion":1066,"start":345,"enrollment":590,"conditions":11630,"interventions":11631},[93],[11610,11611,6913],[11591,11613],{"intervention":11633,"totalTrials":247,"cells":11634},"Spinal anesthesia and ultrasound-guided Genicular nerves block",{"EARLY_PHASE1":11635,"PHASE1":11637,"PHASE2":11639,"PHASE3":11641,"PHASE4":11643,"NA":11645},{"trials":11636,"activeCount":100},[],{"trials":11638,"activeCount":100},[],{"trials":11640,"activeCount":100},[],{"trials":11642,"activeCount":100},[],{"trials":11644,"activeCount":100},[],{"trials":11646,"activeCount":100},[11647],{"nctId":11648,"briefTitle":11649,"status":123,"phases":11650,"primaryCompletion":3036,"completion":11651,"start":11652,"enrollment":438,"conditions":11653,"interventions":11655},"NCT05269095","Adductor Canal Block Combined With IPACK vs Genicular Nerves Block in Knee Arthroscopy",[93],"2023-03-21","2022-03-21",[9677,11654],"Genicular Nerves Block",[11633,11656],"Ultrasound-guided Adductor Canal block",{"intervention":11656,"totalTrials":247,"cells":11658},{"EARLY_PHASE1":11659,"PHASE1":11661,"PHASE2":11663,"PHASE3":11665,"PHASE4":11667,"NA":11669},{"trials":11660,"activeCount":100},[],{"trials":11662,"activeCount":100},[],{"trials":11664,"activeCount":100},[],{"trials":11666,"activeCount":100},[],{"trials":11668,"activeCount":100},[],{"trials":11670,"activeCount":100},[11671],{"nctId":11648,"briefTitle":11649,"status":123,"phases":11672,"primaryCompletion":3036,"completion":11651,"start":11652,"enrollment":438,"conditions":11673,"interventions":11674},[93],[9677,11654],[11633,11656],{"intervention":11676,"totalTrials":247,"cells":11677},"Lidocaine 2% then bupivacaine 0.5%",{"EARLY_PHASE1":11678,"PHASE1":11680,"PHASE2":11682,"PHASE3":11684,"PHASE4":11686,"NA":11688},{"trials":11679,"activeCount":100},[],{"trials":11681,"activeCount":100},[],{"trials":11683,"activeCount":100},[],{"trials":11685,"activeCount":100},[],{"trials":11687,"activeCount":100},[],{"trials":11689,"activeCount":100},[11690],{"nctId":11691,"briefTitle":11692,"status":106,"phases":11693,"primaryCompletion":11694,"completion":11694,"start":11695,"enrollment":184,"conditions":11696,"interventions":11699},"NCT06570096","Premixed vs Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation",[93],"2025-03-16","2024-08-24",[10793,10794,358,281,11697,11698],"Supraclavicular Brachial Plexus Block","Arteriovenous Fistula",[11676,11700],"Lidocaine 2% and bupivacaine 0.5%",{"intervention":11700,"totalTrials":247,"cells":11702},{"EARLY_PHASE1":11703,"PHASE1":11705,"PHASE2":11707,"PHASE3":11709,"PHASE4":11711,"NA":11713},{"trials":11704,"activeCount":100},[],{"trials":11706,"activeCount":100},[],{"trials":11708,"activeCount":100},[],{"trials":11710,"activeCount":100},[],{"trials":11712,"activeCount":100},[],{"trials":11714,"activeCount":100},[11715],{"nctId":11691,"briefTitle":11692,"status":106,"phases":11716,"primaryCompletion":11694,"completion":11694,"start":11695,"enrollment":184,"conditions":11717,"interventions":11718},[93],[10793,10794,358,281,11697,11698],[11676,11700],{"intervention":3079,"totalTrials":247,"cells":11720},{"EARLY_PHASE1":11721,"PHASE1":11723,"PHASE2":11725,"PHASE3":11727,"PHASE4":11729,"NA":11731},{"trials":11722,"activeCount":100},[],{"trials":11724,"activeCount":100},[],{"trials":11726,"activeCount":100},[],{"trials":11728,"activeCount":100},[],{"trials":11730,"activeCount":100},[],{"trials":11732,"activeCount":100},[11733],{"nctId":3072,"briefTitle":3073,"status":106,"phases":11734,"primaryCompletion":1378,"completion":1378,"start":206,"enrollment":157,"conditions":11735,"interventions":11736},[],[3076,3077,1237],[3009,3079,3080],{"intervention":3080,"totalTrials":247,"cells":11738},{"EARLY_PHASE1":11739,"PHASE1":11741,"PHASE2":11743,"PHASE3":11745,"PHASE4":11747,"NA":11749},{"trials":11740,"activeCount":100},[],{"trials":11742,"activeCount":100},[],{"trials":11744,"activeCount":100},[],{"trials":11746,"activeCount":100},[],{"trials":11748,"activeCount":100},[],{"trials":11750,"activeCount":100},[11751],{"nctId":3072,"briefTitle":3073,"status":106,"phases":11752,"primaryCompletion":1378,"completion":1378,"start":206,"enrollment":157,"conditions":11753,"interventions":11754},[],[3076,3077,1237],[3009,3079,3080],{"intervention":10017,"totalTrials":247,"cells":11756},{"EARLY_PHASE1":11757,"PHASE1":11759,"PHASE2":11761,"PHASE3":11763,"PHASE4":11765,"NA":11767},{"trials":11758,"activeCount":100},[],{"trials":11760,"activeCount":100},[],{"trials":11762,"activeCount":100},[],{"trials":11764,"activeCount":100},[],{"trials":11766,"activeCount":100},[],{"trials":11768,"activeCount":100},[11769],{"nctId":10010,"briefTitle":10011,"status":106,"phases":11770,"primaryCompletion":10013,"completion":10013,"start":6109,"enrollment":724,"conditions":11771,"interventions":11772},[93],[10015],[10017,10018,9986],{"intervention":10018,"totalTrials":247,"cells":11774},{"EARLY_PHASE1":11775,"PHASE1":11777,"PHASE2":11779,"PHASE3":11781,"PHASE4":11783,"NA":11785},{"trials":11776,"activeCount":100},[],{"trials":11778,"activeCount":100},[],{"trials":11780,"activeCount":100},[],{"trials":11782,"activeCount":100},[],{"trials":11784,"activeCount":100},[],{"trials":11786,"activeCount":100},[11787],{"nctId":10010,"briefTitle":10011,"status":106,"phases":11788,"primaryCompletion":10013,"completion":10013,"start":6109,"enrollment":724,"conditions":11789,"interventions":11790},[93],[10015],[10017,10018,9986],{"intervention":11792,"totalTrials":247,"cells":11793},"Dexmedetomedine",{"EARLY_PHASE1":11794,"PHASE1":11796,"PHASE2":11798,"PHASE3":11800,"PHASE4":11802,"NA":11804},{"trials":11795,"activeCount":100},[],{"trials":11797,"activeCount":100},[],{"trials":11799,"activeCount":100},[],{"trials":11801,"activeCount":100},[],{"trials":11803,"activeCount":100},[],{"trials":11805,"activeCount":100},[11806],{"nctId":11807,"briefTitle":11808,"status":123,"phases":11809,"primaryCompletion":11810,"completion":11810,"start":3036,"enrollment":197,"conditions":11811,"interventions":11814},"NCT05786833","Dexmedetomidine vs Ketofol on Delirium in Children Undergoing Congenital Inguinal Hernia Repair",[93],"2023-10-20",[15,11812,222,11813],"Ketofol","Hernia",[11792,11812,11815],"isotonic saline 0.9%",{"intervention":11812,"totalTrials":247,"cells":11817},{"EARLY_PHASE1":11818,"PHASE1":11820,"PHASE2":11822,"PHASE3":11824,"PHASE4":11826,"NA":11828},{"trials":11819,"activeCount":100},[],{"trials":11821,"activeCount":100},[],{"trials":11823,"activeCount":100},[],{"trials":11825,"activeCount":100},[],{"trials":11827,"activeCount":100},[],{"trials":11829,"activeCount":100},[11830],{"nctId":11807,"briefTitle":11808,"status":123,"phases":11831,"primaryCompletion":11810,"completion":11810,"start":3036,"enrollment":197,"conditions":11832,"interventions":11833},[93],[15,11812,222,11813],[11792,11812,11815],{"intervention":11815,"totalTrials":247,"cells":11835},{"EARLY_PHASE1":11836,"PHASE1":11838,"PHASE2":11840,"PHASE3":11842,"PHASE4":11844,"NA":11846},{"trials":11837,"activeCount":100},[],{"trials":11839,"activeCount":100},[],{"trials":11841,"activeCount":100},[],{"trials":11843,"activeCount":100},[],{"trials":11845,"activeCount":100},[],{"trials":11847,"activeCount":100},[11848],{"nctId":11807,"briefTitle":11808,"status":123,"phases":11849,"primaryCompletion":11810,"completion":11810,"start":3036,"enrollment":197,"conditions":11850,"interventions":11851},[93],[15,11812,222,11813],[11792,11812,11815],{"intervention":11853,"totalTrials":247,"cells":11854},"Apitoxin",{"EARLY_PHASE1":11855,"PHASE1":11857,"PHASE2":11859,"PHASE3":11861,"PHASE4":11863,"NA":11865},{"trials":11856,"activeCount":100},[],{"trials":11858,"activeCount":100},[],{"trials":11860,"activeCount":100},[],{"trials":11862,"activeCount":100},[],{"trials":11864,"activeCount":100},[],{"trials":11866,"activeCount":100},[11867],{"nctId":11868,"briefTitle":11869,"status":106,"phases":11870,"primaryCompletion":11871,"completion":11871,"start":10049,"enrollment":197,"conditions":11872,"interventions":11876},"NCT07135609","Apitoxin Versus Soft Laser for Management of Aphthous Ulceration.",[93],"2025-02-02",[11853,11873,11874,11875],"Bee Venom Therapy","Management","Aphthous Ulceration",[11853],{"intervention":9719,"totalTrials":247,"cells":11878},{"EARLY_PHASE1":11879,"PHASE1":11881,"PHASE2":11883,"PHASE3":11885,"PHASE4":11887,"NA":11889},{"trials":11880,"activeCount":100},[],{"trials":11882,"activeCount":100},[],{"trials":11884,"activeCount":100},[],{"trials":11886,"activeCount":100},[],{"trials":11888,"activeCount":100},[],{"trials":11890,"activeCount":100},[11891],{"nctId":9711,"briefTitle":9712,"status":106,"phases":11892,"primaryCompletion":9714,"completion":9714,"start":9715,"enrollment":1110,"conditions":11893,"interventions":11894},[93],[9717],[243,9719],{"intervention":11896,"totalTrials":247,"cells":11897},"Magnesium",{"EARLY_PHASE1":11898,"PHASE1":11900,"PHASE2":11902,"PHASE3":11904,"PHASE4":11906,"NA":11908},{"trials":11899,"activeCount":100},[],{"trials":11901,"activeCount":100},[],{"trials":11903,"activeCount":100},[],{"trials":11905,"activeCount":100},[],{"trials":11907,"activeCount":100},[],{"trials":11909,"activeCount":100},[11910],{"nctId":11911,"briefTitle":11912,"status":106,"phases":11913,"primaryCompletion":1349,"completion":1349,"start":11914,"enrollment":289,"conditions":11915,"interventions":11916},"NCT07082894","Effect of Preoperative Oral Magnesium on Emergence Agitation",[93],"2025-07-25",[11896,466,1114],[11896],{"intervention":9771,"totalTrials":247,"cells":11918},{"EARLY_PHASE1":11919,"PHASE1":11921,"PHASE2":11923,"PHASE3":11925,"PHASE4":11927,"NA":11929},{"trials":11920,"activeCount":100},[],{"trials":11922,"activeCount":100},[],{"trials":11924,"activeCount":100},[],{"trials":11926,"activeCount":100},[],{"trials":11928,"activeCount":100},[],{"trials":11930,"activeCount":100},[11931],{"nctId":9764,"briefTitle":9765,"status":123,"phases":11932,"primaryCompletion":9767,"completion":9767,"start":9768,"enrollment":274,"conditions":11933,"interventions":11934},[93],[15,4578,18],[4396,9771,9772],{"intervention":9772,"totalTrials":247,"cells":11936},{"EARLY_PHASE1":11937,"PHASE1":11939,"PHASE2":11941,"PHASE3":11943,"PHASE4":11945,"NA":11947},{"trials":11938,"activeCount":100},[],{"trials":11940,"activeCount":100},[],{"trials":11942,"activeCount":100},[],{"trials":11944,"activeCount":100},[],{"trials":11946,"activeCount":100},[],{"trials":11948,"activeCount":100},[11949],{"nctId":9764,"briefTitle":9765,"status":123,"phases":11950,"primaryCompletion":9767,"completion":9767,"start":9768,"enrollment":274,"conditions":11951,"interventions":11952},[93],[15,4578,18],[4396,9771,9772],{"intervention":11954,"totalTrials":247,"cells":11955},"Lactium",{"EARLY_PHASE1":11956,"PHASE1":11958,"PHASE2":11960,"PHASE3":11962,"PHASE4":11964,"NA":11966},{"trials":11957,"activeCount":100},[],{"trials":11959,"activeCount":100},[],{"trials":11961,"activeCount":100},[],{"trials":11963,"activeCount":100},[],{"trials":11965,"activeCount":100},[],{"trials":11967,"activeCount":100},[11968],{"nctId":11969,"briefTitle":11970,"status":106,"phases":11971,"primaryCompletion":11972,"completion":11972,"start":11973,"enrollment":452,"conditions":11974,"interventions":11975},"NCT07172594","Preemptive Oral Lactium to Prevent Emergence Agitation",[93],"2026-01-08","2025-09-22",[11954,466,1114],[11954],{"intervention":11977,"totalTrials":247,"cells":11978},"ultrashort GnRHa",{"EARLY_PHASE1":11979,"PHASE1":11981,"PHASE2":11983,"PHASE3":11985,"PHASE4":11987,"NA":11989},{"trials":11980,"activeCount":100},[],{"trials":11982,"activeCount":100},[],{"trials":11984,"activeCount":100},[],{"trials":11986,"activeCount":100},[],{"trials":11988,"activeCount":100},[],{"trials":11990,"activeCount":100},[11991],{"nctId":11992,"briefTitle":11993,"status":106,"phases":11994,"primaryCompletion":3429,"completion":3429,"start":11995,"enrollment":5007,"conditions":11996,"interventions":12001},"NCT05567731","Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve",[93],"2022-10-15",[11997,11998,11999,12000],"Intracytoplasmic Sperm Injection","GnRH Agonist","Infertility","Ovarian Reserve",[11977,12002,12003],"short GnRHa","long GnRHa",{"intervention":12002,"totalTrials":247,"cells":12005},{"EARLY_PHASE1":12006,"PHASE1":12008,"PHASE2":12010,"PHASE3":12012,"PHASE4":12014,"NA":12016},{"trials":12007,"activeCount":100},[],{"trials":12009,"activeCount":100},[],{"trials":12011,"activeCount":100},[],{"trials":12013,"activeCount":100},[],{"trials":12015,"activeCount":100},[],{"trials":12017,"activeCount":100},[12018],{"nctId":11992,"briefTitle":11993,"status":106,"phases":12019,"primaryCompletion":3429,"completion":3429,"start":11995,"enrollment":5007,"conditions":12020,"interventions":12021},[93],[11997,11998,11999,12000],[11977,12002,12003],{"intervention":12003,"totalTrials":247,"cells":12023},{"EARLY_PHASE1":12024,"PHASE1":12026,"PHASE2":12028,"PHASE3":12030,"PHASE4":12032,"NA":12034},{"trials":12025,"activeCount":100},[],{"trials":12027,"activeCount":100},[],{"trials":12029,"activeCount":100},[],{"trials":12031,"activeCount":100},[],{"trials":12033,"activeCount":100},[],{"trials":12035,"activeCount":100},[12036],{"nctId":11992,"briefTitle":11993,"status":106,"phases":12037,"primaryCompletion":3429,"completion":3429,"start":11995,"enrollment":5007,"conditions":12038,"interventions":12039},[93],[11997,11998,11999,12000],[11977,12002,12003],{"intervention":12041,"totalTrials":247,"cells":12042},"Retrolaminar block group",{"EARLY_PHASE1":12043,"PHASE1":12045,"PHASE2":12047,"PHASE3":12049,"PHASE4":12051,"NA":12053},{"trials":12044,"activeCount":100},[],{"trials":12046,"activeCount":100},[],{"trials":12048,"activeCount":100},[],{"trials":12050,"activeCount":100},[],{"trials":12052,"activeCount":100},[],{"trials":12054,"activeCount":100},[12055],{"nctId":12056,"briefTitle":12057,"status":106,"phases":12058,"primaryCompletion":12059,"completion":12059,"start":4684,"enrollment":197,"conditions":12060,"interventions":12064},"NCT06088836","Ultrasound- Guided Continuous Retro Laminar Block Versus Continuous Erector Spinae Plane Block in Multiple Rib Fractures",[93],"2025-06-18",[12061,21,12062,35,12063],"Retrolaminar Block","Spirometry","Multiple Rib Fractures",[12041,12065],"Erector spinae plane block group.",{"intervention":12065,"totalTrials":247,"cells":12067},{"EARLY_PHASE1":12068,"PHASE1":12070,"PHASE2":12072,"PHASE3":12074,"PHASE4":12076,"NA":12078},{"trials":12069,"activeCount":100},[],{"trials":12071,"activeCount":100},[],{"trials":12073,"activeCount":100},[],{"trials":12075,"activeCount":100},[],{"trials":12077,"activeCount":100},[],{"trials":12079,"activeCount":100},[12080],{"nctId":12056,"briefTitle":12057,"status":106,"phases":12081,"primaryCompletion":12059,"completion":12059,"start":4684,"enrollment":197,"conditions":12082,"interventions":12083},[93],[12061,21,12062,35,12063],[12041,12065],{"intervention":384,"totalTrials":247,"cells":12085},{"EARLY_PHASE1":12086,"PHASE1":12088,"PHASE2":12090,"PHASE3":12092,"PHASE4":12094,"NA":12096},{"trials":12087,"activeCount":100},[],{"trials":12089,"activeCount":100},[],{"trials":12091,"activeCount":100},[],{"trials":12093,"activeCount":100},[],{"trials":12095,"activeCount":100},[],{"trials":12097,"activeCount":100},[12098],{"nctId":376,"briefTitle":377,"status":106,"phases":12099,"primaryCompletion":368,"completion":379,"start":380,"enrollment":171,"conditions":12100,"interventions":12101},[93],[382],[15,384],{"intervention":10044,"totalTrials":247,"cells":12103},{"EARLY_PHASE1":12104,"PHASE1":12106,"PHASE2":12108,"PHASE3":12110,"PHASE4":12112,"NA":12114},{"trials":12105,"activeCount":100},[],{"trials":12107,"activeCount":100},[],{"trials":12109,"activeCount":100},[],{"trials":12111,"activeCount":100},[],{"trials":12113,"activeCount":100},[],{"trials":12115,"activeCount":100},[12116],{"nctId":10035,"briefTitle":10036,"status":106,"phases":12117,"primaryCompletion":1078,"completion":1078,"start":309,"enrollment":171,"conditions":12118,"interventions":12119},[93],[1755,10039,10040,10041,10042],[10044,10020],{"intervention":12121,"totalTrials":247,"cells":12122},"Maintenance of general anesthesia by Sevoflurane",{"EARLY_PHASE1":12123,"PHASE1":12125,"PHASE2":12127,"PHASE3":12129,"PHASE4":12131,"NA":12133},{"trials":12124,"activeCount":100},[],{"trials":12126,"activeCount":100},[],{"trials":12128,"activeCount":100},[],{"trials":12130,"activeCount":100},[],{"trials":12132,"activeCount":100},[],{"trials":12134,"activeCount":100},[12135],{"nctId":12136,"briefTitle":12137,"status":106,"phases":12138,"primaryCompletion":12139,"completion":12139,"start":2548,"enrollment":438,"conditions":12140,"interventions":12142},"NCT05148637","General Anesthesia and Regional Cerebral Oxygenation inSpine Surgery Prone Position",[93],"2021-10-01",[12141],"Spinal Disease",[12121,12143,12144],"Maintenance of general anesthesia by Desflurane","Anesthesia was maintained by inhalational anesthesia",{"intervention":12143,"totalTrials":247,"cells":12146},{"EARLY_PHASE1":12147,"PHASE1":12149,"PHASE2":12151,"PHASE3":12153,"PHASE4":12155,"NA":12157},{"trials":12148,"activeCount":100},[],{"trials":12150,"activeCount":100},[],{"trials":12152,"activeCount":100},[],{"trials":12154,"activeCount":100},[],{"trials":12156,"activeCount":100},[],{"trials":12158,"activeCount":100},[12159],{"nctId":12136,"briefTitle":12137,"status":106,"phases":12160,"primaryCompletion":12139,"completion":12139,"start":2548,"enrollment":438,"conditions":12161,"interventions":12162},[93],[12141],[12121,12143,12144],{"intervention":12144,"totalTrials":247,"cells":12164},{"EARLY_PHASE1":12165,"PHASE1":12167,"PHASE2":12169,"PHASE3":12171,"PHASE4":12173,"NA":12175},{"trials":12166,"activeCount":100},[],{"trials":12168,"activeCount":100},[],{"trials":12170,"activeCount":100},[],{"trials":12172,"activeCount":100},[],{"trials":12174,"activeCount":100},[],{"trials":12176,"activeCount":100},[12177],{"nctId":12136,"briefTitle":12137,"status":106,"phases":12178,"primaryCompletion":12139,"completion":12139,"start":2548,"enrollment":438,"conditions":12179,"interventions":12180},[93],[12141],[12121,12143,12144],{"intervention":4689,"totalTrials":247,"cells":12182},{"EARLY_PHASE1":12183,"PHASE1":12185,"PHASE2":12187,"PHASE3":12189,"PHASE4":12191,"NA":12193},{"trials":12184,"activeCount":100},[],{"trials":12186,"activeCount":100},[],{"trials":12188,"activeCount":100},[],{"trials":12190,"activeCount":100},[],{"trials":12192,"activeCount":100},[],{"trials":12194,"activeCount":100},[12195],{"nctId":4681,"briefTitle":4682,"status":123,"phases":12196,"primaryCompletion":1378,"completion":1378,"start":4684,"enrollment":1618,"conditions":12197,"interventions":12198},[93],[321,4686,15,358,4687],[321,4689],{"intervention":9662,"totalTrials":247,"cells":12200},{"EARLY_PHASE1":12201,"PHASE1":12203,"PHASE2":12205,"PHASE3":12207,"PHASE4":12209,"NA":12211},{"trials":12202,"activeCount":100},[],{"trials":12204,"activeCount":100},[],{"trials":12206,"activeCount":100},[],{"trials":12208,"activeCount":100},[],{"trials":12210,"activeCount":100},[],{"trials":12212,"activeCount":100},[12213],{"nctId":9653,"briefTitle":9654,"status":106,"phases":12214,"primaryCompletion":9656,"completion":9657,"start":9658,"enrollment":513,"conditions":12215,"interventions":12216},[93],[114,4100,498,9660],[9662,281,9663],{"intervention":9663,"totalTrials":247,"cells":12218},{"EARLY_PHASE1":12219,"PHASE1":12221,"PHASE2":12223,"PHASE3":12225,"PHASE4":12227,"NA":12229},{"trials":12220,"activeCount":100},[],{"trials":12222,"activeCount":100},[],{"trials":12224,"activeCount":100},[],{"trials":12226,"activeCount":100},[],{"trials":12228,"activeCount":100},[],{"trials":12230,"activeCount":100},[12231],{"nctId":9653,"briefTitle":9654,"status":106,"phases":12232,"primaryCompletion":9656,"completion":9657,"start":9658,"enrollment":513,"conditions":12233,"interventions":12234},[93],[114,4100,498,9660],[9662,281,9663],{"intervention":12236,"totalTrials":247,"cells":12237},"Amniotic membrane extract eye drops",{"EARLY_PHASE1":12238,"PHASE1":12240,"PHASE2":12242,"PHASE3":12244,"PHASE4":12246,"NA":12248},{"trials":12239,"activeCount":100},[],{"trials":12241,"activeCount":100},[],{"trials":12243,"activeCount":100},[],{"trials":12245,"activeCount":100},[],{"trials":12247,"activeCount":100},[],{"trials":12249,"activeCount":100},[12250],{"nctId":12251,"briefTitle":12252,"status":106,"phases":12253,"primaryCompletion":11250,"completion":11250,"start":12254,"enrollment":370,"conditions":12255,"interventions":12258},"NCT06909149","Role of Amniotic Membrane Extract Eye Drops as an Adjunctive Therapy in Resistant Corneal Ulcers",[93],"2019-05-01",[12256,12257],"Amniotic Membrane Extract Eye Drops","Resistant Corneal Ulcers",[12236,12259],"Specific treatment",{"intervention":12259,"totalTrials":247,"cells":12261},{"EARLY_PHASE1":12262,"PHASE1":12264,"PHASE2":12266,"PHASE3":12268,"PHASE4":12270,"NA":12272},{"trials":12263,"activeCount":100},[],{"trials":12265,"activeCount":100},[],{"trials":12267,"activeCount":100},[],{"trials":12269,"activeCount":100},[],{"trials":12271,"activeCount":100},[],{"trials":12273,"activeCount":100},[12274],{"nctId":12251,"briefTitle":12252,"status":106,"phases":12275,"primaryCompletion":11250,"completion":11250,"start":12254,"enrollment":370,"conditions":12276,"interventions":12277},[93],[12256,12257],[12236,12259],{"intervention":12279,"totalTrials":247,"cells":12280},"Rectointercostal facial plane block using bupivacaine 0.25%",{"EARLY_PHASE1":12281,"PHASE1":12283,"PHASE2":12285,"PHASE3":12287,"PHASE4":12289,"NA":12291},{"trials":12282,"activeCount":100},[],{"trials":12284,"activeCount":100},[],{"trials":12286,"activeCount":100},[],{"trials":12288,"activeCount":100},[],{"trials":12290,"activeCount":100},[],{"trials":12292,"activeCount":100},[12293],{"nctId":12294,"briefTitle":12295,"status":106,"phases":12296,"primaryCompletion":2337,"completion":12297,"start":4359,"enrollment":590,"conditions":12298,"interventions":12301},"NCT06820216","Recto-intercostal Facial Plane Block in Laparoscopic Hiatus Hernia Repair",[93],"2025-08-21",[12299,5073,12300],"Rectointercostal","Hiatus Hernia",[12279],{"intervention":12303,"totalTrials":247,"cells":12304},"Oral ketamin",{"EARLY_PHASE1":12305,"PHASE1":12307,"PHASE2":12309,"PHASE3":12311,"PHASE4":12313,"NA":12315},{"trials":12306,"activeCount":100},[],{"trials":12308,"activeCount":100},[],{"trials":12310,"activeCount":100},[],{"trials":12312,"activeCount":100},[],{"trials":12314,"activeCount":100},[],{"trials":12316,"activeCount":100},[12317],{"nctId":12318,"briefTitle":12319,"status":106,"phases":12320,"primaryCompletion":12321,"completion":12321,"start":71,"enrollment":197,"conditions":12322,"interventions":12323},"NCT06879496","Comparison of Oral Dexmedetomidine, Ketamine Versus Midazolam for Premedication in Children Undergoing Injuinal Surgeries",[93],"2025-09-10",[498,1363],[12303,12324,12325],"Oral Midazolam","Oral dexmedetomidine",{"intervention":12324,"totalTrials":247,"cells":12327},{"EARLY_PHASE1":12328,"PHASE1":12330,"PHASE2":12332,"PHASE3":12334,"PHASE4":12336,"NA":12338},{"trials":12329,"activeCount":100},[],{"trials":12331,"activeCount":100},[],{"trials":12333,"activeCount":100},[],{"trials":12335,"activeCount":100},[],{"trials":12337,"activeCount":100},[],{"trials":12339,"activeCount":100},[12340],{"nctId":12318,"briefTitle":12319,"status":106,"phases":12341,"primaryCompletion":12321,"completion":12321,"start":71,"enrollment":197,"conditions":12342,"interventions":12343},[93],[498,1363],[12303,12324,12325],{"intervention":12325,"totalTrials":247,"cells":12345},{"EARLY_PHASE1":12346,"PHASE1":12348,"PHASE2":12350,"PHASE3":12352,"PHASE4":12354,"NA":12356},{"trials":12347,"activeCount":100},[],{"trials":12349,"activeCount":100},[],{"trials":12351,"activeCount":100},[],{"trials":12353,"activeCount":100},[],{"trials":12355,"activeCount":100},[],{"trials":12357,"activeCount":100},[12358],{"nctId":12318,"briefTitle":12319,"status":106,"phases":12359,"primaryCompletion":12321,"completion":12321,"start":71,"enrollment":197,"conditions":12360,"interventions":12361},[93],[498,1363],[12303,12324,12325],{"intervention":10054,"totalTrials":247,"cells":12363},{"EARLY_PHASE1":12364,"PHASE1":12366,"PHASE2":12368,"PHASE3":12370,"PHASE4":12372,"NA":12374},{"trials":12365,"activeCount":100},[],{"trials":12367,"activeCount":100},[],{"trials":12369,"activeCount":100},[],{"trials":12371,"activeCount":100},[],{"trials":12373,"activeCount":100},[],{"trials":12375,"activeCount":100},[12376],{"nctId":10046,"briefTitle":10047,"status":106,"phases":12377,"primaryCompletion":10049,"completion":10049,"start":1751,"enrollment":1886,"conditions":12378,"interventions":12379},[93],[15,4579,508,10051,18,10052],[10020,10054],{"intervention":1084,"totalTrials":247,"cells":12381},{"EARLY_PHASE1":12382,"PHASE1":12384,"PHASE2":12386,"PHASE3":12388,"PHASE4":12390,"NA":12392},{"trials":12383,"activeCount":100},[],{"trials":12385,"activeCount":100},[],{"trials":12387,"activeCount":100},[],{"trials":12389,"activeCount":100},[],{"trials":12391,"activeCount":100},[],{"trials":12393,"activeCount":100},[12394],{"nctId":1075,"briefTitle":1076,"status":106,"phases":12395,"primaryCompletion":1078,"completion":1078,"start":1079,"enrollment":128,"conditions":12396,"interventions":12397},[93],[15,1081,30,1082],[1084,431],{"intervention":12399,"totalTrials":247,"cells":12400},"Botulinum toxin injection under anatomical landmark",{"EARLY_PHASE1":12401,"PHASE1":12403,"PHASE2":12405,"PHASE3":12407,"PHASE4":12409,"NA":12411},{"trials":12402,"activeCount":100},[],{"trials":12404,"activeCount":100},[],{"trials":12406,"activeCount":100},[],{"trials":12408,"activeCount":100},[],{"trials":12410,"activeCount":100},[],{"trials":12412,"activeCount":100},[12413],{"nctId":12414,"briefTitle":12415,"status":106,"phases":12416,"primaryCompletion":3213,"completion":3213,"start":12417,"enrollment":12418,"conditions":12419,"interventions":12423},"NCT06941883","Ultrasound-Guided Versus Anatomically Guided Botulinum Toxin Injection in Spasticity in Adults in Tanta University Hospitals",[],"2023-07-16",68,[30,12420,12421,12422],"Botulinum Toxin","Spasticity","Adults",[12399,12424],"Ultrasound-guided botulinum toxin",{"intervention":12424,"totalTrials":247,"cells":12426},{"EARLY_PHASE1":12427,"PHASE1":12429,"PHASE2":12431,"PHASE3":12433,"PHASE4":12435,"NA":12437},{"trials":12428,"activeCount":100},[],{"trials":12430,"activeCount":100},[],{"trials":12432,"activeCount":100},[],{"trials":12434,"activeCount":100},[],{"trials":12436,"activeCount":100},[],{"trials":12438,"activeCount":100},[12439],{"nctId":12414,"briefTitle":12415,"status":106,"phases":12440,"primaryCompletion":3213,"completion":3213,"start":12417,"enrollment":12418,"conditions":12441,"interventions":12442},[],[30,12420,12421,12422],[12399,12424],{"intervention":10141,"totalTrials":247,"cells":12444},{"EARLY_PHASE1":12445,"PHASE1":12447,"PHASE2":12449,"PHASE3":12451,"PHASE4":12453,"NA":12455},{"trials":12446,"activeCount":100},[],{"trials":12448,"activeCount":100},[],{"trials":12450,"activeCount":100},[],{"trials":12452,"activeCount":100},[],{"trials":12454,"activeCount":100},[],{"trials":12456,"activeCount":100},[12457],{"nctId":10131,"briefTitle":10132,"status":123,"phases":12458,"primaryCompletion":10134,"completion":10135,"start":10136,"enrollment":197,"conditions":12459,"interventions":12460},[],[10138,10139],[8339,10141],{"intervention":12462,"totalTrials":247,"cells":12463},"ferric carboxymaltose , α erythropoietin, vitamin B12, oral folic acid",{"EARLY_PHASE1":12464,"PHASE1":12466,"PHASE2":12468,"PHASE3":12470,"PHASE4":12472,"NA":12474},{"trials":12465,"activeCount":100},[],{"trials":12467,"activeCount":100},[],{"trials":12469,"activeCount":100},[],{"trials":12471,"activeCount":100},[],{"trials":12473,"activeCount":100},[],{"trials":12475,"activeCount":100},[12476],{"nctId":12477,"briefTitle":12478,"status":106,"phases":12479,"primaryCompletion":6196,"completion":400,"start":1751,"enrollment":590,"conditions":12480,"interventions":12483},"NCT04343170","Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction",[93],[12481,12482,1051],"Ultra-short-term","Iron Deficiency Anemia",[12462],{"intervention":12485,"totalTrials":247,"cells":12486},"insulin infusion without basal insulin",{"EARLY_PHASE1":12487,"PHASE1":12489,"PHASE2":12491,"PHASE3":12493,"PHASE4":12495,"NA":12497},{"trials":12488,"activeCount":100},[],{"trials":12490,"activeCount":100},[],{"trials":12492,"activeCount":100},[],{"trials":12494,"activeCount":100},[],{"trials":12496,"activeCount":100},[],{"trials":12498,"activeCount":100},[12499],{"nctId":12500,"briefTitle":12501,"status":106,"phases":12502,"primaryCompletion":12503,"completion":12503,"start":8440,"enrollment":184,"conditions":12504,"interventions":12508},"NCT07423559","Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients",[93],"2024-12-30",[12505,12506,12507],"Diabetic Ketoacidosis","Insulin","Intensive Care Unit Stay",[12485,12509,12510],"insulin infusion with basal insulin","Insulin infusion with basal insulin and bolus",{"intervention":12509,"totalTrials":247,"cells":12512},{"EARLY_PHASE1":12513,"PHASE1":12515,"PHASE2":12517,"PHASE3":12519,"PHASE4":12521,"NA":12523},{"trials":12514,"activeCount":100},[],{"trials":12516,"activeCount":100},[],{"trials":12518,"activeCount":100},[],{"trials":12520,"activeCount":100},[],{"trials":12522,"activeCount":100},[],{"trials":12524,"activeCount":100},[12525],{"nctId":12500,"briefTitle":12501,"status":106,"phases":12526,"primaryCompletion":12503,"completion":12503,"start":8440,"enrollment":184,"conditions":12527,"interventions":12528},[93],[12505,12506,12507],[12485,12509,12510],{"intervention":12510,"totalTrials":247,"cells":12530},{"EARLY_PHASE1":12531,"PHASE1":12533,"PHASE2":12535,"PHASE3":12537,"PHASE4":12539,"NA":12541},{"trials":12532,"activeCount":100},[],{"trials":12534,"activeCount":100},[],{"trials":12536,"activeCount":100},[],{"trials":12538,"activeCount":100},[],{"trials":12540,"activeCount":100},[],{"trials":12542,"activeCount":100},[12543],{"nctId":12500,"briefTitle":12501,"status":106,"phases":12544,"primaryCompletion":12503,"completion":12503,"start":8440,"enrollment":184,"conditions":12545,"interventions":12546},[93],[12505,12506,12507],[12485,12509,12510],{"intervention":12548,"totalTrials":247,"cells":12549},"COVID-19 Diagnostic and Assessment Tests",{"EARLY_PHASE1":12550,"PHASE1":12552,"PHASE2":12554,"PHASE3":12556,"PHASE4":12558,"NA":12560},{"trials":12551,"activeCount":100},[],{"trials":12553,"activeCount":100},[],{"trials":12555,"activeCount":100},[],{"trials":12557,"activeCount":100},[],{"trials":12559,"activeCount":100},[],{"trials":12561,"activeCount":100},[12562],{"nctId":12563,"briefTitle":12564,"status":123,"phases":12565,"primaryCompletion":12566,"completion":12567,"start":12568,"enrollment":370,"conditions":12569,"interventions":12570},"NCT04583566","Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients",[],"2021-10-03","2022-10-03","2020-10-04",[1207],[12548],{"intervention":4136,"totalTrials":247,"cells":12572},{"EARLY_PHASE1":12573,"PHASE1":12575,"PHASE2":12577,"PHASE3":12579,"PHASE4":12581,"NA":12583},{"trials":12574,"activeCount":100},[],{"trials":12576,"activeCount":100},[],{"trials":12578,"activeCount":100},[],{"trials":12580,"activeCount":100},[],{"trials":12582,"activeCount":100},[],{"trials":12584,"activeCount":100},[12585],{"nctId":4129,"briefTitle":4130,"status":106,"phases":12586,"primaryCompletion":4132,"completion":4132,"start":368,"enrollment":197,"conditions":12587,"interventions":12588},[93],[4124,15,209,52,4134],[52,4136,4137],{"intervention":4137,"totalTrials":247,"cells":12590},{"EARLY_PHASE1":12591,"PHASE1":12593,"PHASE2":12595,"PHASE3":12597,"PHASE4":12599,"NA":12601},{"trials":12592,"activeCount":100},[],{"trials":12594,"activeCount":100},[],{"trials":12596,"activeCount":100},[],{"trials":12598,"activeCount":100},[],{"trials":12600,"activeCount":100},[],{"trials":12602,"activeCount":100},[12603],{"nctId":4129,"briefTitle":4130,"status":106,"phases":12604,"primaryCompletion":4132,"completion":4132,"start":368,"enrollment":197,"conditions":12605,"interventions":12606},[93],[4124,15,209,52,4134],[52,4136,4137],{"intervention":12608,"totalTrials":247,"cells":12609},"Anesthesia Agent",{"EARLY_PHASE1":12610,"PHASE1":12612,"PHASE2":12614,"PHASE3":12616,"PHASE4":12618,"NA":12620},{"trials":12611,"activeCount":100},[],{"trials":12613,"activeCount":100},[],{"trials":12615,"activeCount":100},[],{"trials":12617,"activeCount":100},[],{"trials":12619,"activeCount":100},[],{"trials":12621,"activeCount":100},[12622],{"nctId":12623,"briefTitle":12624,"status":123,"phases":12625,"primaryCompletion":1962,"completion":9768,"start":5992,"enrollment":4256,"conditions":12626,"interventions":12628},"NCT04275531","Neurotoxicity of Anesthesia in Middle Aged Patients",[],[12627],"Anesthesia; Adverse Effect",[12608],{"intervention":1806,"totalTrials":247,"cells":12630},{"EARLY_PHASE1":12631,"PHASE1":12633,"PHASE2":12635,"PHASE3":12637,"PHASE4":12639,"NA":12641},{"trials":12632,"activeCount":100},[],{"trials":12634,"activeCount":100},[],{"trials":12636,"activeCount":100},[],{"trials":12638,"activeCount":100},[],{"trials":12640,"activeCount":100},[],{"trials":12642,"activeCount":100},[12643],{"nctId":1796,"briefTitle":1797,"status":106,"phases":12644,"primaryCompletion":332,"completion":332,"start":401,"enrollment":128,"conditions":12645,"interventions":12646},[],[1800,1801,1802,1803,1804],[1806,1768],{"intervention":12648,"totalTrials":247,"cells":12649},"Methylprednisolone and mepacaine",{"EARLY_PHASE1":12650,"PHASE1":12652,"PHASE2":12654,"PHASE3":12656,"PHASE4":12658,"NA":12660},{"trials":12651,"activeCount":100},[],{"trials":12653,"activeCount":100},[],{"trials":12655,"activeCount":100},[],{"trials":12657,"activeCount":100},[],{"trials":12659,"activeCount":100},[],{"trials":12661,"activeCount":100},[12662],{"nctId":12663,"briefTitle":12664,"status":106,"phases":12665,"primaryCompletion":12666,"completion":12666,"start":332,"enrollment":157,"conditions":12667,"interventions":12670},"NCT06710704","Transcutaneous Pulsed Radiofrequency and Corticosteroids Injections in Management of Pain in Lateral Epicondylitis",[93],"2024-10-24",[10415,10416,12668,35,12669],"Corticosteroids Injections","Lateral Epicondylitis",[12648],{"intervention":12672,"totalTrials":247,"cells":12673},"Botulinum Toxin type a",{"EARLY_PHASE1":12674,"PHASE1":12676,"PHASE2":12678,"PHASE3":12680,"PHASE4":12682,"NA":12684},{"trials":12675,"activeCount":100},[],{"trials":12677,"activeCount":100},[],{"trials":12679,"activeCount":100},[],{"trials":12681,"activeCount":100},[],{"trials":12683,"activeCount":100},[],{"trials":12685,"activeCount":100},[12686],{"nctId":12687,"briefTitle":12688,"status":106,"phases":12689,"primaryCompletion":12690,"completion":12690,"start":12691,"enrollment":3813,"conditions":12692,"interventions":12694},"NCT07076355","Ultrasound-Guided Botulinum Toxin A Injection for TMJ Disc Displacement With Reduction",[93],"2024-12-26","2024-05-23",[12693],"Anterior Disc Displacement",[12672],{"intervention":12696,"totalTrials":247,"cells":12697},"trimetazidine hydrochloride \"metacardia\" ® 20 mg",{"EARLY_PHASE1":12698,"PHASE1":12700,"PHASE2":12702,"PHASE3":12704,"PHASE4":12706,"NA":12708},{"trials":12699,"activeCount":100},[],{"trials":12701,"activeCount":100},[],{"trials":12703,"activeCount":100},[],{"trials":12705,"activeCount":100},[],{"trials":12707,"activeCount":100},[],{"trials":12709,"activeCount":100},[12710],{"nctId":12711,"briefTitle":12712,"status":123,"phases":12713,"primaryCompletion":12714,"completion":12715,"start":12716,"enrollment":370,"conditions":12717,"interventions":12718},"NCT04702906","Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity",[93],"2021-06","2021-07","2021-02",[9410],[12696],{"intervention":12720,"totalTrials":247,"cells":12721},"Tranexamic acid + conventional therapy.",{"EARLY_PHASE1":12722,"PHASE1":12724,"PHASE2":12726,"PHASE3":12728,"PHASE4":12730,"NA":12732},{"trials":12723,"activeCount":100},[],{"trials":12725,"activeCount":100},[],{"trials":12727,"activeCount":100},[],{"trials":12729,"activeCount":100},[],{"trials":12731,"activeCount":100},[],{"trials":12733,"activeCount":100},[12734],{"nctId":12735,"briefTitle":12736,"status":106,"phases":12737,"primaryCompletion":51,"completion":51,"start":7177,"enrollment":184,"conditions":12738,"interventions":12741},"NCT07481682","Impact of Inhaled Tranexamic Acid in Pulmonary Hemorrhage in Pediatric Intensive Care Unit",[93],[12739,12740,498,1072],"Tranexamic Acid","Pulmonary Hemorrhage",[12720,12742],"Tranexamic acid",{"intervention":12742,"totalTrials":247,"cells":12744},{"EARLY_PHASE1":12745,"PHASE1":12747,"PHASE2":12749,"PHASE3":12751,"PHASE4":12753,"NA":12755},{"trials":12746,"activeCount":100},[],{"trials":12748,"activeCount":100},[],{"trials":12750,"activeCount":100},[],{"trials":12752,"activeCount":100},[],{"trials":12754,"activeCount":100},[],{"trials":12756,"activeCount":100},[12757],{"nctId":12735,"briefTitle":12736,"status":106,"phases":12758,"primaryCompletion":51,"completion":51,"start":7177,"enrollment":184,"conditions":12759,"interventions":12760},[93],[12739,12740,498,1072],[12720,12742],{"intervention":12762,"totalTrials":247,"cells":12763},"Anhydrous glucose",{"EARLY_PHASE1":12764,"PHASE1":12766,"PHASE2":12768,"PHASE3":12770,"PHASE4":12772,"NA":12774},{"trials":12765,"activeCount":100},[],{"trials":12767,"activeCount":100},[],{"trials":12769,"activeCount":100},[],{"trials":12771,"activeCount":100},[],{"trials":12773,"activeCount":100},[],{"trials":12775,"activeCount":100},[12776],{"nctId":12777,"briefTitle":12778,"status":106,"phases":12779,"primaryCompletion":12780,"completion":12780,"start":12781,"enrollment":171,"conditions":12782,"interventions":12785},"NCT06833671","Preoperative Two Hours Carbohydrate Load On Pediatric Patient Undergoing Elective Surgery",[93],"2024-10-21","2022-06-01",[1381,12783,498,12784],"Carbohydrate","Elective Surgery",[12762],{"intervention":12787,"totalTrials":247,"cells":12788},"Bifidobacterium Infants plus Enterococcus Feacium plus Lactobacillus Acidophilus",{"EARLY_PHASE1":12789,"PHASE1":12791,"PHASE2":12793,"PHASE3":12795,"PHASE4":12797,"NA":12799},{"trials":12790,"activeCount":100},[],{"trials":12792,"activeCount":100},[],{"trials":12794,"activeCount":100},[],{"trials":12796,"activeCount":100},[],{"trials":12798,"activeCount":100},[],{"trials":12800,"activeCount":100},[12801],{"nctId":12802,"briefTitle":12803,"status":123,"phases":12804,"primaryCompletion":7177,"completion":12805,"start":1235,"enrollment":8336,"conditions":12806,"interventions":12808},"NCT05674864","Effect of Probiotics on Eradication of Persistent H.Pylori Infection",[93],"2023-09-10",[12807],"Persistent Helicobacter Pylori Infection",[12787],{"intervention":12810,"totalTrials":247,"cells":12811},"Castor oil",{"EARLY_PHASE1":12812,"PHASE1":12814,"PHASE2":12816,"PHASE3":12818,"PHASE4":12820,"NA":12822},{"trials":12813,"activeCount":100},[],{"trials":12815,"activeCount":100},[],{"trials":12817,"activeCount":100},[],{"trials":12819,"activeCount":100},[],{"trials":12821,"activeCount":100},[],{"trials":12823,"activeCount":100},[12824],{"nctId":12825,"briefTitle":12826,"status":106,"phases":12827,"primaryCompletion":483,"completion":219,"start":8812,"enrollment":12828,"conditions":12829,"interventions":12831},"NCT05723900","Evaluation of Pulp Response to Castor Oil",[93],31,[12830],"Pulp Response to Castor Oil",[12810,12832],"Formocresol",{"intervention":12832,"totalTrials":247,"cells":12834},{"EARLY_PHASE1":12835,"PHASE1":12837,"PHASE2":12839,"PHASE3":12841,"PHASE4":12843,"NA":12845},{"trials":12836,"activeCount":100},[],{"trials":12838,"activeCount":100},[],{"trials":12840,"activeCount":100},[],{"trials":12842,"activeCount":100},[],{"trials":12844,"activeCount":100},[],{"trials":12846,"activeCount":100},[12847],{"nctId":12825,"briefTitle":12826,"status":106,"phases":12848,"primaryCompletion":483,"completion":219,"start":8812,"enrollment":12828,"conditions":12849,"interventions":12850},[93],[12830],[12810,12832],{"intervention":9671,"totalTrials":247,"cells":12852},{"EARLY_PHASE1":12853,"PHASE1":12855,"PHASE2":12857,"PHASE3":12859,"PHASE4":12861,"NA":12863},{"trials":12854,"activeCount":100},[],{"trials":12856,"activeCount":100},[],{"trials":12858,"activeCount":100},[],{"trials":12860,"activeCount":100},[],{"trials":12862,"activeCount":100},[],{"trials":12864,"activeCount":100},[12865],{"nctId":9665,"briefTitle":9666,"status":106,"phases":12866,"primaryCompletion":9668,"completion":9668,"start":7177,"enrollment":171,"conditions":12867,"interventions":12868},[93],[15,281,1382,4100,24,1082],[281,9671],{"intervention":4215,"totalTrials":247,"cells":12870},{"EARLY_PHASE1":12871,"PHASE1":12873,"PHASE2":12875,"PHASE3":12877,"PHASE4":12879,"NA":12881},{"trials":12872,"activeCount":100},[],{"trials":12874,"activeCount":100},[],{"trials":12876,"activeCount":100},[],{"trials":12878,"activeCount":100},[],{"trials":12880,"activeCount":100},[],{"trials":12882,"activeCount":100},[12883],{"nctId":4208,"briefTitle":4209,"status":106,"phases":12884,"primaryCompletion":4211,"completion":4211,"start":4212,"enrollment":1618,"conditions":12885,"interventions":12886},[93],[201,508,372,509,35],[201,4215],{"intervention":12888,"totalTrials":247,"cells":12889},"Crystalloid and blood as resuscitation",{"EARLY_PHASE1":12890,"PHASE1":12892,"PHASE2":12894,"PHASE3":12896,"PHASE4":12898,"NA":12900},{"trials":12891,"activeCount":100},[],{"trials":12893,"activeCount":100},[],{"trials":12895,"activeCount":100},[],{"trials":12897,"activeCount":100},[],{"trials":12899,"activeCount":100},[],{"trials":12901,"activeCount":100},[12902],{"nctId":12903,"briefTitle":12904,"status":106,"phases":12905,"primaryCompletion":10882,"completion":9340,"start":10882,"enrollment":197,"conditions":12906,"interventions":12908},"NCT07053163","Low Dose of Norepinephrine Within 24-Hour Mortality in Traumatic Patient With Hemorrhagic Shock",[93],[12907,11096],"Mortality Rate",[12888,12909],"crystalloid, blood and low dose of norepinephrine",{"intervention":12909,"totalTrials":247,"cells":12911},{"EARLY_PHASE1":12912,"PHASE1":12914,"PHASE2":12916,"PHASE3":12918,"PHASE4":12920,"NA":12922},{"trials":12913,"activeCount":100},[],{"trials":12915,"activeCount":100},[],{"trials":12917,"activeCount":100},[],{"trials":12919,"activeCount":100},[],{"trials":12921,"activeCount":100},[],{"trials":12923,"activeCount":100},[12924],{"nctId":12903,"briefTitle":12904,"status":106,"phases":12925,"primaryCompletion":10882,"completion":9340,"start":10882,"enrollment":197,"conditions":12926,"interventions":12927},[93],[12907,11096],[12888,12909],{"intervention":1136,"totalTrials":247,"cells":12929},{"EARLY_PHASE1":12930,"PHASE1":12932,"PHASE2":12934,"PHASE3":12936,"PHASE4":12938,"NA":12940},{"trials":12931,"activeCount":100},[],{"trials":12933,"activeCount":100},[],{"trials":12935,"activeCount":100},[],{"trials":12937,"activeCount":100},[],{"trials":12939,"activeCount":100},[],{"trials":12941,"activeCount":100},[12942],{"nctId":1129,"briefTitle":1130,"status":106,"phases":12943,"primaryCompletion":656,"completion":368,"start":1067,"enrollment":1132,"conditions":12944,"interventions":12945},[93],[1134],[1099,1136,1136,1136,431],{"intervention":12947,"totalTrials":247,"cells":12948},"Group I: Patients will receive norepinephrine \u003C0.15 µg\u002Fkg\u002Fmin",{"EARLY_PHASE1":12949,"PHASE1":12951,"PHASE2":12953,"PHASE3":12955,"PHASE4":12957,"NA":12959},{"trials":12950,"activeCount":100},[],{"trials":12952,"activeCount":100},[],{"trials":12954,"activeCount":100},[],{"trials":12956,"activeCount":100},[],{"trials":12958,"activeCount":100},[],{"trials":12960,"activeCount":100},[12961],{"nctId":12962,"briefTitle":12963,"status":106,"phases":12964,"primaryCompletion":9003,"completion":9003,"start":9341,"enrollment":128,"conditions":12965,"interventions":12968},"NCT07330908","Different Norepinephrine Doses on Accuracy of Peripheral Perfusion Index in Predicting Tissue Perfusion in Septic Shock Patients",[93],[12966,12967],"Septic Shock","Peripheral Perfusion Index",[12947,12969],"Group II: Patients will receive norepinephrine ≥ 0.15 µg\u002Fkg\u002Fmin",{"intervention":12969,"totalTrials":247,"cells":12971},{"EARLY_PHASE1":12972,"PHASE1":12974,"PHASE2":12976,"PHASE3":12978,"PHASE4":12980,"NA":12982},{"trials":12973,"activeCount":100},[],{"trials":12975,"activeCount":100},[],{"trials":12977,"activeCount":100},[],{"trials":12979,"activeCount":100},[],{"trials":12981,"activeCount":100},[],{"trials":12983,"activeCount":100},[12984],{"nctId":12962,"briefTitle":12963,"status":106,"phases":12985,"primaryCompletion":9003,"completion":9003,"start":9341,"enrollment":128,"conditions":12986,"interventions":12987},[93],[12966,12967],[12947,12969],{"intervention":12989,"totalTrials":247,"cells":12990},"Fluid and Catheter Treatment Trial \"FACTT Lite\"",{"EARLY_PHASE1":12991,"PHASE1":12993,"PHASE2":12995,"PHASE3":12997,"PHASE4":12999,"NA":13001},{"trials":12992,"activeCount":100},[],{"trials":12994,"activeCount":100},[],{"trials":12996,"activeCount":100},[],{"trials":12998,"activeCount":100},[],{"trials":13000,"activeCount":100},[],{"trials":13002,"activeCount":100},[13003],{"nctId":13004,"briefTitle":13005,"status":106,"phases":13006,"primaryCompletion":940,"completion":13007,"start":13008,"enrollment":157,"conditions":13009,"interventions":13013},"NCT04219150","Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome Patients",[93],"2021-02-20","2020-01-10",[13010,13011,13012],"ARDS","Fluid Management","Cardiometry",[12989],{"intervention":13015,"totalTrials":247,"cells":13016},"Intra-articular Ozone and corticosteroids",{"EARLY_PHASE1":13017,"PHASE1":13019,"PHASE2":13021,"PHASE3":13023,"PHASE4":13025,"NA":13027},{"trials":13018,"activeCount":100},[],{"trials":13020,"activeCount":100},[],{"trials":13022,"activeCount":100},[],{"trials":13024,"activeCount":100},[],{"trials":13026,"activeCount":100},[],{"trials":13028,"activeCount":100},[13029],{"nctId":13030,"briefTitle":13031,"status":106,"phases":13032,"primaryCompletion":1895,"completion":1895,"start":12781,"enrollment":171,"conditions":13033,"interventions":13037},"NCT05837494","Intra Articular Injection of Ozone With Corticosteroids vs PRGF in Knee Osteoarthritis",[93],[13034,13035,13036,487],"Intra Articular Injection","Corticosteroids","Plasma Rich in Growth Factors",[13015,13038],"intra-articular PRGF Method",{"intervention":13038,"totalTrials":247,"cells":13040},{"EARLY_PHASE1":13041,"PHASE1":13043,"PHASE2":13045,"PHASE3":13047,"PHASE4":13049,"NA":13051},{"trials":13042,"activeCount":100},[],{"trials":13044,"activeCount":100},[],{"trials":13046,"activeCount":100},[],{"trials":13048,"activeCount":100},[],{"trials":13050,"activeCount":100},[],{"trials":13052,"activeCount":100},[13053],{"nctId":13030,"briefTitle":13031,"status":106,"phases":13054,"primaryCompletion":1895,"completion":1895,"start":12781,"enrollment":171,"conditions":13055,"interventions":13056},[93],[13034,13035,13036,487],[13015,13038],{"intervention":13058,"totalTrials":247,"cells":13059},"methylprednisolone acetate and lidocaine",{"EARLY_PHASE1":13060,"PHASE1":13062,"PHASE2":13064,"PHASE3":13066,"PHASE4":13068,"NA":13070},{"trials":13061,"activeCount":100},[],{"trials":13063,"activeCount":100},[],{"trials":13065,"activeCount":100},[],{"trials":13067,"activeCount":100},[],{"trials":13069,"activeCount":100},[],{"trials":13071,"activeCount":100},[13072],{"nctId":13073,"briefTitle":13074,"status":123,"phases":13075,"primaryCompletion":13076,"completion":13076,"start":13077,"enrollment":438,"conditions":13078,"interventions":13080},"NCT05914350","Comparison Between Ultrasound Guided Ozone, Platelet-Rich Plasma or Steroid Injection in the Treatment of Sacroiliitis; a Randomized Double Blinded Controlled Study",[93],"2025-03-23","2023-06-23",[13079],"the Efficacy of Ultrasound Guided Sacroiliac Injection of Ozone, Platelet Rich Plasma (PRP) or Steroid for Treatment of Sacroiliitis",[13058,13081,13082],"PRP and lidocaine","medical ozone",{"intervention":13081,"totalTrials":247,"cells":13084},{"EARLY_PHASE1":13085,"PHASE1":13087,"PHASE2":13089,"PHASE3":13091,"PHASE4":13093,"NA":13095},{"trials":13086,"activeCount":100},[],{"trials":13088,"activeCount":100},[],{"trials":13090,"activeCount":100},[],{"trials":13092,"activeCount":100},[],{"trials":13094,"activeCount":100},[],{"trials":13096,"activeCount":100},[13097],{"nctId":13073,"briefTitle":13074,"status":123,"phases":13098,"primaryCompletion":13076,"completion":13076,"start":13077,"enrollment":438,"conditions":13099,"interventions":13100},[93],[13079],[13058,13081,13082],{"intervention":13082,"totalTrials":247,"cells":13102},{"EARLY_PHASE1":13103,"PHASE1":13105,"PHASE2":13107,"PHASE3":13109,"PHASE4":13111,"NA":13113},{"trials":13104,"activeCount":100},[],{"trials":13106,"activeCount":100},[],{"trials":13108,"activeCount":100},[],{"trials":13110,"activeCount":100},[],{"trials":13112,"activeCount":100},[],{"trials":13114,"activeCount":100},[13115],{"nctId":13073,"briefTitle":13074,"status":123,"phases":13116,"primaryCompletion":13076,"completion":13076,"start":13077,"enrollment":438,"conditions":13117,"interventions":13118},[93],[13079],[13058,13081,13082],{"intervention":13120,"totalTrials":247,"cells":13121},"sedative",{"EARLY_PHASE1":13122,"PHASE1":13124,"PHASE2":13126,"PHASE3":13128,"PHASE4":13130,"NA":13132},{"trials":13123,"activeCount":100},[],{"trials":13125,"activeCount":100},[],{"trials":13127,"activeCount":100},[],{"trials":13129,"activeCount":100},[],{"trials":13131,"activeCount":100},[],{"trials":13133,"activeCount":100},[13134],{"nctId":13135,"briefTitle":13136,"status":123,"phases":13137,"primaryCompletion":401,"completion":401,"start":1409,"enrollment":184,"conditions":13138,"interventions":13142},"NCT05619965","Awake Endotracheal Intubation in Cervical Injury",[93],[13139,13140,13141],"Trauma","Patient Satisfaction","Airway Morbidity",[13120],{"intervention":13144,"totalTrials":247,"cells":13145},"Intraoperative Dexmedetomidine",{"EARLY_PHASE1":13146,"PHASE1":13148,"PHASE2":13150,"PHASE3":13152,"PHASE4":13154,"NA":13156},{"trials":13147,"activeCount":100},[],{"trials":13149,"activeCount":100},[],{"trials":13151,"activeCount":100},[],{"trials":13153,"activeCount":100},[],{"trials":13155,"activeCount":100},[],{"trials":13157,"activeCount":100},[13158],{"nctId":13159,"briefTitle":13160,"status":106,"phases":13161,"primaryCompletion":13162,"completion":13162,"start":13163,"enrollment":171,"conditions":13164,"interventions":13167},"NCT06352593","Intraoperative Dexmedetomidine Infusion in Endovascular Intervention for Aneurysmal Subarachnoid Hemorrhage",[93],"2025-10-22","2024-04-06",[15,406,13165,13166],"Endovascular","Aneurysmal Subarachnoid Hemorrhage",[13144],{"intervention":489,"totalTrials":247,"cells":13169},{"EARLY_PHASE1":13170,"PHASE1":13172,"PHASE2":13174,"PHASE3":13176,"PHASE4":13178,"NA":13180},{"trials":13171,"activeCount":100},[],{"trials":13173,"activeCount":100},[],{"trials":13175,"activeCount":100},[],{"trials":13177,"activeCount":100},[],{"trials":13179,"activeCount":100},[],{"trials":13181,"activeCount":100},[13182],{"nctId":479,"briefTitle":480,"status":106,"phases":13183,"primaryCompletion":482,"completion":482,"start":483,"enrollment":197,"conditions":13184,"interventions":13185},[93],[485,455,486,15,35,487],[455,489,15],{"intervention":12506,"totalTrials":247,"cells":13187},{"EARLY_PHASE1":13188,"PHASE1":13190,"PHASE2":13192,"PHASE3":13194,"PHASE4":13196,"NA":13198},{"trials":13189,"activeCount":100},[],{"trials":13191,"activeCount":100},[],{"trials":13193,"activeCount":100},[],{"trials":13195,"activeCount":100},[],{"trials":13197,"activeCount":100},[],{"trials":13199,"activeCount":100},[13200],{"nctId":13201,"briefTitle":13202,"status":106,"phases":13203,"primaryCompletion":13204,"completion":13205,"start":13206,"enrollment":769,"conditions":13207,"interventions":13210},"NCT04554615","Intensive Insulin Therapy as Therapeutic Strategy for Non-diabetic Hyperglycemia After Surgery in ICU",[93],"2018-03-03","2018-06-10","2017-09-14",[13208,1013,13209],"Hyperglycemia","Insulin Resistance",[12506],{"intervention":13212,"totalTrials":247,"cells":13213},"IVF\u002FICSI",{"EARLY_PHASE1":13214,"PHASE1":13216,"PHASE2":13218,"PHASE3":13220,"PHASE4":13222,"NA":13224},{"trials":13215,"activeCount":100},[],{"trials":13217,"activeCount":100},[],{"trials":13219,"activeCount":100},[],{"trials":13221,"activeCount":100},[],{"trials":13223,"activeCount":100},[],{"trials":13225,"activeCount":100},[13226],{"nctId":13227,"briefTitle":13228,"status":106,"phases":13229,"primaryCompletion":238,"completion":238,"start":13230,"enrollment":2055,"conditions":13231,"interventions":13233},"NCT03476759","Laparoscopic Tubal Adhesiolysis Versus IVF-ICSI",[93],"2018-05-01",[13232],"Tubal Factor Infertility",[13212],{"intervention":10111,"totalTrials":247,"cells":13235},{"EARLY_PHASE1":13236,"PHASE1":13238,"PHASE2":13240,"PHASE3":13242,"PHASE4":13244,"NA":13246},{"trials":13237,"activeCount":100},[],{"trials":13239,"activeCount":100},[],{"trials":13241,"activeCount":100},[],{"trials":13243,"activeCount":100},[],{"trials":13245,"activeCount":100},[],{"trials":13247,"activeCount":100},[13248],{"nctId":10105,"briefTitle":10106,"status":106,"phases":13249,"primaryCompletion":1822,"completion":1822,"start":4345,"enrollment":1510,"conditions":13250,"interventions":13251},[93],[3318],[10110,10111],{"intervention":4326,"totalTrials":247,"cells":13253},{"EARLY_PHASE1":13254,"PHASE1":13256,"PHASE2":13258,"PHASE3":13260,"PHASE4":13262,"NA":13264},{"trials":13255,"activeCount":100},[],{"trials":13257,"activeCount":100},[],{"trials":13259,"activeCount":100},[],{"trials":13261,"activeCount":100},[],{"trials":13263,"activeCount":100},[],{"trials":13265,"activeCount":100},[13266],{"nctId":4318,"briefTitle":4319,"status":106,"phases":13267,"primaryCompletion":4321,"completion":4321,"start":4322,"enrollment":274,"conditions":13268,"interventions":13269},[93],[4298,113,4324],[4265,4326],{"intervention":13271,"totalTrials":247,"cells":13272},"Tumescent local anesthesia",{"EARLY_PHASE1":13273,"PHASE1":13275,"PHASE2":13277,"PHASE3":13279,"PHASE4":13281,"NA":13283},{"trials":13274,"activeCount":100},[],{"trials":13276,"activeCount":100},[],{"trials":13278,"activeCount":100},[],{"trials":13280,"activeCount":100},[],{"trials":13282,"activeCount":100},[],{"trials":13284,"activeCount":100},[13285],{"nctId":13286,"briefTitle":13287,"status":106,"phases":13288,"primaryCompletion":13289,"completion":13289,"start":13290,"enrollment":171,"conditions":13291,"interventions":13294},"NCT04425447","Thoracic Interfascial Plane Block Versus Thoracic Paravertebral Block in Gynecomastia Surgery",[93],"2021-12-31","2020-06-20",[13292,13293,7266,1363],"Gynecomastia","Thoracic Interfascial Plane Block",[13271,13295,13296],"Thoracic paravertebral block","Thoracic interfascial plane block",{"intervention":13295,"totalTrials":247,"cells":13298},{"EARLY_PHASE1":13299,"PHASE1":13301,"PHASE2":13303,"PHASE3":13305,"PHASE4":13307,"NA":13309},{"trials":13300,"activeCount":100},[],{"trials":13302,"activeCount":100},[],{"trials":13304,"activeCount":100},[],{"trials":13306,"activeCount":100},[],{"trials":13308,"activeCount":100},[],{"trials":13310,"activeCount":100},[13311],{"nctId":13286,"briefTitle":13287,"status":106,"phases":13312,"primaryCompletion":13289,"completion":13289,"start":13290,"enrollment":171,"conditions":13313,"interventions":13314},[93],[13292,13293,7266,1363],[13271,13295,13296],{"intervention":13296,"totalTrials":247,"cells":13316},{"EARLY_PHASE1":13317,"PHASE1":13319,"PHASE2":13321,"PHASE3":13323,"PHASE4":13325,"NA":13327},{"trials":13318,"activeCount":100},[],{"trials":13320,"activeCount":100},[],{"trials":13322,"activeCount":100},[],{"trials":13324,"activeCount":100},[],{"trials":13326,"activeCount":100},[],{"trials":13328,"activeCount":100},[13329],{"nctId":13286,"briefTitle":13287,"status":106,"phases":13330,"primaryCompletion":13289,"completion":13289,"start":13290,"enrollment":171,"conditions":13331,"interventions":13332},[93],[13292,13293,7266,1363],[13271,13295,13296],{"intervention":4153,"totalTrials":247,"cells":13334},{"EARLY_PHASE1":13335,"PHASE1":13337,"PHASE2":13339,"PHASE3":13341,"PHASE4":13343,"NA":13345},{"trials":13336,"activeCount":100},[],{"trials":13338,"activeCount":100},[],{"trials":13340,"activeCount":100},[],{"trials":13342,"activeCount":100},[],{"trials":13344,"activeCount":100},[],{"trials":13346,"activeCount":100},[13347],{"nctId":4143,"briefTitle":4144,"status":123,"phases":13348,"primaryCompletion":4146,"completion":4146,"start":4147,"enrollment":4148,"conditions":13349,"interventions":13350},[93],[4150,4151],[243,52,1030,62,4153],{"intervention":13352,"totalTrials":247,"cells":13353},"Pentoxifylline 400 mg SR",{"EARLY_PHASE1":13354,"PHASE1":13356,"PHASE2":13358,"PHASE3":13360,"PHASE4":13362,"NA":13364},{"trials":13355,"activeCount":100},[],{"trials":13357,"activeCount":100},[],{"trials":13359,"activeCount":100},[],{"trials":13361,"activeCount":100},[],{"trials":13363,"activeCount":100},[],{"trials":13365,"activeCount":100},[13366],{"nctId":13367,"briefTitle":13368,"status":106,"phases":13369,"primaryCompletion":13370,"completion":13370,"start":13371,"enrollment":171,"conditions":13372,"interventions":13374},"NCT05640817","Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer",[93],"2026-01-20","2023-01-10",[13373],"Pentoxifylline, Cisplatin, Nephrotoxixcity",[13352,13375],"cisplatin with standard hydration with normal saline",{"intervention":13375,"totalTrials":247,"cells":13377},{"EARLY_PHASE1":13378,"PHASE1":13380,"PHASE2":13382,"PHASE3":13384,"PHASE4":13386,"NA":13388},{"trials":13379,"activeCount":100},[],{"trials":13381,"activeCount":100},[],{"trials":13383,"activeCount":100},[],{"trials":13385,"activeCount":100},[],{"trials":13387,"activeCount":100},[],{"trials":13389,"activeCount":100},[13390],{"nctId":13367,"briefTitle":13368,"status":106,"phases":13391,"primaryCompletion":13370,"completion":13370,"start":13371,"enrollment":171,"conditions":13392,"interventions":13393},[93],[13373],[13352,13375],{"intervention":13395,"totalTrials":247,"cells":13396},"Group K:nebulized ketamine group",{"EARLY_PHASE1":13397,"PHASE1":13399,"PHASE2":13401,"PHASE3":13403,"PHASE4":13405,"NA":13407},{"trials":13398,"activeCount":100},[],{"trials":13400,"activeCount":100},[],{"trials":13402,"activeCount":100},[],{"trials":13404,"activeCount":100},[],{"trials":13406,"activeCount":100},[],{"trials":13408,"activeCount":100},[13409],{"nctId":13410,"briefTitle":13411,"status":106,"phases":13412,"primaryCompletion":318,"completion":877,"start":13413,"enrollment":197,"conditions":13414,"interventions":13415},"NCT07564037","Nebulized Dexmedetomidine, Ketamine, or Midazolam in Children Undergoing Adenotonsillectomy",[93],"2024-11-30",[15,1114,209,409],[13395,13416,13417],"Group D:dexmedetomidine group","Group M: midazolam group",{"intervention":13416,"totalTrials":247,"cells":13419},{"EARLY_PHASE1":13420,"PHASE1":13422,"PHASE2":13424,"PHASE3":13426,"PHASE4":13428,"NA":13430},{"trials":13421,"activeCount":100},[],{"trials":13423,"activeCount":100},[],{"trials":13425,"activeCount":100},[],{"trials":13427,"activeCount":100},[],{"trials":13429,"activeCount":100},[],{"trials":13431,"activeCount":100},[13432],{"nctId":13410,"briefTitle":13411,"status":106,"phases":13433,"primaryCompletion":318,"completion":877,"start":13413,"enrollment":197,"conditions":13434,"interventions":13435},[93],[15,1114,209,409],[13395,13416,13417],{"intervention":13417,"totalTrials":247,"cells":13437},{"EARLY_PHASE1":13438,"PHASE1":13440,"PHASE2":13442,"PHASE3":13444,"PHASE4":13446,"NA":13448},{"trials":13439,"activeCount":100},[],{"trials":13441,"activeCount":100},[],{"trials":13443,"activeCount":100},[],{"trials":13445,"activeCount":100},[],{"trials":13447,"activeCount":100},[],{"trials":13449,"activeCount":100},[13450],{"nctId":13410,"briefTitle":13411,"status":106,"phases":13451,"primaryCompletion":318,"completion":877,"start":13413,"enrollment":197,"conditions":13452,"interventions":13453},[93],[15,1114,209,409],[13395,13416,13417],{"intervention":13455,"totalTrials":247,"cells":13456},"bupivacaine-calcitonin-fentanyl",{"EARLY_PHASE1":13457,"PHASE1":13459,"PHASE2":13461,"PHASE3":13463,"PHASE4":13465,"NA":13467},{"trials":13458,"activeCount":100},[],{"trials":13460,"activeCount":100},[],{"trials":13462,"activeCount":100},[],{"trials":13464,"activeCount":100},[],{"trials":13466,"activeCount":100},[],{"trials":13468,"activeCount":100},[13469],{"nctId":13470,"briefTitle":13471,"status":106,"phases":13472,"primaryCompletion":8706,"completion":229,"start":4509,"enrollment":8336,"conditions":13473,"interventions":13475},"NCT06330168","Paravertebral Calcitonin in Thoracotomy",[93],[4632,13474,509],"Paravertebral",[13455,13476],"Bupivacaine-fentanyl",{"intervention":13476,"totalTrials":247,"cells":13478},{"EARLY_PHASE1":13479,"PHASE1":13481,"PHASE2":13483,"PHASE3":13485,"PHASE4":13487,"NA":13489},{"trials":13480,"activeCount":100},[],{"trials":13482,"activeCount":100},[],{"trials":13484,"activeCount":100},[],{"trials":13486,"activeCount":100},[],{"trials":13488,"activeCount":100},[],{"trials":13490,"activeCount":100},[13491],{"nctId":13470,"briefTitle":13471,"status":106,"phases":13492,"primaryCompletion":8706,"completion":229,"start":4509,"enrollment":8336,"conditions":13493,"interventions":13494},[93],[4632,13474,509],[13455,13476],{"intervention":13496,"totalTrials":247,"cells":13497},"oral perixicam",{"EARLY_PHASE1":13498,"PHASE1":13500,"PHASE2":13502,"PHASE3":13504,"PHASE4":13506,"NA":13508},{"trials":13499,"activeCount":100},[],{"trials":13501,"activeCount":100},[],{"trials":13503,"activeCount":100},[],{"trials":13505,"activeCount":100},[],{"trials":13507,"activeCount":100},[],{"trials":13509,"activeCount":100},[13510],{"nctId":13511,"briefTitle":13512,"status":106,"phases":13513,"primaryCompletion":11414,"completion":11414,"start":13514,"enrollment":184,"conditions":13515,"interventions":13517},"NCT02382653","Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain",[93],"2014-12",[13516],"Neoplasm Metastases",[13496],{"intervention":13519,"totalTrials":247,"cells":13520},"Alcohol 30%",{"EARLY_PHASE1":13521,"PHASE1":13523,"PHASE2":13525,"PHASE3":13527,"PHASE4":13529,"NA":13531},{"trials":13522,"activeCount":100},[],{"trials":13524,"activeCount":100},[],{"trials":13526,"activeCount":100},[],{"trials":13528,"activeCount":100},[],{"trials":13530,"activeCount":100},[],{"trials":13532,"activeCount":100},[13533],{"nctId":13534,"briefTitle":13535,"status":106,"phases":13536,"primaryCompletion":13537,"completion":13537,"start":13538,"enrollment":184,"conditions":13539,"interventions":13543},"NCT06520384","Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain",[93],"2025-01-05","2024-07-25",[13540,13541,13542,487,35],"Radiofrequency","Alcohol","Genicular Nerve",[13519,13544,13545],"Alcohol 50%","Alcohol 70%",{"intervention":13544,"totalTrials":247,"cells":13547},{"EARLY_PHASE1":13548,"PHASE1":13550,"PHASE2":13552,"PHASE3":13554,"PHASE4":13556,"NA":13558},{"trials":13549,"activeCount":100},[],{"trials":13551,"activeCount":100},[],{"trials":13553,"activeCount":100},[],{"trials":13555,"activeCount":100},[],{"trials":13557,"activeCount":100},[],{"trials":13559,"activeCount":100},[13560],{"nctId":13534,"briefTitle":13535,"status":106,"phases":13561,"primaryCompletion":13537,"completion":13537,"start":13538,"enrollment":184,"conditions":13562,"interventions":13563},[93],[13540,13541,13542,487,35],[13519,13544,13545],{"intervention":13545,"totalTrials":247,"cells":13565},{"EARLY_PHASE1":13566,"PHASE1":13568,"PHASE2":13570,"PHASE3":13572,"PHASE4":13574,"NA":13576},{"trials":13567,"activeCount":100},[],{"trials":13569,"activeCount":100},[],{"trials":13571,"activeCount":100},[],{"trials":13573,"activeCount":100},[],{"trials":13575,"activeCount":100},[],{"trials":13577,"activeCount":100},[13578],{"nctId":13534,"briefTitle":13535,"status":106,"phases":13579,"primaryCompletion":13537,"completion":13537,"start":13538,"enrollment":184,"conditions":13580,"interventions":13581},[93],[13540,13541,13542,487,35],[13519,13544,13545],{"intervention":9923,"totalTrials":247,"cells":13583},{"EARLY_PHASE1":13584,"PHASE1":13586,"PHASE2":13588,"PHASE3":13590,"PHASE4":13592,"NA":13594},{"trials":13585,"activeCount":100},[],{"trials":13587,"activeCount":100},[],{"trials":13589,"activeCount":100},[],{"trials":13591,"activeCount":100},[],{"trials":13593,"activeCount":100},[],{"trials":13595,"activeCount":100},[13596],{"nctId":9917,"briefTitle":9918,"status":106,"phases":13597,"primaryCompletion":3028,"completion":9920,"start":1943,"enrollment":1886,"conditions":13598,"interventions":13599},[93],[1414,27,1412],[9923,9924]]